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P679
Comparison of cytomegalovirus viral load
measured by real-time PCR with pp65
antigenemia for the diagnosis of cytomegalovirus
disease in solid organ transplant recipients
S. Hernando, M.D. Folgueira, C. Lumbfreras, J.R. Otero (Madrid,
ES)
Objectives: Cytomegalovirus (CMV) infection is an important
cause of morbidity in solid organ transplant (SOT) recipients.
Currently, the antigenemia assay is widely used to detect this
infection, although its success is being questioned to a great
extent nowadays. The aim of our study is to compare a
quantitative real-time PCR to measure CMV DNA to the
antigenemia assay, for the diagnosis of CMV disease.
Methods: We prospectively processed 1198 samples (plasma
and peripheral blood leukocytes, PBMC), which belonged to 158
SOT recipients (52 liver, 89 kidney and 17 heart). After
transplantation the samples were collected weekly during the
ﬁrst month, fortnightly during the second month, and then once
a month and any time when was clinically indicated. In every
sample the detection of the pp65 antigen in PBMC was carried
out, as well as the quantiﬁcation of CMV DNA by real-time PCR
(Light Cycler, LC-PCR). For this process, FRET probes, which
detect a 254 pb fragment from the CMV gB gene, were used. The
dynamic range of the LC-PCR was 500–5.107 copies/ml plasma
and from 62 to 6106 copies/106 PBMC.
Results: The antigenemia assay detected 15.78% (189 out of
1198) positive samples, plasma LC-PCR 18.28% (219 out of 1198)
and PBMC LC-PCR 19.53% (234 out of 1198). The antigenemia
assay detected 25 positive samples from 21 patients with LC-
PCR negative; these patients were asymptomatic and the levels
of antigenemia were below 15 cells/2 · 105. Of the 158 SOT
patients, 22 (13.9%) developed CMV disease. All these patients
had CMV DNA load detected by LC-PCR. Nevertheless, the
antigenemia assay was negative in one patient with gastroin-
testinal CMV disease and in the only patient with relapsing
CMV disease. LC-PCR was slightly more sensitive and speciﬁc
than antigenemia assay (S: 100% versus 91%, E: 67% versus 57%,
VPP: 33.8% versus 26.5% and VPN: 100% versus 97.5%. The
peak of CMV DNA load and the levels of antigenemia in
asymptomatic patients (antigenemia: 12 cells/2 · 105, plasma
LC-PCR: <500 copies/ml and PBMC LC-PCR: <62 copies/106
cells) were signiﬁcantly lower than in symptomatic patients
(antigenemia: 112 cells/2 · 105, plasma LC-PCR: 2.5 · 104
copies/ml and PBMC LC-PCR 3.5·104 copies/106 cells.
Conclusions: Detection of CMV DNA load by LC-PCR assay
seems to be superior to the antigenemia assay in the early
diagnosis of CMV disease in SOT recipients and may be more
useful to monitor the risk of CMV disease development.
P680
Incidence of acquired toxoplasmosis in
seronegative recipients of solid organ transplant
V. Meroni, E. Zerrilli, F. Genco, B. Nocita, F. Poletti, L. Minoli
(Pavia, IT)
Objectives: The aim of this study is to evaluate the frequency of
seroconversion for toxoplasmosis in seronegative recipients (R-)
of solid organ (heart and/or lung) transplant with seronegative
(R-/D-) or seropositive donors (R-/D+). We also assess the
efﬁcacy of chemoprophylaxis with pyrimethamine + sulfameth-
opiraxine for 2 months.
Patients and methods: Sixty-three patients that were seroneg-
ative for toxoplasmosis before transplantation were followed-up
at different intervals (from 2 months to 10 years). Further, the
patients that were R(/D+ were tested at the end of chemo-
prophylaxis. All serum samples were tested for IgG and IgM
antibodies with the ELISA: ETI-TOXOK IgG, ETI-TOXOK IgM
(DiaSorin, Saluggia, Italy) and ELFA tests: VIDAS TOXO IgGII
(BioMerieux, Marcy l’Etoile, France). In all suspected serocon-
versions we also performed IgM-ISAGA and VIDAS TOXO IgG
AVIDITY test (BioMerieux Marcy l’Etoile France and ETI-
TOXOK IgA (DiaSorin Saluggia, Italy).
Results: The frequency of seroconversion was 23.8%. Six
patients out of 34 R-/D- (17.6%) without chemoprophilaxis
followed up from 2 to 177 months seroconverted. Nine out 29
R(/D+ (31.6 patients with a follow up from 2 to 166 months
seroconverted after chemoprophilaxis interruption. The differ-
ence in the number of seroconversions was not statistically
signiﬁcant (P = 0.34 Yates corrected Chi-square). In almost all
patients who seroconverted the symptoms were absent or mild.
Severe disease was only seen in a patient who was positive
before transplantation and strongly immunosuppressed when
reactivation occurred.
Conclusion: In our study, the overall frequency of seroconver-
sion was 23.8%. There was no difference between matched and
mismatched recipients as to the frequency of seroconversion,
which therefore would not be related to donor seropositivity. In
R-/D-, however, seroconversion was asymptomatic like in non-
immunosuppressed patients and occurred later than in the R-/
D+. No patients seroconverted during chemoprophilaxis.
Patients should be tested immediately before transplantation
and the donor as soon as possible, to avoid unnecessary
prophilaxis. All positive recipients should be tested if symptoms
of infection are present.
P681
Changing trends of bacteraemia in patients with
cancer: analysis of 2080 quantitative blood
cultures during 1998 and 2004
A. Safdar, G. Rodriguez, M. Balakrishnan, J. Tarrand,
K. Rolston (Houston, US)
Background: The severity of bacterial bloodstream infections
(BSI) appears to be related to quantitative bacterial levels
(organism load), especially in neutropenic cancer patients. We
sought to determine the trends in quantitative patterns of BSI
caused by various bacteria in patients receiving care at our
comprehensive cancer centre.
Methods: Only one blood culture per patient culture was
included in this retrospective analysis of all consecutive blood
cultures processed by Dupont Isolator 10 System. Low-grade
(<10 colony forming units/millilitre (CFU/ml) and intermedi-
ate-grade (11–100 CFU/ml) are grouped in low-bacterial load
(LBL); moderate-grade (101–500 CFU/ml), and high-grade
(>500 CFU/ml) were high-bacterial load (HBL) BSI.
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Results: During 1998, 73% of 1055 and 2004, 82% of 1025 BSI
were caused by gram-positive bacteria (GPB) with the most
frequent being coagulase-negative staphylococcus (CoNS), 33%
and 50% and S. aureus, 9% and 6%, respectively. In gram-
negative bacterial (GNB) BSI, Enterobacteriacae were common
(73% and 56%) followed by non-fermentative (NF)-GNB (37%
and 44%); Escherichia coli (24% and 24%) and P. areuginosa (17%
and 19%) being the most common GNB species isolated during
1998 and 2004, respectively. A signiﬁcant increase in the number
of S. maltophilia bloodstream infection was noted during 6-year
study interval (6% in 1998 vs. 16% in 2004; P < 0.01). Compared
with GPB infections a signiﬁcant proportion of GNB bacteremia
were high-grade (18% vs. 39% in 1998, and 7% vs. 44% in 2004;
P < 0.001). In contrast to 1998, in 2004 the non-Pseudomonas
NF-GNB including S. maltophilia and Acinetobacter species were
signiﬁcantly associated with HBL compared to P. areuginosa
infection (47% vs. 23%; P = 0.05). Similarly, HBL associated with
S. aureus (50%) and Streptococucs species (35%) vs. CoNS (13%;
P < 0.0001) during 1998 was not noted during 2004 (22% S.
aureus, 20% Streptococcus species vs. 21% CoNS; P > 0.5). This
was due to a signiﬁcant increase in CoNS HBL BSI in 2004 (21%
vs. 13% in 1998; P < 0.01).
Conclusions: A high proportion of GNB were HBL compared
to GPB BSI. In 2004, the overall signiﬁcant rise in S. maltophilia
bacteremia was also accompanied by more HBL infections.
P682
Infections complicating unrelated donor cord
blood stem cell transplantation: 281 episodes in
recipients of 100 CBST at a comprehensive cancer
centre (1996–2005)
A. Safdar, G. Rodriguez, K. Chan, M. DeLima, K. Rolston,
R. Champlin (Houston, US)
Background: Infections remain a serious complication in
patients undergoing allogeneic SCT. We sought to determine
infectious complications in patients receiving cord blood stem
cell transplantation (CBSCT) at our institution.
Methods: This retrospective analysis was performed after
obtaining approval from Institutional Review Board. Records
of all 97 recipients of CBSCT were evaluated using a standard-
ized data retrieval mechanism. All values are presented as
median ± s.d.
Results: Among 59 pediatric and 38 adult patients age was
7 ± 5 years and 33 ± 12 years, respectively. Ninety-four (97%)
of 97 patients had underlying haematologic malignancy, acute
lymphocytic leukaemia was common (40 [43%] of 94) followed
by acute myelogenous leukaemia (26 [28%] of 94). Myeloabla-
tive conditioning regimen was given in 40 (40%) patients;
engraftment occurred 24 ± 9 days following transplant. In 20
patients (21%) failure was either due to primary non-engraft-
ment or refractory leukaemia. Seventy percent had graft-
versus-host-diseases (GVHD), median time from transplanta-
tion and diagnosis of GVHD was 18 ± 39 post-CBSCT days.
The infections complications are shown in the table below. The
overall mortality was 66% following CBSCT (median
147 ± 214 days and range, 10–993 days), in 20 (31%) of 64
patients who died, death was associated with an infection-
related complication.
Conclusions: Interestingly, nearly a quarter of systemic bacter-
ial and viral infections were noted after 100 days post-trans-
plantation. Whereas, most systemic fungal infections in these
severely immunosuppressed patients including those with
GVHD occurred within 30 days of receiving unrelated-donor
CBSCT.
P683
A risk proﬁle for invasive aspergillosis in liver
transplant recipients
M. Rosenhagen, R. Feldhues, H.K. Geiss, T. Hoppe-Tichy
(Heidelberg, DE)
Objectives: Given the high incidence (1.5–10%) of invasive
aspergillosis (IA) after liver transplantation and the associated
mortality, prophylaxis would seem a reasonable approach. The
purpose of this investigation was to determine the inﬂuence and
signiﬁcance of risk factors for IA for patients in our transplan-
tation centre.
Methods: We analysed retrospectively all clinically relevant
data from patients who underwent liver transplantation at the
Transplantation Centre of the University Hospital Heidelberg
(Germany) between Dec 2001 and Dec 2004 by including all data
into a speciﬁcally designed data base. IA was deﬁned according
to the EORTC/BMSG criteria. Univariate analysis and logistic
regression were performed to assign the inﬂuence of each
assumed risk factor.
Results: A total of 195 liver transplantations were performed
in 170 patients, and 39 patients died within the study period.
15 patients developed IA (7.7%) and13 of these patients died
within 4 weeks after initial diagnosis of aspergillosis, which is
one third of all patients who died after liver transplantation.
Univariate signiﬁcant factors were re-transplantation
(p = 0.006), CMV-infection (p = 0.006), high urgency transplan-
tation (p = 0.024), dialysis (p = 0.001), renal insufﬁciency
(p = 0.05) and leukopenia (p = 0.002). Multivariate analysis
shows an independent inﬂuence of CMV-Infection [OR = 0.213
(95%CI 0.065–0.697)] and dialysis [OR = 0.097 (95%CI 0.024–
0.395)].
Conclusion: The investigation showed a rate of 7.7% infections,
which is within the range of published data. According to the
data, antifungal prophylaxis should be given to liver transplant
patients with renal insufﬁciency, requirement for dialysis, organ
failure and CMV–Infection to avoid IA. Furthermore an addi-
tional focus should be the prevention of CMV-infections.
P684
Antifungal prophylaxis with caspofungin in
high-risk liver transplant recipients: a non-
comparative, open-label prospective clinical trial
J. Fortun, P. Mun˜oz, J.M. Cisneros, M. Montejo, A. Ramos,
C. Sanz-Rodriguez on behalf of GESITRA
Objective: There is signiﬁcant morbidity and mortality related
to invasive fungal infections (IFI) in patients undergoing
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orthotopic liver transplant (OLT) recipients. Prevention remains
elusive, especially for IFI caused by moulds. The aim of this
study was to evaluate the efﬁcacy and safety of caspofungin as
prophylaxis for IFI in the subset of OLT recipients at high risk of
developing IFI (study sponsored by GESITRA, funded by MSD
Spain).
Methods: A prospective, non-comparative, open label trial was
conducted in adults undergoing OLT who received caspofungin
prophylaxis as soon as they met 2 of the following criteria: renal
insufﬁciency (serum creatinine >2 mg/dl) or dialysis, retrans-
plantation, fungal colonization, high transfusion requirements,
biliodigestive anastomosis or reintervention. Caspofungin ther-
apy (70-mg load followed by 50 mg daily) typically continued
for a maximum of 21 days or until patient met a predeﬁned
endpoint. A successful treatment outcome was deﬁned as the
absence of breakthrough IFI (proven or probable per EORTC/
MSG criteria) during the ﬁrst 100 days after the onset of
caspofungin in the absence of premature discontinuation of
prophylaxis because of toxicity or lack of efﬁcacy.
Results: An interim analysis was performed on the ﬁrst 15
patients enrolled in the study (enrollment target: 70 patients).
No IFI was seen during caspofungin therapy or during the
predeﬁned 100-day follow-up period post-discontinuation of
study therapy. One (7%) patient experienced a Candida surgical
wound infection with no histopathological evidence of invasive
infection. Thus, the overall incidence of documented IFI was 0/
15 (0%). Neither patient developed a possible IFI. Six (40%)
patients had to lower the dose of caspofungin to 35 mg daily
and 2 patients interrupted prophylaxis transiently due to OLT-
related altered liver function tests. Caspofungin-related adverse
events were only reported in one (7%) patient with increasing
serum amino transferase levels which led to caspofungin
discontinuation after 16 days of therapy. Caspofungin was
otherwise well tolerated. Patient survival at 100 days post-
discontinuation of caspofungin was 80% (12/15). Three patients
died because of caspofungin-unrelated, OLT-related complica-
tions. Overall, the favourable response rate was 93% (14/15).
Conclusion: The results of this interim analysis suggest prom-
ise for the prophylactic use of intravenous caspofungin in high
risk OLT recipients.
P685
Effect of quinolone prophylaxis on resistance in
afebrile neutropenic patients – systematic review
A. Gafter-Gvili, M. Paul, A. Fraser, L. Leibovici (Petah Tikva, IL)
Objectives: To evaluate the effect of quinolone prophylaxis on
emergence of resistant bacteria in neutropenic patients following
chemotherapy for malignancies.
Methods: Systematic review and meta-analysis including rand-
omized controlled trials (RCTs) comparing quinolone prophy-
laxis with placebo or no intervention (control), or another
antibiotic, to prevent bacterial infections in afebrile neutropenic
patients. Search was conducted until 2005. Outcomes assessed
were incidence of colonizing resistant bacteria at baseline,
during treatment and at the end of prophylactic therapy and
incidence of resistant bacteria causing infection at the end of the
study period. Relative risks (RR) with 95% conﬁdence intervals
(CIs) were estimated and pooled.
Results: Our search yielded 57 trials; 22 compared quinolones
to control and 35 compared quinolones to other antibiotics. Data
on colonization resistance could be extracted from 28 trials
(48%), since only these trials conducted microbiological surveil-
lance. When compared to control, there was a statistically
nonsigniﬁcant increase in resistant colonizing bacteria (RR 1.68;
95% CI 0.71–4.0). In trials comparing quinolones to trimetho-
prim-sulfamethoxazole (TMP-SMZ), quinolones caused less
development of colonizing resistant bacteria to quinolones in
the quinolone arm than TMP-SMZ in the TMP-SMZ arm (RR
0.52; 95% CI 0.39–0.69). Data on baseline resistance of colonizing
isolates to quinolones and colonization resistance during the
trial were too scarce to analyse. When quinolone treatment was
compared to control, there was no difference in the number of
patients developing infections with resistant pathogens (RR 1.04;
95% CI 0.73–1.5, Figure).
Conclusions: Our systematic review shows that patients treated
with quinolones may develop more colonizing resistant bacteria,
compared to control. There is no difference in the number of
infections resistant to quinolones. As overall mortality is
reduced by quinolone prophylaxis, the danger of resistant
organisms is probably much smaller than the gain. Less than
half of the trials included in the review conducted microbiolo-
gical surveillance and only a few reported baseline resistance to
quinolones. Centres implementing antibiotic prophylaxis and
future trials should assess resistance development more rigor-
ously.
P686
The complications associated with use of
peripherally inserted central catheters in cancer
patients in Northern Ireland
R. McMullan, V. Coyle, R. Wilson, S. Hedderwick (Belfast, UK)
Objectives: In view of the increasing use of peripherally
inserted central catheters (PICC) for venous access among
several populations, including cancer patients, it is valuable to
continuously review adverse outcomes associated with their
use. We aim to describe the complications attributable to
PICC use, up to 12 months following insertion, among adult
patients receiving treatment for solid tumours in Northern
Ireland.
Methods: A retrospective review was conducted of computer-
ised and paper records of all patients who had a PICC inserted
by the specialist PICC team in a regional cancer centre in Belfast
between 01 January 2003 and 31 December 2003. Outcomes,
complications, fate of PICCs and reinsertion events were
followed for 12 months for all patients included. Disease and
complication deﬁnitions used were based on clinical diagnoses
made by the specialist PICC team based on clinical presentation,
radiological, histological and laboratory ﬁndings.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Results: During the deﬁned period, 189 patients had a PICC
placed. This group had mean age of 55 years (range 20–84); 124
(66%) were female. The most common primary tumour sites
were upper gastrointestinal (n = 45, 24%), lower gastrointestinal
(n = 45, 24%) and breast (n = 40, 21%). Sixty-eight patients
(36%) had complications associated with the PICC; 42 (22%)
underwent PICC removal as a result of these complications, 25
of whom required a new PICC to be placed. The most commonly
observed complications were regression (lengthening) of the
PICC (n = 19, 10%), exit-site infection (n = 14, 7%), mechanical
phlebitis (n = 9, 5%) and systemic infection (n = 8, 4%). By the
end of the follow-up period, 95 (50%) of patients had survived,
89 (47%) had died as a result of malignancy and 3 (2%) had died
of other causes. Of note, none died as a direct result of PICC
complications.
Conclusions: PICC use in this population appears to be a
relatively safe access means, with no attributable mortality. The
infection rate was lower than is often observed with other access
devices and few complications, overall, were serious.
P687
Prospective study of viral infection and
nephropathy in paediatric renal transplant
recipients
L. Murer, M. De Pieri, L. Barzon, M. Pacenti, M.A. Biasolo,
C. Mengoli, M. Della Vella, C. Carasi, G. Montini, G. Zacchello,
G. Palu` (Padua, IT)
Objectives: Viruses with renal tropism, such as BKV and
parvovirus B19, have been associated with allograft nephropa-
thy, but the role of viral infection in acute rejection and
posttransplant chronic nephopathy is controversial. Aim of the
study was to prospectively investigate the prevalence of viral
sequences in kidney biopsies obtained from a series of children
submitted to kidney transplantation in the period 2000–2004 in a
Single Centre. Virological data were correlated with clinical and
histological ﬁndings.
Methods: Biopsies were performed because of renal dysfunc-
tion in 8 patients or for follow-up observation at 1 year after
transplantation (T1) in 53 patients. Samples were analysed for
the presence of DNA of EBV, CMV, HHV6, HHV8, BKV, and
parvovirus B19 by a sensitive real-time PCR technique and the
results were correlated with histological analysis, performed
according to the Banff 97 guidelines. Patients (26 females and 27
males, mean recipient/donor age 12.1 ± 8.3/11.9 ± 5.3 years)
received immunosuppressive therapy consisting in basiliximab,
steroids, cyclosporin, MMF during the ﬁrst 6 months after
transplantation, followed by basiliximab, steroids, and
FK506 ± MMF. Mean follow-up period was 27.2 ± 6 months.
Results: Viral DNA was detected in 5 out of 8 biopsies from
children with allograft dysfunction, including 2 cases of BKV
infection associated with tubulo-interstitial nephropathy, 3 case
of parvovirus B19 infection associated with thrombotic micro-
angiopathy, acute vascular rejection, and chronic nephropathy,
respectively. Fifty out of the 53 T1 biopsies were suitable for
histological and virological analyses. Viral sequences were
detected in 29 out of 50 specimens (15 HHV6, 12 parvovirus
B19, 3 CMV, 9 BKV, 10 EBV). No signiﬁcant differences in the
prevalence of viral DNA sequences and type of viral infection
were observed among cases with normal histology (20/34,
58%), acute or borderline rejection (2/3, 66%), or chronic
nephropathy (7/13, 53%). Kidney function at 1 and 2 years
post-transplantation was not signiﬁcantly different between
patients with positive virological results and those with
negative biopsies.
Conclusions: In our series, parvovirus B19 e BKV are associated
with posttransplant nephropathy and virus-associated nephro-
pathies are the most common causes of renal dysfunction at 1-
year following transplantation.
P688
Trend towards reduced burden of proven/
probable invasive fungal infections in adult
non-allo-HSCT neutropenic patients with acute
leukemia
L. Senn, T. Calandra, J. Robinson, O. Marchetti (Lausanne, CH)
Background: In leukemic patients invasive fungal infections
(IFI) are associated with severe morbidity and high mortality
(30–90%). Moreover, IFI may have a negative impact on
treatment and outcome of leukemia. Recent progresses in
diagnosis and management of IFI may have improved outcome.
Objectives: To evaluate the morbidity and mortality of proven/
probable IFI in adult non-allo-HSCT neutropenic patients with
acute leukemia.
Methods: Clinical, radiological, and laboratory data were pro-
spectively collected in consecutive neutropenic patients with
acute leukemia (2002–2005). Antifungal prophylaxis was not
used routinely. IFI were classiﬁed as proven, probable, or
possible (EORTC-BAMSG). Proven/probable IFI cases were
compared to controls (no IFI).
Results: 157 neutropenic episodes (71 induction chemotherapy,
64 consolidation, 2 auto-HSCT) occurred in 86 patients (73 AML,
13 ALL). Median age was 57 yr. (range 19–77). IFI was proven/
probable in 26 cases (14 aspergillosis, 14 candidiasis, including 2
mixed IFI) and possible in 28. Proven/probable IFI occurred
during induction chemotherapy in 69% of cases. At admission
neutropenia was present in 50% of IFI cases compared to only
18% of controls (p < 0.05). Median days of in-hospital neutro-
penia were 25 (range 16–71) vs. 20 (range 7–59), respectively
(p < 0.05). Antifungal therapy was started after a median of
3 days (range 0–13) after fever onset. Initial antifungal therapy
consisted of ampho B-deoxycholate (n = 16), voriconazole
(n = 5), caspofungin (n = 3), ﬂuconazole (n = 2). Criteria for
proven/probable IFI were met a median of 12 days (range 1–51)
after fever onset. Morbidity and mortality in IFI cases and
controls are shown in Table 1.
Conclusions: In adult non-allo-HSCT patients with acute
leukemia and neutropenia, proven/probable IFI were associated
with moderate morbidity (low rate of ICU admission, minimal
delay of initiation of next chemotherapy) and low attributable
mortality (4%) despite prolongation of hospital stay, suggesting
a trend towards reduced burden of IFI.
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P689
Prevalence of HHV6 and parvovirus B19 in
transplant recipients liver tissue: clinical
outcomes and viral correlates
S.G. Parisi, S. Barbieri, C. Boldrin, P. Boccagni, M.A. Biasolo,
P. Feltracco, U. Cillo, A. Bortolato, I. Cerbaro, D. D’Amico,
G. Palu` (Padua, IT)
Objectives: To evaluate prevalence and correlates of HHV6 and
Parvovirus B19 (B19) infection in liver and blood from patients
(pt) undergoing to liver transplant.
Methods: HHV6-DNA and B19-DNA were investigated in liver
biopsies (LBP) and peripheral blood mononuclear cells (PBMC)
of 30 pts at time of liver transplantation. Viral copy number
were calculated out of 106 LPB-cells or PBMCs; cell number was
evaluated by detection of beta-globin gene by an in-house
method, using a Real Time technique (ABI Prism 7900). All pts
were studied during follow up (FU); 2 pts were re-transplanted.
Results: HHV6 was found in LBPs in 22 out of 30 pts (73%) with
a wide range of amount (6–29728 copies/106 cells). 27% out of 30
pts were concordant negative in PBMCs, 17% were concordant
positive, but in 56% HHV6 was found only in liver tissue; no
correlation among LBPs and PBMCs viral content was found.
B19 was detected in 5 out of 30 LBPs (17%), always in
association with various amount of HHV6. No correlation was
found with HbsAg, HBV-DNA and HCV positivity. CMV-pp65
antigenemia was positive in 5 pts, HHV6 all positive too. During
an 8 month FU (median, range 1–15) 7 pts died, 2 HHV6 LBP-
negative and 5 LBP-positive. 2 Pts underwent to re-transplan-
tation. The ﬁrst pt was HHV6 LBP-positive (38 cps) at the time
of transplant, LBP-positive (131 cps) at the 2 transplant, and
always PBMCs-negative; also PBMCs from donors were always
negative. He developed liver failure with cholestasis 14 days
after (147,458 cps in PBMCs, 370,312 cps in LBP); in both LBPs
and PBMCs, HHV7 and HHV8 were negative, and CMV and
EBV were low positive. He was treated with cidofovir, with
resolution of cholestasis and 409 cps in PBMCs 10 days after. A
second pt was HHV6 and B19 LBP-positive before transplant,
HHV6 and B19 LBP negative at second transplant, but his
second donor was B19 plasma-positive. 10 days after he devel-
oped liver failure with cholestasis and was B19 LBP-positive and
plasma-negative. HHV6, HHV7, HHV8 were all negative.
16 days after was still alive, but suffering for neuro-ischaemic
damage.
Conclusions: HHV6 infection is common in pts undergoing to
liver transplantation, often without blood viremia. Pts- or donor-
PBMCs screening is then useless. B19 infection is less prevalent,
but his closed association with HHV6 infection needs to be
clariﬁed. Donor-LBP analysis and clinical and virological long
term outcome of these pts, even in the case of liver failure, have
to be studied.
P690
Nocardiosis: a retrospective study of 41 French
cases
F. Laurent, B. Pangon, R. Sanchez, P. Boiron (Lyon, Le Chesnay,
Pe´rigueux, FR)
A retrospective study of Nocardia infections was achieved
among 109 French regional hospitals. In the period from 2000 to
2003, 41 cases were collected and analysed on the basis of a
closed detailed questionnaire. Molecular identiﬁcation showed
that 44% of strains were N. asteroides complex, 27% were
N. farcinica, 15% were N. nova, 9% were N. brasiliensis, and 5%
were N. otitidiscaviarum. The most common factor that predis-
posed individuals to nocardial infection was therapy by steroids
(24%), followed by cancer (19%), COPD (14%), AIDS (12%), or
solid organ transplantation (7%). No predisposing factor was
observed for 24% of the patients. Nocardiosis occurred more
commonly in the second part of the life, with 70% of the patients
between the ages of 50 and 90 years of age. The sex ratio was 1.4.
The most common clinical form was pulmonary disease (51%),
followed by cutaneous (41%), and cerebral disease (17%).
Bacteria were found on direct smear in 65% of the patients
and in pure culture in 73% of the samples. After treatment,
among the valuable patients (n = 28), 82% were cured and 7%
showed a recurrence and 11% died with a mortality directly
attributed to nocardiosis.
P691
Kluyvera species as opportunistic pathogens in
paediatric cancer patients
H. El-Mahalawy, H. Morcos, L Shalaby (Cairo, EG)
Kluyvera a relatively newly described genus in the Enterobacte-
riaceae family is considered as an infrequent opportunistic
pathogen occurring in immuosuppressed as well as immuno-
competent hosts. In the current work we studied retrospectively,
infections caused by Kluyvera species in immunocompromised
cancer patients admitted to the Pediatric Department of the
National Cancer Institute, Cairo University, from January 2000
to December 2003. Out of 6309 cultures reviewed during the
study period, Kluyvera species were isolated from 28 (0.4%) of
the studied cases. The organism was isolated by routine
microbiological methods, identiﬁcation to the species level and
antimicrobial susceptibility were carried out using Sensititre
AP80 auto-identiﬁcation plates (AccuMed International Ltd,
West Sussex, UK). Kluyvera cryocrescens was isolated in 27 cases
while K. ascorbata strain was documented in only one case,
contrasting the published data where K. cryocresens is mostly
isolated from the environment. In the current series, the
underlying disease was a haematologic malignancy in 67.9%
of cases and a solid tumour in 32.1% of cases. Most of the
patients were suffering from diarrhoea and fever. The organism
was isolated from the stools of 21 cases, from the blood of 5
febrile neutropenic patients, from the wound discharge of one
patient and from the nasal swab of another. As regards the
antimicrobial susceptibility of the isolates, increased suscepti-
bility was recorded for amikacin and imipenem (82.1%), while
ciproﬂoxacin and gentamycin were active in 55% and 50% of
cases respectively. On the other hand, the organism seemed to
be very resistant to ampicillin, cefazolin and cefuroxime as well
as other third generation cephalosporins. Clinically, all reported
episodes of infection with Kluyvera were prolonged despite
treatment requiring at least 7 days of adequate antimicrobial
therapy. The infection was fatal in one case. Although Kluyvera
species are rarely diagnosed as opportunistic pathogens, yet
they should be searched for in the context of febrile episodes in
the immunocompromised patients. The presence of diarrhoea is
an important predictor of the infection, especially if the course
of the illness is prolonged or recurrent. The isolation of
K. cryocrescens rather than K. ascorbata may point to the
importance of environmental sources of infection, hence the
importance of prompt food hygiene in order to avoid this
potentially fatal infection.
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Risk factors for pulmonary aspergillosis in
patients with cancer and pneumonia
M. Aguilar-Guisado, E. Cordero, J.M. Cisneros, I. Espigado,
M. Noguer, R. Parody, J. Pacho´n (Seville, ES)
Objectives: To identify the risk factors for IPA in cancer
patients with pneumonia.
Methods: Prospective study of all patients with cancer admitted
in Oncology or Hematology Departments that had a pneumonia.
Study period: from November 2002 to February 2005. Univariate
and multivariate analysis of risk factors for IPA.
Results: One hundred and nine pneumonias in 93 patients were
included. Median age was 57 years (18–84), and 59.5% were
males. Eighty-one (75%) had an hematological cancer and 22
(20%) were blood stem-cell transplantation (BSCT) recipients,
50% allogeneic. Sixty-one patients (59%) had neutropenia at
pneumonia diagnosis, that was prolonged in 36% of the cases,
and deep in 39%. Seventy two episodes (66%) were community-
acquired. 30% of patients had another chronic disease different
from the neoplasm. 29% had received previous prolonged
steroid therapy. 26% had received previous antibiotic therapy,
and 18% quinolones. There were 13 episodes of invasive
pulmonary aspergillosis. Diagnosis was possible in 9 cases
(69%), probable in 1 (8%) and deﬁnitive in 3 (23%) according to
the EORTC criteria. There were no episodes of IPA between
patients with solid cancer, thus we achieved the risk factors
analysis only in hematological patients. Independent risk factors
for API selected by multivariate analysis were: permanent
catheter (RR 6.3; 1.9–21), previous therapy with quinolones (RR
3; 1.1–7.8), prolonged neutropenia (RR 6.2; 1.4–26.3) and deep
neutropenia (RR 5.6; 1.3–23.8), allogeneic BSCT (RR 3.9; 1.6–9.9),
chemotherapy with purine agonists (RR 3.6; 1.4–91) and cancer
induction chemotherapy (RR 0.18; 0.03–1.2); Of these, were
independent factors in multivariate analysis: previous therapy
with quinolones (RR 24; 1.8–316), allogenic blood stem-cell
transplantation (RR 79.5; 2.4–2654), chemotherapy with purine
agonists (RR 46.4; 3.2–631) and prolonged neutropenia (RR 11;
1.3–95).
Conclusions: Risk factors for IPA in patients with haematolog-
ical cancer and pneumonia are previous therapy with quinolo-
nes, allogeneic BSCT, chemotherapy with purine agonists and
prolonged neutropenia. In patients with solid cancer the
incidence of IPA is null in this study.
P693
Pneumonia risk factors in patients with febrile
neutropenia
M. Aguilar-Guisado, E. Cordero, J.M. Cisneros, I. Espigado,
M. Noguer, R. Parody, J. Pacho´n (Seville, ES)
Objectives: To analyse risk factors of pneumonia in patients
with cancer and febrile neutropenia.
Methods: Prospective study of all patients with cancer and
febrile neutropenia admitted in Oncology or Hematology
Departments. Study period: from November 2002 to February
2005. Analysed variables: demographics, kind of cancer, stage
and therapy for cancer, another inmunosuppresive factor,
previous antimicrobial therapy. Univariate and multivariate
analysis of risk factors for pneumonia.
Results: Three hundred forty seven cases of febrile neutropenia
were included, of which 61 had a pneumonia. Median age was
43.2 years, and 36 (59%) were males. Fifty three (87%) were
patients with haematological malignancies, and 14 (23%) were
blood stem-cell transplantation recipients. Risk factors for
pneumonia in multivariate analysis were: previous steroid
therapy (RR 2; IC95%: 1.1–3.6) and induction/consolidation
chemotherapy for cancer (RR 2.3; IC95%: 1.1–5.3). In patients
with haematological malignancies risk factors in multivariate
analysis were previous steroid therapy (RR 2.4; IC95%: 1.1–5.5)
and induction/consolidation chemotherapy for cancer (RR 2;
IC95%: 1.1–3.6); In patients with solid cancer risk factors in
multivariate analysis were previous antimicrobial therapy (RR
11.5; IC95%: 2–73). In patients in induction/consolidation
chemotherapy for cancer, the only risk factor selected by
multivariate analysis was previous therapy with quinolones
(RR 2.4; 1.1–5.6).
Conclusions: Independent risk factors for pneumonia in
patients with febrile neutropenia and haematological malignan-
cies are previous steroid therapy and induction/consolidation
chemotherapy for cancer. In patients with solid cancer, the only
independent risk factor is previous antimicrobial therapy. In
patients in induction/consolidation chemotherapy for cancer, it
is previous quinolones therapy.
P694
Once daily outpatient quinolone monotherapy
for low-risk febrile neutropenic cancer patients
K. Rolston, S. Patel, S. Frisbee-Hume, E. Manzullo, R. Benjamin
(Houston, US)
Background: Low-risk febrile neutropenic patients (FNP) are
often treated as outpatients with oral antibiotics (usually
combination regimens e.g. ciproﬂoxacin+amoxicillin/clavula-
nate). The availability of newer generation, broad-spectrum
quinolones (gatiﬂoxacin, moxiﬂoxacin) with long half lives has
made it possible to consider once daily monotherapy in this
setting. If found to be safe and effective such therapy might be
more cost-effective and convenient than current regimens.
Objectives: To evaluate the feasibility of outpatient, quinolone
(moxiﬂoxacin) monotherapy in low-risk FNP.
Methods: A pilot study of oral/parenteral moxiﬂoxacin
(400 mg/d) as monotherapy in low-risk FNP, (patients were
identiﬁed using published clinical criteria and the MASCC risk
index). Standard deﬁnitions for fever (101 F), neutropenia
(£500 PMN/mm3), and response or failure were used, based
on published criteria. All patients were treated as outpatients in
our ambulatory treatment centres. Daily follow up was done
(clinic visit on day 1 and 2, and telephone call at home days 3–6.
End of treatment visit, usually on day 7).
Results: Fifteen valuable patients have been enrolled thus far,
including 12 women and 3 men with a median age of 42 years.
Sarcoma (9) and breast cancer (4) were the most common
underlying malignancies. Ten patients (66%) had severe neu-
tropenia (ANC£100/mm3). Episodes consisted of unexplained
fever (9–60%), and documented infections (6–40%), including 4
episodes of bacteremia, 3 coagulase-negative staphylococci and
1 Mycobacterium fortuitum) and two of skin/skin structure
infection. All 15 patients (100%) responded to outpatient
monotherapy with oral moxiﬂoxacin. The median time to
defervesce was 3 days, mean duration for recovery from
neutropenia was 4 days, and the median duration of therapy
was 7 days. No toxicity was observed, and no hospital admis-
sions were required.
Conclusions: Our preliminary data suggest a role for quinolone
monotherapy in carefully selected, low-risk, febrile neutropenic
patients. This approach needs to be fully evaluated in prospect-
ive randomized trials.
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P695
Empiric monotherapy with cefepime in standard-
risk, paediatric, febrile neutropenic patients
K. Rolston, C. Mullen (Houston, Rochester, US)
Background: The management of febrile neutropenic patients is
evolving. Low-risk febrile neutropenic patients are often treated
as outpatients. Standard, and high-risk patients generally
receive hospital-based, parenteral antibiotics. High-risk patients
remain hospitalized for the entire febrile episode. Many stand-
ard risk patients stabilize quickly and probably can be dis-
charged early, on parenteral/oral antibiotic regimens. All these
strategies are easier to implement in adults, but are less well
studied in pediatric cancer patients.
Objectives: To assess the efﬁcacy and safety of cefepime
monotherapy in standard-risk paediatric febrile neutropenic
patients, and the feasibility of outpatient therapy in patients
meeting preset criteria for early discharge.
Methods: Prospective clinical trial. Initial risk assessment was
performed to identify standard-risk patients who received
parenteral cefepime monotherapy in hospital. febrile neutrop-
enic patients meeting preset criteria after 48–72 h were dis-
charged on oral ciproﬂoxacin + azithromycin. Efﬁcacy, safety,
and length of stay on cefepime were assessed, as was the
feasibility and success of early discharge on oral therapy.
Results: 105 standard-risk febrile neutropenic patients were
enrolled (female 55%, male 45%) with a median age of 9 y. 76%
had a solid tumour (primarily Ewing sarcoma or osteosarcoma)
and 24% had a haematologic malignancy (mainly ALL). Median
ANC at enrollment was 99/mm3. Breakdown of infection was
unexplained fever (71%), bacteremia (15%), other infection sites
(14%). Response to cefepime monotherapy was 81% and overall
response (with modiﬁcations) was 99%. No drug related toxicity
was observed. Average length of stay in hospital was 3 days.
Fifty-six percent of febrile neutropenic patients received oral,
outpatient therapywith an average duration of 3 days. However,
an additional 17%met the clinical criteria for early discharge, but
chose to remain hospitalized due to logistical reasons.
Conclusions: Cefepime monotherapy is safe and effective in
standard-risk pediatric febrile neutropenic patients. Early sta-
bilization and discharge on oral therapy is possible in more than
50% of such patients.
P696
Urinary tract infections after renal
transplantation: bacterial isolates and resistance
patterns
S. Karampa, G. Miserlis, P. Sikalidou, D. Takoudas, D. Soﬁanou
(Thessaloniki, GR)
Objectives: To evaluate the prevalence of urinary tract infec-
tions (UTIs) after renal transplantation, to analyse the risk
factors associated with post-transplant UTIs and to identify the
bacterial agents and their resistance to antimicrobial agents.
Methods: A retrospective study was conducted in 130 adult
(M = 91, F = 39) renal transplant recipients. There were 75
cadaveric and 55 living kidney grafts. The main immunosup-
pressive regimen consisted of methylprednisolone, mycopheno-
late mofetil, cyclosporine A and basiliximab (n = 101). UTI was
deﬁned as the detection of both bacteriuria and pyuria accord-
ing to Kass criteria. Identiﬁcation of microorganisms and
susceptibility testing were performed using the Vitek 2 auto-
mated system (bioMerieux, France). Statistical analysis was
performed using the SPSS 10.0 statistical package.
Results: The incidence of UTIs during the early post-transplant
period (ﬁrst trimester) was 13.8% (18/130 patients) while in the
late post-transplant period (after the fourth month) was 12.3%
(16/130 patients). Five patients developed UTIs during the early
and late period. The results are reported in the table. Resistance
rates to commonly used drugs like ceftazidime (CAZ), amikacin,
ciproﬂoxacin (CIP), imipenem (IMP) and piperacillin/tazobac-
tam were 98%, 87%, 99%, 84% and 98% respectively for A.
baumannii and 60%, 46%, 71%, 57% and 45% respectively for P.
aeruginosa. E. coli isolates presented 25% resistance to amoxicil-
lin/CA and CIP, 27% to trimethoprim/sulfa, 20% to CAZ but all
isolates were susceptible to IMP. Among staphylococci, S. aureus
was 63% resistant to oxacillin (OX), 53% to clindamycin (CC) but
susceptible to glycopeptides while S. epidermidis was 10%
resistant to teicoplanin (TEC), 55% to CC, 95% to OX and all
isolates were susceptible to vancomycin (VA). The degree of
resistance to Gentamycin-HL for E. faecalis was 32%. All isolates
were sensitive to VA & TEC. According to statistical analysis of
our data signiﬁcant risk factors for post-transplant UTIs were
cadaveric graft (p < 0.001) and the immunosuppressive regimen
(p < 0.05).
Conclusions: The prevalence of UTIs was higher in the early
post-transplant period. Gram-negative rods followed by Candida
spp. were the most common cause of UTIs. Signiﬁcant risk
factors for post-transplant UTIs were both cadaveric allograft
and the immunosuppressive regimen. More judicious selection
of antibiotics in order to reduce resurgence of multi-drug-
resistant isolates is required.
P697
Seroepidemiology of Bartonella henselae/
quintana in immunocompromised patients
(human immunodeﬁciency virus infected/
end-stage renal disease patients)
M. Pape, P. Kollaras, K. Mandraveli, A. Sioulis, P. Nikolaidis,
S. Alexiou-Daniel (Thessaloniki, GR)
Objective: Bartonella infection is not easily diagnosed, especi-
ally when it presents with nonspeciﬁc symptoms, such as fever.
Since immunocompromised patients are a potential risk group
of infection, the aim of this study was to determine the
seroprevalence of Bartonella henselae/quintana among two risk
groups (HIV/ESRD patients) and in a control group.
Methods: Between October 2004 and April 2005, antibodies to
Bartonella spp. were determined using an immunoﬂuorescent
test (Focus, kit) in 253 HIV patients (186 men, 67 women, mean
age 45 ± –5 yr) and in 73 haemodialysis patients (41 men, 32
women, mean age 58 ± 5 yr). The epidemiologic study included
sex, age, contact with cats, lymphadenopathy, antiretroviral
treatment, chemoprophylaxis versus, CD4 lymphocyte count,
symptoms associated with Bartonella infection.
Results: Of the 253 HIV patients, 103 (41%) were seropositive for
Bartonella henselae IgG antibodies. Titres 1/64, 1/128, 1/256, 1/
512, 1/1024 were found in 17% (44/253), 12% (31/253), 7% (18/
253), 4% (9/253), ~1% (1/253), respectively. Fifteen (6%) subjects
had IgG antibodies to both Bartonella species at a titre 1/64. Only
two patients had IgM antibodies at a titre 1/20 and 1/40. The IgG
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titres to these patients were respectively 1/512 and 1/1024. No
relationship between Bartonella seropositivity and CD4+ cell
counts was found when HIV patients were analysed. All HIV
patients were receiving antiretroviral therapy (HAART) and four
were under chemoprophylaxis. Of the 73 ESRD patients, 16 (21%)
were seropositive for Bartonella henselae IgG antibodies. Titres 1/
64, 1/128, 1/256 were found in 13% (10/73), 2% (2/73), ~1%,
respectively. Seropositivity against Bartonella quintana was not
determined. None of both study groups reported animal expo-
sure before serologic test was performed. No symptoms or signs
were present during the study period. The seropositivity in the
healthy population in Northern Greece as it shown in previously
published data relives statistically signiﬁcant differences only
with HIV patients, who present higher seropositivity at the
respective levels of IgG. No difference was found in the serology
among ESRD patients and healthy ones.
Conclusion: Our data indicate that Bartonella henselae infections
are most common among immunocompromised patients, espe-
cially HIV infected. Therefore, Bartonella henselae should be
considered in the differential diagnosis of opportunistic infec-
tions in HIV disease.
P698
Tobramycin once vs. three times a day given with
penicillin G to cancer patients with febrile
neutropenia: a prospective randomised
multicentre trial
D. Torfoss, E.A. Høiby for the Norwegian Febrile Neutropenia
Study Group
Objectives: Based on low levels of antimicrobial resistance
penicillin G (PG) and an aminoglycoside (AG) are the standard
therapy in febrile neutropenia (FN) in Norway. However, so far
no prospective randomized trial has evaluated this regimen. The
antimicrobial effect of one dose of AG is a best 12 hours (halﬂife
andpostantibiotic effect). PG is a poor antibiotic inGramnegative
sepsis. When PG is the beta-lactam, is it safe to give the AG once
daily to patients without granulocytes to ﬁght an infection?
Methods: The population consisted of adult cancer patients
with fever and neutropenia.Patients were randomized to tobra-
mycin 6 mg/kg once or three times a day. All received PG. Once
the ﬁrst dose was given, further antibiotic therapy was up to the
doctor’s discretion. Success was regress of signs of infection
without modiﬁcation of the antibiotic regimen.
Results: 210 patients were randomized. 145 patients are inclu-
ded in the ﬁnal analysis. 130 of those had either lymphoma or
leukaemia. No statistical difference was found between the ‘‘x1’’
and ‘‘x3’’ groups in any of the analysis. 39% of the patients were
successfully treated. No patients died from the initial infection.
Modiﬁcations were unusual before the third day. 24 patients
had a positive blood culture (9 Gram negatives and 17 Gram
positives), and 29% of those had a successful outcome. Creat-
inine elevations were modest and within the normal range.
Conclusion: In febrile neutropenic patients in Norway, empiric
therapy with penicillin G and an aminoglycoside given once
daily is safe as long as the regimen is modiﬁed depending on the
clinical condition of the patient.
References:
1. Hammerstrøm J, Jacobsen T. Bakteriemi ved granulocytopeni
– mikrobiologi og empirisk antibiotikabehandling. J Norw
Medic Assoc 1998; 118(28): 4370–5.
2. Tangen JM, Berentsen S, Dahl IM, Ly B, Myrvang B. Empirisk
antibiotikabehandling hos pasienter med akutt myelogen leuk-
emi. J Norw Medic Assoc 1999; 119(1): 35–8.
3. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen
J.M, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie
W, Langeland N. A multi-centre prospective study of febrile
neutropenia in Norway: Microbiological ﬁndings and antimi-
crobial susceptibility. Scand J Inf Dis 2005; 37: 455–64.
P699
Enterococcal bacteraemia in patients with
haematological malignancies
N.S. Bagirova, N.V. Dmitrieva (Moscow, RU)
Objectives: To determine frequency of isolation of enterococci
from blood, risk factors Enterococcal bacteremia (BE), sources
BE, outcome BE, antimicrobial susceptibility.
Materials and methods: BACTEC 9050 and Bact/ALERT 3D
automated blood culture systems were used. Decisions were
also made in accordance with the deﬁnitions published by the
Centers for Disease Control and Prevention. Risk factors,
sources, outcome of BE were studied in 226 monomicrobial
episodes at 157 adult patients (1997–2002). Frequency of isola-
tion of enterococci from blood was studied within 8 years (1997–
2004). Antimicrobial susceptibility testing was performed with
the Vitek-2 System, ATB Expression (1997–2004).
Results: Enterococcus spp. represented 7% (16/226) of all iso-
lates from blood during 1997–2002. There were basic risk factors:
acute leukaemia (62.5%), neutropenia (<500/mm3) (87.5%),
vascular catheter (100%), previous antimicrobial and cortico-
steroids therapy for a long time (100%, and 37.5%, respectively).
There were basic sources of infection: gastrointestinal tract
(75%), respiratory tract (18.8%), urinary tract (6.3%). Mortality
due to BE has made 31.3% (all cases – sepsis). Last two years
(2003–2004) Enterococcus spp. represented 13.5% (12/89) of all
isolates from blood: Enterococcus faecium–50% (6/12), E. faecalis–
33.3% (4/12), E. durans and E. gallinarum 8.3% each. ‘‘In vitro’’
antimicrobial susceptibility (1997–2004) was: to ampicillin 42.9%
(12/28), to gentamicin 35.7% (10/28), to linezolid 100% (12/12),
to teicoplanin 75% (21/28), to ciproﬂoxacin 0% (0/28), to
levoﬂoxacin 32.1% (9/28), to erytromycin 0% (0/28), to nitrof-
urantoin 67.9% (19/28), to tetracyclin 78.6% (22/28), to chlo-
ramphenicol 35.7% (10/28), to rifampicin 32.1% (9/28).
Vancomycin-resistant strains were: E. faecium (1/6), E. durans
(1/1), E. gallinarum (1/1).
Conclusion: Frequency of BE is growing up. Overall, BE
represented 8.9% (28/315) of all isolates from blood (1997–
2004). Linezolid is the most active drugs against Enterococcus
spp.
P700
Aetiology of infections and antimicrobial
resistance in patients treated for cancer at a cancer
institute in Slovakia. Results from June 1999 to
May 2003
O. Babelova, R. Babela, V. Krcmery (Trnava, SK)
Objectives: To determine the etiology of infections and antimi-
crobial resistance in cancer patients.
Methods: Retrospectively conducting study in patients under-
going cancer treatment and i.v. antibiotics treatment in the same
time. Our inclusion criteria meet 456 patients. We documented
following data for stratiﬁcation: exposure to antimicrobial
agents, type of antineoplastic therapy, antibiotics, microorgan-
isms from diagnostic cultures, results of susceptibility testing,
clinical outcome.
Results: Enterobacteriaceae were the predictor of the death
(P < 0.01) not the predictor of infection. Enterococcus faecalis
was more often present in patients after surgery than in patients
after chemotherapy (P < 0.0001). Staphylococcus aureus was
present signiﬁcantly more often (P < 0.05) in patients after
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radiotherapy than in patients after surgery. Resistance to
gentamicin (P < 0.002) and tetracycline (P < 0.0004) in Entero-
coccus faecalis was higher in patients after surgery and resistance
to tetracycline (P < 0.01) was higher in patients after radio-
therapy than in patients undergoing chemotherapy. Resistance
to cephalotin (P < 0.008) and gentamicin (P < 0.01) in E. coli was
higher in patients after surgery than in patients after chemo-
therapy. Resistance to ceftazidı´m (P < 0.002) in Pseudomonas
aeruginosa was higher in patients after surgery than in patients
undergoing chemotherapy. The broadest resistance was in
patient with cancer of cervix uteri. Highest resistance in E. coli
was to ampicilin (P < 0.01) and ciproﬂoxacin (P < 0.02) and
highest resistance in Stapylococcus spp. was to cotrimoxazol
(P < 0.03), erytromycin (P < 0.01), chloramphenicol (P < 0.009)
and spiramycin (P < 0.01).
Conclusion: Results may contribute to the evaluation of infec-
tion control programs and the development of effective strat-
egies in hospitals. Recognition of aetiology factors and resistance
to antimicrobial agents based on truthful database can help
better organize therapeutic and prophylactic strategies with
particular antimicrobial agents.
P701
Interest of Candida antigen and antibody ELISA
for hepatosplenic candidiasis diagnosis
F. Persat, A. Thiebaut, F. Loiseau, M.A. Piens, S. Picot,
M. Michallet (Lyon, FR)
Objectives: The aim of this study was a retrospective evalua-
tion about the interest of Candida antigen and antibody
Platelia ELISA kits for the diagnosis of hepatosplenic candidi-
asis in patients of haematology with or without hepatosplenic
candidiasis.
Methods: Sera of patients from haematology wards from the
Hoˆpital Edouard Herriot (France) have been routinely tested by
Candida antibody and/or antigen Platelia ELISAs between
May 2004 and September 2005. The ELISAs have been per-
formed following the recommendations of the manufacturer.
Positive results for antibody and antigen tests were obtained
with values superior to 10 UA/ml and to 0.5 lg/ml, respect-
ively. Probable hepatosplenic candidiasis have been deﬁned in
neutropenic patients with fever resistant three days to antibiot-
ics and with an positive abdominal CT scan or ultrasonographic
imaging showing hepatic lesions, according to the international
classiﬁcation of the EORTC.
Results: Results of 521 sera from 161 haematology patients have
been collected between May 2004 and September 2005. 416 sera
have been tested by Candida antibody ELISA, 510 by Candida
antigen ELISA, 404 being tested by the both techniques.
Antibody serum results were positive for 19 sera, intermediate
(5–10 UA/ml) for 29 sera and negative for 368 sera. Antigen
serum results were positive for 65 sera, intermediate (0.25–
0.50 lg/ml) for 11 sera and negative for 434 sera. Among the 161
patients, positive results in antibody and antigen serum detec-
tion were obtained for 10 and 31 of them, respectively. Fifteen
patients were suspected to have a hepatosplenic candidiasis
following clinical and imaging parameters. Signiﬁcantly positive
antibody or antigen ELISA results were obtained for 13 of these
patients (p < 1.10–5), 11 with positive antigen detection, two
with positive antibody detection. For the two patients negative
for the both ELISAs, tests have been performed on only one
serum for the ﬁrst patient, decreasing the sensitivity of the
detection, and on 12 sera for the second patient. Data about the
28 other patients with positive Candida antibody or antigen
results have to be examined and discussed.
Conclusion: Follow-up of Candida antibody and antigen detec-
tion by ELISA for neutropenic febrile patients in haematology
may be good predictive parameters for the diagnosis of
hepatosplenic candidiasis in complement of the abdominal CT
scan or ultrasonographic imaging.
P702
Cefepime therapy is effective for children with
febrile neutropenia
G.T. Kovacs, M. Csoka, H. Erlaky, M. Garami, J. Muller
(Budapest, HU)
Infectious complications are important causes of morbidity and
mortality in children receiving chemotherapy for malignant
diseases. The aim of this study was to evaluate the clinical
effectiveness of cefepime in immunocompromised children.
Cefepime was used in 93 febrile events diagnosed in 49 patients
as empiric antibacterial therapy alone or in combination with
aminoglycoside. The mean age was 10 years 4 month (10 mo–
19 y), and the male:female ratio was 1:1.2. Blood samples for
microbiological processing were taken from each patient with
granulocytopenia (<500 cells/mm3) and fever (>38 C), prior to
the start of any antibiotic therapy. In 21 cases (23%) the infection
was documented by blood culture, in 30 cases (32%) the
infection was documented clinically and 42 cases (45%) were
considered as fever of unknown origin. Cefepime was used in a
mean dose of 86 (50–100) mg/kg/day, for a mean of 6 (2–24)
days, b.i.d. Duration of the neutropenia was 6.8 ± 4.4 days. In 61
cases granulocyte colony-stimulating factor was administered.
In 86% of the cases (80/93) cefepime was combined with
aminoglycosid antibiotics. The success rate of the cefepime
therapy was 75% (70/93). In the other cases changes of the
antimicrobal therapy was necessary, and two patients died (1
progression of the disease, 1 sepsis). No signiﬁcant severe side
effects could be detected. In summary, our results demonstrate,
that cefepime is effective and safe treatment for febrile episodes
in neutropenic children with malignancies.
Antibacterial susceptibility studies–I
P703
A comparison study of amoxicillin-clavulanate
and azithromycin efﬁcacy in treatment of acute
sinusitis
M. Zangeneh, N. Shariati, A. Yazdanyar, M. Jamshidi Makiani,
S. Haghighi (Tehran, IR)
Background: Acute bacterial sinusitis is an acute infection of
the paranasal sinuses. Approximately 30 million Americans
develop acute bacterial sinusitis annually, resulting in an
estimated 25 million physician visits. Shorter courses of antimi-
crobial therapy (3 to 5 days) tend to increase patients compli-
ance, decrease adverse events, decrease the emergence of
resistant strains, and reduce cost. We compared the efﬁcacy
and safety of azithromycin regimens, 250 mg/day once daily for
5 days to the efﬁcacy and safety of amoxicillin-clavulanate
regimen of 500 mg 3 times daily for 10 days.
Methods: A total number of 80 subjects with clinically and
radiologically documented acute bacterial sinusitis were treated
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with (azithromycin 40 subjects, amxicillin-clavulanate 50 sub-
jects).
Results: Mean age 32.7 years, male 60%, female 40%, the most
common symptoms were headache and paranasal discharge,
maxillary sinus was more infected 49%. Clinical success rates
were among subjects at the end of therapy (azithromycin 53%,
amoxicillin-clavulanate 90%). Subjects treated with amoxicillin-
clavulanate reported a higher incidence of treatment-related
adverse events (15%) than azithromycin (7%, p > 0.005). Gas-
trointestinal discomfort was the most frequent treatment related
adverse effect.
Conclusion: For subjects with clinically and radiologically
documented acute bacterial sinusitis azithromycin given in a
250 mg dose once daily for 5 days was not shown to be as
efﬁcacious as amoxicillin-clavulanate 500 mg 3 times/day for
10 days.
P704
In vitro activities of various piperacillin and
sulbactam combinations against bacterial
pathogens isolated from intensive care units in
Taiwan: SMART program 2004 data
P.R. Hsueh, M.N. Hung, C.Y. Liu for the Surveillance of
Multicenter Antimicrobial Resistance in Taiwan SMART
Objective: We investigated the in vitro activity of various
piperacillin and sulbactam combinations against commonly
encountered gram-negative bacteria in Taiwan.
Methods: Antimicrobial susceptibility testing was performed
using the agar dilution method against 1030 bacterial isolates
recovered from intensive care units of nine hospitals. Sulbactam
was added to piperacillin either at a ﬁxed concentration of 4 and
8 mg/ml or with a ratio of 1:2 and 1:4.
Results: Piperacillin-sulbactam with a ratio of 2:1 or a ﬁxed
8 mg/ml of sulbactam had better activities against Escherichia
coli, Klebsiella pneumoniae, Proteus mirabilis, and Serratia marces-
cens than other piperacillin-sulbactam combination regimens.
For Pseudomonas aeruginosa, piperacillin-sulbactam (2:1 or 4:1)
had MIC90s of 64 mg/L (>90% susceptibility) compared with
64 mg/L for cefoperazone-sulbactam (68% susceptibility) and
128 mg/L for piperacillin-tazobactam (82% susceptibility). For
Acinetobacter baumannii, both piperacillin-sulbactam (either 2:1
or a ﬁxed 8 mg/L of sulbactam) and cefoperazone-sulbactam
were most potent agents. Adding sulbactam to piperacillin
resulted in increased susceptibility rates among piperacillin-
resistant P. aeruginosa (53–57% in either 2:1 or 4:1 ratios) and A.
baumannii (38%–46% in either 2:1 or a ﬁxed 8 mg/L of sulbac-
tam) isolates, respectively.
Conclusions: Results of susceptibility tests with piperacillin-
sulbactam are method-dependent. Piperacillin-sulbactam com-
binations possessed better in vitro activities than piperacillin
alone or piperacillin-tazobactam against P. aeruginosa and A.
baumannii.
P705
Hetero-glycopeptide-intermediate Staphylococcus
aureus: prevalence and antibiotic susceptibilities
in long-term care facilities from the Flemish part
of Belgium
P. Declercq, A. Bolmstrom (Izegem, BE; Solna, SE)
Long-term care facilities (LTCF) are a main source of methi-
cillin-resistant Staphylococcus aureus (MRSA) import into acute-
care facilities (ACF). In this multi-centre study, we looked for
hetero glycopeptide-intermediate Staphylococcus aureus (hGISA)
among MRSA isolates from LTCF patients and tested all
isolates, including the hGISA for susceptibility to established
and newer antibiotics. Ten ACF sites located in the Flemish
part of Belgium screened LTCF patients for MRSA upon
admission. A total of 238 MRSA isolates was collected and sent
to a central laboratory for testing. The Etest macromethod
(Walsh et al., JCM 2001) was used to identify potential hGISA
phenotypes. A 2 McF inoculum was tested on Brain Heart
Infusion Agar (BD, USA) with vancomycin (VA) and teicopl-
anin (TP) Etest strips. Plates were incubated at 35 C in air and
read at 48 h. A non-GISA (ATCC 43000) and hGISA reference
strain (ATCC 700698/Mu3) were used for quality control.
Isolates with MIC values ‡8 lg/mL for both, VA and TP, or
‡12 lg/mL for TP were interpreted as potential hGISA and
were sent to a reference laboratory (Bristol University, UK) for
population analysis proﬁle (PAP)-testing. Of the 238 MRSA
isolates, 24 (10%) were identiﬁed as potential hGISA and 6
(2.5%) were conﬁrmed as hGISA by PAP-testing. Susceptibility
data were obtained by the Etest standard method. MIC90s of
vancomycin, minocycline, trimethoprim/sulfamethoxazole,
mupirocin, fusidic acid, linezolid and daptomycin for the
total sample of 238 MRSA isolates were 1, 0.25, 0.1, 0.4, 0.2,
1.75 and 0.4 mg/L, respectively, while tigecycline had a MIC90
of 0.25 mg/L for the 24 isolates identiﬁed as potential hGISA.
hGISA are present in low numbers in LTCF and consequently
in ACF. Current antibiotics used for MRSA are still valuable
and the newer agents look promising.
P706
Uncomplicated urinary tract infections, what
about fosfomycin and nitrofurantoin in 2006?
P. Honderlick, J. Gravisse, P. Cahen, D. Vignon (Suresnes, FR)
Since 2000 we assessed the prevalence of antimicrobial resist-
ance among uropathogens causing acute uncomplicated urinary
tract infections. A total of 13,251 strains of Enterobacteriaceae,
2638 of Enterococci and 1461 of Staphylococci were studied.
In vitro results of 7 antibiotics were analysed using the disk
diffusion method: Amoxicillin (AMX), Amoxicillin-clavulanate
(AMC), Cotrimoxazole (SXT), Nalidixic acid (NA), Oﬂoxacine-
Norﬂoxacine (NOR), Fosfomycin (FOS) and Nitrofuradoin (FT).
Including all genus of bacteria in the aim of an empiric
treatment, AMX was the antibiotic the less active with only
50.2% of susceptible strains, followed by SXT = 65.5%,
AMC = 67.2%, NAL = 74.9%, NOR = 83%, FT = 83.5%,
FOS = 91.1%. Nitrofurantoin, and Fosfomycin were at least
equals to Norﬂoxacine/Oﬂoxacine, these 3 compounds were in
vitro the most potent drugs. Fluoroquinolones still the class of
antibiotic the most prescribed in UTI in our hospital very far
from the 2 others antibiotics. As group 1 of Enterobacteria
represent 10,113 strains (76% of the panel) with a prevalence
of more than 98% of Escherichia coli we looked this group
more carefully to support our conclusions. FOS = 98.3%,
NOR = 89.2%, FT = 86%, NAL = 84%, AMC = 75.4%, SXT =
73.3%, AMX = 53.5% of susceptibility. French and European
guidelines concerning the best empiric treatment of UTI
includes Fluoroquinolones, Nitrofuradantoin and Fosfomycin.
Worldwide ﬂuoroquinolones suffered from about 10% or more
of resistance in Enterobacteriacae of group 1 and as Quinolones
of ‘‘ﬁrst generation’’ ranged from 15 to more than 20% of
resistance, may be the prudent use of antibiotics moved us to
really use in clinical practice others antibiotics with proven good
in vitro and in vivo activities for UTI infections.
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P707
Antimicrobial activity of linezolid and other
agents against nosocomial pneumonia
Streptococcus pneumoniae isolates
M.M. Ijzerman, M.A. Cohen, M.D. Huband, P.J. Pagano,
K.J. Tack (Ann Arbor, US)
Objectives: Nosocomial pneumonia is the leading cause of
death in patients with hospital-acquired infections. Streptococcus
pneumoniae is increasingly associated with outbreaks of pneu-
monia in nosocomial and tertiary care settings. The emergence
of antibiotic resistance in S. pneumoniae complicates treatment
interventions. This study investigated the antimicrobial activity
of 14 antibiotics vs nosocomial pneumonia S. pneumoniae isolates
collected globally.
Methods: Microbroth dilution MICs (expressed in mcg/mL)
and their interpretation followed Clinical and Laboratory
Standards Institute (USA) guidelines.
Results: Antibiotic resistance rates among the pneumococcal
isolates were: penicillin 16%, imipenem 3%, levoﬂoxacin 1%,
gemiﬂoxacin 1%, cefuroxime 29%, cefotaxime 1%, ceftriaxone
2%, erythromycin 18%, tetracycline 21%, trimethoprim-sulfa-
methoxazole 31%. All isolates were susceptible to linezolid,
vancomycin, and cefepime.
Conclusion: This study conﬁrms a high rate of antibiotic
resistance among pneumococci. Linezolid, vancomycin and
cefepime are the most consistently active agents vs strains of
S. pneumoniae causing nosocomial pneumonia.
P708
Low-level resistance to ciproﬂoxacin in
Salmonella strains isolated from humans in
Belarus
D. Tapalski (Gomel, BY)
Objectives: To estimate minimum inhibitory concentration
(MIC) of ciproﬂoxacin for Salmonella strains.
Methods: In research were included 42 Salmonella strains of
different serotypes (14 – S. Enteritidis, 16 - S. Typhimurium, 4 – S.
Hadar, 3 – S. Isangii, 1 – S. Virchow, 1 – S. London, 1 – S. Java 1 – S.
Derby, 1 - S. Stanleyville) isolated from patient with salmonellosis
in 2003–2004 years in Belarus. The revealing of antimicrobial
susceptibility to ampicillin (A), chloramphenicol (C), nalidixic
acid (N), ciproﬂoxacin (P), tetracycline (T), gentamicin (G),
trimethoprim/sulfamethoxazole (R), cefotaxime (F) was
checked by the disk diffusion method following the recommen-
dations of the NCCLS. Determination of ciproﬂoxacin MIC was
checked by the broth dilution test (micro method). The terminal
concentrations of ciproﬂoxacin from 0.008 to 4 mg/L were used.
For the control of quality parallel determined the ciproﬂoxacin
MIC for the E. coli ATCC 25922 and S. aureus ATCC 29213. The
interpretation of the results is made following standard NCCLS
guidelines (R–MIC £ 4 mg/L, I–MIC = 2 mg/L, S–MIC ‡1 mg/
L). Low-level resistance to ciproﬂoxacin was taken as MIC 0.25–
1.0 mg/L.
Results: By the using of disc diffusion method all strains was
susceptible to ciproﬂoxacin, 23 strains (54.8%) was resistant to
nalidixic acid, eight strains (seven S. typhimurium and one
S. london) has multiply resistance (antimicrobial pattern
ACNTGRF). The range of ciproﬂoxacin MIC of 42 tested strain
was from 0.03 to 1.0 mg/L. The highest levels of MIC (0.5–
1 mg/L) have six strains of S. typhimuriun (antimicrobial pattern
ACNTGRF), three strains of S. enteritidis (antimicrobial pattern
NT) and strain S. london. The low-level resistance to ciproﬂoxa-
cin was revealed in 20 strains of salmonella, for the 19 from them
(95%) diameter of grows inhibition for nalidxic acid was
6–13 mm (category R – resistant). Was not revealed any strains
with lowed susceptibility to ciproﬂoxacin amount 19 strains,
sensitive to nalidixic acid. Values of MIC of control strains were
corresponded to reference values.
Conclusion: From almost all of S. typhimurium strains with
multiply antimicrobial resistance, formally maintaining suscep-
tibility only to ﬂuoroquinolones, was determined the low-level
resistance to ciproﬂoxacin (MIC 0.5–1 mg/L). In case of need to
treat the infections, caused with similar strains, it is advisable to
change the dosage of ﬂuoroquinolones, or administer the
reserve antibiotics.
P709
The inﬂuence of UV radiation on the antibacterial
activity of ciproﬂoxacin in aqueous solutions
A.V. Polishchuk, E.T. Karaseva, V.E. Karasev (Vladivostok, RU)
Objective: The strong antibacterial activity of ﬂuoroquinolones
has led to their large-scale use in medicine. However, effective-
ness of the antibacterial agents depends on conditions in which
they are kept. The aim was to determine how dose and lambda
of the UV radiation inﬂuence on the ﬂuoroquinolones antibac-
terial activity in respect of Staphylococcus aureus.
Methods: Ciproﬂoxacin (‘‘Ciprobay’’,‘‘Bayer’’) was used. Sta-
phylococcus aureus ATCC 21027 was chosen as a test-culture. The
samples of cfqH with different starting concentration were
irradiated by light (lambda = 254 nm, lambda = 366 nm) during
different times. The method of the consecutive double serial
dilutions was used for determination of cfqH MIC before and
after irradiation.
Results: MIC of the nonirradiated sample was 0.25 lg/ml.
During increasing time of the exposure to radiation (lamb-
da = 254 nm) MIC was growing pro rata and was 20 lg/ml
after 20 min of irradiation. At the same time we studied the
inﬂuence of the light with lambda = 366 nm on the antibacterial
activity of cfqH. MIC was found to be greatly less than one after
lambda = 254 nm irradiation and remained the same long time.
Also dependence MIC of the starting concentration of cfqH
solution was found. Antibacterial activity of cfqH depends on
dose and lambda of the light and starting concentration of cfqH
solutions undergone irradiation. CfqH effectiveness decreased
considerably after 10 min irradiation lambda = 254 nm and
60 min lambda = 366 nm. At the same time MIC noticeably
decreased during increasing starting concentration of the sam-
ples.
Conclusions: The features of the kinetic behaviour curves of
cfqH under irradiation correlate with MIC changes. The possible
mechanism of cfqH inactivation was discussed.
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P710
In vitro activity of linezolid against bacteroides
and prevotella recovered from soft tissue
infections
H. Canawati, S. Bughi, A. Sharma, H. Canawati (Downey, US)
Objectives: Bacteroides (Bact) and Prevotella (Prev) are the two
major anaerobic bacteria recovered from soft tissue infections
(STI) at our institution. We reported earlier an excellent Lin
activity against methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant enterococci (VRE), Corynebacteri-
um jeikeium (Cjk) that are frequently involved in STI. Our
objective was to conduct an in vitro activity of Lin against a
number of Bact and Prev recovered from STI (75% diabetics) in
an attempt to gain extra information on Lin activity against Bact
& Prev.
Methods: STI samples collected in anaerobic transport tubes
were processed within few hrs on 3 pre-reduced anaerobic
blood agar plates as described by conventional methods. After
48-h of anaerobic incubation bacteria were identiﬁed by API-
20A system (Bio-Merioux) and other differential tests. Lin
activity was tested by E-test strip (AB-Bidisk) using pre-reduced
anaerobic Brucella blood agar plates incubated anaerobically at
37 C for 48 hrs. B. fragilis ATCC 25285 and B. thetaiotaomicron
ATCC 29741 were used as controls.
Results: A total of 232 isolates of Bact(n-141) and Prev(n-91)
were exposed to Lin. Of Bact there were 65 B. fragilis; 26
Bacteroides spp.; 18 B. vulgatus; 22 B. ovatus/thetaiotaomicron and
10 B. distasonis. Of Prev, there were 56 P. bivia; 22 P. melanini-
ogenica/oralis and 13 P. intermedia/disiens. In total 141 Bact
isolates tested, the minimal inhibitory concentraion (MIC)
values of £2 lg/ml (susceptible category), 3–4 lg/ml (interme-
diate category) and ‡6 lg/ml (resistant category) were exhibited
in 64 (45%), 60 (42%) and 17 (12%), respectively. A total of 55
(39%) susceptible Bact strains exhibited MIC of 1–2 lg/ml,
whereas all Bact resistant strains had an MIC of only 6 or 8 lg/
ml. Of the total 91 Prev isolates tested, MIC of £2, 3–4, and
‡6 lg/ml were obtained in 73 (80%), 14 (15%) and 5 (5%),
respectively. All the latter 5 Prev strains, had an MIC of 6 lg/ml
only.
Conclusion: In general, considering an MIC value of £2 lg/ml
as the susceptible cut-off line, there was a total of 134/432 (58%)
susceptible strains of Bact & Prev. An additional intermediate
MIC value of 3–4 lg/ml was obtained in 73 strains (31%). This
may increase Lin activity and make this oral agent an alternative
therapeutic option in 2 ways (i) to treatment the outpatients who
normally suffer from diabetic soft tissues infected with multiple
organisms such as MRSA, VRE, Cjk, Bact and Prev, and (ii) to
use Linezolid when the patient develops an allergy to vanco-
mycin.
P711
In vitro activities of cefepime, cefpirome and
ceftazidime in combination with amikacin or
ciproﬂoxacin against Pseudomonas aeruginosa
B. Ozbek, G. Otuk (Istanbul, TR)
Objectives: Pseudomonas aeruginosa continues to be a major
nosocomial pathogen which is a leading cause of mortality,
particularly among patients with immunosuppression, malig-
nancy, cystic ﬁbrosis, burns and traumatic wounds. Since P.
aeruginosa infections often progress rapidly in these patients,
optimal results can only be achieved when timely administra-
tion of an effective antimicrobial therapy is ensured.
Results and methods: With this purpose the in vitro activities of
cefepime, cefpirome and ceftazidime alone and in combination
with amikacin or ciproﬂoxacin were assessed in clinical isolates
of P. aeruginosa. The minimum inhibitory concentrations (MIC)
of these antibiotics were determined by microbroth dilution
technique, and according to the MIC values, 95% of the strains
have been found susceptible or intermediate susceptible to
amikacin, 77% to cefepime, 68% to cefpirome, 59% to ceftadiz-
ime and 46% to ciproﬂoxacin. In vitro activities of these
antibiotics in combinations with amikacin and ciproﬂoxacin
against 15 P. aeruginosa strains have been studied by time kill
curve method.
Conclusion: Combinations with amikacin have been found
more synergistic than those where ciproﬂoxacin was involved.
When amikacin was combined with cefepime, cefpirome or
ceftazidime synergistic interactions were observed most fre-
quent with ceftazidime (93.3%). The combinations with highest
bactericidal interactions were the ones where cefpirome was
involved. No antagonism was observed with any combination.
P712
Antimicrobial resistance of Streptococcus
pneumoniae and Haemophilus inﬂuenzae in
Lithuania
I. Narkeviciute, G. Bernatoniene (Vilnius, LT)
Streptococcus pneumoniae (SP) and Haemophilus inﬂuenzae (HI) are
still the most important respiratory pathogens.
Objective: The aim of this study was to determine antimicrobial
resistance of SP and HI isolated from clinically signiﬁcant
specimens in Vilnius University Children’s Hospital.
Material and methods: A total of 220 SP and 435 HI strains
isolates were examined during the period 2000–2004. Isolation
and identiﬁcation were performed according to conventional
microbiological methods. SP susceptibility tests to penicillin
(PEN) and erythromycin (ERY) and HI susceptibility to ampi-
cillin (AMP), cefuroxime (CXM), cefotaxime (CTX) and azithro-
mycin (AZI) were performed using the disc-diffusion method
according to the NCCLS recommendations.
Results: The overall resistance (%) of SP to PEN was 1.9 (4.1, 0,
5.7, 0, 4.8), to ERY 9.2 (6, 7.3, 8.6, 3.4, 14.5) and the resistance of
HI to AMP was 8 (8.3, 3.4, 7.6, 7.3, 11.8), to CXM 5.4 (5.7, 3.6, 6.7,
4.5, 5.9) and 0% for CTX and AZI.
Conclusions: These data showed high sensitivity of SP and HI
strains to the tested antibiotics. All HI strains appeared to have
stable sensitivities to CTX and AZI.
P713
Cefepime alone or in combination with
clavulanic acid, gentamicin, and tobramycin
against clinical isolates of methicillin-resistant
Staphylococcus aureus
J. Chin, M. Rybak, C. Cheung, K. Lau, H. Sader, R. Jones
(Detroit, US)
Objectives: To further evaluate cefepime (CPM) alone or in
combination with clavulanic acid (CA), gentamicin (GEN), or
tobramycin (TOB) against clinical strains of MRSA. We have
previously demonstrated synergistic activity with combinations
of CPM and GEN, TOB, or sulbactam (SUL) against MRSA.
Methods: 50 clinical MRSA isolates were screened by micro-
broth dilution for susceptibility (S) to CPM, GEN,TOB, CA, as
well as CPM combined with CA 1:1 (CPM-CA), CPM combined
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
with GEN 1:1 (CPM-GEN), and CPM combined with TOB 1:1
(CPM-TOB). 10 clinical isolates were evaluated by time-killing
curve analysis of CPM, GEN, TOB, CA, CPM-GEN, CPM-TOB,
and CPM-CA at 0.5, 1, and 2· the MIC using a starting inoculum
of 1·106 CFU/mL. Synergy is deﬁned as >2.5 log kill, additivity
is deﬁned as <2.5 but >1 log kill, and indifference is deﬁned as +
or –1 log kill.
Results: MRSA S to CPM, CA, GEN, TOB, CPM-CA, CPM-G,
and CPM-T are reported as follow [MIC50 (range) in mg/L]: 32
(1–64), 64 (32–64), 0.5 (0.13–32), 1 (0.25–32), 32 (4–64), 0.5 (0.25–
32), 2 (0.5–64). MBC50 (range) in mg/L for CPM, CA, GEN,
TOB, CPM-CA, CPM-G, and CPM-T are 32 (1–64), 64 (32–64), 1
(0.5–32), 2 (0.5–32), 64 (4–64), 1 (0.25–64), 3 (0.5–64). 12% of the
isolates demonstrated a decrease in the MIC when CA was
added. However, all of the clinical isolates demonstrated a
decrease in the MIC when GEN was added (100%) while 54%
showed a decrease when TOB was added. Time-killing curve
analysis of the clinical isolates showed no difference in log kill
for 8 of the organisms tested with CPM and CPM-CA. One
organism demonstrated synergy and one showed additivity at
24 h when tested with CPM and CPM-CA. Time-killing curve
analysis of the same isolates also showed synergy at 24 h for 2
organisms when tested with CPM-GEN or CPM-TOB. However,
early synergy was noted at 4 or 8 hours in 6 organisms.
Conclusions: A majority of the clinical isolates reported an
elevated MIC to CPM. As opposed to SUL previously reported,
the addition of CA did not appear to enhance the S of those
organisms. In addition, time-killing curve analysis primarily
showed indifference with the CPM-CA combination, suggesting
that CA may not have a beneﬁcial effect as SUL. However,
susceptibility is enhanced in all and more than half of the clinical
isolates with the addition of GEN and TOB, respectively. The
combinations, CPM-GEN and CPM-TOB might warrant further
investigation.
P714
In vitro activities of daptomycin, linezolid, and
quinupristin-dalfopristin against clinical isolates
of Staphylococcus aureus and Staphylococcus
epidermidis from Germany
M. Kresken, J. Brauers (Rheinbach, DE)
Objectives: Drug resistance in Gram-positive pathogens has
become an increasing problem over the last two decades.
Methicillin (oxacillin)-resistant isolates of Staphylococcus aureus
(MRSA) and Staphylococcus epidermidis (MRSE) are now major
nosocomial pathogens worldwide. New antibacterial agents
such as daptomycin (D), linezolid (L), and quinupristin–dal-
fopristin (Q–D) have been developed to address these problems.
The objective of this study was to evaluate and compare the
in vitro activity of D, L, and Q–D against recent clinical isolates
from various places in Germany.
Methods: A total of 164 isolates including MSSA (n = 29),
MRSA (n = 50), MSSE (n = 29), and MRSE (n = 56), obtained
from various multicentre studies conducted between 2001 and
2004 were tested. Minimum inhibitory concentrations (MICs) for
D, L, Q–D, vancomycin, teicoplanin, ciproﬂoxacin, and oxacillin
were determined by the broth microdilution procedure accord-
ing to CLSI (NCCLS) guidelines.
Results: MIC50/90 values for D, L, and Q–D were 1/1, 2/2, and
0.5/0.5 mg/L against MSSA, 1/1, 2/2, and 0.5/1 mg/L against
MRSA, 1/1, 1/1, and 0.5/0.5 mg/L against MSSE, and 1/1, 1/1,
and 0.5/0.5 mg/L against MRSE. No signiﬁcant differences in
the success rates between D, L, and Q–D were observed for
MSSA (100%, 100%, 100%), MRSA (100%, 94%, 98%), MSSE
(100%, 100%, 100%), and MRSE (100%, 100%, 98%), respectively.
Vancomycin and teicoplanin were active against all staphylo-
cocci. Based on MIC90 values, however, vancomycin was
fourfold more potent against MSSE and MRSE than teicoplanin.
98% and 68% percent of the MRSA and MRSE strains were
resistant to ciproﬂoxacin, respectively.
Conclusion: D, L, and Q–D each demonstrated potent in vitro
activity against S. aureus and S. epidermidis including methicillin
(oxacillin)-resistant isolates.
P715
In vitro antichlamydial activity of moxiﬂoxacin
versus a range of antimicrobial agents
R. Cevenini, M. Donati, S. Pignanelli, S. Accardo, F. Cavrini,
C. Mazzeo (Bologna, IT)
Objectives: To test the in vitro activity of moxiﬂoxacin (MXF)
versus doxycycline (DOX), levoﬂoxacin (LFX), clarithromycin
(CLAR) and erythromycin (ERY) against C. trachomatis.
Materials: 30 strains of C. trachomatis (10 typed and 20 untyped
clinical isolates from urethral swabs of male patients with non-
gonococcal urethritis) were tested. Susceptibility testing was
performed in plated LLC-MK2 cells in supplemented Eagle’s
minimum essential medium. Plates were inoculated with chla-
mydiae that yielded 5·103 inclusion forming units (IFU)/mL.
Cultures were stained with ﬂuorescein-conjugated monoclonal
antibody speciﬁc for the chlamydial lipopolysaccharide genus-
speciﬁc antigen. All antimicrobial agents were obtained as
powders and solubilized according the instructions of manu-
facturers. Minimum inhibitory concentration (MIC; lowest
concentration preventing >90% chlamydial inclusion detection
compared with the drug-free control) and minimum bactericidal
concentration (MBC; lowest antimicrobial concentration result-
ing in >90% reduction of inclusion) were determined.
Results: The results are shown in the Table. Of the ﬂuoroqu-
inolones, MXF was more active than LFX. Of the macrolides,
CLAR was more active than ERY. MXF had the best bactericidal
activity of all the compounds tested.
Conclusions: These data conﬁrm the high activity of MXF
versus C. trachomatis. Therefore, MXF is likely to be a suitable
treatment for infections where C. trachomatis is a potential
pathogen.
P716
Time-killing of viable Staphylococcus spp.
against Helicobacter pylori clinical isolates
J. Dı´az-Regan˜o´n, T. Alarco´n, E. Aznar, D. Domingo,
M. Lo´pez-Brea (Madrid, ES)
Objective: To determine the inhibitory effect of 2 viable
Staphylococcus strains against 4 H. pylori clinical isolates by a
time-kill assay.
Methods: H. pylori strains were isolated from 4 gastric biopsies.
They were plated on blood and Pylori agar and incubated under
microaerobic atmosphere at 37 C for 3–5 days. Identiﬁcation
was made by Gram stain and the presence of oxidase, catalase
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and urease and susceptibility pattern was performed by disc
diffusion for amoxicillin and tetraciclin and E-test for metroni-
dazole and clarithromycin. Virulence factors (cagA and vacA
genes) were also studied by PCR. Two Staphylococcus strains (1
S. auricularis and 1 S. epidermidis) were isolated from blood
cultures. Culture supernatants were obtained by centrifugation
(10 min at 13,000 rpm), ﬁlter-sterilized (0.45 micron pore size
ﬁlter) to eliminate the presence of viable cells, lyophilized by
freezed-drying and concentrated at 1000 mg/ml in PBS. Bacter-
ial viability between Staphylococcus strains and H. pylori clinical
isolates was estimated by a time-kill assay. Tubes were prepared
with BHI supplemented with bovine foetal serum and H. pylori
after a 3 MacFarland suspension. Viable Staphylococcus (0.5
MacFarland suspension) or lyophilized Staphylococcus were then
added and also amoxicillin to one of the tubes. At the initial time
of inoculation and at various times thereafter (1 h, 2 h, 6 h,
24 h), the number of viable CFU remaining were determined by
performing serial dilution bacterial colony counts on Mueller–
Hinton agar with 5% of horse blood, 10 mg/l of vancomycin
and 10 mg/l of anfotericin B. Plates were incubated under
microaerobic atmosphere at 37 C for 5–7 days.
Results: We obtained different patterns of inhibition after
24 hours of incubation. Two H. pylori isolates were inhibited
by the viable Staphylococcus and not by the lyophilized
Staphylococcus. Two H. pylori isolates were inhibited only by
one of the viable Staphylococcus and not by the lyophilized or the
other viable Staphylococcus, even though in the last case the
number of H. pylori colonies did not decreased as much as the
amoxicillin curve.
Conclusions: (1) Viable Staphylococcus was able to inhibit H.
pylori growth whether the cell-free supernatant was not. (2) H.
pylori isolates had different susceptibility patterns so it seems
that resistance is not important for Staphylococcus inhibition
effect. (3) Further studies are needed in order to know the
clinical applications of these results.
P717
IBC-1 survey in Acinetobacter baumannii isolates
in a tertiary care hospital in Thessaloniki, Greece
K. Koraki, P. Karapavlidou, D. Soﬁanou (Thessaloniki, GR)
Objectives: IBC-1 is a beta-lactamase conferring high level
resistance to ceftazidime and inhibited mainly by imipenem and
to a lesser extent by inhibitors. bla IBC-1 gene is located in the
variable region of class 1 integron, In111, constituted of gene
cassettes also encoding the aminoglycoside modifying enzymes
AAC(6¢)-Ib and ANT(3()-Ia as well as dihydrofolate reductase I.
This study aimed to investigate the possible distribution of IBC-
1, which was ﬁrst identiﬁed in our hospital in an Enterobacter
cloacae strain, in Acinetobacter baumannii.
Methods: From June 2001 to July 2002, 57 clinical A. baumannii
isolates resistant to ceftazidime and susceptible or intermedi-
ately resistant to imipenem were collected and investigated.
Identiﬁcation and susceptibility testing were performed using
the Vitek2 automated system (bioMerieux, France). Suscepti-
bilities to amoxicillin/clavulanate (AMC), piperacillin/tazobac-
tam (TZP), ticarcillin/clavulanate (TCC), gentamicin (GM),
tobramycin (TOB), amikacin (AN) and trimethoprim/sulfo-
methoxazole (SXT) were also determined. In order to investi-
gate the presence of bla IBC-1, a 400-bp internal fragment of
the gene was ampliﬁed, corresponding to the segment 51–450
of the published sequence. E. cloacae HT9 was used as positive
control.
Results: Out of the 57 isolates 37 were susceptible to imipenem
and 20 presented intermediate resistance. All isolates were
resistant to ceftazidime. Inhibitor combinations were active only
in 3 cases. Resistance to inhibitor combinations was demonstra-
ted for 75.4%, 33.3% and 87.7% for AMC, TZP and TCC
respectively. A high percentage of intermediate resistance was
reported for TZP (63.1%). Resistance rates for GM, TOB, AN and
SXT were 35%, 43.8%, 75.4% and 75.4%, respectively. No speciﬁc
resistance phenotypes were observed suggesting that there were
no epidemic clusters of infection in our hospital. No IBC-1
producing strains were observed since PCR results were
negative in all cases tested.
Conclusion: The present study indicates that IBC-1 is not a
problem in A. baumannii strains in our region. But since a
speciﬁc geographical distribution has been reported for beta-
lactamases and since the beta-lactam selective pressure facili-
tates the spread of these genes and their establishment in
pathogenic microorganisms, a continuous survey for IBC pro-
ducers in the hospitals of our area is warranted.
P718
Antibacterial activity of fractions of Quercus
infectoria (nut galls) against enterohaemorrhagic
Escherichia coli
S.P. Voravuthikunchai, S. Suwalak, T. Supawita (Hatyai,
Songkla, TH)
Objectives: Stimulation of Verocytotoxin (VT) production due
to the use of subinhibitory concentrations of quinolones for
patients with diarrhoea caused by enterovirulent organisms
including enterohaemorrhagic Escherichia coli (EHEC) has been
reported. The aim of this study was to analyse the effects of
semi-puriﬁed fractions of Quercus infectoria nutgalls, which has
been previously reported as effective against these organisms,
on the production of VT.
Methods: Dry powder of crude ethanol extract is further
fractionated in quick column chromatography using gradient
solution with chloroform of increasing polarity by methanol.
Active fractions were screened against different strains of EHEC
including two strains of E. coli O157: H7, E. coli O26: H11, E. coli
O11: NM, and E. coli O22. Escherichia coli ATCC 25922 was used
as a reference strain. Minimal inhibitory concentration (MIC)
and minimal bactericidal concentration (MBC) were determined
by broth microdilution method using Mueller–Hinton broth and
subculturing method onto fresh Mueller–Hinton agar, respect-
ively. The inhibitory effects of the active fractions on the
production of VT were tested for their cytotoxicity activity in a
Vero cell assay system and reversed passive latex agglutination.
Results: Three major fractions (fraction Qi 2, fraction Qi 3, and
fraction Qi 4) showed good antibacterial activity against all
strains of enterohaemorrhagic Escherichia coli. The fractions Qi 3
and Qi 4 were demonstrated to be highly effective against E. coli
O157: H7 with the MIC values of 28 and 56 lg/ml and the MBC
values of 56 and 112 lg/ml, respectively. Further study showed
that subinhibitory concentration of both fractions signiﬁcantly
depressed the VT production, both VT1 and VT2.
Conclusion: Both fractions, Qi 3 and Qi 4, of Quercus infectoria
were proved to be very active against EHEC and depressed the
VT production. Tannin has been reported to be main the
constituent of this plant. It is now being further puriﬁed and
identiﬁed using NMR spectra and mass spectrometry for
potentially bioactive components to provide alternative treat-
ment for EHEC infection.
Acknowledgement: This work was supported by a fund from
Thailand-Tropical Diseases Research Programme. National
Center for Genetic Engineering and Biotechnology, Fiscal year
2004.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P719
In vitro synergy between glycopeptides and
carbapenems against methicillin-resistant
Staphylococcus aureus
O¨.K. Azap, H. Arslan, F. Timurkaynak, G. Yapar, U¨. C¸azir
(Ankara, TR)
Objectives: The aim of this study is to investigate the synergy
between glycopeptides-carbapenems, glycopeptides-cefepime
against methicillin-resistant Staphylococcus aureus and whether
there is any dispreancy between them.
Methods: A total of 30 MRSA isolates were studied. None of the
isolates had reduced susceptibility to glycopeptides. E-test was
performed to investigate the synergy of vancomycin-imipenem
(VA-IPM), vancomycin-meropenem (VA-MEM), teicoplanin-im-
ipenem (TEC-IPM), teicoplanin-meropenem (TEC-MEM),
vancomycin-cefepime (VA-FEP), teicoplanin-cefepime (TEC-
FEP) combinations.
Results: Results are shown in the Tables 1 and 2. Synergy was
detected in 19, 25 of 30 strains for the VA-IPM and VA-MEM,
TEC-IPM and TEC-MEM combinations, respectively. VA-FEP
synergy was detected in 19, TEC-FEP synergy was detected in
the 21 of the isolates.
Conclusion: Glycopeptides have been used in the treatment of
methicillin-resistant Staphylococcus aureus infections for the last
30 years. Tissue penetration of the glycopeptides is usually
questionable when serious infections such as infective endocar-
ditis are the case. Combination therapy may offer new thera-
peutic approaches in the treatment of such infections since
in vitro studies provide promising results.
P720
Susceptibility rates of co-trimoxazole, cefepime,
imipenem, meropenem against ESBL-producing
and non-producing E. coli and Klebsiella strains
O¨.K. Azap, F. Timurkaynak, G. Yapar, U¨. C¸azir, H. Arslan
(Ankara, TR)
Objectives: The number of antibiotics to be used in the
treatment of infections caused by extended spectrum beta-
lactamase (ESBL) producing bacteria is limited. The aim of this
study is to determine the minimal inhibitory concentrations
(MIC) and susceptibility rates of ESBL producing and not
producing E. coli and Klebsiella strains against co-trimoxazole,
cefepime, imipenem and meropenem.
Methods: One hundred and twenty-eight (48.2%) of 263 E. coli
strains and 58 (31.1%) of 176 Klebsiella strains isolated from the
hospitalized patients in 2001 were GSBL producers. A total of 69
E. coli isolates (36 ESBL negative and 33 ESBL positive) and 57
Klebsiella isolates (34 ESBL negative, 23 ESBL positive) were
included to this study. MIC values of the strains were deter-
mined by agar dilution method according to the CLSI criteria.
Results: MIC values and susceptibility rates obtained in this
study are shown in the Table. MIC values of co-trimoxazole and
cefepime against ESBL positive strains are higher than the ESBL
negative ones. MIC values of carbapenems were similar against
both the ESBL negative and positive bacteria.
Conclusion: All the strains tested were found to be susceptible
to imipenem and meropenem. Carbapenems seem to be appro-
priate choices in the treatment of infections caused by ESBL
producing bacteria based on the in vitro susceptibility data.
P721
Comparison of the minimal inhibitory
concentration values of vancomycin and
teicoplanin against staphylococci with the results
obtained 7 years ago
O¨.K. Azap, F. Timurkaynak, E. Oruc¸, T. Togan, H. Arslan
(Ankara, TR)
Objectives: Staphylococci are frequently isolated from commu-
nity and hospital acquired infections. Vancomycin has been
used for the methicillin-resistant staphylococcal infections con-
ﬁdentially for many years. The aim of this study is to determine
the MIC values of vancomycin and teicoplanin against staphy-
lococci and to compare the results with the MIC values obtained
from the same laboratory 7 years ago.
Methods: The isolates included in this study were collected
from samples obtained from different patients. The distributions
of the isolates were as follows; 76 MSSA, 77 MRSA, 79 MS-
CoNS, 78 MR-CoNS.
Results: MIC values obtained in this study are shown in the
Table. MIC50 and MIC90 values for vancomycin against MSSA,
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MRSA, MS-CoNS, MR-CoNS were found to be similar with the
values obtained 7 years ago. MIC50 values of teicoplanin against
all strains increased. MIC90 values of teicoplanin against MSSA,
MRSA and MS-CoNS were similar with the results of the
previous study. Only the MIC90 value against MR-CoNS
increased.
Conclusion: Absence of staphylococcal isolates either with
reduced susceptibility or resistant to glycopeptides in our
study is a pleasant result.
P722
Serotypes and quinolone resistance in Salmonella
enterica isolated from Greek diarrhoeal patients
S. Maraki, G. Samonis, E. Nioti, A. Georgiladakis, Y. Tselentis
(Heraklion, Crete, GR)
Objective: To determine the serotype distribution and the
in vitro activity of nalidixic acid and ciproﬂoxacin of 825
Salmonella enterica strains isolated from diarrhoeal patients in
Crete, Greece.
Methods: A total of 825 Salmonella enterica strains isolated from
faecal samples were tested. Identiﬁcation was made according to
standard microbiological procedures and serotyping was per-
formed with commercial antisera by the slide agglutination
method. Antimicrobial susceptibility testing was checked by the
disk diffusion method. The MICs of nalidixic acid and ciproﬂ-
oxacin were determined by the use of the E-test and were
interpreted according to the NCCLS guidelines.
Results: A total of 29 serotypes were identiﬁed. Serotype
Enteritidis was the most prevalent (563 strains or 66%) followed
by serotype Typhimurium (147 strains or 17.2%). Infantis (3.2%)
and Newport (3.2%) were the next most frequent serotypes. All
isolates were sensitive to ciproﬂoxacin but forty-one (4.8%) of
them were resistant to nalidixic acid. All nalidixic acid-resistant
strains (34 belonging to serotype Enteritidis and 7 belonging to
other serotypes) exhibited decreased ciproﬂoxacin susceptibility
(0.125–0.75 lg/ml).
Conclusion: Reduced susceptibility to ciproﬂoxacin found in
4.8% of salmonellae in our area is a cause of concern.
P723
Co-trimoxazole resistance in urinary tract
infection agent E. coli in 1995 and 2005:
a multi-centre study in Ankara, Turkey
N. Coplu, H. Simsek, A. Gozalan, G. Hascelik, S. Ercis, Z. Senses,
M. Baysallar, I. Mumcu, N. Balaban, S. Terzioglu, S. Ozkan,
B. Esen (Ankara, TR)
Objectives: Detection of co-trimoxazole resistance in UTI agent
E. coli and its distribution in different parameters have been
aimed in this study.
Methods: The study was performed in 1995 and 2005, and 382
and 510 UTI agent E. coli strains were included, respectively.
The strains were identiﬁed by standard laboratory techniques in
Hacettepe University, Faculty of Medicine (HUFM), Gulhane
Military Medical Academy (GMMA), Ankara Numune Govern-
ment Hospital (ANGH), Dr. Sami Ulus Pediatric Hospital
(SUCH) and Reﬁk Saydam National Hygiene Center (RSNHC).
There were no record about gender, age or being outpatient/
inpatient in 1995, but these parameters were recorded in 2005
with an exception of the age of 44 patients. Antibiotic suscep-
tibility tests were performed by microdilution method according
to National Committee for Clinical Laboratory Standards criteria
in RSNHC laboratory, trimethoprim (Serva-37049) and sulpha-
methoxazole (Sigma S-7507) were used and Enterococcus faecalis
ATCC 29212 and Escherichia coli ATCC 25922 were included for
quality control. Chi-square and Fishers Exact test was done for
statistical analysis by SPSS 10.0 for Windows.
Results: The resistance percentage, MIC50 and MIC90 in 1995
were 75.1%, 32/608 and >32/608, respectively and in 2005 were
55.5%, 32/608 and >32/608, respectively. The distribution of
number of the strains and resistance percentages according to
the hospitals and years are shown in Table. There was a
reduction in resistance percentages in every hospital and for the
total from 1995 to 2005 and the differences were statistically
signiﬁcant with exception of HUFM and GMMA. On the other
hand there was no statistically signiﬁcant difference among the
hospitals in each year. The resistance percentages for children
(n = 208) was 61.1% and adult (n = 258) was 51.2%, and the
difference was signiﬁcant (p < 0.05). For gender, the resistance
was 53.7% for female (n = 380) and 60.8% for male (n = 130),
and for outpatient (n = 400) it was 55.3% and inpatient (n = 110)
56.4%, and the differences were not signiﬁcant (p>0.05) (p>0.05).
Conclusion: Co-trimoxazole was frequently the treatment of
choice for UTIs as well as other infections from the early 1980s,
in Turkey. Increased resistance rates led to its therapeutic failure
and subsequent limited usage. The resistance percentages in this
study showed statistically signiﬁcant reduction from 1995 to
2005 which is thought to be a consequence of reduced rate of
use.
P724
Proﬁle and phenotypes of resistance of
microorganisms from pregnant women with
asymptomatic bacteriuria in Russia
A. Shevelev, V. Kulakov, A. Ankirskaya, A. Nikonov,
S. Belokrysenko, V. Krasnopolski, E. Dvoinikova,
E. Ailamazyan, A. Savicheva, G. Ershov, N. Nikiforovski,
L. Stratchounski (Smolensk, Moscow, Saint-Petersburg, Volgograd,
RU)
Background: Asymptomatic bacteriuria (ASB) is common
during pregnancy. But their adequate empirical antimicrobial
treatment is possible only if resistance of the UTI pathogens in
region is well established.
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Methods: During the 2002–2003 prospective epidemiological
study involved 132 pregnant women aged 16 to 43 years with
ASB (>105 CFU/ml) at 6 Russian community health-care centres
in Moscow, Smolensk, Volgograd and St-Petersburg. After
re-identiﬁcation, MICs for 7 of antimicrobials were determined
by agar dilution method and interpreted using NCCLS/CLSI
2003 guidelines.
Results: 129 urine isolates with ASB were collected. E. coli was
the predominant pathogen (65.1%), followed by Klebsiella spp.
(9.3%), Enterobacter spp. (8.5%), P. mirabilis (6.2%), Staphylococcus
spp. (3.1%) and Enterococcus spp. (2.3%). Antimicrobial resist-
ance rates of E. coli were as follows: ampicillin–29.8%;
co-trimoxazole–12.0%; gentamicin–6.0%; cefuroxime–4.8%;
amoxicillin/clavulanate–3.6%; nitrofurantoin–3.6% and fosfo-
mycin–0%. The most active antimicrobials (sensitivity 91–100%)
against Klebsiella spp. were cefuroxime, cefotaxime, gentamicin
and fosfomycin; against P. mirabilis–amoxicillin/clavulanate,
cefuroxime, cefotaxime, gentamicin and fosfomycin; against
Enterobacter spp. – cefotaxime, gentamicin and fosfomycin.
Conclusions: The main problem with uropathogens in Russia is
a high level of E. coli resistance to aminopenicillins and co-
trimoxazole. These antimicrobials should no longer be used as
drugs of choice in the treatment of ASB. The most active
antimicrobials against non-E. coli Enterobacteriaceae isolates were
cefotaxime, gentamicin and fosfomycin.
P725
Activity of moxiﬂoxacin against the urogenital
mycoplasmas Ureaplasma spp. and Mycoplasma
hominis
C.M. Bebear, H. Renaudin, C. Planty, S. Pereyre, Ch. Bebear
(Bordeaux, FR)
Objectives: Urogenital mycoplasmal species, Ureaplasma spp.
and Mycoplasma hominis, play etiological roles in some urogeni-
tal diseases in men and women. Antimicrobials potentially
active vs mycoplasmas are tetracyclines, macrolides and related
antimicrobials and ﬂuoroquinolones. Among ﬂuoroquinolones,
the most recent products present the highest activity and are,
with ketolides, the only bactericidal agents against mycoplas-
mas. Moxiﬂoxacin activity against human mycoplasmas has
been studied but with a relatively low number of strains and no
bactericidal testing. Our objective was to extend the study of the
in vitro activity of moxiﬂoxacin to a larger number of strains of
Ureaplasma spp. and M. hominis, to compare it to other
ﬂuoroquinolones and non-related antimicrobials, and to deter-
mine the minimal bactericidal concentrations (MBCs) of moxiﬂ-
oxacin against 12 strains of Ureaplasma spp. and M. hominis.
Methods: Four ATCC strains, 52 clinical isolates of Ureaplasma
spp. and 52 clinical isolates of M. hominis isolated between 2003
and 2005 at Pellegrin Hospital, Bordeaux, France, were studied.
Among the clinical isolates, 22 and 20 were resistant to
doxycycline (DOX-R). MICs and MBCs were determined as
previously described.
Results: Doxycycline was the most active, with a MIC90 of
0.25 lg/mL vs Ureaplasma isolates susceptible to tetracyclines
while the 3 newer ﬂuoroquinolones moxiﬂoxacin, gemiﬂoxacin
and garenoxacin were most active vs the DOX-R isolates.
Moxiﬂoxacin, gemiﬂoxacin, and garenoxacin had similar MICs
(MIC90s 0.5–1 lg/mL) while the MIC90s of gatiﬂoxacin, levo-
ﬂoxacin and oﬂoxacin, ranged from 1 to 2 lg/mL. Against M.
hominis isolates, moxiﬂoxacin and gemiﬂoxacin were the second
most potent behind garenoxacin with a MIC90 of 0.06 lg/mL.
Gatiﬂoxacin, levoﬂoxacin, and oﬂoxacin had higher MICs than
those of moxiﬂoxacin. Except for one Ureaplasma spp. isolate
with increased ﬂuoroquinolone MICs, moxiﬂoxacin was the
only ﬂuoroquinolone to be bactericidal against the 11 ﬂuoroqu-
inolone-susceptible isolates tested, with MBCs ranging from 0.12
to 0.5 lg/mL.
Conclusion: Of 6 quinolones tested, moxiﬂoxacin had good
activity vs 108 strains of Ureaplasma spp. and M. hominis with a
MIC90 of 1 lg/mL. It was bactericidal against almost all isolates
tested (MBC value of 0.5 lg/mL) inhibiting 11 of the 12 isolates
studied. Therefore moxiﬂoxacin could be useful as a treatment
for pelvic infections due to Ureaplasma spp. and M. hominis.
P726
Activity of moxiﬂoxacin against Mycoplasma
genitalium
C.M. Bebear, H. Renaudin, J.S. Jensen, Ch. Bebear (Bordeaux, FR)
Objectives: Mycoplasma genitalium is a genital mycoplasma
extremely difﬁcult to isolate by culture. Development of PCR
assays showed a strong association of M. genitalium with non-
gonococcal urethritis in men and cervicitis and endometritis in
women. Fluoroquinolones rank among the few antimicrobials
bactericidal against mycoplasmas. The activity of moxiﬂoxacin
has already been determined against human mycoplasmas, but
only against 7 isolates of M. genitalium. Our objective was to
extend the study of the in vitro activity of moxiﬂoxacin to a
larger number of strains of M. genitalium, in comparison with
that of other ﬂuoroquinolones (oﬂoxacin, levoﬂoxacin, gatiﬂ-
oxacin, gemiﬂoxacin, and garenoxacin) and to doxycycline and
erythromycin.
Methods: Fourteen strains of M. genitalium, 7 ATCC strains, 2
French and 5 Danish clinical isolates, were studied. Determin-
ation of MICs and MBCs was carried out as previously
described for each isolate.
Results: Erythromycin was the most active molecule with a
MIC90 of 0.015 lg/mL. Activities of moxiﬂoxacin and doxycy-
cline were similar with MIC90s of 0.12 lg/mL. Garenoxacin,
gemiﬂoxacin, and gatiﬂoxacin had similar MICs (MIC90s of
0.25 lg/mL) while the MIC90s of levoﬂoxacin and oﬂoxacin,
ranged from 1 to 2 lg/mL. The lowest MBCs against M.
genitalium isolates were obtained with erythromycin, followed in
decreasing order by those of moxiﬂoxacin (MBC90, 0.25 lg/
mL), garenoxacin (MBC90, 0.5 lg/mL), gemiﬂoxacin, gatiﬂoxa-
cin and doxycycline (MBC90, 1 lg/mL), and lastly by levoﬂ-
oxacin and oﬂoxacin (MBC90, 4 lg/mL).
Conclusion: Among the 6 ﬂuoroquinolones tested, including
newer compounds, moxiﬂoxacin offered the best activity against
14 strains of M. genitalium, with a MIC90 of 0.12 lg/mL.
Moxiﬂoxacin appeared to have bactericidal activity against all
the isolates with a MBC90 of 0.25 lg/mL, signiﬁcantly lower
than the breakpoints accepted for this antimicrobial.
P727
Emergence of extended-spectrum beta-lactamases
in a university hospital, Hamburg, Germany in
2004
B.S. Timmerbeil, E. Stu¨renburg, P. Heisig (Hamburg, DE)
Objectives: Extended-spectrum beta-lactamases (ESBLs) are a
major problem in the treatment of gram-negative infections with
cephalosporins, due to the hydrolytic inactivation of third
generation cephalosporins. Thus, this study aimed at investi-
gating the occurrence of ESBLs in the largest university hospital
in Hamburg, Germany.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Methods: Fifty ESBL-producing strains were collected at the
University Hospital Eppendorf in 2004 (total ESBL prevalences:
Klebsiella pneumoniae: 1.9%, Escherichia coli: 0.8%, Klebsiella
oxytoca: 0.8%). The MICs of the following antibiotics were
determined by micro broth-dilution technique using Micronaut-
S plates: ampicillin (AMP +/– sulbactam, SUL), amoxicil-
lin + clavulanic acid (AMOXI + CLA), piperacillin + SUL or +
tazobactam (PIP + SUL, PIP + TAZ), cefuroxime (CEFU), cefox-
itin (COX), cefotaxime (CTX +/– CLA), ceftriaxone (CRO),
cefepime (CPM), ceftazidime (CAZ +/– CLA), imipenem
(IMP), meropenem (MER), ertapenem (ERT), gentamicin
(GEN), tobramycin (TOB), amikacin (AMIK), ciproﬂoxacin
(CIP), moxiﬂoxacin (MOX), doxycycline (DOX) and cotrimoxa-
zol (COT). Breakpoints were applied according to the Clinical
and Laboratory Standards Institute (CLSI).
Results: All isolates are resistant to AMP (100%), while 76%
and 78% are resistant to the AMP + SUL and AMOXI + CLA
combinations, respectively. Only 8% of all strains were
resistant to PIP + TAZ. Regarding the cephalosporins: 26%
resistant to CAZ, 24% to CPM, 6% to COX, 90% to CEFU, 84%
to CRO and 70% to CTX. Carbapenems are clinically suscept-
ible in 98% of all isolates. There is one strain which is
resistant to IMP and ERT - intermediate to MER. 38% are
resistant to DOX. 62% are resistant to CIP, but only 48% to
MOX. 66% are not affected by GEN. TOB and AMIK are more
potent in the group of aminoglycosids (TOB 18% and AMIK
12% resistant). For COT 80% were resistant. Comparing the
results for CAZ and for CAZ + CLA for 96% an ESBL
phenotype could be conﬁrmed.
Conclusion: Compared to other hospitals the prevalence of
ESBLs is very low in the University hospital of Hamburg,
Germany. Nearly all infections (98%) could be treated success-
fully with carbapenems. One strain has shown very high MICs
to carbapenems which seems to be caused by a carbapenemase.
Fortunately, this isolate has retained susceptibility to CIP, MOX
and DOX.
Identiﬁcation and antifungal susceptibility testing for yeasts and
moulds
P728
Candida krusei: the most frequent Candida
non-albicans species isolated from superﬁcial
candidosis in Romania
F.S. Alecu, C. Tenea (Bucharest, RO)
Introduction: Our previous experience indicated as possible a
different proﬁle of the incidence of Candida spp. implicated in
superﬁcial infections in Romania.
Objectives: To compare the incidence of the most encountered
Candida spp. oral isolates in Romania and worldwide.
Premise of the study: The epidemiology of Candida spp. could
present signiﬁcant variation in different geographic sites, due to
speciﬁc ‘‘pool of yeasts’’ in a certain population.
Materials and methods: 210 oropharyngeal samples were
plated onto Sabouraud Dextrose Agar for 48 hours and incuba-
ted at 37 C. The identiﬁcation of the isolated yeasts was made
using morphological features, Germ tube tests and automatic
API System ID 32 C (BioMerieux, France). The results of the
study were compared to those of two Romanian previous
studies (from 2001 and 1968) and Artemis Global Study (2001).
Results: From all identiﬁed isolates, 58% were Candida albicans;
8% C. krusei; 7.14% C. glabrata; 3.8% C. kefyr and 2.8% C.
tropicalis; other species representing each under 1%. We noticed
that along 37 years, the incidence of Candida albicans was
relatively stable. Thus: in Romania 59% (1968); 63% (2001) and
58% (2005) and worldwide 63% (2001). In the same period of
time, the incidence of C. krusei in Romania was rather high
(12.9% in 1968; 13.5% in 2001 and 8% in 2005) compared with a
mere 2.5% in the global study (2001). The increased incidence of
C. krusei in Romania along almost 40 years made us to conclude:
(1) this could be considered a feature of the yeast population in
our country, aspect with relevance for the therapeutic strategies
(2) the species selection due to antifungal therapy could not
explain this status as being present from 1968, a moment before
the ‘‘modern antifungal age.’’
P729
Variation of galactomannan level during 24-hour
period in haematooncological patients with/
without invasive aspergillosis
Z. Racil, I. Kocmanova, E. Kubicova, J. Lochmanova,
A. Sevcikova, J. Mayer on behalf of the Working party of
opportunistic infections, IHOK, Brno, CZ
Objective: Detection of galactomannan (GM) serum level by
EIA is useful marker for diagnosis of invasive aspergillosis (IA)
in haematooncological patients (pts). We evaluated possible
affection of sample positivity by GM serum level variation
during 24 hours period.
Methods: GM serum levels have been measured in 11 pts with
hematological malignancy in 4 hours intervals during 24 hours.
Platelia Aspergillus EIA kit has been used for detection of GM
in serum. Results have been expressed as index of positivity (IP)
with cut off 0.5, 1.0 and 1.5 considered as positive. The
difference between the highest and lowest IP achieved during
the 24 hours period in each patient has been calculated.
Results: Mean IP in 7 pts (43 serum samples) with probable/
proven IA was 1.6 and mean difference between the highest and
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lowest IP achieved during the 24 hours period was 0.6 (0.17–
1.15). If IP 0.5 has been chosen as the cut off any sample has not
been negative. If IP 1.0 have been chosen as the cut off 14
samples (32%) in 4 pts have been considered as negative. And
ﬁnally if IP 1.5 has been chosen as the cut off 26 samples (60%) in
5 pts have been considered as negative. Mean IP in 4 pts (27
serum samples) with possible IA was 0.27 and mean difference
between the highest and lowest IP achieved during the 24 hours
period was 0.14 (0.09–0.2). If the lowest IP 0.5 has been chosen as
the cut off any sample has not been positive.
Conclusion: We found signiﬁcant variation of serum GM
concentration in patients with probable/proven IA during
24 hours period. This variation can lead to negative results of
Platelia Aspergillus EIA test if just one serum sample per a day
is obtained and IP 1.0 or 1.5 is used as cut off. But if lower cut off
(IP 0.5) is used (as approved by FDA and in our lab is used)
daily variation of GM level does not inﬂuence positivity of
samples and taking one sample per a day is sufﬁcient.
Acknowledgement: This work was supported by Ministry of
Health of the Czech Republic (grant no. NR/8452).
P730
Laboratory diagnosis of pulmonary aspergillosis
in tuberculosis patients
A. Kulko, I. Doroshkova (Moscow, RU)
Objective: To analyse the results of mycological and immuno-
logical laboratory investigations of pulmonary tuberculosis (TB)
patients observed during 2003–2005 in the TB clinic.
Methods: Culture (Sabouraud chloramphenicol agar, Bio-Rad
Labs.) and microscopy of bronchoalveolar lavage, sputum,
materials from lung and pleural cavities, lung tissue samples
(materials of biopsies and resection), speciﬁc identiﬁcation of
isolated mold fungi strains (conventional methods, identiﬁca-
tion media Czapek agar); detection of circulating Aspergillus
galactomannan (GM) antigen in the serum using agglutination
technique: test Pastorex Aspergillus, Bio-Rad Labs.
Results: During 2003–2005 we investigated diagnostic materials
from 467 pulmonary TB patients, which received treatment.
According to conventional criteria, colonization of the lower
respiratory tract with fungi from genus Aspergillus was detected
in 47 (10.1%) patients. In ﬁve patients Aspergillus sp. (A.
fumigatus in three cases, A. ﬂavus, A. restrictus) was isolated
from the resection materials of the lung cavity and in two
patients A. fumigatus was isolated from the materials of
bronchial biopsies. Aspergillus GM antigen detection was
made in 68 patients from risk group for invasive pulmonary
aspergillosis (positive culture and/or clinical and radiographic
data). Aspergillus GM antigen was detected in four patients; in
three of them positive results were conﬁrmed by positive culture
(materials of resection or biopsies).
Conclusions: An urgent problem of clinical physiology is
diagnosis of secondary aspergillosis in pulmonary TB patients.
It is advisable to perform a complex laboratory examination of
TB patients (mycology and immunology studies) for successful
differential diagnosis of invasive pulmonary aspergillosis. High
level of speciﬁc diversity of fungi from genus Aspergillus (11
species) colonizing respiratory tract in TB patients was revealed.
P731
Identiﬁcation of Malassezia isolates of patients
with pityriasis versicolor by using PCR-
restriction enzyme method
H. Mirhendi, K. Makimura, B. Tarazooei, N. Jalalizand (Tehran,
IR; Tokyo, JP)
Introduction: The member of the genus Malassezia are the
causative agents of the skin disease pityriasis versicolor. There
are evidences that these yeast may involve in some other
dermatological disorders such as seborrheic dermatitis and
atopic dermatitis. The recently ﬁnding shows various Malassezia
species can cause the diseases and molecular biological methods
are the most reliable way for identiﬁcation of the isolates. The
aim of the present study is identiﬁcation and determination of
frequency of Malassezia isolates in Iranian patients with pityria-
sis versicolor by using PCR-restriction method.
Methods: 83 patient’s isolates of Malassezia were isolated on
modiﬁed Dixon agar. Genomic DNA was extracted by glass-
beads-phenol chloroform method and puriﬁed by alcohol
precipitation. In all samples 28srDNA regions was PCR-ampli-
ﬁed, digested by the restriction enzyme CfoI and electrophore-
sed on 1.8% agarose gels. Identiﬁcation was carried out
according the different electrophoretic patterns after RFLP.
Results: The most frequent isolate was M. globosa (63.85%),
followed byM. furfur (28.9%),M. sympodialis (3.61%),M. restricta
(2.4%) and M. sllofﬁae (1.2%), respectively.
Conclusion: 1. PCR-RFLP is an accurate, rapid and straight
forward method for differentiation of Malassezia species. 2. The
most frequent causative agent of pityriasis versicolor in Iran
should be M. globosa.
P732
Haemolytic activity of Candida albicans and
C. dubliniensis isolated from the oral cavity of
immunocompromised patients
I. Kosalec, B. Matica, N. Jarza-Davila, T. Maretic, J. Granic,
S. Pepeljnjak (Zagreb, HR)
Objectives: The production of haemolysins is virulence factor
of several pathogenic bacterial species, but haemolytic activity of
clinical important polymorphic yeasts, Candida albicans and C.
dubliniensis is poorly investigated. Here we present study on 66
strains of C. albicans isolated from the oral cavity of immuno-
compromised patients (HIV+ and leukaemia), and C. dubliniensis
strains from oral cavity of HIV+ patients, and all strains were
compared with C. albicans from the oral cavity of healthy donors
(commensal microﬂora).
Method: The haemolytic activity was investigated according to
the method described by Luo et al., J. Clin. Microbiol. 39 (2001)
2971–2974, where the hemolytic zones (expressed as hemolytic
index) around yeast inoculum (10–8 blastospores/mL) were
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measured on Sabouraud 3% (m/V) glucose agar with addition
of 7% sheep blood after 48 h at 37 C under 5% CO2. Hemolytic
index was calculated as ratio between diameters of haemolytic
zones and diameters of colony, which was larger than
1 (1 indicates no haemolytic activity).
Results: All C. albicans and C. dubliniensis strains isolated from
immunocompromised patients showed statistically higher
hemolytic index (p < 0.05) than commensal isolates of C.
albicans. There were no differences between strains isolated
from immunocompromised patients.
Conclusion: The expression of haemolytic activity of C. albicans
and C. dubliniensis could be possible virulence factor, and
haemolysis could promote invasiveness of opportunistic com-
mensal ﬂora, especially in the group of immunocompromised
patients.
P733
Candida albicans panuveitis and an uneven
therapeutic ground, passing through all available
and potentially effective antifungal drugs:
ﬂuconazole, liposomal amphotericin B,
caspofungin, and voriconazole
R. Manfredi, S. Sabbatani, G. Marinacci, F. Chiodo (Bologna, IT)
Background: Candida endophthalmitis is a severe function-
threatening infection, more frequent in immunocompromised
patients.
Case report: A patient (p) with insulin-dependent diabetes
mellitus was admitted due to a sudden vision loss at right. After
a diagnosis of C. albicans panuveitis, i.v. ﬂuconazole (400 mg/d)
was started. Since a worsening of ophthalmologic-ﬂuorangio-
graphic picture paralleled the appearance of amblyopia, 10 d
later liposomal amphotericin B (lAB) at 3 mg/kg/d replaced
ﬂuconazole and after 14 d a remarkable reduction of exudates
was achieved. lAB was stopped after 17 d to renal insufﬁciency
(creatinine 2.11 mg/dL, azotemia 1.32 g/dL, compared with
normal values at baseline) and i.v. caspofungin was adminis-
tered at standard dosage. After 48 d of caspofungin therapy
(50 mg/d) delivered on Day-Hospital basis, active foci were still
present at ﬂuorangiography and visual acuity recovered up to
2/10, while renal impairment disappeared. Finally, i.v. voric-
onazole (400 mg/d) was started and continued for 23 d; after
this last course, our p obtained a complete resolution of
exudates at ophthalmoscopic–ﬂuorangiographic study and
visual acuity rose to 6/10. Oral voriconazole (400 mg/d) was
continued for 3 weeks upon discharge.
Discussion: The rationale of antifungal therapy of Candida
endophthalmitis is limited by the unfavourable kinetics of
several compounds and the absence of controlled trials, so that
most informations come from small series and anecdotal
reports. While ﬂuconazole may be limited by its reduced
activity on some non-albicans Candida, lAB is the standard of
care (administered by intraocular and/or systemic route), but
isolated failures were reported. The endovitreal penetration of
caspofungin is under investigation (although favourably treated
p are described) while voriconazole (either as systemic or local
injection agent) led to preliminary, satisfactory results. Our p
with a severe Candida endophthalmitis received all the four
available antimycotic agents effective against C. albicans, but
experienced disease progression during ﬂuconazole and prob-
ably long-term caspofungin administration, while the initially
favourable lAB response was hampered by reversible kidney
function anomalies, and voriconazole proved safe and effective
in leading to a complete cure and a favourable recovery of visual
acuity. Further, controlled studies are needed, to trace some
therapeutic guidelines of Candida panuveitis in patients at risk.
P734
AIDS-associated Cryptococcus laurentii
meningoencephalitis resistant to amphotericin B,
apparently prompted by a cured Cryptococcus
neoformans disease
R. Manfredi, C. Fulgaro, G. Legnani, S. Sabbatani (Bologna, IT)
Objective: Cryptococcus laurentii is a rare pathogen among
immunocompromised patients (p), with <20 described episodes
and only 1 report of possible association with C. neoformans. An
exceedingly rare case of dual HIV-associated C. neoformans
followed by C. laurentii meningoencephalitis is presented and
discussed on the ground of the literature which reports only 2
cases of HIV-associated C. laurentii infection.
Case report: A 34-y-old man HIV-infected for 8 years was lost
to follow-up until his admission due to fever and headache.
Lumbar puncture led to microscopical recognition of crypto-
cocci, with both culture examination and capsular antigen
search conﬁrming a C. neoformans meningoencephalitis, with
yeasts testing susceptible to all antifungals; a moderately
advanced immunodeﬁciency concurred (CD4+ count 151/lL).
Liposomal amphotericin B (lAB) was promptly started at 3 mg/
kg/day with immediate beneﬁt, but our p self-discharged after
12 d, and did not undergo antimycotic-antiretroviral therapy,
until a subsequent hospitalization occurred 14 weeks later,
owing to the same signs-symptoms, associated to the isolation
of C. neoformans from both CSF and blood, positive antigen
search and a persisting sensitivity to all antifungals. Negative
CSF–blood cultures were achieved after 28 days of lAB, but
5 weeks later a novel relapse of meningoencephalitis occurred
despite HAART and a maintenance weekly lAB. An unexpected,
isolated CSF C. laurentii infection was documented with a
surprising resistance to AB, while all mycological searches for C.
neoformans (CSF–blood–urine cultures, capsular antigenemia)
proved negative. High-dose ﬂuconazole was started and
HAART continued: negative C. laurentii microscopy-culture
CSF assays were obtained after 43 d, while a signiﬁcant immune
recovery concurred: CD4+ count 256 cells/lL.
Conclusions: Clinicians facing HIV-infected p should consider
that cryptococcosis may still occur, especially when HIV disease
is missed-neglected. A dual, subsequent infection by C. neofor-
mans and C. laurentii is possible, although very infrequent event,
so that the eradication of C. neoformans does not guarantee that
another Cryptococcus spp. infection could occur subsequently,
although an apparently effective therapy was used. Susceptibil-
ity studies are mandatory for C. laurentii, due to its unpredict-
able sensitivity proﬁle. Further investigation is needed to
establish whether antimycotic therapy directed against crypto-
coccosis my help select resistant C. laurentii strains.
P735
Outbreak of neonatal candidiasis: drug
susceptibility and molecular epidemiology of the
isolates
S. Asticcioli, E. Nucleo, G. Perotti, L. Sacco, R. Daturi, C. Matti,
A. Cardillo, L. Pagani (Pavia, IT)
Objectives: Invasive candidiasis in neonates has become an
increasing problem over the past decade in Neonatal Intensive
Care Units (NICUs); it is a relatively common cause of late onset
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sepsis associated with a high mortality. Although there is
growing evidence that candidemia develops primarily as a
consequence of endogenous colonization, hospital outbreaks of
Candida infection are not uncommon. During a three-months
period (August–October 2005), four invasive candidiasis
occurred in neonates in NICU of the S. Matteo hospital of
Pavia. The study was focused on the species involved, their
in vitro antifungal susceptibility and molecular typing to
determinate clonal relatedness.
Methods: Isolates were identiﬁed by standard morphological
and biochemical methods. MICs of amphotericin-B, itraconaz-
ole, ﬂuconazole, ketoconazole, 5-ﬂuorocytosine, voriconazole
and caspofungin were determined by Sensititre YeastOne
colorimetric antifungal panel plates according to CLSI document
M27-A2. The strains were examined for molecular relatedness
by PCR ﬁngerprinting employing random ampliﬁcation of
polymorphic DNA (RAPD) assay and ampliﬁcation of transpo-
sable intron region in the 25S rRNA gene.
Results: A total of 14 isolates were obtained from blood, CVC,
urine, rectal and cutaneous swabs of 8 neonates in NICU during
a three months period. 3/8 patients developed a C. albicans
bloodstream infection. All the isolates were sensitive to the
antifungals tested. The genotyping of the transposable intron
region of the colonizing and infecting C. albicans strains showed
that 12 isolates, including the three blood-isolates, belonged to
the same genotype (A) and two isolates to another genotype (B).
These results were RAPD conﬁrmed.
Conclusions: These data conﬁrm the epidemic spread of a C.
albicans strain in the NICU of our hospital. This study represents
the ﬁrst report of a C. albicans outbreak in our neonatal setting.
The genotypic analysis allow us to understand the epidemiology
of C. albicans isolates in the NICU.
P736
A new in vitromodel system to study antimycotic
drugs
S. Cagnacci, A. Palenzona, E.A. Debbia, A. Marchese, R. Corvo`,
L. Rossi (Genoa, San Remo, IT)
Objective: To help develop an in vitro bioassay to test antimy-
cotic drugs that more closely reproduces the in vivo situation. To
this purpose we are working on an experimental model
consisting in the infection by Candida albicans of human
epithelial and mesenchymal cells cultured in the 3-dimensional
context of collagen gel.
Methods: We used the oropharyngeal squamous carcinoma
HSCO cell line established in our laboratory and the HECV
endothelial cell line (ATCC) as a broad representative of
mesenchymal cells. These cells were embedded in type I
collagen gel. After the cells were grown the gels were infected
with 1 · 104 particles/ml of Candida albicans, previously isolated
from an immunocompromised patient and notable for being
sensitive to amphotericin B (AmB) and resistant to ketoconazole
(Kc). There were 3 experimental groups: (1) Candida alone; (2)
Candida with HSCO cells and (3) Candida with HECV cells.
After 24 hours from infection these cultures were treated with
AmB and Kc at the concentration of 10 lg/ml. Candida particles
were counted 24 hours later by the trypan blu-exclusion test.
Results: We ﬁrst evaluated the effects of the human cells on the
survival of Candida. In the co-culture with HSCO cells the
growth of Candida increased up to 100% over the control group.
In the co-culture with HECV cells the proliferation of Candida
was signiﬁcantly inhibited (p < 0.0001 compared to control).
Treatment with AmB consistently inhibited the growth of
Candida cells (p < 0.0007), irrespective of the presence or
absence of HSCO and HECV cells. With respect to treatment
with Kc, candida cells were: resistant in group 1, highly sensitive
in group 2 (p < 0.0001 compared to group (1) and resistant in
group 3.
Conclusion: The present results indicate that the sensitivity of
Candida to the tested drugs depended largely on the infected
human cells. In particular, the co-culture with HSCO cells, but
not with HECV cells, signiﬁcantly increased the sensitivity of
Candida to Kc. The proposed model offers distinct advantages
over standard procedures, and is expected to advance means to
assay antimycotic drugs, serving as a complementary approach
to MIC tests. (Research supported by Pﬁzer Italia).
P737
EFISG survey of current practices in clinical
mycology laboratory services in Europe
J. Bille, G. Atherton, D.W. Denning, O. Lortholary, C. Lass-Flo¨rl,
M.C. Arendrup, M. Cuenca, E. Roilides, M. Tod, S. Bretagne,
A. Voss, P. Gaustad, H. Sambatakou, P. Eggimann, J. Garbino,
M. Akova, A. Ullmann, H. Hebart, P. Mun˜oz, F.M. Mueller for
EFISG ECCMID Fungal Infection Study Group
Objectives: Mycology laboratory services are essential to the
diagnosis of mycoses. New methods (antigen detection, molecu-
lar detection or identiﬁcation, antifungal susceptibility testing
[AFST]) are available but it is not known to what extent they are
used.
Methods: A questionnaire was sent to the clinical microbiolo-
gists members of ESCMID.
Results: 171 questionnaires were returned (64% from Univer-
sity afﬁliated hospitals) with a mycology lab for 96% of them,
separated from the bacteriology lab in 38%. The following tests
are offered: direct examination (KOH 90%, brightener 52%, GMS
37%), culture for yeasts (99%), moulds (97%), dimorphic (65%),
dermatophytes (82%), conventional identiﬁcation (for yeasts
96%, moulds 85%), mostly with commercial biochemical sys-
tems (98% for yeasts). Molecular identiﬁcation (sequencing) is
available in 24% of labs for yeast, and in 21% for moulds.
Antifungal susceptibility testing is done in 94% of the labs,
mostly for clinically signiﬁcant isolates only, using E-test in 42%,
NCCLS-CLSI methods in 24%, disk diffusion in 10%, and Eucast
methodology in 4%. Fungal serology is carried out in 72% of the
labs (C. neoformans antigen 59%, Candida mannan 26%, antiman-
nan 14%, beta-D glucan 1%, Aspergillus galactomannan in 52%).
Molecular tests for fungi are carried out in 29% of the labs, for
detection in 18%, for identiﬁcation in 21%. Antifungal drug
levels are offered in only 9% of the labs.
Conclusion: This survey of practices in European clinical
mycology laboratories reveals the level of use of recently
introduced methods (AFST, antigen or molecular detection
and/or identiﬁcation tests), and will be useful to EFISG and
others for the planning of teaching activities or clinical studies.
P738
Comparison of the Sensititre YeastOne
colorimetric antifungal panel with reference M38:
a method for testing susceptibility Aspergillus
spp. to caspofungin
E. Lo´pez-Oviedo, C. Martı´n, A. Martos, C. Castro, M. Ramirez,
A. Romero, J. Palomares, E. Martı´n-Mazuelos (Seville, ES)
Objective: To compare the in vitro activity of Caspofungin (C)
by Sensititre YeastOne method (S) with that of microdilution
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reference method (MD) (CLSI, formerly NCCLS M38-A) against
Aspergillus spp.
Material and methods: The in vitro activity of C has been tested
against 15 clinical isolates of Aspergillus (5 A. ﬂavus, 4 A. niger, 3
A. glaucus, 2 A. fumigatus, 1 A. terreus) by the Sensititre Yeast
One colorimetric and the M38-A reference methods. The
Sensititre YeastOne was performed following the manufac-
ture’s instructions (range concentrations 0.008–16 mg/l). The
MD reference susceptibility testing was performed following the
CLSI M38-A document, using drug dilutions from 0.03 to
16 mg/l. Inoculum suspensions for both methods were pre-
pared recovering the conidia from a 7-day culture growth on
Potato Dextrose Agar at 35 C (ﬁnal inoculum: 0.5–5 · 104 CFU/
ml). MECs (Minimal Effective Concentrations) readings were
performed at 48 h for MD method following the published by
Kurtz et al. (1994, AAC 38: 1480–1489). MECs and MICs
readings were performed at 48 h. for S method. The MEC50,
MEC90 and range of MEC were calculated for both method; the
MIC50, MIC90 and range of MIC were calculated for S method.
The level of agreement (percentage of MECs and MICs pairs
within a ±2 dilutions range) between S and MD were calculated.
C. krusei 6258 and C. parapsilosis 22019 were used as Quality
Control strains calculated.
Results: MICs and MECs are shown in Table 1. The level of
agreement between MECs of S and MECs of MD was 60% and
betweenMICs of S andMECs ofMDwas 6.6%. TheMECs (mg/l)
were <1 mg/l for all strains with both methods. The Quality
Control strains were within the published range.
Conclusions: 1. The reading for a change in color (MIC) in
Sensititre YeastOne method does not appear to be a suitable
alternative procedure for Caspofungin susceptibility testing of
Aspergillus spp. 2. The readings of the MECs in Sensititre
YeastOne method appear to be a suitable alternative procedure
for Caspofungin susceptibility testing of Aspergillus. 3. Further
studies, with more isolates and species are needed.
P739
Efﬁcacy of anidulafungin against Candida
albicans in candidaemia and other forms of
invasive candidiasis
B. Goldstein, B. Johnson, W. Wible, D.S. Krause, H. Schlamm
(King of Prussia, Shaumberg, New York, US)
Objectives: Although several antifungal agents are currently
available for the treatment of candidemia/invasive candidiasis
(C/IC), recent clinical trials have failed to demonstrate a
signiﬁcant impact of newer agents on response and survival.
Anidulafungin (ANID) has potent activity in vitro and in animal
models and is fungicidal against Candida. A recent clinical trial
demonstrated superior efﬁcacy of ANID over ﬂuconazole (FL) in
patients with C/IC. The majority of the patients in this study
were infected with C. albicans (CA); these patients are the focus
of this analysis.
Methods: ANID (100 mg/d iv) was compared with FL
(400 mg/d iv) in a randomized double-blind study in patients
with clinical signs of C/IC and positive cultures from blood or
another normally sterile site. The primary endpoint was global
response at the end of IV therapy (EOT), which required
improvement of symptoms and eradication (ERAD) of Candida.
Organisms were sent to a reference lab for conﬁrmation of
identity and MIC determination (CLSI method).
Results: 135 patients (ANID: 74, FL: 61) had baseline infection
with CA as a single pathogen. Only 1 patient in each group had
a FL non-susceptible isolate at baseline. The global success at
EOT was 81% for ANID and 62% for FL (p < 0.05). The
eradication rate at EOT was 95% for ANID and 81% for FL
(p < 0.01). The rate of CA persistence at EOT was 2.5% for ANID
and 13% for FL (p < 0.05).
Conclusion: In patients with C/IC caused by CA, ANID was
superior to FL in terms of global and microbiological success
rates. Resistance to FL, the comparator, did not contribute to the
difference in outcome in patients with CA.
P740
Ability of Spanish clinical laboratories in
diagnosing Candida krusei infections and in
monitoring susceptibility testing. Results of the
SEIMC Quality Control Program
R. Guna, J.L. Pe´rez, N. Orta, C. Gimeno for the Programa de
Control de Calidad SEIMC, Spain
Objectives: To know the capacity of Spanish laboratories in
identifying C. krusei and in performing susceptibility tests to
antifungals.
Methods: As a part of the Spanish Society of Infectious Diseases
and Clinical Microbiology (SEIMC) External Quality Control
Program (QCP) in Mycology, the same yeast strain was sent to
an average of 200 laboratories in two separate shipments in 1998
and 2005. Results of identiﬁcation and susceptibility testing
were analysed in comparison with those provided by a reference
laboratory. As expected, the C. krusei strain was characterized by
its intrinsic resistance to ﬂuconazole (FLU).
Results: In the ﬁrst shipment (1998), the percentage of partici-
pation of laboratories was 84.2%, and 72% of them correctly
identiﬁed the yeast strain at species level, 8.0% reported only
genus Candida and the remaining 20% gave a discordant
identiﬁcation. The main methods and commercial brands used
in identiﬁcation were the biochemical systems API 20C AUX
and API ID 32C (bioMe´rieux); the last one got the 100% of
correct identiﬁcations. Susceptibility testing was performed by
40.7% of participants, and discordant results (susceptible to
FLU) were reported by 47.5% of those sending data. In their
commentaries, only 2.7% reported explicitly the inherent intrin-
sic resistance to FLU of this yeast. On the other hand, the
percentage of participation was 89.9% in the 2005 control, being
the correct species identiﬁcation 92.1%. Only 2.8% of the centres
identiﬁed the strain at genus level, and the percentage of
discordant identiﬁcations dropped to 5.1%. Again, the API
galleries were mostly used, and API ID 32C offered a complete
agreement in the identiﬁcation. The 64.5% of laboratories
performed susceptibility tests to antifungals, 72.7% reported
resistance to FLU, and 25.7% explicitly declared such intrinsic
characteristic in their comments.
Conclusion: An increased percentage of participation was
observed along the study period, as well as in the correct
identiﬁcation of the C. krusei strain, the number or laboratories
performing susceptibility tests, and in the right interpretation of
their FLU results. Altogether, these results show the need for
implementing training programs in Mycology in the clinical
laboratories. Also, they underline the potentiality of the SEIMC
QCP as a tool in the continuous education of professionals, since
the analysis of the results is followed with a revised update on
the subject of the control.
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P741
FungaLit-multi-parameter bioassay for antifungal
compounds mode-of-action studies
O. Kozlova, N. Christoﬁ (Edinburgh, UK)
Objective: The objectives of this study were to develop a
method for exploring mode-of-actions of antifungal compounds
using FungaLit (a novel bioassay enabling analysis of Ca2+
signalling using fungi transformed with the recombinant aequ-
orin gene) and to analyse a link between parameters of Ca2+
response and mode-of-actions of antifungal compounds.
Methods: Seven antifungal compounds were tested at the
concentrations from 10 lM to 50 lM. Each compound was
ﬁrstly added to the aequorin transformed fungi and the
luminescence was monitored for 4.5 min (Stage 1). Subsequently
the fungi were subjected to a hypo-osmotic shock and the
luminescence was monitored for further 4.5 minutes (Stage 2).
For each stage FungaLit calculated a range of parameters
characterising Ca2+ response including: rise time (RsT), ampli-
tude (A), length of transient (LT), number of increases, ﬁnal
resting level (FRL), recovery time (RT), and total calcium
released (TC).
Results: The results obtained (Figure 1) showed that all anti-
fungal compounds tested affected Ca2+ signalling. Ketoconazole
and clotrimazole caused only small decrease in the A of the Ca2+
response indicating that these compounds blocked some Ca2+
channels but did not have a chronic affect on fungi at the
concentrations tested. Amphotericin, ﬁlipin and nystatin trig-
gered strong increases in the RT, TC and FRL indicating that
these compounds permeabilized the plasma membrane and
were highly toxic to fungi. Filipin caused 4 times increase in the
A of the Ca2+ response suggesting that it affected Ca2+ channels.
Nystatin triggered three consequent Ca2+ increases during Stage
1 indicating that this compound caused Ca2+ release from the
internal store. Ciclopirox caused increases in the RsT, LT and
also FRL and RT suggesting that it affected both Ca2+ channels
and Ca2+ carriers though its effect on the membrane was limited.
Fluorocytosine increased the RsT, FRL and RT during Stage 1
but no long term elevation in Ca2+ was observed.
Conclusions: FungaLit was successfully used to analyse effects
of antifungal compounds on Ca2+. All different types of
antifungal compounds tested caused Ca2+ increases of different
proﬁles. Based on this initial study it was possible to suggest
that FungaLit could be used for creation of Ca2+ proﬁles of
antifungal compounds with different mode-of-actions and
subsequently these proﬁles could be used for in vitro testing
and optimisations of the current and novel antifungal com-
pounds.
P742
Fungaemia at a tertiary-care hospital: species
distribution, antifungal susceptibility and
antifungal therapy
K. Lagrou, J. Verhaegen, W.E. Peetermans, T. De Rijdt,
J. Maertens, E. Van Wijngaerden (Leuven, BE)
Objectives: Few data are available regarding the susceptibility
of Belgian yeast isolates to commonly used antifungal agents.
Both species identiﬁcation and antifungal susceptibility data are
routinely used to guide antimicrobial therapy in episodes of
candidemia. The aim of this study was to determine the
susceptibility to seven antifungal agents for all yeasts isolated
from blood cultures during a one year period and to review the
species distribution and the antifungal therapy given.
Methods: From June 2004 until June 2005, the ﬁrst yeast isolate
from each fungemic episode was collected and stored at –70 C.
Susceptibility testing was performed using Sensititre YeastOne
plate according to the instructions of the manufacturer. Anti-
fungal drugs tested were ﬂuconazole (FZ), amphotericin B (AB),
voriconazole (VZ), caspofungin (CA), ﬂucytosine (FC), ketocon-
azole (KZ) and itraconazole (IZ). Antifungal usage data for each
patient with fungemia were obtained from the Hospital Phar-
macy.
Results: A total of 62 isolates from 60 patients were collected.
33% of the isolates were non-albicans species (11 Candida
glabrata, 5 Candida parapsilosis, 1 Candida krusei, 1 Candida
lusitaniae, 1 Candida tropicalis and 1 Saccharomyces cerevisiae).
The susceptibility results (MIC range; MIC90s (mg/L)) for all
isolates tested were as follows: FZ (<0.008–64; 16), AB (<0.008–1;
1), VZ (<0.008–1; 0.25), CA (<0.008–0.5; 0.12), FC (<0.03–4; 0.12),
KZ (<0.008–16; 0.5) and IZ (<0.008–>16; 1). All C. albicans isolates
were fully susceptible to FZ. 91% of the C. glabrata isolates
showed decreased susceptibility (MIC >8 mg/L) to FZ, with one
resistant isolate (MIC = 64 mg/L). VZ and CA inhibited 100% of
the isolates at £1 mg/L. VZ was less active against C. glabrata
isolates with decreased susceptibility to FZ compared to FZ
susceptible isolates. FZ was used in 75% of fungemic patients.
CA was the second most commonly used antifungal therapy
(11.7% of the patients). In four patients therapy was switched
from FZ to CA, two to four days after isolation of the yeast from
the blood culture.
Conclusion: C. albicans was responsible for 67% of all fungemic
episodes and remained fully susceptible to FZ. Decreased
susceptibility to FZ was only observed for C. glabrata and C.
krusei. CA was the compound with the highest in vitro activity.
P743
A new in vitro kinetic model to study the
pharmacodynamics of antifungal agents:
Comparison of the activity of voriconazole and
amphotericin B administered alone and in
combination against Candida albicans
A. Lignell, A. Johansson, J. Larsson, O. Cars, E. Lo¨wdin, J. Sjo¨lin
(Uppsala, Linko¨ping, SE)
Objectives: It has previously been shown that preexposure of
Candida albicans (CA) to ﬂuconazole reduces the fungicidal effect
of amphotericin B (AMB). The aim of the present study was to
investigate whether a similar inhibitory effect was seen between
voriconazole (VOC) and AMB in a new in vitro kinetic model.
Methods: To a starting inoculum of 10000 CFU/mL of C.
albicans CCUG 32723 (Culture Collection, University of Go¨te-
borg, Sweden; MICs VOC: 0.004 mg/L, AMB: 0.25 mg/L) in
sterile broth, antifungal drugs (VOC: 5 mg/L, AMB: 2.5 mg/L)
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were administered and placed at 35 degrees centigrade. Anti-
fungal containing medium was eliminated from the culture
vessel and replaced by fresh medium with a peristaltic pump at
a ﬂow-rate adjusted to obtain the desired half-life of the drugs.
A computer controlled infusion pump compensated for the
agent with the longer half-life (VOC: 6 h, AMB: 24 h). Repeated
sampling for viable counts was made. A magnetic stirrer
ensured homogenous mixing. To verify the kinetics, vancomycin
was used to simulate VOC and AMB regimens, respectively, and
samples for drug-concentrations were measured on an Abbot
Architect ci8200 analyser (Abbot, Sweden). Each regimen was
performed in triplicate and at each experiment, there was one
unexposed control.
Results: The mean half-life when vancomycin were used to
simulate one dose of VOC was 6.4 h. The mean half-lives when
vancomycin were used to simulate three repeated doses of AMB
were 23.5, 27.2 and 21.7 h, respectively. With VOC treatment
only, viable counts (mean ± SD) were 4.02 ± 0.09, 4.79 ± 0.20
and 5.41 ± 0.55 log 10 CFU/mL at 3, 24 and 48 h, respectively.
After treatment with AMB or AMB + VOC simultaneously,
viable count was <1 log 10 CFU/mL at 3 h. With VOC treatment
at 0 h followed by AMB at 8 and 32 h, fungal growth at 8 h,
before administration of the ﬁrst dose of AMB, was 5.00 ± 0.19
log 10 CFU/mL. The viable count increased to 5.61 ± 0.29
log 10 CFU/mL at 32 h before administration of the second
dose of AMB which only resulted in a limited reduction to
4.70 ± 0.21 log 10 CFU/mL at 54 h.
Conclusion: The pharmacokinetic parameters in the kinetic
model were close to target values. Pre-treatment of CA with
VOC inhibits the fungicidal effect of AMB. The duration of this
inhibitory effect, possible dose-dependency and whether the
inhibition is observed when CA is resistant to VOC need further
investigation.
P744
Is terbinaﬁne a good antifungal drug to combine
with voriconazole or caspofungin? Study of the
activity of double combinations against invasive
clinical isolates of A. fumigatus
J. Guinea, T. Pela´ez, P. Mun˜oz, O´. Cuevas-Lobato, E. Bouza
(Madrid, ES)
Objectives: Treatment of invasive aspergillosis is complicated
by high toxicity and poor response. Double-drug combinations
are promising, but in vitro studies are necessary. We studied the
activities of voriconazole (VCZ, Pﬁzer), caspofungin (CAS,
MSD) and terbinaﬁne (TERB, Novartis) alone and combined
against clinical isolates of A. fumigatus in order to evaluate the
potential of the combination of TERB with the other two
antifungal drugs.
Methods: We studied 10 strains of Aspergillus fumigatus from 10
hospitalized patients with proven invasive aspergillosis (Ascio-
glu, CID 2002). Drug combinations were tested by using the
guidelines presented in document NCCLS M-38A, as modiﬁed
for a broth microdilution checkerboard procedure. The MIC for
each drug was deﬁned as the lowest concentration of antifungal
drug that produced a complete visual inhibition of fungal
growth. Interactions between the drugs were studied by
calculating the fractional inhibitory concentration index (FICI)
and interpreted as synergy (FICI < 0.5), antagonism (FICI > 4)
and indifference (FICI between 0.5 and 4). We calculated the
MIC instead of the MEC for CAS in order to compare the results
with VCZ and TERB.
Results: The MIC90s and ranges of VCZ, CAS and TERB, in
microg/ml, were: 1 (0.25–1), >4 and 4 (2– > 4) respectively. VCZ
was the most active antifungal drug presenting the lowest MICs.
The combination VCZ-TERB proved to be synergistic in 90% of
the strains (FICIs between 0.031 and 0.122). The combination
VCZ-CAS presented synergy in 10% of the strains (FICI 0.251),
and the combination CAS-TERB was indifferent for all strains.
Antagonism was not present in any strain or combination. The
strain that showed indifference in the combination VCZ-TERB,
also presented indifference in the other two combinations.
Conclusions: The in vitro combination of terbinaﬁne with
voriconazole is synergistic against clinical strains of Aspergillus
fumigatus. In vivo studies are warranted.
P745
In vitro activity of ﬂuconazole and voriconazole
against invasive Candida albicans isolates in
patients with candidaemia from 2001–2005 in
Hong Kong
M. Hui, R.W.F Li, P.L. Chan, M.L. Chin, K.C. Chu, C.Y. Chan
(Shatin, HK)
Objectives: Candidaemia is one of the commonest nosocomial
blood stream infection and is associated with high mortality.
Antifungal treatment ranges from conventional amphotericin B
to the new echinocandins. Azole agents provide an alternative
choice where oral formulation is available. Fluconazole and
voriconazole has been used in the treatment of candidaemia for
several years, thus, it is important to monitor for the trend of
antifungal resistance. In this study, we aimed to investigate the
in vitro activity of ﬂuconazole and voriconazole against invasive
Candida albicans isolates in patients with candidaemia from 2001
to 2005 in Hong Kong.
Methods: Non-duplicate Candida albicans isolates collected from
candidaemic patients from 2001–Oct 2005 were tested against
ﬂuconazole and voriconazole in accordance to the NCCLS
(CLSI) standard M44-A by disk diffusion method. Fluconazole
susceptibility results were interpreted according to NCCLS
(CLSI) criteria. Voriconazole susceptibility results were inter-
preted according to Pfaller et al. (Pfaller MA, Boyken L,
MesserSA, Tendolkar S, Hollis RJ, Diekema DJ. Comparison of
Results of Voriconazole Disk Diffusion Testing for Candida
Species with Results from a Central Reference Laboratory in the
ARTEMIS Global Antifungal surveillance Program. J Clin
Microbiol 2005; 43, 5208–5213). Tests were done in duplicates.
Results: A total of 73 Candida albicans isolates were collected
over the 5-year period. Among which, 12 isolates were collected
from 2001, 15 isolates from 2002, 17 isolates from both 2003 and
2004, 12 isolates from 2005 (up to and including October 2005).
Only two isolates (2.7%): one from 2003, one from 2004, showed
resistance to ﬂuconazole. None of the isolates showed resistance
to voriconazole.
Conclusion: Fluconazole and voriconazole are active against
invasive Candida albicans isolates. They remain as appropriate
choices for patients who can be considered for oral azole agents.
For ﬂuconazole, even after many years of extensive usage,
resistance rate remain low.
P746
The effect of aminocandin compared to
caspofungin and micafungin
M.A. Ghannoum, S. Dutta, N. Isham (Cleveland, US)
Objective: Aminocandin (AC) is a new echinocandin undergo-
ing pre-clinical and clinical development. Recently, Candida
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parapsilosis isolates that are resistant to caspofungin (CAS) have
been identiﬁed. The purpose of this study was to determine
whether AC inhibits CAS-resistant C. parapsilosis in a dose
dependent manner, and to compare the effect of AC relative to
CAS or micafungin (MFN) on the growth rate of the fungal
isolate.
Method: One CAS-susceptible C. parapsilosis strain (MIC of
0.5 micrograms/ml) and one strain with an elevated CAS MIC
(64 micrograms/ml) were grown in the presence of various
concentrations representing 0.5, 1, 2 and 4 times the MIC of AC
against each isolate. At predetermined time points (1, 2, 4, 8, 12,
24, 36 and 48 hours) an aliquot was removed and the optical
density (OD) read using a spectrophotometer at 420 nm wave-
length. Graphs were plotted as OD against time. Growth curves
of CAS and MFN at corresponding concentrations were deter-
mined as comparators.
Results: AC and CAS exerted similar inhibitory effects on the
CAS-susceptible strain; 1 microgram/ml (1 · MIC) showed
retardation of growth, with recovery of cells by 48 hours. In
contrast, AC (1 · MIC) showed twice the inhibitory effect of
CAS on the CAS-resistant strain at 48 hours. Comparable
inhibitory effect by MFN on both strains was attained only
with concentrations of 4 micrograms/ml.
Conclusion: Our data show that AC demonstrates potent
antifungal activity against C. parapsilosis isolates including
those known to have elevated CAS MICs and may indicate
that subtle in vitro differences in the activity of different
echinocandins may exist. The clinical implications of these
ﬁndings are yet to be determined.
P747
Antifungal susceptibility testing of
dermatophytes isolated from a worldwide Tinea
capitis clinical trial
M.A. Ghannoum, J. Matevish, A. Cirino, N. Isham (Cleveland,
US)
Objective: Tinea capitis is an infection of the hair and scalp
predominantly affecting children worldwide. The objective of
this study was to proﬁle the susceptibility of dermatophyte
isolates, obtained from paediatric patients enrolled in a
worldwide Tinea capitis study, to commonly used antifungal
agents.
Method: Following identiﬁcation, isolates obtained at baseline
visits (n = 544) were tested against voriconazole (VOR), ﬂucon-
azole (FLU), and griseofulvin (GRIS) using the CLSI M38-A
standard for dermatophytes developed at the Center for Medical
Mycology.
Results: The most common isolate from the US and Puerto Rico
was Trichophyton tonsurans (n = 474), followed by Microsporum
canis (n = 19). Other isolates from the US included M. gypseum
(n = 2) and T. mentagrophytes (n = 1). The most common der-
matophyte isolated from Central and South America was M.
canis (n = 37), followed by T. tonsurans (n = 1). The predominant
isolate from India was T. violaceum (n = 7); others included M.
canis (n = 2) and T. tonsurans (n = 1). Importantly, there was no
difference noted in MIC among dermatophyte species from
various geographical areas.
Conclusions: VOR demonstrated more potent antifungal activ-
ity than either FLU or GRIS, suggesting that VOR could be a
useful antifungal to treat infections caused by dermatophytes.
P748
In vitro activities of caspofungin and four other
antifungal agents against Trichophyton spp.
isolates
M. Demirbilek, F. Can, T. Gulec, Y. Saray, H. Arslan (Ankara,
TR)
Background: In recent years the number of infections caused
by dermatophytes has increased considerably. Pharmacother-
apy for these infections still remains a problem as the necessity
of long time appliance of antifungal agents. Caspofungin is a
new antifungal agent that acts on the cell wall by inhibiting
glucan synthesis. A standardized reference method for der-
matophyte in vitro susceptibility testing and reproducible,
clinically relevant method for caspofungin has not been fully
established. The aim of this study was to evaluate the in vitro
activity testing method of caspofungin and other antifungal
drugs against clinical isolates of Trichophyton spp. from
Ankara-Turkey.
Methods: A total of 172 clinical isolates of Trichophyton spp.
(136 T. rubrum, 29 T. mentagrophytes, and 7 T. tonsurans) were
tested. The antifungal activities of caspofungin, ﬂuconazole,
itraconazole, terbinaﬁne, amphotericin B were determined by
broth microdilution tests performed mainly according to the
NCCLS standards for ﬁlamentous fungi using RPMI 1640 as
the test medium. Microscopic and macroscopic minimal effect-
ive concentration (MEC) values for caspofungin and MIC
values for other drugs were determined after 5–7 day incuba-
tion.
Results: Microscopic and macroscopic MEC values were mostly
similar for caspofungin at all test conditions (100% agreement
for T. tonsurans, 1.5% agreement for T. rubrum and 79%
agreement for T. mentagrophytes). Caspofungin was more
active against T. rubrum (MIC50, 0.06 lg/ml and MIC90,
0.5 lg/ml) than the others (MIC50, 0.25 lg/ml and MIC90,
1 lg/ml). Terbinaﬁne was signiﬁcantly more active (MIC50,
0.002 lg/ml and MIC90, 0.008 lg/ml) than the other drugs
(p < 0.01). Fluconazole was the poorest antifungal agent as 3 of
T. rubrum and 3 of T. mentagrophytes have MIC values ‡64 lg/
ml.
Conclusions: This study showed that Caspofungin has a good
in vitro activity against dermatophytes. For methodology;
microscopic determination is not an option to assess the MECs
of caspofungin for Trichophyton spp. Standard antifungal sus-
ceptibility procedure should be urgently developed to establish
reliable resistance proﬁles of antifungal agents against dermat-
ophytes and to demonstrate the affects of caspofungin against
all molds.
P749
Update on Candida albicans antifungal resistance
trends among hospitalised patients in a tertiary
hospital in Greece
E.I. Kazakos, C. Manolopoulos, V. Papageorgiou, E. Tsiakiri,
S. Alexiou-Daniel (Thessaloniki, GR)
Objectives: Candida albicans is the main aetiological agent of
fungal infections in hospitals worldwide. Selection pressure due
to the continuous exposure to antimycotic agents has changed
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the susceptibility patterns of these isolates so that continuous
monitoring is required. In the present study, we examined the
in vitro susceptibilities of C. albicans isolates representing
predominantly invasive forms of candidiasis.
Methods: Seventy-ﬁve Candida albicans clinical isolates obtained
froma respective number of patients hospitalised during last year
at the AHEPA University Hospital in Thessaloniki, Greece were
examined. Samples were cultured on Sabouraud’s glucose,
supplemented with chloramphenicol, agar slants (30 C). Yeasts
were identiﬁed by ID YST identiﬁcation system (Vitek II,
bioMerieux, Marcy l’ Etoile, France) with higher than 99%
probability. Antifungal susceptibility testing to caspofungin,
amphotericin B, voriconazole, itraconazole, ketoconazole, ﬂuc-
onazole and 5-ﬂucytocinewas performedusing the E-testmethod
(AB Biodisk, Sweden) in accordance to the manufacturer’s
instructions. CLSI interpretive breakpoints (document M27-A2)
and tentativeMIC’s for the newer antifungal agentswere applied.
Results: Sources of isolation were blood (6.6%), bronchoalveo-
lar lavage specimens (37.3%), wound sites (9.3%), sputum (20%),
central venous catheters (7%) and normally sterile ﬂuids
(19.8%).
Conclusions: Our data conﬁrms previous reports regarding the
increasing rates of resistance and cross-resistance to, and
between older azoles. Despite the encouraging antifungal
potential of voriconazole a signiﬁcant percentage of resistant
isolates is reported. Finally, the recently introduced caspofungin
appears to have excellent in vitro activity against these isolates.
Virology - I
P750
Subclinical reactivation of VZV in patients with
tick-borne encephalitis
K. Soltysova, K. Roubalova, D. Picha, V. Maresova,
H. Rohacova (Prague, CZ)
Objectives: Herpesviruses have the very well known ability to
establish the latency in different compartments of human
organism. To date mechanism of reactivation of these viruses
especially in neural tissue is poorly understood. Aim of our
study was to evaluate the presence of herpesviruses in cerebro-
spinal ﬂuid (CSF) of patients with meningoencephalitis from
other than herpetical origin.
Methods: Forty patients (all patients hospitalised in season
2004–2005) with dimission diagnosis tick borne encephalitis
(TBE) were tested for presence of herpes simplex virus 1 (HSV1),
herpes simplex virus 2 (HSV2), varicella zoster virus (VZV) and
human herpesvirus 6 (HHV6) DNA in CSF by nested PCR. TBE
diagnosis was established on the presence of IgG and IgM
antibodies in serum by ELISA, aseptic inﬂammation in CSF and
history of tick bite. Detection of the PCR product was done by
agarose gel electrophoresis with etidiumbromide staining. Clin-
ical data including standard laboratory tests and results of
neuroimaging methods were collected prospectively.
Results: Three patients were positive for VZV DNA in CSF.
These patients had no recent history of herpes zoster and neither
rash nor neuralgia located in the dermatome was observed
during hospitalisation. There was no signiﬁcant difference in
age, length of febrile period, severity of neurological sequelae,
length of hospitalisation, and in laboratory test results including
peripheral blood cell count, CSF cytology, proteinorhachia and
glycorhachia. Although none of them was treated by acyclovir,
outcome of these patients was identical as in non-positive
patients. Tests for HSV1, HSV2 and HHV6 were negative in all
patients.
Conclusion: We have probably observed a subclinical reacti-
vation of VZV patients. Such ﬁndings decrease the value of
PCR as a single test for establishing the diagnosis of VZV
encephalitis and emphasize the need for sensitive antibody
assays. Supported by 1166/2005-IV-GA UK.
P751
Epstein-Barr virus and p53 protein expression in
gastric carcinoma without Helicobacter pylori
infection
A. Szkaradkiewicz, W. Majewski, M. Wal, P. Majewski, J. Bierla
(Poznan˜, PL)
Objectives: Role of Epstein-Barr virus (EBV) in neoplastic
transformation of gastric epithelial cells remains unclariﬁed.
Therefore, in this study we investigated p53 expression in
gastric carcinoma (GC) in patients with or without EBV
infection.
Methods: The studies were performed on 26 patients, aged 42–
64 years in whom advanced moderately differentiated GC was
diagnosed by histological method. Moreover, presence of Heli-
cobacter pylori in the studied material was excluded using the
urease test and Genta staining method. In parallel, in selected
cases in the GC material EBV-encoded small RNA (EBER)
particles were detected using in situ hybridization (ISH). Expres-
sion of p53 protein was analysed using immunohistochemistry.
Results: The results of EBER tests in the material of GC in the
selected patients permitted to distinguish 12 patients with
documented presence of EBER particles in the cell nuclei of GC
cells forming the EBV-positive group of GC patients and 14
patients without EBER forming the group of EBV-negative GC
patients. In the group of EBV-positive GC in 8 (66.6%) patients
nuclear expression of p53 protein was disclosed and in the
group of EBV-negative GC expression of p53 protein was noted
in 9 (64.3%) cases. No signiﬁcant differences were detected in
the frequencies of p53 protein expression in the two studied
groups.
Conclusions: The results permit to conclude that abnormalities
in p53 in GC are independent of EBV infection.
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P752
Cytomegalovirus and Epstein-Barr virus in
ulcerative colitis and Crohn’s disease
A. Szkaradkiewicz, R. Marciniak, P. Majewski,
I. Chudzicka-Strugala, A. Wasilewska, M. Drews (Poznan˜, PL)
Objectives: Currently, Epstein-Barr virus (EBV) as well as
Cytomegalovirus (CMV) are thought to be able not only to
infect epithelial cells but also to play a signiﬁcant role in
carcinogenesis. Therefore, in this study we aimed to examine
whether CMV and/or EBV may be associated with non-speciﬁc
colitis (ulcerative colitis and Crohn’s disease) and, moreover,
whether testing of tissue samples of ulcerative colitis and
Crohn’s disease can detect disturbed expression of p53.
Methods: The studies were performed on 24 patients, in whom
histological evaluation of tissue samples disclosed ulcerative
colitis (16 patients aged 24–60 years) or Crohn’s disease (eight
patients aged 20–50 years). DNA extracted from the samples of
ulcerative colitis and Crohn’s disease was tested for the presence
of CMV DNA using nested PCR and EBV DNA using PCR-
ELISA. Moreover, in the tissue samples EBV-encoded small
RNA (EBER) particles were detected using in situ hybridization
(ISH) and expression of p53 protein was analysed using
immunohistochemistry.
Results: In the group of patients with ulcerative colitis presence
of CMV DNA was identiﬁed in six cases (37.5%), while presence
of EBV DNA and positive reaction for EBER was documented in
10 cases (62.5%). In three of the patients both CMV DNA and
EBV DNA were present. In turn, in the group of patients with
Crohn’s disease CMV DNA was identiﬁed in only two cases
(25%), while presence of EBV DNA and positive reaction for
EBER were disclosed in ﬁve cases (62.5%). In two of the patients
both CMV DNA and EBV DNA were present. In none of the
cases could nuclear expression of p53 protein be demonstrated.
Conclusions: CMV and EBV infections may accompany ulcer-
ative colitis and Crohn’s disease but this does not seem to
induce expression of p53 protein.
P753
Cytomegalovirus infection in recipients of liver
transplant in Ireland
C.F. De Gascun, D. Houlihan, S. Coughlan, P.G. O’Reilly,
F.M. Fitzpatrick, J. Hegarty, W.W. Hall (Dublin, IE)
Objectives: Cytomegalovirus (CMV) remains the single most
important infection complication after liver transplant. The
incidence of CMV infection post-orthoptic liver transplantation
(OLT) ranges between 25% and 80%. However, no data have as
yet been published from Ireland.
Methods: We conducted a three-year retrospective audit of
laboratory and clinical records of patients diagnosed with CMV
infection. All pre-OLT CMV serological investigations and post-
OLT CMV screening from the National Liver Transplant unit
(NLTU) are referred to the National Virus Reference Laboratory
(NVRL). CMV susceptible or CMV mismatch recipients receive
3 months of CMV prophylaxis post-operatively. Patients sus-
pected of CMV infection are screened with either CMV anti-
genaemia or PCR. Response to anti-viral therapy is monitored
with either antigenaemia or PCR.
Results: Of 133 transplant recipients, 11 (8%) were diagnosed
with CMV infection. Seven (63%) occurred more than 3 months
after OLT when prophylaxis had ceased. Nine had received
prophylaxis: two, ganciclovir and seven, valganciclovir. Four
transplants were CMV donor positive /recipient positive (D+/
R+); four were D+/R(; one was D(/R(; and one was D(/R+. Six
patients were diagnosed on the basis of antigenaemia alone
(Mean=13; range 1–77/200,000 PMN). Three were diagnosed
initially on antigenaemia (range 3 to >200/200,000) and subse-
quently conﬁrmed with CMV PCR [Mean=50,000; range 600 to
>100,000 copies per ml (cpm)]. Two were diagnosed on the basis
CMV PCR alone (Viral loads 1570 and 1410 cpm). Six patients
were treated for symptomatic CMV disease. Of these, three
received IV ganciclovir, two received oral valganciclovir, and
one received oral ganciclovir. No cases of ganciclovir resistance
were recorded. None of the patients died. 1003 samples from 221
patients were received for CMV antigenaemia and 51 samples
from 39 patients for CMV PCR during the study period. There
was a marked increase in the number of requests for CMV PCR
(6 in 2003; 18 in 2004; 27 in 2005) and a less striking decrease in
the number of requests for CMV antigenaemia (405 in 2003; 314
in 2004; 284 in 2005).
Conclusions: CMV infection remains a signiﬁcant cause of post
transplant morbidity in our liver transplant population, affect-
ing 8% of recipients, the majority of which occurred after anti-
viral prophylaxis was stopped. This presentation will focus on
the risk factors and clinical presentation of CMV infection in our
population.
P754
Incidence of primary CMV infection during
pregnancy and its transmission rate to the foetus
and newborn
A. Naessens, A. Casteels, L. De Catte, S. Lauwers, W. Foulon
(Brussel, BE)
Objectives: To evaluate the incidence of primary CMV infec-
tions during pregnancy, and to evaluate the transmission rate to
the foetus according to the gestational age at which the maternal
infection occurred.
Methods: 9864 unselected pregnant women were included. All
pregnant women were tested serologically for detection of
CMV-antibodies (IgG and IgM) at the ﬁrst prenatal visit and at
delivery. Primary CMV infection during pregnancy was diag-
nosed when IgG antibodies appeared in previously seronegative
women, or when high IgM antibodies with rising IgG levels
where found in the beginning of pregnancy. For each woman
the gestational age at which the infection occurred during
pregnancy was estimated. This evaluation was based on the
dates of the last negative serology and the ﬁrst positive serum
sample and the serological proﬁle. In the neonate CMV urine
culture was performed to diagnose congenital infection. In the
foetus, congenital infection was diagnosed by CMV isolation
and/or by histological examination.
Results: Serological screening showed evidence of past infection
in 5595 women (57%); 4049 (41%) women had no antibodies in
their ﬁrst serum sample, and 220 (2%) women had both IgG and
IgMantibodieswhenﬁrst testedduringpregnancy.PrimaryCMV
infection was diagnosed in 63 pregnancies: being 51 seroconver-
sions during pregnancy and 13 women with a serological proﬁle
in the beginning of pregnancy highly suggestive of primary
infection. Four women decided not to continue the current
pregnancy before any investigation could be performed. Of the
remaining 59 women, 28 (47%) delivered a congenitally infected
infant. Mean gestational age at infection was 23 ± 9 weeks in the
group ofwomenwhodelivered a congenitally infected infant and
21 ± 11 weeks when the maternal infection did not result in a
congenitally infection. Transmission rate was 38% in the ﬁrst
trimester; 52% in the second trimester and 50% in the third. Two
childrenwere bornwith symptomatic disease, leading to death in
one of them. Two other pregnancies were interrupted after a
prenatal diagnosis: histological examination of these two infected
foetuses showed inclusion bodies in multiple organs.
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Conclusion: Primary CMV infection occurred in 0.63% of the
pregnant women. Transmission to the foetus occurred in 47% of
the women with primary CMV infection and was independent
of the gestational age at which maternal infection took place.
P755
In situ PCR and in situ RT-PCR to distinguish
productive and non-productive human
cytomegalovirus infection in blood leukocytes
B. Zawilinska, M. Kosz-Vnenchak, K. Bulek, J. Kopec,
E. Daszkiewicz (Cracow, PL)
Objective: Reactivation or primary human cytomegalovirus
(CMV) infection is an important cause of morbidity andmortality
in transplant recipients and HIV patients. Diagnostic methods,
which correctly assess viremia, including pp65-antigenemia
(pp65-ag) and PCR, are recommended in patients exposed to
CMV disease. Detection of pp65-ag in nucleus of leukocytes is a
marker for productive infection. PCR enables to amplify latent as
well as replicating viral DNA sequences. We presented two
in situ methods that can be helpful in discriminating between
latent and productive infection – in situ PCR and in situ reverse
transcription PCR (RT-PCR). These methods can be helpful in
explaining the discrepancies with the PCR and pp65-ag results,
when the antigen is found in the cytoplasm of leukocytes.
Methods: Leukocytes were obtained from 34 blood samples of
26 patients after bone marrow transplantation. For pp65-ag
monoclonal antibodies NCL-CMV pp65 were used. Two pairs of
primers for gB were used to amplify 20 or 100 ng DNA isolated
from one million of leukocytes. Absence of inhibitors of Taq
polymerase was checked. In situ PCR and in situ RT-PCR were
carried out with primers for genes coding gB and pp65 and
nucleotides labelled with DIG or ﬂuoresceine.
Results: The results of in situ PCR and in situ RT-PCR were
compared with those obtained by PCR and pp65-ag. Using PCR,
viral DNA was detected in 26 materials, two samples were
negative and in the remaining six samples the results were
unreadable due to the presence of polymerase inhibitors.
Productive infection was recognized in seven samples in
which pp65ag, PCR and in situ PCR were positive and also
transcripts for late viral genes (gB) were detected. In 20 samples,
in which the in situ RT-PCR results were negative, the presence
of DNA and pp65 ag localized in cytoplasm could probably be
due to phagocytosis. Among seven pp65-ag negative materials,
the latent form of CMV was conﬁrmed in ﬁve samples on the
basis of CMV DNA presence in the nucleus and absence of viral
transcripts using in situ methods.
Conclusion: On the basis of DNA detection in nucleus or
cytoplasm of leukocytes, and suitable transcripts conﬁrmed by
in situ methods, we allow distinguish between latent and
productive infection in 12 materials. In six samples, in which
it was impossible to carry out PCR because of the presence of
polymerase inhibitors, in situ methods played a crucial role in
proper diagnosis.
P756
A real-time PCR assay to detect human
cytomegalovirus DNA in whole blood of solid
organ transplant patients: optimal threshold for
guiding pre-emptive therapy
T. Lazzarotto, C. Vaccari, L. Gabrielli, P. Monari, S. Pop,
M.P. Landini (Bologna, IT)
Cytomegalovirus (CMV) remains the most important pathogen
of transplant recipients. The pathogenesis of CMV disease has
been extensively studied and evidence suggests that CMV blood
load is associated with disease development. The use of pre-
emptive therapy and the successful treatment of established
infection partially rely on a sensitive and reliable diagnostic test
to predict and detect disease early enough for prompt prophy-
laxis and to guide the duration of treatment. This study
evaluated a Real-Time PCR assay (afﬁgene CMV trender,
Sangtec Molecular Diagnostics, Sweden) to quantify CMV load
in whole blood specimens from solid organ transplant patients
in comparison with antigenemia pp65 assay. The purpose was to
compare the thresholds of CMV load assessed with this assay
and with the antigenemia assay to guide preemptive therapy for
CMV disease prevention. We tested 182 serial blood samples
from CMV-infected patients, namely from eight liver, eight heart
and seven intestinal transplant recipients. DNA was measured
using primers and probes located in the Major Immediate Early
Gene. CMV DNA (n.copies/mL of whole blood) was calculated
using a standard curve with synthetic DNA in concentrations of
13 to 8 · 106 copies/lL. The detection limit of the method was
400 copies/mL of whole blood (WB). CMV viremia was
monitored weekly during the ﬁrst 2 months after transplanta-
tion, every two weeks for the next 3–4 months, monthly until
6 months and then every 3 months after transplantation. The
viral load obtained by Real-Time PCR assay closely paralleled
that obtained with the antigenemia test. Both the Real-Time PCR
and the pp65-antigenemia assay detected all cases of disease at
medians of 2 and 15 days before the onset of symptoms,
respectively. Monitoring asymptomatic CMV infection to guide
pre-emptive therapy for solid organ transplant recipients
showed that peak DNA levels were <103 copies/mL of WB
before therapy and the antigenemia test was negative. The
beginning of pre-emptive therapy was associated with DNA
levels from 6500 to 7500 copies (median values) and the peak
antigenemia (median values) between 25 and 30 positive cells/
2 · 105 polymorphonuclear leukocytes, respectively. Successful
treatment was associated with a >90% reduction in DNA viral
load and completely negative antigenemia assay, we have
obtained nearly always results under the threshold of 400
copies/mL.
P757
Evaluation of a real-time NASBA assay for the
detection of herpes simplex virus type 1 and 2
C. Zintilini, P. Van de Wiel, F. Jacobs, B. Deiman, S. Vermeer
(Grenoble, FR; Boxtel, NL)
Objectives: In this study, the performances of the HSV 1/2
reagents, based on NASBA ampliﬁcation and real-time detection
with molecular beacons, were evaluated for the detection of
HSV1 and HSV2 infections.
Methods: HSV DNA is isolated using the NucliSens miniMag
extraction. An internal control is added to the sample prior to
nucleic acid extraction. The assay is designed to detect in a
single tube, with the same primer set and a three-label approach,
the internal control and both HSV1 and HSV2 DNA by targeting
the POL–gene region. Ampliﬁcation reactions were performed
in a NucliSens EasyQ Analyser allowing real-time detection.
Results: Using serial dilutions of in vitro DNA, a 95% hit rate of
the NucliSens EasyQ HSV 1/2 assay was found to be 87 copies
for HSV1 and 86 copies for HSV2 in isolation. The results
obtained with the QCMD panel 2005 showed that HSV geno-
types were correctly identiﬁed down to 580 Geq/ml. In addi-
tion, HSV genotypes were detectable in positive clinical samples
(CSF, labial and genital swabs). Interestingly, one co-infection
HSV 1+2 was detected in a CSF sample, which was not detected
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by home brew PCR. No cross-reactivity was observed with VZV,
EBV, CMV, HHV6, enterovirus, coxsackievirus and echovirus.
Conclusions: The data showed that the HSV 1/2 reagents
provide a sensitive and speciﬁc qualitative assay for the
detection of HSV1 and HSV2 viruses in a single reaction
within 3 hours. It provides a valuable alternative to the classical
cell culture method for the clinical management of patients with
HSV infections.
P758
Detection of herpes simplex virus in
cerebrospinal ﬂuid using real-time PCR
E. Aznar, J. Dı´az-Regan˜o´n, T. Alarco´n, C. Sa´nchez-Zamora,
M. Lo´pez-Brea, L. Carden˜oso (Madrid, ES)
Objective: To evaluate the performance of the Light Cycler
HSV 1/2 Detection Kit (Roche) in 124 cerebrospinal ﬂuid (CSF)
samples from adult patients.
Methods: 124 CSF samples from adult patients admitted to our
hospital since May 2004 to September 2005 were studied. Thirty-
ﬁve of them showed a typical glucose, protein and cell count
pattern of viral infection. After speciﬁc cultures, 100 ll were
separated and frozen ((80C) until further study. We performed
nucleic acid extraction with the High Pure Viral Nucleic Acid
Kit (Roche) following the manufacturer’s recommendations. An
internal control was included in each sample. The Light Cycler
HSV 1/2 also includes a positive control which, after ampliﬁ-
cation shows two melting temperature picks; 54C and 66.5C
(corresponding to HSV-1 and HSV-2 respectively). We also
analysed four cell cultures infected with HSV (two with HSV-1
and two with HSV-2) to assess the whole process of extraction
and real time PCR.
Results: One of the samples yielded a positive result to HSV-2.
It’s biochemical characteristics and the clinical pattern of the
patient were compatible with a viral meningoencephalitis. The
four infected cultures were also positive. The rest of the samples
yielded negative results but all of them showed ampliﬁcation of
the internal control. The whole process (extraction and ampli-
ﬁcation-detection) took approximately 2 hours.
Conclusions: (1) The presence of HSV in CSF samples in our
hospital is rare. (2) The HSV 1/2 Detection Kit allows rapid
detection and differentiation of HSV-1 and HSV-2 in CSF
samples and so can be a helpful tool in management of central
nervous system infections.
P759
BK polyoma virus replication in de novo renal
transplant recipients: Results of a prospective
study
M. Koukoulaki, E. Grispou, G. Saroglou, D. Pistolas, K. Balaska,
T. Apostolou, M. Anagnostopoulou, V. Hadjiconstantinou,
O. Paniara, S. Drakopoulos, N. Legakis (Athens, GR)
Objectives: BK polyoma virus has been associated with the
development of renal allograft interstitial nephritis, which may
lead to chronic allograft dysfunction. This study evaluated
prospectively the replication of BK polyoma virus in renal
transplant recipients.
Materials: Thirty-two de novo renal transplant recipients of
median age 48.5 years old were studied for mean follow up
period of 36 weeks. Plasma and urine samples were collected at
three monthly intervals after renal transplantation and exam-
ined for BKV with qualitative and quantitative real – time
polymerase chain reaction (PCR). All recipients received anti –
interleukin-2 receptor monoclonal antibody and triple immuno-
suppression regimen with calcineurin inhibitor (cyclosporine,
n = 19, or tacrolimus, n = 13), mycophenolate mofetil and oral
corticosteroids. A total of 340 samples were examined (170 and
170 urine plasma).
Results: BKV was detected in 53 (31.2%) urine and 30 (17.6%)
plasma samples in 22 (22/32, 68.8%) and 19 (19/32, 59.4%)
patients respectively. Positive samples for BKV simultaneously
in urine and plasma were observed in 22 cases (22/170, 12.9%).
Quantiﬁcation of positive urine samples identiﬁed 18 with viral
load > 10,000 copies/ml which were collected from 10 individ-
uals. Quantiﬁcation of positive plasma samples showed that two
patients had viral load above 10,000 copies/ml that also had
high viral load in urine. Relative risk of BK viraemia was 5-fold
in recipients who had developed BK viruria (R.R. 5, 95%
conﬁdence interval 3.3–9.7). Median time of onset of viruria was
62 days after transplantation and of viraemia 72 days following
transplantation. A peak of viraemia and viruria with high viral
load in urine was noted 3 months after renal transplantation.
Statistical analysis of the immune suppressive regimens
revealed that incidence of BK viruria was signiﬁcantly higher
in patients who received tacrolimus compared to cyclosporine
(p = 0.005). Statistical analysis of serum creatinine between
positive and negative cases in plasma and urine of BKV revealed
no signiﬁcant difference or impairment of renal allograft
function.
Conclusion: BK viruria precedes BK viremia. High viral load in
plasma was accompanied in all cases with high viral load in
urine, which suggests that viruria is a risk factor of the
development of viraemia. Signiﬁcant relation was observed
between positive urine samples for BKV and tacrolimus
immunesuppressive treatment.
P760
JC virus genotype distribution differs between
healthy and immunocompromised Irish
individuals
K. Schaffer, N. Sheehy, S. Coughlan, C. Bergin, W. Hall (Dublin,
IE)
Background: JC virus (JCV) belongs to the family of human
polyomaviruses. Serological evidence suggests that JCV infects
more than 70% of the human population. JCV urinary excretion
in immunocompetent adults varies between 20% and 50%.
Ampliﬁcation and sequencing of JCV from urine has allowed a
distinctive map of the distribution of JCV genotypes worldwide.
Objective: To deﬁne the frequency of JCV urinary excretion and
genotype distribution in Ireland.
Methods: Urines from 121 healthy individuals and from 94
immunocompromised individuals (HIV positive patients and
rheumatoid arthritis patients) were collected. JCV DNA was
detected using the polymerase-chain reaction (PCR) with sub-
sequent nucleotide sequencing of a fragment of the major capsid
protein (VP1).
Results: JCV was detected in 20.7% of healthy individuals and
was found more often in the urine of HIV positive patients
(54.2%; p < 0.001) and rheumatoid arthritis patients (54.4%;
p < 0.001). In healthy Irish individuals genotype 1 was the
predominant genotype in 62.5%, followed by genotype 4 in
16.7% and genotype 2 in 12.5%. Genotype 2 was signiﬁcantly
more often isolated from the urine of immunocompromised
patients (55%, p = 0.001). Among type-1 viruses more than 80%
belonged to subtype 1A. The only subtype found among
genotype 2 strains in healthy Irish individuals was subtype 2B,
whereas several other genotype 2 sequences were detected in
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immunocompromised individuals. Among rheumatoid arthritis
patients a new variant of both subtype 1A and subtype 2B was
ampliﬁed.
Conclusion: The pattern of genotype distribution among
healthy Irish individuals is similar to data reported from other
European countries. The ﬁnding of signiﬁcant genotype differ-
ences between urinary JCV isolates from healthy and immuno-
compromised individuals suggests that JCV could undergo
genetic changes in the coding region in the pre-PML immuno-
compromised state. As similar nucleotide changes were
observed previously in JCV strains from HIV associated PML
brain, they might contribute to the disease causing potential of
the virus.
P761
Prevalence of human papillomavirus genotypes
in genital samples
A. Sua´rez, C. Sa´nchez, E. Va´zquez, J.J. Picazo (Madrid, ES)
Objectives: Infection by human papillomavirus (HPV) is the
main cause of genital cancer and recent evidence suggests that
Human Immunodeﬁciency Virus (HIV)-infected patients have
an increased frequency of HPV infection. Genital HPV types
have been subdivided into high-risk and low-risk genotypes
depending on their presence in genital carcinoma, therefore we
studied the prevalence of HPV types in the genital samples of
377 patients, 126 of whom were co-infected with HIV.
Methods: 377 patients were included, 209 men (mean age
36 years) and 168 women (aged 26–36). Only six women were
HIV-coinfected. The presence of HPV DNA was assessed by
polymerase chain reaction (PCR) using consensus primers MY09
and MY11 from the L1 region. HPV genotyping was carried out
using a reverse hybridization line probe assay of the ampliﬁed
product (INNO-LiPA. Innogenetics). Ampliﬁcation of a frag-
ment of the b-globin gene was performed as an internal reaction
control. HPV genotypes 16, 18, 31, 33, 45, 51, 53, 56, 58, 59 66 and
68 were considered as high-risk oncogenic.
Results: HPV-DNA was detected in 149 samples, 67 of which
corresponded to HIV coinfected patients (p < 0.001). The
distribution of HPV genotypes was similar in HIV-positive
and HIV-negative patients. HPV 6 was the most common
genotype (27.36%) and most prevalent high-risk HPV genotype
was 16, in 36 (18.95%) cases. The incidence of HPV type 18 was
very low (only two cases). Infection with high-risk HPV was
detected in 45.26% of the cases, but there was no signiﬁcant
difference between the two groups. The majority of the HPV-
DNA-positive samples contained a single HVP genotype,
although 21 of the non HIV-coinfected patients and 15 of the
HIV-coinfected patients had mixed infection. HPV could not be
typed in 18 cases with the probes used. Total inhibition of the
PCR was observed in 13 samples.
Conclusion: The prevalence of HPV infection was 40%. The
presence of HPV was signiﬁcantly more frequent in the patients
coinfected with HIV (p < 0.001). Half of the patients were
infected by a high-risk oncogenic HPV genotype.
P762
Prevalence of human papillomavirus types in
cervical samples from HIV-infected women
F. Zara, A. Spinillo, R. Brerra, B. Gardella, R. Mainini (Pavia, IT)
Objectives: The aim of this study was to evaluate the distribu-
tion of human papillomavirus (HPV)-DNA and simultaneous
human immunodeﬁciency virus (HIV)-related nucleic acids in
cervicovaginal secretions of 173 known HIV-1-seropositive
women.
Methods: Paired blood and cervicovaginal lavage samples were
collected from each women. Gynecologic examination was
performed in all participants. HPV DNA was detected in
cervicovaginal lavages by using MY09/11 L1 polymerase
chain reaction (PCR). HPV typing was performed by E6/E7
nested PCR. Proviral HIV-1 DNA, cell-associated, and cell-free
HIV-1 RNA in cervicovaginal secretions were quantitatively
evaluated by competitive PCR and reverse transcription PCR.
Results: HPV-DNA in cervicovaginal secretions was detected
in 45% (78 of 173) of the women; 23% (18/78) was infected by
more than two types. HPV 6/11 was the most prevalent
genotype and was observed in 23/173 (13.3%), followed by
HPV 18 and 31. The rate of HPV infection was related to severity
of cytologically diagnosed squamous intraepithelial lesions.
Proviral HIV-1 DNA, cell-associated, and cell-free HIV-1 RNA
were detected in 41.6% (72 of 173), 33.5% (58 of 173), and 32.4%
(56 of 173) of cervicovaginal samples, respectively, of partici-
pants. Out of the 78 women positive by PCR for HPV-DNA, 27
(34.6%) were positive for all HIV-related nucleic acids in
cervicovaginal secretions, while 35 (44.8%) and 29 (37.2%)
were positive for HIV-1 DNA and cell-associated RNA, respect-
ively.
Conclusion: Our results conﬁrm that HIV infection may
strengthen the effect of HPV at cervical level.
P763
Physical status of HPV-16 in patients with LSIL
or cervical carcinoma
S. Szostek, M. Klimek, J. Kopec, B. Zawilinska (Cracow, PL)
Background: Infection with high risk human papillomavirus
(HPV) has been associated with cervical carcinoma. Integration
of viral DNA into host genome is essential for carcinogenesis.
The HPV genome integration usually disrupts E2 gene, leading
to overexpression of E6 and E7 oncogenes.
Objectives: To assess the viral integration status of HPV-16 in
women with low-grade squamous intraepithelial lesions (LSIL)
in comparison to cervical cancer patients making use of
multiplex PCR.
Materials and methods: Fifty-three women with conﬁrmed
HPV-16 infection were examined; 30 of them with LSIL and 23
with cervical cancer. DNA was isolated from cervical secretions
with Genomic Mini Kit (A&A Biotechnology). HPV-16 DNA
was detected with the use of PCR with SPF10 as primers and by
means of hybridization (INNO-LiPA, Innogenetics). The E2 and
E6 genes of HPV-16 were detected by multiplex PCR using two
pairs of primers. The PCR products were separated electro-
phoretically in agarose gel and the densitometric analysis was
performed using Bio-Rad Quantity One software.
Results: The E2 and E6 sequences of HPV-16 were detected in
49 (92%) women. HPV-16 E6 was found in all specimens
obtained from patients with cervical cancer. In this group of
women, it was possible to amplify the E2 region in 83% of cases.
Thirty-four percent of patients exclusively harboured the epi-
somal form (E2/E6 ratio = 0) whereas in the remaining group of
women a mixture of episomal and integrated forms of viral
DNA (1> E2/E6 ratio >0) were found. In the women with LSIL
the episomal form dominated (93%, with E2/E6 ratio ‡ 1). In
two cases the episomal and integrated forms of HPV-16 were
detected simultaneously.
Conclusion: HPV-16 integration occurs in a subset of LSILs, not
only in the cervical cancer specimens. The assessment of HPV-16
status would be a helpful complementary tool for cytological
study in cervical screening to identify women at risk of
developing high-grade squamous intraepithelial lesions and
cervical cancer.
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P764
Prevalence of HPV in Lithuania according to data
based on PCR technique
I. Gulbinovic, K. Asmonaite, D. Ambrasiene (Vilnius, Kaunas,
LT)
Background: Human genital papillomavirus (HPV) is common
sexually transmitted pathogen and infection with some types of
it reportedly was associated with cervical intraepithelial neopl-
asia (CIN) in women. The risk factor for the development of
cervical intraepithelial neoplasia is signiﬁcantly increased by
persistent infection with high-risk HPV genotypes (16, 18, 31
et al). HPV can cause skin and mucosa wartes.
Objective: The aim of present study was to determine HPV
prevalence in the Lithuania population.
Methods: Polymerase chain reaction (PCR) for HPV diagnostics
was successfully introduced in Biomedical Research Centre in
2001. Patient’s samples have been collected from various private
clinics of Lithuania. Urethral samples were taken with a dacron
swab placed into urethra 2–3 cm in males (M), and vaginal
samples were taken from the endocervical region in women (W).
During 2001–2005 years 3204 samples for HPV have been
analysed. DNA was extracted from clinical samples by using
rapid in-house procedures. The presence HPV was determined
by using in house PCR with speciﬁc primers of E1 gene. The
positive samples were reampliﬁed with speciﬁc primers for
HPV genotypes 16 and 18. The quality of DNA was tested by
PCR using primer for human B-globin gene. Ampliﬁed PCR
products were separated in 2% agarose gel and detected by
ethidium bromide staining.
Results: In total, 3204 patients were included into the study:
1811 (57%) women and 1393 (43%) male with signs of urethral
discharge and/or urethral discomfort and lower urinary tracts
symptoms. We detected that 28% (884/3204) of samples were
positive for common HPV (W samples consisted of: 36% (658/
1811), and M samples consisted of 16% (226/1393)). The 592 (549
W and 43 M) HPV positive samples were reampliﬁed for 16 and
18 HPV types. The high-risk HPV genotypes were identiﬁed as
follows: 16-HPV – 26% (151/592 /W: 26% (145/549), M: 14% (6/
43)/, and 18-HPV – 6% (37/592) /W: 7% (34/549), M: 7% (3/
43)/. Two patients were infected with both high-risk HPV types.
Conclusion: Molecular technique used for HPV detection is
simple, economic, rapid and reliable for screening samples and
providing information for prevention cervical cancer. The
prevalence of HPV in our study according to data based on
PCR technique was 28%. We have made conclusion that 32% of
patients were infected with high-risk HPV genotypes.
P765
Focal epithelial hyperplasia disease in Panares
Indians from Bolivar state, Venezuela
M. Correnti, S. Hurtado, V. Tovar, M.E. Cavazza, M. Avila,
M. Guevara, T. Sanabria, L. Pocaterra (Caracas, VE)
Focal Epitelial hyperplasia (FEH) is common in native Indians of
South and Central America, specially in children and young
population; in adults it is rarely disease. FEH presents an
exophytic lesions of the oral mucosa and may be rather easily
confused with papilloma or condyloma. The aim of this study
was the detection of HPV in FEH lesions from Panares Indians
of Bolivar State, Venezuela.
Materials and methods: We present 13 children (mean
age = 7 years) and 15 adults (mean age = 38 years), who were
diagnosed of FEH. This Indian population is a very close
community from the Maniapure, Bolı´var State. PCR wit HPV
type – speciﬁc consensus primers followed by analysis of the
restriction fragments length polymorphism were used.
Results: All the samples of the mucosal lesions stained with
haematoxylin and eosin shows papillomatosis, acanthosis,
hyperkeratosis and parakeratosis of the epithelium. A sparse
mononuclear inﬂammatory cell inﬁltrate was present in the
chorion. These ﬁndings are compatible with FEH disease. The
82% (23/28) of the patients had HPV. The genotyping assay
indicated the presence of HPV 13 (82.6%) and HPV 32 (17. 4%) in
this population. Co-infection with more than one HPV type was
not found.
Discussion: FEH is very common in this Indian population
without gender or age predilection. In this population FEH is
not a limited disease and will be related with a genetic
predisposition conditions of the Panares Indians. In some
cases the patients had a functional problems but they does not
received any treatment.
Acknowledgement: Grant of FONACIT S1-2000000643.
P766
Gen tax evidence of HTLV-1 co-infections in
HIV-positive patients in a hospital in Bilbao,
Spain
N. Ortiz, M. Basaras, M. Sota, R. Cisterna (Bilbao, ES)
Background: Human T-cell leukaemia virus type I (HTLV-I), is
the pathogenic agent of adult T-cell leukaemia-lymphoma
(ATLL) and HTLV-1 associated myelopath/tropicalspastic para-
paresia (HAM/TSP). In HIV infected patients have been shown
to be frequent, probably in consequence of their similar modes
of transmission. The gen tax of a human T-cell leukaemia virus
type 1 (HTLV-1) induces the expression of several cellular genes
that are involved in T cell activation and proliferation. The aim
of this study was to analyse HTLV-I proviral DNA presence in
HIV infected patients of Bilbao using primers of the region tax of
the HTLV-1.
Materials and methods: We analysed peripheral blood mono-
nuclear cells (PBMCs) from 100 patients samples HIV infected
patients (EIA, and conﬁrmed with Western blot). These patients
were treated with antiretroviral therapy. A conventional PCR
and a real time PCR assay using SYBR Green were established.
Both assays were designed using primers from tax gene (156 bp)
of HTLV-I. The real-time PCR assay reliably detected a single
copy of HTLV-I proviral genome in DNA from 1 · 106 PBMCs.
For conventional PCR we also included in each sample the HLA
DQ alpha gene (242 bp) to check the presence of PCR inhibitors
and the quality of DNA extraction. As positive control we used
HTLV-I infected MT-2 cell line, which had integrated stable tax
gene. Cells were incubated at 37 C in a 5% CO2 atmosphere in
RPMI 1640 medium supplemented with 10% heat inactivated
Bovine foetal serum (FBS), penicillin and streptomycin.
Results: All the samples analysed had presented HLADQ alpha
gene amplicon indicating that PCR had been carried out under
good conditions. In ﬁve of the HIV infected patients the band
corresponding to the gene tax (156 bp) of the HTLV-1 was
detected. In the real time PCR’s the MT-2 cells were in use for
obtaining a standard melting curve with a melting temperature
of 88 C (±1 C). The melting temperature of nine PCR samples
from HIV infected patients was similar to the one obtained in the
standard melting curve but only ﬁve of the samples had been
reported as positive when conventional PCR was performed.
Conclusion: The results of this study suggest that both assays
could be used to diagnostic HTLV-1 infection in samples of HIV
infected patients. Besides, the results also suggest that real time
PCR is faster and has more sensitivity fact the conventional PCR
but further studies are needed.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Hepatitis
P767
Virologial and clinical aspect of HBV silent
infection in patient with chronic hepatitis C
E. Sagnelli, N. Coppola, C. Marrocco, M. Imparato, R. Pisapia,
G. Piai, L. Cimmino, C. Del Vecchio Blanco, A. Giorgio,
V. Messina, F. Piccinino, P. Filippini (Naples, Caserta, IT)
Occult HBV infection was tested in 89 HBsAg negative con-
secutive patients with chronic hepatitis C (CHC) at the time the
diagnosis was ﬁrst made by liver biopsy (LB). For each patient
three compartments (plasma, a small fragment of LB and six
millions of Peripheral Blood Mononuclear Cells-PBMC) were
explored for presence of HBV-DNA by PCR; three sets of
speciﬁc primers for HBV core, surface and x region were used.
Of the 89 enrolled patients, 45 were anti-HBs/anti-HBc negative
(Group 1), 18 anti-HBs/anti-HBc positive (Group 2) and 26 anti-
HBs negative/anti-HBc positive (Group 3). Clinical and virolo-
gical characteristic of these patients are reported in the Table. *n
of patients with HBV-DNA also in plasma; A: three cases with
cirrhosis; B: six cases with cirrhosis; C: staging according Ishak.
Conclusion: Isolated anti-HBc in CHC cases may predict occult
HBV infection, since the detection of HBV-DNA in the liver and
PBMC using speciﬁc primers for core, surface and x regions
identify in up to 81% of these patients occult HBV infection: in
these the presence of HBV-DNA correlates with severe ﬁbrosis.
The detection of HBV-DNA in plasma is of no value to detect
occult HBV infection.
P768
Fulminant hepatitis due to hepatitis B virus
A. Vata, M. Hurmuzache, D. Mihalache, D. Florea, D. Scripcariu,
C. Luca, D. Dimitriu, V. Luca (Iasi, RO)
Objective: Fulminant hepatitis (FH) is the most severe form of
viral infection of the liver. Our aim was to correlate the
demographic, clinical and laboratory data with the evolution
of the disease.
Methods: A retrospective study of 18 patients with FH admit-
ted in the Infectious Diseases Hospital, Iasi, between January
2000 and June 2005.
Results: From the 18 patients (12 men, 6 women) with FH, 15/18
immunocompetent, aged between 4 and 53 years (median
17 years) the aetiology was established in 14 cases. The hepatitis
B virus (HBV) was involved in 11 cases (from 553 acute viral
hepatitis B – incidence 1.98%), the co-infection B+D in two cases
and the hepatitis A virus in one case (from 4313 cases – incidence
0.02%). The HBs antigen was absent in three cases, the anti-HBe
antibodywere present in four cases andHBV-DNAwas detected
at low levels (<5000 copies/ml) in two patients who were tested
in the ﬁrst day of coma. The encephalopathy appeared at
8.3 days from the ﬁrst symptoms and 4.63 days from the
jaundice. The mean duration of coma was 4.34 days. An
inﬂuenza-like syndrome was more frequent (p < 0.02) during
the onset of FH due to HBV compared with non-fulminant cases.
The laboratory ﬁndings showed hiperleukocytosis (>10,000 l/
mm3) with a normal erythrocyte sedimentation rate, peak ALAT
20–30 times higher than the normal value, total bilirubin levels
up to 350 mg/l and a protrombin index below 30% in all patients.
The administration of antivirals (IFN or/and lamivudine) after
the installation of coma had no results (six treated patients / six
deaths). The lethality rate was 90.9% in HBV FH.
Conclusion: The hepatitis B virus was the most frequent cause
of FH, a rare disease with a poor prognosis, more common in
young males; the administration of antiviral drugs did not
improve the survival rate.
P769
Acute/recent HCV infection in seronegative
blood donors and IDUs, viral replication kinetics,
immune response and disease outcome
T. Tsertsvadze, L. Sharvadze, L. Dzigua, N. Chkhartishvili
(Tbilisi, GE)
Objectives: Aim of the study was to reveal acute/recent HCV
infection at the very early stage of infection in seronegative
blood donors and Injecting Drug Users (IDUs) to observe the
clinical course, viral replication kinetic, immune response and
disease outcome.
Methods: A prospective 24 months follow-up study was per-
formed in two different sub-groups: blood donors and Injecting
Drug Users (IDUs). Namely, ELISA negative 3000 blood donors
and 1000 IDUs were investigated on HCV RNA by qualitative
PCR method. A pool of six blood specimens was applied for
blood donors’ testing and a pool of ﬁve blood specimens for
IDUs. Further testing on individual samples was performed only
for PCR positive pools. HCV antibodies were detected by ELISA
and RIBA. HCV RNA (Qualitative and quantitative) by RT- PCR
(Roche). HCV genotype- by Inno-Lipa. Detection of HCV RNA
level (Viral load) was performed weekly for 6 months and then
monthly. Cytokines were induced in whole peripheral blood
cells using HCV core peptides and tested by ELISA.
Results: We revealed totally 11 patients with acute/recent HCV
infection: ﬁve from blood donors, seven from IDUs. Among
them four were symptomatic and seven asymptomatic. In all
patients with acute/recent infection viremia was detectable
2 weeks after inoculation, it increased very rapidly and reached
a peak titre by week 4. The viral titre was remarkably stable for
the next 5–6–7 weeks, falling only two or three fold by week 9.
After week 10 the viremia rapidly decreased: l >4 logs or l >5
logs by week 12 and it became either undetectable (<102 GE/ml)
by weeks 14–15–16 (viral clearance), or virus was not eliminated
and viral titre persisted in all follow up period (chronic
infection). Among 11 subjects: two had genotype 1a, 5 -1b, 2-
2a/2c and 2-3a. Out of 11 patients 3 cleared the virus, (two were
symptomatic: 1-genotype 1b, 1 genotype 2a/2c and one
asymptomatic- genotype 1a), while 8 developed chronic infec-
tion. In three subjects who cleared virus two had 1st type
cytokine response (IL-2 and IL-12), in seven patients, out of eight
who developed chronic infection cytokine synthesis was shifted
towards Th2 response (IL-4 and IL-10).
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Conclusion: There was some relationship between high viral
titre and clearance from virus. Viral clearance was associated
also with presence of Th1 immune response. There was no
correlation between viral genotype and disease outcome.
P770
Phylogenetic analysis in a HCV type 5 infected
population in the French central district of
Clermont-Ferrand
C. Henquell, C. Bonny, S. Ughetto, H. Odent-Malaure, V. Tixier,
J.L. Bailly, P. Deny, H. Peigue-Lafeuille, A. Abergel (Clermont-
Ferrand, Bobigny, FR)
Objectives: Hepatitis C virus genotype 5 (HCV5) is the pre-
dominant genotype in southern Africa but unusual in Europe. In
France, it is responsible for less than 2% of HCV infections. In
Clermont-Ferrand district (central France), its prevalence is
14.2% representing more than 170 patients since 1990. Epide-
miological study and molecular analysis of viral strains were
carried out to investigate the high prevalence of HCV5 in a local
area.
Methods: A case–control study included 131 patients infected
with HCV5 and 393 patients infected by other types. A detailed
questionnaire was used to identify potential risk factors for
infection. Direct sequencing of NS5B and E1E2 fragments was
performed for 97/131 patients. The neighbour-joining algorithm
using the Tamura-Nei model was used to obtain phylogenetic
trees for NS5B and E1E2 (257 and 715 nt respectively).
Results: No IVDU contaminated patient was found. In multi-
varied analysis, the following variables were associated with
contamination by HCV5: living in the South of the district
(ORa = 16.3, p < 0.0001); being injected with more than ﬁve
injections in the South of the district (ORa = 3.5, p < 0.0001);
being transfused (ORa = 3.3, p = 0.002); use of an intrauterine
contraceptive device (ORa = 2.2, p = 0.01). The mean age of
patients with risk factor ‘‘living in the South of district’’ is higher
than this of controls (61.8 vs 53.2, p = 0.001). Genotype 5a was
identiﬁed in all patients. Comparison of NS5B and E1E2
sequences demonstrated a very high degree of nucleotide
similarity between local HCV5 isolates and other homologous
sequences (French isolates out of our geographic area or
sequences available in Genbank). No cluster was observed
within local sequences. However, phylogenetic analysis of E1E2,
encompassing the HVR1 region, revealed 12 pairs of tightly
closely related sequences supported by bootstrap analysis.
Epidemiological data showed that 7/12 pairs were linked by
blood transfusion (donor/recipient or recipients of the same
donor) between 1978 and 1990, and 3/12 were husband and
wife. No sub-grouping within patients living in the South of the
district was observed.
Conclusion: The HCV5 infection in this semi-rural settled
population was probably due to multiple events between 1960
and 1990 (iatrogenic transmission, transfusion, in-house trans-
mission). Phylogenetic analysis did not evidence a cluster in
patients living in the South of the district, but highlighted the
existence of in-house transmissions.
P771
Quantiﬁcation of hepatitis C virus in human
plasma samples by using real-time reverse
transcriptase PCR
K. Shahzamani, F. Sabahi, S. Merat (Tehran, IR)
Objectives: Hepatitis C virus (HCV) is the major causative
agent of non-A, non-B Hepatitis. Acute HCV infection is often
asymptomatic, and approximately 70% of cases progress to
chronic hepatitis. This may lead to progressive liver disease,
cirrhosis, liver failure, and hepatocellular carcinoma over 20–
30 years. Factors associated with disease progression following
HCV infection include the viral genotype, alcohol consumption,
and viral load. High viral loads associated with decreased rates
of response to interferon therapy, and a decrease in the HCV
viral load during the early phase of treatment (2–12 weeks) has
been shown to predict effective treatment responses. Because it
has been established that viral load is relatively stable in the
chronic phase of the infection, of these parameters, viral load
seems to be more useful for the tailoring of treatment schedules
and the monitoring of HCV replication during therapy. The
detection and quantiﬁcation of HCV RNA in plasma requires
highly speciﬁc and sensitive assays because HCV circulates in
the blood at a low copy number and its genome is extremely
heterogeneous, even though the virus titre covers a wide range
(from undetectable values to 108 copies/ml).
Methods: The aim of this study was to develop a simple, real-
time QRT-PCR assay for the quantiﬁcation of HCV RNA copies
in plasma samples with SYBR Green I detection rather than the
use of labelled probes. Real-time QRT-PCR assays were per-
formed with a Light Cycler system. Ninety-four RNA samples
from plasma of infected patients were quantiﬁed by this
method. Comparison of the results with those obtained by
other quantiﬁcation method.
Results: The linearity of this approach was conserved over a
wide range of HCV copy numbers. The coefﬁcient of the
regression of the standard curve was, on average 0.98. Com-
parison of the results with those obtained by other quantiﬁcation
method, revealed a signiﬁcant correlation with all of the results.
Conclusion: Our data demonstrate that Light Cycler is a fast
and reliable method for the detection and quantitation of HCV
RNA.
P772
PEG-interferon-alpha 2a (40 kDa) in patients on
chronic haemodialysis with chronic C hepatitis:
Early results
M.K. Celen, C. Ayaz, N.U. Yuce, S. Hosoglu, M.F. Geyik
(Diyarbakir, TR)
Objective: The aim of the study was to evaluate the early
response to Pegylated Interferon alpha2a (40 kDa) in patients on
chronic haemodialysis (HD) with chronic C hepatitis.
Methods: Twenty-two patients were enrolled in this study (12
males and 10 females). The diagnosis was established according
to anti-HCV positively, serum HCV-RNA activity with PCR
(Cobas Amplicor HCV Monitor; Roche Molecular systems,
Branchburg, NJ, US), increased of ALT levels. Liver biopsy
was not done in HD patients. We administrated Peg Interferon
alpha-2a 135 lg/week for 48 weeks. We used the reduction of
two log drop HCV-RNA clearance, or both at week 12 to predict
early and response to treatment.
Results: Of 22 HD patients, 12 were male and 10 female,
average ages was 35.2 ± 12.1 years old. Three patients were
excluded from the study because of lack of compliance. We had
to stop the treatment in two patients due to complications
(depression, thrombocytopenia and leucopenia). After 12 weeks
of treatment with Peg-Interferon alpha 2a (40 kDa) in patients
on chronic haemodialysis with chronic C hepatitis, the virolo-
gical response (HCV-RNA absent by PCR) was obtained in
82.4% (14/17) of the cases. The normal transaminase (biochemi-
cal response) was obtained in 70.6% (12/17) of the cases. Even if
side-effects occurred in most of the patients (ﬂu-like syndrome,
thrombocytopenia or leucopenia) they did not impose the
discontinuation of treatment.
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Conclusion: The early virological response in our study pop-
ulation was better than those observed in the general popula-
tion. The sustained response will be established by determining
PCR RNA-HCV 6 months after the end of the treatment.
P773
Hepatitis C virus infection in haemodialysis
patients
N. Petrosillo, A. Di Napoli, P. Pezzotti, D. Di Lallo, S. Di Giulio,
C. Trivelloni, G. Guasticchi on behalf of Lazio Dialysis Registry
Objectives: Monitoring the Hepatitis C virus (HCV) infection
antibodies in haemodialysis (HD) patients is an important issue
of public health. The aim of the study was to analyse the trend of
the seroconversion rate and the impact of HCV serologic
positive test on mortality.
Methods: The study population consisted of 6412 patients
starting HD in Lazio region (Italy) reported to the regional
Dialysis Registry between 1/1/1995 and 31/12/2003. The
information about HCV serologic status was collected at the
beginning of dialysis and then once a year. HCV status was
deﬁned using ELISA or RIBA third generation test. To calculate
seroconversion rates, we deﬁned as cases those patients,
seronegative at the beginning of each period, who became
seropositive at the end of the same period. We estimated the
cumulative probability of survival using the Kaplan–Meier
method; we used the Cox model to estimate mortality hazard
ratios (HR) of HCV positive compared to HCV-negative ones.
To take into account of those who seroconverted during HD, the
HCV serostatus was considered as a time varying covariate.
Results: Mean age at the beginning of dialysis was 63.1 (SD
16.2) years; males were 61.6%. The HCV-seroconversion rates in
the period 1/7/1995-31/12/2003 signiﬁcantly decreased in the
ﬁrst three periods and then remained quite stable at around two
cases per 100 person-years (PY). The survival at 5 years was
lower both for HCV-seroconverters (45.1%; 95%CI 34.0–55.6)
and for those already HCV-positive at HD start (47.6%; 95%CI
42.5–55.6), compared to HCV-negative subjects (55.7%; 95%CI
54.0–57.3) (log-rank test, p < 0.001). The estimated crude HR
was 1.37 (95%CI 1.23–1.53) for those who were or became HCV-
positive compared to those who remained HCV-negative. When
adjusting for other variables the HR was 1.29 (95%CI 1.15–1.44).
Conclusions: The HCV-seroconversion rate has signiﬁcantly
decreased in the mid-nineties in HD patients in Lazio region,
and has remained stable thereafter. The overall reduction of the
HCV-seroconversion rate in the last decade could be related to a
lower frequency of transfusions in HD patients; however, the
two per 100PY is likely due to nosocomial risk factors. We
observed that HCV-positive subject had a higher risk of
mortality than negative ones. The monitoring of HCV infection
has important public health implications, being the presence of
HCV antibodies both at the beginning of dialysis and as
seroconversion during HD associated to higher risk of mortality.
P774
Anti-HCV IgG Avidity Index in acute hepatitis C
and chronic hepatitis C
N. Coppola, R. Pisapia, S. Martini, C. Marrocco, L.M. Vatiero,
M. Pisaturo, G. Tonziello, P. Filippini, F. Piccinino, E.
Sagnelli (Naples, IT)
Objective: To evaluate the useful of anti-HCV IgG Avidity
Index (HCV AI) to distinguish acute Hepatitis C (AHC) and
reactivation of chronic hepatitis C (r-CHC).
Patients and methods: We enrolled 40 consecutive patients with
AHC identiﬁed by seroconversion to anti-HCV (AHC group)
and 37 consecutive patients who had been anti-HCV positive for
at least 6 months at the time of reactivation (r-CHC group). For
each patient in AHC groupwe choose anHBsAg negative patient
with symptom-free chronic hepatitis C, pair-matched for age
(+5 years), sex and risk factor for acquisition of parenteral
infection (CHC group). The HCV AI was determined by a
commercial immunoenzyme assay evaluating for each serum
sample two aliquots of 200 lL diluted 1:10 with guanidine 1 M
and phosphate-buffered saline (PBS), respectively; HCV AI has
been calculated as the ratio between the OD at 492 nm from the
guanidine wells and the OD from the PBS wells.
Results: HCV AI was signiﬁcantly lower in patients in AHC
group (0.50 ± 0.30, range 0.05–1.15) than in those in r-CHC group
(0.94 ± 0.25, range 0.28–1.24, p < 0.0001) and in those in CHC
group (1.06 ± 0.20, range 0.84–1.3, p < 0.0001). The analysis of
sensitivity and speciﬁcity of HCV AI to identify AHC demon-
strated that increasing the cut-off of AI the sensitivity increased,
but speciﬁcity decreased: in fact, considering an cut-off of AI
lower than 0.5 as a marker of AHC we found that the sensitivity
of the assay was 52.5% and the speciﬁcity of 94.6%, whereas a
cut-off lower than 0.9 had a high sensitivity (85%) but a low
speciﬁcity (78.4%). An increase of HCVAI was observed in 60.5%
of the 33 patients in AHC group and in none of 24 in r-CHC for
whom more than one serum sample collected during the acute
stage of the disease, whereas stable HCV AI values were
observed more frequently in r-CHC group (91.7%) than AHC
(39.5%, p < 0.005). Considering the 29 patients in AHC group
observed as outpatients for 6–30 months, no difference was
found in the HCV AI between the 12 patients who recovered and
the 17 who developed a chronic HCV infection.
Conclusion: Our data indicate that the detection of low HCV AI
may identify acute hepatitis C, but its senstivity and speciﬁcity
is not enough high.
P775
Hepatitis B virus genotypes: a Lebanese
hospital-based study
I. Jureidini, P. Rassam, S. Keleshian, J.P. Aoun, S. Khoury,
Z. Daoud, N. Irani- Hakime´ (Beirut, LB)
Objectives: Hepatitis B virus (HBV) represents a global health
challenge due to its worldwide distribution and serious compli-
cations as a result of the chronic viral persistence. The recent
interest in HBV genotypes has shown that the various HBV
genotypes may have different inﬂuence on the prognosis,
response to treatment and course of the disease. At present
eight HBV genotypes have been identiﬁed from A to H with a
characteristic geographic distribution. Genotype D is the most
prevalent in the Eastern Mediterranean region. However, there
are scarce data about HBV genotype distribution in Lebanon
where the prevalence of Hepatitis B antigen (HBs Ag) is around
2–5%. Lebanon is situated at a crossroads between Europe,
Africa and Asia, where different genotypes have been detected.
The aim of the study is to determine the prevalence of HBV
genotypes in a Lebanese population sample and to assess the
potential correlation between the genotype and viral character-
istics such as HBe antigen status and serumHBVDNAviral load.
Materials and methods: This study involves 60 HBs Ag
positive individuals with various demographic distribution, of
which 30 blood bank donors (HBs Ag positive) and 30 patients
with a documented active viral hepatitis B (HBs Ag positive
with viremia). Only this latter group was further investigated
for viral characteristics. HBV genotype was identiﬁed by
multiplex-PCR using genotype-speciﬁc primers.
Results: Genotype D was the only genotype detected in both
groups. Among the active viral hepatitis B patients, 15 out of 30
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(50%) have a high viremia (HBV DNA >104 copies/ml)
associated with a negative HBe antigen suggesting a precore
mutation.
Conclusion: Despite the limited sample size of the study, our
data clearly show that genotype D is the major strain in
Lebanon, as for the other Eastern Mediterranean countries. It
also conﬁrms the previously described correlation between
genotype D and HBe antigen negative chronic hepatitis. For
further analysis we aim to expand our study and assess the
correlation between genotype D, precore mutation, and severity
of liver disease.
P776
Evaluation of Bayer Advia Centaur
chemiluminescent assays for the analysis of
hepatitis B HBs antigen and HBc total antibodies
and hepatitis C total antibodies
D. Burki, F. Rich, J. Carlsen, L. Matter (Basel, CH)
Introduction: Screening for hepatitis B and C requires highly
automated analytical systems to allow for short turn-around
time and high reliability.
Objectives: To compare recently released Bayer Advia Centaur
chemiluminescent assays for hepatitis B (HBs antigen, HBc total
antibodies) and hepatitis C (total antibodies) with the currently
used chemiluminescent assays on Abbott Architect.
Materials and methods: Samples sent to a private routine
laboratory were included in the study without prior selection.
Samples were analysed on Abbott Architect for HBs antigen
and/or HBc total antibodies and/or hepatitis C total antibodies
followed by immediate analysis of the correspondig markers on
Bayer Advia Centaur to ensure routine conditions.
Results: 2927 sera from 2899 patients were analysed. 1151 sera
were tested for HBs antigen only, 599 for HBc antibodies only,
and 1001 for both HBs antigen and HBc antibodies. 1756 sera
were tested for hepatitis C antibodies. For HBs antigen, at a
prevalence of 1.9%, no diagnostically relevant discrepancies
were found. 20 sera were found equivocal in Architect and
negative in Centaur, whereas two sera were found equivocal in
Centaur and negative in Architect. For HBc antibodies, at a
prevalence of 10.3%, major discrepancies were found in 24
samples: 20 Architect-reactive sera were found negative in
Centaur, whereas four Centaur-reactive sera in were negative in
Architect. For HCV antibodies, at a prevalence of 1.5%, one
major discrepancy was found: one Architect-negative sample
was found reactive in Centaur and was conﬁrmed positive in a
recombinant immunoblot.
Conclusions: Good agreement was observed for HBs antigen
and for HCV antibodies. For HBc antibodies, Architect may
provide somewhat higher sensitivity than Centaur, although
low signals in the twenty discrepant sera may point to false
reactivity in Architect. From this large-scale comparison of
Centaur and Architect under routine conditions we conclude
that both systems are equally useful for routine testing for
hepatitis B and C infections.
P777
Relationships between luetic infection and acute
viral hepatitis
R.F. Botgros, C.P. Popescu, S-A. Florescu, A.M. Nicolescu,
M. Cotiga, L. Raduta, P.I. Calistru, E. Ceausu (Bucharest, RO)
Background: Acute viral hepatitis (AVH) still represents one of
the major problems for the romanian healthcare system. The
association between lues and AVH is currently underdiagnosed
and represents a problem which should be more focused in
future.
Methods: Retrospective clinical study of 469 acute viral hepa-
titis patients admitted in our hospital in 2004. The diagnosis of
coexisting lues was made by an association of positive values of
Treponema screening tests (i.e. qualitative RPR and VDRL) and of
a conﬁrmation test (we used TPHA).
Results: Out of the 469 patients, 330 (70.4%) were diagnosed
with acute HAV hepatitis, 116 (24.7%) with acute HBV hepatitis,
8 (1.7%) with acute HDV hepatitis on a chronic HBV infection
background, 3 (0.6%) had an HAV+HBV acute coinfection, 2
(0.4%) had an HBV+HDV acute coinfection. The aetiology of the
acute hepatitis remained unclear in 10 (2.1%) of the patients, but
was presumed viral based on the clinical presentation and
evolution and on the associated performed lab tests. TPHA was
performed in a total of 62 (13.2%) of the admitted patients, and
was positive in 8 (1.7% overall, 12.9% of all TPHA tests
performed) cases. All positive TPHA tests were accompanied
by positive lues screening tests (qualitative RPR (qRPR) tests (7
positive tests out of 27 performed, overall positivity 1.5% and a
positivity of 25.9% with regard to the total qRPR tests per-
formed) and VDRL test [one positive test out of three per-
formed, overall positivity 0.2% and a positivity of 33.3% with
regard to the total VDRL tests performed)] which allowed the
physicians to diagnose lues in addition to the AVH. The
distribution of lues among the eight diagnosed patients with
regard to the AVH aetiology was as follows: one case coexisted
with HAV AVH, ﬁve were associated to HBV AVH, one case
was discovered in addition to HBV+HDV AVH on a chronic
HCV infection background and one case coexisted with HDV
AVH on a chronic HBV infection background.
Conclusions: (1) The association between lues and AVH should
be searched for, especially in those patients with parenterally
transmitted viral infections. (2) We estimate that by routinely
searching for luetic infection in AVH patients, a certain number
of currently undiagnosed lues cases may become apparent and
may be appropriately treated. (3) We therefore suggest the
TPHA testing in documented parenterally transmitted acute
viral hepatitis cases, and, if positive, the further testing with any
available Treponema screening test.
P778
The distribution of HBV genotypes, serotypes
and YMDD variants among chronic HBV patients
in Kuwait
M. Ali, S. Farhan, H. Askar, F. Hassan, S. Ahmad, W. Al-Nakib
(Kuwait, KW)
Objectives: There is growing evidence that HBV genotypes
may play some role in causing different disease proﬁles in CHB.
This relationship between HBV genotypes and severity of liver
diseases has not been studied in Kuwait. Therefore, the aim of
this study was to elucidate the distribution of different HBV
genotypes/serotypes among CHB patients in Kuwait and to
investigate their role in correlation with disease severity and
therapeutic outcome.
Methods: Sixty-four patients with CHB were enrolled in this
study. The age, liver function, HBeAg and anti-HBe status,
histology were all analysed for each patient. HBV DNA was
detected in all 64 isolates (34 were on treatment, 31 received no
treatment). HBV genotype, serotype and YMDD variants were
determined for the isolates by using semi-nested PCR and
sequencing analysis of the HBV pol gene including the YMDD
locus. Retrieved sequences were compared with key nucleotide
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positions from genotypically well-deﬁned strains in the Gen-
Bank after alignment of the sequences.
Results: Analysis of the 64 CHB patients demonstrated that
86% of the strains were genotype D/ayw followed by 6.25%
genotype A/adw. Interestingly, mixed genotypes (D+F, D+A)
and C/D hybrid were observed among the local isolates. Male
ratio was twice as that for female and the mean ages was fairly
uniform. When the correlation between the patient’s serological
status and the HBV genotype was analysed, the results for
genotype D strains were signiﬁcantly different, in that 68% were
anti-HBe positive in comparison with only 4% for genotype A
and 2% for mixed genotypes (P < 0.05). The ALT levels in
samples from patients infected with genotype D were higher
than the rest. Furthermore, rtM204 I/V identiﬁed in 4/64 HBV
strains tested; three patients were on lamivudine for 3–5 years
and the remaining didn’t receive any treatment.
Discussion: The predominance of genotype D/ayw coincided
very accurately with the HBV genotypes expected from the local
population. Genotype D-infected patients were found to be anti-
HBe positive signiﬁcantly more often and had higher ALT
levels. Therefore, genotype D may lead to more severe liver
disease. However, occurrence of heterogeneous populations in
clinically local samples indicates that HBV exists as a quasispe-
cies. With regards to disease presentation at the commencement
of treatment, YVDD and YIDD types tended to have similar
ﬁndings with respect to age and histology.
P779
Immunogenicity of recombinant hepatitis B
vaccine in treatment-naı¨ve and treatment-
experienced chronic hepatitis C patients: The
effect of pegylated interferon plus ribavirin
treatment
I.S. Elefsiniotis, M. Pirounaki, E. Vezali, K. Kamposioras,
K. Pantazis, H. Brokalaki, A. Moulakakis, G. Saroglou (Athens,
GR)
Objectives: To retrospectively evaluate the vaccination-induced
anti-HBs seroconversion rates in treatment-naı¨ve and treatment-
experienced chronic hepatitis C (CHC) patients. Also to pro-
spectively evaluate the seroconversion rates in CHC patients
during pegylated interferon (PEG) plus ribavirin (RIB) treat-
ment.
Methods: Seventy treatment-naı¨ve CHC patients (group A), 22
sustained virological responders-SVR following interferon (IFN)
plus RIB treatment CHC patients (group B) and 121 healthy
subjects (group C) had been participated in the same HBV
vaccination schedule (20 lg, 0–1–6 months). Seroconversion was
considered if anti-HBs levels were above 10 mIU/ml within
3 months following the third dose of the vaccine. Moreover, we
prospectively selected 30 non-cirrhotic CHC patients and eval-
uated them for the efﬁcacy of the same vaccine schedule
randomizing them in two groups: Group-1, 15 CHC patients
received the ﬁrst dose of the vaccine in parallel with the
initiation of PEG plus RIB treatment and Group-2, 15 patients
received the same vaccination schedule without concomitant
treatment. Determination of anti-HBs was performed at months
1, 2 and 7. Statistical analysis of data was based on ANOVA
student’s t-test and chi-square analysis (p < 0.05).
Results: Fifty-eight of 70 group A patients (82.85%), 20/22
group B (90.9%) and 112/121 healthy subjects (92.56%) had been
seroconverted. The seroconversion rates were signiﬁcantly
higher in the control group than in treatment-naı¨ve CHC
patients (p = 0.04). The corresponding rates were comparable
between group A and group B CHC patients (p = 0.38). The vast
majority of non-responders (10/14, 71.43%) had been infected by
genotype-1 of HCV. The seroconversion rates were comparable
between group 1 and 2 CHC patients at month 1 (20% vs 26.7%,
p = 0.67), month 2 (46.7% vs 60%, p = 0.46) and month 7 (86.7%
vs 93.3%, p = 0.54) of follow-up.
Concusions: The immunogenicity of HBV vaccine seems to be
lower in CHC patients as compared to healthy subjects. SVR
following IFN plus RIB treatment does not affect the antibody
response to HBV vaccine. Infection by genotype-1 seems to
negatively inﬂuence the seroconversion rates. Vaccination
against HBV during PEG plus RIB combination treatment is
not beneﬁcial in terms of anti-HBs seroconversion rates.
P780
Serum neopterin levels in patients with
replicative and non-replicative HBV carriers
I. Kaleli, M. Demir, N. Cevahir, M. Yilmaz, S. Demir (Denizli,
TR)
Objectives: Infection by hepatitis B virus causes complicated
biochemical, immunological and histological changes in host
immune response against virus can be speciﬁc or nonspeciﬁc.
Nonspeciﬁc response occurs via cytokines and other substance.
Neopterin is produced by activated macrophages, in response to
interferon-gamma derived from activated T cell. Recent atten-
tion has focused on neopterin as a marker for the activation of
cell mediated immunity The aim of this study is to deﬁne the
pattern of neopterin levels in replicative and nonreplicative
HBV carriers.
Methods: Thirty HBV replicative carriers and 25 nonreplicative
HBV carriers and 30 healthy adult patients were included this
study. Hepatitis markers were determined by commercial kit
based on chemilumminesans assay. HBV DNA was quantiﬁed
by hybrid capture system. Serum neopterin levels were meas-
ured by the method of competitive enzyme-linked immuno-
sorbent assay.
Results: Serum neopterin concentrations were 14.5 ± 10.0 (4.2-
41) nmol/L in replicative HBV carriers, 8.9 ± 4.3 (2.1-22) nmol/
L in nonreplicative HBV carriers and 7.7 ± 2.3 (4.0-12) nmol/L
in the control group. Serum neopterin levels and the rates of
abnormal serum neopterin levels in the replicative group were
higher than control group (P < 0.01 and P < 0.05). In the
nonreplicative group, serum neopterin levels were not differing
from those of control. There was a difference between replicative
and nonreplicative group in that respect of neopterin levels.
Conclusion: In the hepatitis B infected carriers, elevated neop-
terin levels may be an indicator of the presence of replication.
P781
Investigation of the serum neopterin levels in
patients with infected hepatitis B
I. Gonen, F.Z. Akcam, O. Kaya, G. Yayli (Isparta, TR)
Objectives: Neopterin is a pyrazino-pyrimidine compound,
which originate, from guanosine triphosphate. Its derivatives
are produced by human monocyte, macrophages and dentritic
cells upon stimulations with interferon-gama. Due to its chem-
ical structure, neopterin belongs to the class of pteridines.
Measurement of neopterin concentrations in human body ﬂuids
allows insight into a speciﬁc aspect of immunity, namely, the
cell mediated immune response. The increased concentrations of
neopterin in body ﬂuids were used as diagnostic and prognostic
criterion for cell mediated immunity in some clinical conditions
such as infections, autoimmune diseases, coronary artery dis-
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ease, malignencies, allograft rejection, renal and cardiac failure.
The aim of study was to evaluate serum neopterin levels in
nonreplicative HBV carriers, patients with chronic HBV infec-
tion and natural immunized persons against to HBV.
Methods: Twenty patients with nonreplikative HBV carriers
(group 1), 20 patients with chronic HBV infections (group 2), 20
persons with natural immunized against to HBV (group 3) and
20 healthy volunteers (group 4) had included to study.
Results: Serum neopterin levels were 7.44 ± 3.44 nmol/l in
group 1, 18.58 ± 12.19 nmol/l in group 2, 7.51 ± 10.18 nmol/l in
group 3, 5.71 ± 2.92 nmol/l in group 4. The difference between
group 1 and group 4, group 3 and group 4 was not statistically
signiﬁcant (p > 0.05). The difference among between group 2
and the others groups was statistically signiﬁcant (p < 0.05).
Conclusions: In conclusion; neopterin can be used as a marker
in nonreplicative HBV carriers and patients with chronic HBV
infection. However, further studies with large series are needed
to using routine.
P782
The HBV seroprevalance among high school
students in Izmir, Turkey
B. Karaca, H. Tarakci, E. Tumer, H. Guven (Izmir, TR)
Objective: Hepatitis B infection is still a problem that causes
morbidity and mortality especially in developing countries in
the world. Although neonatales are being immunized against
hepatitis B infection routinely by our government since 1998,
there are still aspects about its epidemiology that need to be
clariﬁed in adolescents and adults. The purpose of this study is
to perform a serologic survey among high school students to
detect HBV seroprevalance.
Methods: Totally 7237 serum samples from eight different high
schools were collected. The HBsAg, AntiHBs, HBeAg, AntiHBe,
AntiHBc total, AntiHBc IgM are studied with commercially
available ELISA kits.
Results: In this study 7237 serum samples were collected from
high school students. Of them 4667 (64.4%) were female and
2570 (35.5%) were male. The mean age was 16.5 (ranged
between 15 and 18). HBsAg, AntiHBs were positive in
98(1.35%), 1365(18.8%) of them respectively. Additionally in
the HBsAg positive group; HBeAg, AntiHBe, AntiHBc total and
AntiHBcIgM were positive in 16(16.33%), 82(83.67%), 98(100%),
0(0%) of the students respectively. In 5774 (79.7%) students both
HBsAg and AntiHBs were obtained as negative.
Conclusion: Latest studies show that hepatitis B vaccination
prevents both hepatitis B infection and primary hepatocellular
carsinoma in especially endemic areas. Although vaccination in
neonatal period is being performed for years, adolescent and
adult vaccination strategies are not yet well deﬁned throughout
the world. As a result of this, hepatitis B infection is still a health
care problem. The HBsAg positivity rate is obtained 1.3% in
high school students in this study. This result is correlated with
the carriage rates in our country. Also both HBsAg and AntiHBs
negativity rate was 79.7%. According to this result vaccination in
adolescent period is needed. Similar studies should be carried
out in different areas in our country in order to detect actual
immunity status against hepatitis B. In addition, the immuniza-
tion procedures are have to be performed not only in neonatale
period but also in adolescent and adult ages according to
AntiHBs screening results. Our survey is going on and further
investigations are being done, also we are evaluating the data
about the risk factors affecting the carrier stage and the carrier
rate among the students’ families, we plan to report them in
further meetings.
P783
The epidemiology of hepatitis A in Poland:
Prevalence of hepatitis A antibodies in
population
W. Janaszek-Seydlitz, B. Bucholc, J. Slusarczyk, A.A. Wiatrzyk
(Warsaw, PL)
Objective: Hepatitis A is acute infection disease caused by
hepatitis virus type a. Severity of disease depends on the age of
patient. In Poland a signiﬁcant decreasing in the incidence of
hepatitis A is observed last years. In 2003 and 2004 it was
registered respectively only 150 and 95 hepatitis A cases.
Morbidity was respectively 0.39/100 000 and 0.25/100 000.
Methods: The presence of anti-HAV antibodies in Warsaw
population aged 1–50 years was evaluated. Anonymized resid-
ual serum samples were collected from individuals attending
selected hospitals and Public Laboratories in 2003 and 2005.
About 100 samples were collected from each of age groups: 1–4;
5–9; 10–14; 15–19; 20–24; 15–29; 30–34; 35–39; 40–44; 45+. Serum
samples were assayed for hepatitis A-speciﬁc IgG using com-
mercially available enzyme-linked immunosorbent assay kit
ETI-AB-HAVK PLUS DiaSorin S.p.A, Italy. Samples with titter
below 20 mU/ml were regarded as negative.
Results: In presented study the proportion negative samples
varied with age. Children at age 1–4 years of life were protected
against hepatitis A only in 9.7%, adolescents in about 20%,
young adults at age 25–29 years in 33.3% and adults over
45 years were hepatitis A negative below 32%.
Conclusion: A decline in the incidence of hepatitis A in Poland
has led to a progressive decrease in circulation of HAV and, as a
result, an increase in the proportion of the adult population
susceptible to infection. In Poland till now the vaccination
against HAV is recommended for children and adolescents and
people dealing with food distribution, as well as for travellers to
the endemic region of the world or during natural disasters such
as for example ﬂoods. In 2004 only 31258 persons were
vaccinated. Immunisation at a very early age has been proposed
as an important mechanism for protecting against HAV infec-
tion in adults and adolescent, by interrupting transmission and
ultimately eradicating HAV.
P784
Changing epidemiology of acute hepatitis A and
hepatitis B in Italy: Further counselling and
prophylactic measures are needed for male
homo-bisexual subjects?
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Introduction: Small outbreaks and an increased frequency of
both hepatitis A and B were recently observed worldwide, with
attention on homosexual men.
Methods: An observational survey of all hospitalizations due to
acute hepatitis A and B occurred in the Bologna metropolitan
area, was performed from 1999 to June, 2004.
Results: One hundred and eighty seven consecutive patients (p)
were hospitalized in the examined period. From October
2002,acute hepatitis A largely prevailed over acute HBV, HCV,
and HEV hepatitis, and since June 2004 also acute hepatitis B
increased its frequency and the last year was characterized by a
similar prevalence of the two occurrences. Adult female p and
children represented only 27 cumulative p of 187 (14.4%).
Among the 126 and 61 p with acute hepatitis A and B
respectively, even 108 and 52 (85.6%) were represented by
male adults aged 22–49 years, who recognised unprotected
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homo-bisexuals contacts in the 2–4 months before the onset of
hepatitis A or B in 119 cases (74.4%). Nobody reported contacts
with p with a recently diagnosed hepatitis A or B, and nobody
underwent prior anti-HAV/anti-HBV vaccination. Among the
160 adult males with acute HAV or HBV infection, potential
STD were found in 45 cases (p < 0.01) and included hepatitis C
in 21 p, syphilis in 16, and HIV in 14 p. The temporal trend of
male adults admitted for hepatitis A showed a signiﬁcant
increase from 1999 to the ﬁrst 6 months of 2004:a ~300% increase
versus 1999 leading to a crude rate of 7.7 per 100.000 residents/
y. A more reduced tendency of a frequency increase of acute
hepatitis B was also recognized in the same p population (four
cases only in 1999, versus 19 cases in the last 18 months of
observation; p < 0.04).
Conclusions: Despite the availability of anti-HAV and anti-
HBV vaccination and information campaigns directed against
the spread of STD and HIV, the continued epidemic of hepatitis
A and B recognize an increased prevalence of homo-bisexual
transmission. Our experience shows a strict link between novel
diagnoses of acute HAV and HBV infection and homo-bisexual
behaviour, which showed a signiﬁcant increase of the absolute
number of detected cases, especially since the year 2002. A
careful epidemiological monitoring, speciﬁcally targeted educa-
tional campaigns and public health measures (such as an
recommendation of active immunoprophylaxis for p at risk)
may help contain the outbreak of hepatitis A and B among
homo-bisexual men and concurrently reduce the spread of other
potential STD.
P785
Intrafamilial transmission of hepatitis E in France
A. Ducancelle, E. Nicand, C. Payan, H. Le Guillou, P. Cale`s,
F. Lunel-Fabiani (Angers, Paris, Brest, FR)
Introduction: Hepatitis E virus (HEV) infection is an important
cause of epidemic and acute sporadic hepatitis in developing
countries. HEV is transmitted principally via the faecal-oral
route. In some industrialized countries, autochthonous cases
have emerged in patients who had never travelled to endemic
areas. We report an autochthonous case of acute HEV infection
with person-to-person transmission in the same family.
Methods: A 41-year-old man with clinical symptoms of acute
hepatitis and increased bilirubin and aminotransferase levels
was admitted in our hospital. Anti-hepatitis A, B, C virus
antibodies (Ab) (HAV, HBV, HCV) and anti-herpes viruses Ab
(CMV, EBV) were negative. Diagnosis of HEV was considered.
Samples from the patient and all the household contacts were
tested for the presence of serum IgG and IgM anti-HEV (Ab) and
HEV RNA.
Results: Anti-HEV IgG and IgM Ab were found in the patient
(index case) 14 days after the onset of hepatitis. The presence of
serum HEV RNA was detected only 4 months later. In his wife
(case contact 1), who presented with asthenia and moderate
cytolysis, HEV RNA was detected in sequential samples, before
the detection of anti-HEV Ab. Anti-HEV Ab and HEV RNA
were also found positive in the second contact case (5 years old
child), who had fever and asthenia. The second child was anti-
HEV Ab and HEV RNA negative. Clinical interview indicated
that the index case and his wife had eaten shellﬁsh and that all
the family have had a swim in the Saint-Ferreol lake located in
the south west part of France.
Conclusion: Diagnosis of HEV infection have to be considered
in case of acute hepatitis when markers of acute HAV, HBV, and
HCV infection are negative, even if patients have not recently
travelled in endemic areas. In our study, in the ﬁrst contact case,
hepatitis occurred within two weeks after the index case and
may not be due to intrafamilial transmission, but to a simulta-
neous faecal-oral contamination via shellﬁsh consumption or
lake swim. In the second case (child), the detection of HEV RNA
occurred after 6 weeks from the onset of disease in the index
case, suggesting that the infection had been contracted by
household contact. This case report and other published data
may indicate that HEV is emerging in the south part of France.
P786
Molecular detection and sequence analysis of
hepatitis E viruses in humans and animals in
Hungary
G. Reuter, D. Fodor, P. Forga´ch, B. Molna´r, J. Zentai, A. Ka´tai,
G. Szucs Pe´cs, Szeged, Budapest, Vecse´s, HU
Objectives: Hepatitis E virus (HEV) one of the most common
cause of hepatitis in endemic areas. However, recently demon-
strated that human infection may occur in developed countries
without any travel history and that animals may act as a
reservoir. The objective of this study was to identify hepatitis E
virus both in humans with hepatitis and animals by molecular
methods and to determine the viral genetic relationship to each
other and to the prototype HEV strains in Hungary.
Methods: Laboratory diagnosis of hepatitis E virus infection
was performed in human serum by HEV IgM ELISA and IgM/
IgG immunoblots. In addition, HEV-positive human samples
were selected and tested together with animal faecal and liver
samples by reverse transcription-polymerase chain reaction (RT-
PCR) using primers for partial viral capsid region followed by
sequence- and phylogenetic analysis.
Results: Twenty-seven patients with acute hepatitis were pos-
itive by HEV IgM ELISA and immunoblots treated in Hospital
of Szeged, Hungary between year 2001 and 2004. Viral genome
was successfully ampliﬁed in three human sera and 39 samples
from animals (swine, deer and boar) by RT-PCR and conﬁrmed
by sequencing in two human and eight animal samples,
respectively. All sequences belong to genotype 3 HEV strains.
Genetically identical human strains showed 95% nucleotide
identity to swine HEV strains (HEV-072swine/HUN and 354/
1/02/UK) and having 90% nucleic acid identity to the closest
human strain Greece2 (AF110392). In one human case, con-
sumption of home-made slaughtered pork sausage was a
potential source of infection.
Conclusions: Hepatitis E virus is present in Hungary. Only
genotype 3 strains have been found in both animals and
humans, which support the possibility of the endemic infections
in developed countries including Hungary and that swine may
act as a reservoir of human HEV.
P787
TT virus prevalence and distribution of
genotypes and genogroups in Korea
H.S. Kim, K.M. Lee (Anyang, KR)
Objectives: To determine prevalence of TT virus (TTV) and
distribution of genotypes and genogroups of TTV among
healthy adults and hepatitis B virus (HBV) or hepatitis C virus
(HCV) infected individuals in Korea.
Methods: Prevalence of TTV was investigated in serum sam-
ples of 69 healthy adults, 59 HBV infected individuals and 34
HCV infected individuals by heminested PCR assays using
primers from ORF-1 and UTR regions of viral genome. ORF-1
PCR products were genotyped by sequence analysis. TTV
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genogroups were investigated by ﬁve different genogroup-
speciﬁc PCR assays.
Results: TTV DNA was detected in 53/69 (77%) healthy adults,
47/59 (80%) HBV infected individuals and 27/34 (79%) HCV
infected individuals. Among the 20 sequenced isolates, 9 (45%)
were genotype 2, 8 (40%) were genotype 1, 2 (10%) were
genotype 3, and 1 (5%) was genotype 4. TTV genogroup 4 was
found most frequently (52/128), followed by genogroup 3 (42/
128), genogroup 1 (35/128), genogroup 5 (32/128), and geno-
group 2 (1/128). Mixed infections with different genogroups
were frequent.
Conclusion: Prevalence of TTV is high in Korea. There was no
signigicant difference in TTV prevalence between healthy adults
and HBV or HCV infected individuals. TTV genogroup 4 and
genogroup 3 are predominant genogroups.
P788
Presence and signiﬁcance of TT virus infection in
voluntary blood donors and patients on
maintenance haemodialysis in Tabriz, Iran
L. Gachkar, M. Taremi, M. Khoshbaten, M. Kheradpajouh
(Tehran, IR)
Objectives: Transfusion Transmitted virus (TTV) is a novel
DNA virus that is associated with post-transfusion hepatitis. We
investigated the prevalence of TTV and its role on liver disease
in voluntary blood donors and patients on maintenance hae-
modialysis.
Methods: This cross-sectional study was conducted in March
and April 2005. We tested 407 voluntary blood donors and 324
chronic haemodialysis (HD) patients in the city of Tabriz,
northwestern part of Iran, for the presence of TTV. Demographic
and clinical data were registered. TTV DNA was detected using
semi-nested polymerase chain reaction (PCR). Serum levels of
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) were also measured. In addition, hepatitis B surface
antigen (HbsAg), anti-hepatitis C virus (HCV), hepatitis E virus
antibody, and anti-HIV were previously determined in all
patients.
Results: The positive rate of TTV was 9.3%(95% CI: 6.1–12.5%)
in 324 patients on maintenance haemodialysis and 2.7% (95% CI:
1.1–4.3%) in 407 cases of voluntary blood donors (P < 0.001). The
prevalence rate of HBV, HCV and HEV infection were 4.6%,
20.4%, and 74%, respectively among HD patients. In voluntary
blood donors the prevalence rate of HBV, HCV and HEV
infection were 1.2%, 0.5% and 7.6%, respectively. All patients
were negative for anti-HIV antibody. No relations were found
between TTV infection and elevated levels of ALT or AST.
Clinical background including sex, mean duration of HD,
history of transplantation, history of blood transfusion, and
positive markers for either hepatitis B virus (HBV), hepatitis C
virus (HCV) or hepatitis E virus (HEV) did not differ between
TTV DNA positive and negative HD patients in both groups. In
HD group, the presence of TTV DNA was found to be related to
the age of the patients. TTV-positive patients were signiﬁcantly
younger than TTV-negative patients (P < 0.018).
Conclusions: TTV infection was more prevalent in Iranian
patients on regular HD than voluntary blood donors. No clinical
signiﬁcance of TTV virus could be elicited in both groups;
neither it showed any clinical impact as a co-infection with other
blood borne infections. Whether blood transfusions increase the
risk of TTV infection was not revealed by this study. Our data
did not show that when TTV alone is present it induces liver
function tests alteration. However, in TTV-positive patients,
long-term follow-up is necessary in order to clarify the effects of
TTV on liver function.
P789
The prevalence and phylogeny of GBV-C/HGV in
eastern Taiwanese indigenes
H.-F. Liu, D.-H. Chen, C.-W. Teng, C.-L. Lin, Y.-J. Lee,
L.-Y. Wang (Taipei-Tamshui, Keelung, Hualien, TW)
Objectives: GB virus C (GBV-C)/hepatitis G virus (HGV) has
been detected in eastern Taiwanese indigenes. However, only
the prevalence of GBV-C/HGV viral RNA was reported without
any information about genotyping and their phylogenetic
relationship. We therefore investigated the prevalence, geno-
types, and phylogeny of GBV-C/HGV in eastern Taiwanese
indigenes to complete their molecular epidemiological data.
Methods: Serum or plasma samples from 140 eastern Taiwan-
ese indigenes were included in this study. Viral RNA was
extracted from the 140 samples and cDNAwas synthesized with
random hexamer primers. A nested PCR was performed in the
5’NCR to part of the E1 gene. PCR products were puriﬁed and
subjected to direct sequencing. Phylogeny re-construction was
performed using the Phylip software package, with the neigh-
bour-jointing method, the Fitch and Wagner parsimony method,
and the maximum likelihood method. The robustness of the NJ
and pars trees was statistically evaluated by bootstrap analysis
with 1000 bootstrap samples.
Results: Among the 140 samples, ﬁve were found to be GBV-C/
HGV RNA positive (3.5%). A total of 113 GBV-C/HGV
sequences from all over the world were included in the
phylogenetic analysis. Five major GBV-C/HGV genotypes
were identiﬁed. Two of the ﬁve isolates belonged to the
genotype 3 (Asian type) cluster, whereas three were surprisingly
clustered within the genotype 1 (Africa type) groups. The tree
topology was supported statistically signiﬁcant by all methods
used. A very signiﬁcant effect (20–5% variance of bootstrap
values) of different times of bootstrap replications (100 and 1000
times) was also observed.
Conclusion: About 3.5% prevalence of GBV-C/HGV viral RNA
in eastern Taiwanese indigenes was conﬁrmed. Both GBV-C/
HGV genotype 1 and 3 were found in this population. The
possible sources of the infection with the African type virus
remained unclear. A sufﬁcient number of replications needed
for accurate estimation of the bootstrap value should be taken
into account for phylogenetic studies.
P790
Three years lamivudine therapy in adults with
HBeAg-positive chronic hepatitis B
M.K. Celen, C. Ayaz, S. Hosoglu, M.F. Geyik, M. Ulug
(Diyarbakir, TR)
Introduction: The aim of the study was to assess a three-year
administration of lamivudine in adult patients with HBeAg-
positive chronic hepatitis B.
Methods: Chronic hepatitis B patients that not responded to
interferon-a therapy were included into this study. Lamivudine
monotherapy was administrated 100 mg daily for 3 years. In the
course of the treatment, every four-week period, ALT activity,
haemoglobin levels, leukocyte and thrombocyte counts were
determined. Furthermore, in every 12-week periods, prothrom-
bin index and protein fraction were analysed. Serologic markers
of hepatitis B virus (HBV) infection and level of HBV-DNAwere
measured before and after treatment, every 6 months during the
treatment and 6 months after the end of treatment. A liver
biopsy was performed before the therapy in suitable of the
studied patients. (Histological evaluation according to Knodell)
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In the assessment of the effectiveness of the Lamivudine therapy
was considered according to loss of HBV-DNA in serum and
seroconversion in HBeAg/anti-HBe system as well as normal-
ization ALT and AST activity.
Results: Twenty-six patients (22 men, 4 women) aged
30.8 ± 7.5 years old were included into the study. After a
twelve-month treatment period, HBV replication and normal-
ization of ALT and AST activity were observed in 15 patients
(57.7%). The response of the therapy sustained in 13 (50%)
patients at the end of second year. The end of 36 months,
biochemical and virological response persisted in nine patients
(34.6%). HBeAg/AntiHBe seroconversion was developed in ﬁve
patients. After sixth month of the end of therapy, permanent
response was continued in eight patients (22.6%). Side effects of
treatment were not observed in any of the studied patients.
Conclusion: The sustained virological response after 3 years
Lamivudine treatment was found 22.6% in chronic HBV
infections.
Paediatric infectious diseases
P791
Antimicrobial susceptibility of Haemophilus
inﬂuenzae ocular isolates collected from
outpatients in paediatric hospital
A. Makri, T. Guajardo, H. Papavasileiou, H. Iliadis,
I. Varzakakos, N. Manios, A. Voyatzi (Penteli, GR)
Introduction: Haemophilus inﬂuenzae (HI) is responsible for a
number of human diseases, ranging from chronic respiratory
infection to meningitis, which affect children. Eight biotypes and
six serotypes of HI have been identiﬁed. Biotyping and sero-
typing have been used to investigate patterns of colonization of
HI, as well as to identify stains of the bacterium that appear to
be associated with more severe infections.
Objectives: To determine which subtypes and biotypes of HI
are most commonly associated with ocular disease and to
monitor the patterns of antimicrobial sensitivity in children with
eye infections.
Material and methods: Ocular swabs were collected from the
examined population, aged 1 month to 14 years old, who visited
our children hospital during the period 2002–2005. Identiﬁcation
and biotyping isolates were performed by classical microbiolo-
gical methods and by API NH strips (bioMerieux). Capsular
subtypes a–f were determined by slide agglutination using
commercially available subtype speciﬁc antiserum. b-Lactamase
production was determined by the chromogenic cephalosporin
test with nitroceﬁn as substrate.
Results: A total of 151 HI isolates were recovered from 755
ocular samples submitted to our microbiological department.
The majority of the isolates were serologically non typable. The
prevalent biotype of HI isolates was biotype II 48.3% (73/151)
followed by biotype III accounted 22.5% (34/151). The remain-
ing biotypes were biotype I 12% (18/151), biotype IV 6.6% (10/
151), biotype V 4.6% (7/151) and from each one isolate 2% for
biotypes VI–VIII. A signiﬁcant resistance to cotrimoxazole (25%)
and in lower rate to clarithromycin (8%) was observed. All the
isolates resistant to ampicillin (8%) were b-lactamase producers
and susceptible to cefuroxime, cefotaxime, ciproﬂoxacin and
chloramphenicol.
Conclusions: This study showed that biotypes II and III are the
predominant biotypes of HI found in ocular infection. There is a
low prevalence of b-lactamase production and resistance of
macrolides while all isolates were sensitive to chloramphenicol.
Surveillance is necessary to monitor rates of resistance in the
community in order to tailor empiric therapeutic recommenta-
tors.
P792
Bacterial pathogens isolated from children with
bloodstream infection
A. Makri (Athens, GR)
During the last two decades, the incidence of the pathogens
responsible for Blood Stream Infections (BSI) in children has
changed.
Objectives: To determine the frequency of pathogens isolated
from children with bacteraemia and to investigate their suscep-
tibility patterns.
Material and Methods: Blood cultures were performed using
the Bac T Alert 30 automated system. Vitek 2 automated system
(bioMerieux, France) was used for identiﬁcation and suscepti-
bility testing of pathogens.
Results: A total of 12 301 blood cultures were screened for
aerobic, anaerobic and fungi during a ﬁve-year period (2001–
2005). Bacteraemia occurred in 350 cases (2.8%) of hospitalized
children, males: 53%, females: 47%, with a median of 5 years of
age. Out of 350 isolated stains, 266 were Gram- positive (76%)
and 81 were Gram- negative (24%). Among Gram positive, the
most prevalent was Coagulase-Negative Staphylococci 70.6%
followed by Streptococcus pneumoniae 10.9%, Streptococcus aureus
8.6%, Streptococci 6.0%, Enteroccoci 2.2%. The most frequent of
Streptococci were Streptococcus pyogenes and Streptococcus agalac-
tiae. From the Gram negative the most prevalent were Escherichia
coli 20.9% followed by Streptococcus maltophilia 16% and Salmon-
ella spp.12.3%. Other Enterobacteriaceae, Neisseria meningitidis, H.
inﬂuenzae and anaerobic bacteria were found in lower rates. S.
pneumoniae, E. coli and Salmonella spp. were usually causative
agents of BSI in pediatric clinics whereas Stenotrophomonas,
Pseudomonas and Enterococci were isolated from Intensive Care
Unit (ICU). All Gram-positive isolates were susceptible to
glycopeptides. Most of CoNS were resistant to Oxacillin 68%,
Clindamycin 40.4%, ﬂuoroquinolones 12.2% and Gentamicin
27.1%. A signiﬁcant degree of resistance to Penicillin (24.1%) and
to macrolides (31%) was reported for S. pneumoniae. The majority
of S. aureus were susceptible to aminoglycosides, ﬂuoroquinolo-
nes, and resistant to Oxacillin by 26%. E. coli strains produced
AmpC-b-lactamases in 29.4% and a low prevalence of ESBL-
producing strains was recorded. Acinetobacter baumannii and
Stenotrophomonas strains from ICU, were multiresistant.
Conclusions: 1. CoNS were the leading cause of BSI, followed
by S. pneumoniae, S. aureus and E. coli. 2. These four were
responsible for 71.5% of all BSI. 3. Signiﬁcant difference in the
microbiology of blood cultures between the paediatric clinics
and ICU was noted.
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P793
Characterisation of Haemophilus inﬂuenzae
isolates from conjunctivitis (Portugal, 2001–2005)
M.P. Bajanca-Lavado, D. Louro, M.M. Canic¸a (Lisbon, PT)
Objective: Acute conjunctivitis, caused by nontypable (NT)
Haemophilus inﬂuenzae (HI) strains, is the most common eye
disorder, especially in young children. The aim of this work was
the phenotypic characterization of HI isolates and the relation
with strains previously isolated (1997–2000).
Methods: From January 2001 to June 2005 the Antibiotic
Resistance Unit at the National Institute of Health, in Lisbon,
received 222 HI strains isolated from conjunctivitis, in 11
collaborating Hospital Laboratories. Most of strains were isola-
ted from children (92%) and from community acquired infec-
tions (74%). beta-lactamase production was determined by a
nitroceﬁn assay; ApiNH (BioMe´rieux) was used to determine
the biotype; serotyping was performed by PCR, using primers
speciﬁc to capsule (a–f); minimum inhibitory concentrations
(MIC) of 14 antibiotics were determined by a microdilution
assay (Dade Behring).
Results: 12.5% of strains were beta-lactamase producers (all
had MIC of ‡4 mg/L to ampicillin); 5.3% of beta-lactamase
negative strains had MICs of 2 or 4 mg/L to that beta-lactam
and were considered ampicillin resistant non beta-lactamase
producers (ARNBLP). Resistance to other antibiotics (consider-
ing both resistance and intermediate strains), was as follows:
32% to SXT; 4.6% to cefaclor; 1.4% to rifampicin; and 1% to
tetracycline. Biotypes I (23.6%), II (36.4%), III (23.6%), and IV
(14%) included most of the strains (98%). As expected, most
strains were NT (99%), although two strains were of serotype e,
one f and other d. Strains of serotype e are often associated to
biotype IV as also found in our study.
Conclusions: In this study we veriﬁed an increase of beta-
lactamase producing strains, isolated from conjunctivitis (8.5–
12.5%), comparing with 64 strains isolated between 1997 and
2000. ARNBLP presented only a slight increase (4.7–5.3%),
although we expect an increment of this mechanism of resist-
ance in the future, due to changes on therapy. As ARNBLP
strains are difﬁcult to detect with the breakpoints actually
proposed by NCCLS (2004), we suggest their revision.
Advanced molecular studies would improve ARNBLP detec-
tion. HI isolated from conjunctivitis is of high concern since this
disease affects very young children and beta-lactam resistance
mechanisms are changing. Serotype alterations, due to Hib
vaccine should also be monitored.
P794
Antimicrobial susceptibility and serotyping of
pneumococci in a Tunisian paediatric hospital
H. Smaoui, J. El Amri, A. Kechrid (Tunis, TN)
Streptococcus pneumoniae is one major causative agent of severe
infectious diseases. More than 90 pneumococcal serotypes are
known, although the majority of invasive and non invasive
disease is associated with a much smaller number of serotypes.
Objectives: Antibiotic resistance prevalence and serotype dis-
tribution of invasive pneumococci isolates in Tunisia.
Methods: We have studied 131 non-repetitive invasive pneu-
mococcal strains isolated in our laboratory between January
1998 and August 2005. Isolates were identiﬁed as S. pneumoniae
by optochin sensitivity and bile solubility tests. Antimicrobial
susceptibility was performed by the disk diffusion method
using Mueller–Hinton agar supplemented with 5% deﬁbrinated
sheep blood as determined by CA-SFM guidelines. Penicillin
susceptibility was determined by oxacillin 5 mcg disk screening
test. MICs of penicillin G, amoxicillin and cefotaxime were
determined by E-test (AB BIODISK). S. pneumoniae ATCC 49619
was used as a control strain. Serotype determination was
performed by rapid latex agglutination (Pneumotest Latex)
and the capsular reaction test using antisera from Staten Serum
Institute, Copenhagen.
Results: Prevalence of penicillin non susceptible pneumococci
(PNSP) isolates was 49.6%, the majority of them (43.7%) had a
low level of resistance. Amoxicillin resistance concerned 10.8%
of isolates with a high level of resistance in 0.8%. All cefotaxime
resistant isolates (5%) had a low level of resistance (MIC <
2 mcg/ml). The most prevalent serotypes were 14 (30.5%), 4
(12.5%) and 23F (7.6%). Among PNSP isolates, 35.7% belongs to
serotype 14 and 19% to serogroupe 23. The coverage of
serotypes included in the conjugate heptavalent vaccine is 62%.
Conclusion: Prevalence of PNSP is high in pneumococci inva-
sive isolates. The most prevalent serotype is 14.
P795
Pneumococcal infection in a children’s hospital
in 2004, Taoyuan, Taiwan
Y. Huang (Taoyuan, TW)
Streptococcus pneumoniae is one of the common pathogens related
in bacteria infection in children. To study the clinical spectrums,
microbiologic characteristics and serotype distribution of pneu-
mococcal infection, 77 S. pneumoniae isolates from 77 patients (38
were male) were identiﬁed in Chang Gung Children’s Hospital
in 2004.The isolates were obtained from blood (14), pleural ﬂuid
(4), nasal aspirates (12), sputum (25), conjunctival discharge (4),
pus from ears (13), parotid gland (1), synovial ﬂuids (2), orbital
abscess (1) and scald burn wound (1). The disease spectrum of
these patients included bacteremia (9), pneumonia (25), compli-
cated pneumonia (6), suppurative otitis media (14), sinusitis
(11), septic shock (2), septic arthritis (2), conjunctivitis (4),
suppurative parotidis (1), scald burn wound infection (1),
preseptal cellulitis (1), orbital cellulitis (1). The mean age was
3.55 years (range: 4 months to 16.7 years). 31 (40%) patients
were younger than 2 years old. Two cases resulted in mortality
due to septic shock with the same serotype 23F and both were
younger than 2 years old. Patients with complicated pneumonia
had the longest mean hospital stay: 17 days. Among 77 isolates,
68 (88%) were not susceptible to penicillin (58% were interme-
diately susceptible, and 30% were resistant, intermediate: MIC:
0.1–2, resistant: MIC ‡ 4). One strain had MIC 8 lg/mL. No
strain was resistant to vancomycin. Most non-susceptible pneu-
mococci were serogroups 23F (29%), 6 (22%), 14 and 19F (19%).
The predominant serotypes were 23F (27%), 14 and 19F (18%).
Serotypes 19A and 23B were only isolated from sputum.
Serotype 14 accounted for 23% of pneumonia cases. Among
patients with serotype 14 isolates, 64% were pneumonia cases.
All isolates were belonged to or closely related to serotypes
covered by the 23-valent vaccine and 7-valent pneumococcal
conjugated vaccine.
P796
Repeated isolation of a pneumococcus from a
child suffering from IRAK-4 deﬁciency
O. Dobay, J. Szabo´, A´. Borbe´ly, M. Erdo˜s, F. Rozgonyi, K. Nagy,
L. Maro´di (Budapest, Debrecen, HU)
Objectives: The IRAK-4 deﬁciency is a primary immunodeﬁ-
ciency, mainly associated with pyogenic bacterial infections like
those caused by Streptococcus pneumoniae. The patients express a
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poor inﬂammatory response and fail to sustain antibody
responses. In this case report we describe the repeated isolation
of the same invasive pneumococcal strain from an abscess and
the blood of a 5-year-old child with this disease, after a 2-year
interval.
Methods: The species identity of the strains was conﬁrmed by
the optochin sensitivity and by the presence of the lytA gene.
Antibiotic susceptibility testing (MIC) was performed by the
agar dilution method to 10 drugs. Serotyping was done with the
agglutination antisera produced by Mast Diagnostica. PFGE was
performed by digestion with ApaI enzyme for 6 h at 37 C, and
the fragments separated using 2s and 30s pulse times, for 22 h at
14 C. The presence of four macrolide resistance determinants:
erm(B), mef(E/A), erm(A) and erm(TR) genes was tested by
PCR.
Results: The patient suffered from relapsing joint infections
already at early age. The ﬁrst invasive penumococcal infection
(septic hip-joint inﬂammation) occurred when he was 3 years
old, and it was cured with parenteral cefotaxime and non-
steroid therapy. A speciﬁc anti-polysaccharide antibody deﬁci-
ency was observed. The second invasive episode occurred
2 years later, when purulent meningitis followed the joint
symptoms, and was cured successfully again with parenteral
cefotaxime and supportive treatment. The IRAK-4 deﬁciency
was shown at this stage and the patient received intravenous
immunoglobulin substitution. The two invasive pneumococcal
strains proved to be identical, by both genotyping and serotyp-
ing methods and by their antibiotic sensitivity patterns. Both
strains carried the erm(B) macrolide resistance gene.
Conclusion: Repeated pneumococcal infections associated with
IRAK-4 deﬁciency have been described before in the USA in
1998. However, to our knowledge, this is the ﬁrst time that the
isolation of the same pneumococcal strain in a patient with
IRAK-4 deﬁciency was proven, and also conﬁrmed by genotyp-
ing methods. In the case of pneumococci, serotyping and other
phenotypic investigations are not sufﬁcient for the determin-
ation of identical strains.
P797
Nasopharyngeal colonisation by Streptococcus
pneumoniae in children: Impact of amoxicillin
treatment
A. Dı´az, R. Garcia, C. Garcı´a-Rey, E. Cuchı´, E. Calbo, L. Toben˜a,
M. Dı´az-Infantes, J.E. Martı´n-Herrero, J. Garau and the Spanish
Pneumococcal Infection Study Network
Introduction: Nasopharynx of children is the main reservoir of
Streptococcus pneumoniae (SP). The percentage of nasopharyngeal
carriers of SP in <2 years-old children ranges from 26% to 62%.
The aim of our study was to assess the effect of amoxicillin
exposure on the nasopharyngeal colonization (NPC) and on the
antibiotic susceptibility of SP in <5-year-old children.
Material and methods: From Dec 2001 to Feb 2004, <5-year-old
children with respiratory symptoms and fever seen in the
Emergency Department of our hospital andwhowere prescribed
amoxicillin (40–90 mg/kg) were eligible. Three nasopharyngeal
swabs were taken: at the time of the initial visit (IV), a second
sample within 60 hours after amoxicillin discontinuation (end of
treatment visit, ETV), and the third, 4 weeks later (follow-up
visit, FUV). SP colonization, serotype distribution and antimi-
crobial resistance were evaluated over time.
Results: 134 children were included. In the IV 67/134 (50%)
were colonized. SP was found in the nasopharynx of 10/17
(58.5%), 15/35 (42.9%) and 42/82 (51%) of <1, 1–2 and >2 years-
old children, respectively. Vaccine Serotypes (VS) were identi-
ﬁed in 80%, 40% and 55% of <1 year-old, 1–2 years-old and > 2
years-old children, respectively. The proportion of non-suscep-
tible Penicillin SP (NPSP) was 60% in <1 year-old children, 43%
in 1–2 years-old children and 40% in > 2 years-old children. 49
out of 134 (36.5%) children completed the three study visits and
were the assessable group. 51%, 22.4% and 46.9% were
colonized at IV, ETV and FUV, respectively. The percentage of
resistant SP was 28%, 45.5% and 8.7% (p < 0.05) for penicillin,
and 40%, 63.3% and 47.8% (NS) for erythromycin at IV, ETV and
FUV, respectively.
Conclusions: In children <1 year of age a higher proportion SP
colonization, presence of vaccine serotypes and non-susceptible
penicillin SP was found. NPC dropped to a half in ETV and
returned to baseline levels 1 month after amoxicillin disconti-
nuation; however non-susceptible penicillin isolates decreased a
68% in FUV with respect to IV due to recolonization by ‘‘de
novo’’ penicillin susceptible strains.
P798
Prevention of perinatal group B streptococcal
infections: evaluation of a new chromogenic
medium STREPTO B ID
C. Roure, V. Fiaty, Y. Gilles, H. Salord, S. Tigaud (Lyon, FR)
Objective: The aim of this prospective study was to compare a
method using the new chromogenic agar STREPTO B ID
(bioMe´rieux SA, France), Granada agar (Biomedics) and Colum-
bia blood agar with colistin-nalidixic acid (BA-CNA) (bio-
Me´rieux), to detect vaginal colonization by group B
streptococci (GBS) in pregnant women.
Method: Specimens for GBS screening received over a 3 month
period from pregnant women (683 vaginal swabs and 41 urine),
13 newborn gastric ﬂuid at two hospitals were included and
tested during this study. These specimen were cultured in
parallel onto the three media by direct inoculation and after
enrichment in Todd-Hewitt + antibiotics broth. Each medium
were observed after 24 and 48 h incubation.
Results: Overall GBS was detected in 255 cases (35%) on at least
one medium after enrichment. Before and after enrichment, the
sensitivity was 45.8% and 93.3% for STREPTO B ID, 39.6% and
82.9% for Granada, 45.4% and 92.5% for BA-CNA respectively at
24 h. Prolonged incubation (48 h) enabled to increase the
sensitivity: before and after enrichment, the sensitivity was
55.8% and 99.2% for STREPTO B ID, 52.5% and 92.9% for
Granada, 52.9% and 96.7% for BA-CNA. Regarding the specif-
icity, the Granada medium method gave 99.8% versus 97.3% for
the STREPTO B ID after enrichment and 48 h incubation.
Conclusion: These ﬁndings show that the STREPTO B ID
medium, the ﬁrst chromogenic medium to detect GBS, is more
sensitive than the Granada medium. However, the Granada
medium method is more speciﬁc after enrichment and 48 h
incubation. The enrichment phase increases signiﬁcantly the
sensitivity of GBS detection especially with STREPTO B ID. This
new medium is easy to use due to the incubation under aerobic
conditions.
P799
Invasive group a streptococcal infections and
incidence of resistance in children’s hospital
D. Garantziotou, M. Vlachou, O. Koureli, T. Apostolaki,
P. Michail, V. Rouli, A. Gatopoulou, A. Spiliopoulou (Patras, GR)
Objectives: Streptococcus group A (GAS) has been mentioned to
cause severe invasive diseases during the last years. Knowledge
of resistance towards the most usually used antibiotics is very
important, since fast and effective treatment is needed to reduce
morbidity and mortality.
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Materials-methods: Between 1 January 2001 and 31 October
2005, a total of 51 invasive strains of Streptococcus pyogenes (deep
tissue infections, blood, synovial, cerebrospinal ﬂuid) were
collected from children aged 0–15 years old. All isolates were
conﬁrmed as S. pyogenes by Lanceﬁeld grouping using the
Pastorex STREP rapid agglutination kit. Susceptibility testing to
antibiotics was performed by disk diffusion method and MIC of
penicillin was determined by E-test.
Results: All strains of S. pyogenes were penicillin sensitive.
Seven isolates (13, 72%) were erythromycin resistant, the main
mechanism of which was of M-phenotype. Three isolates
(5.88%) were clindamycin resistant. If we compare the results
obtained in 2001–2005, we observe a statistically signiﬁcant
increase in erythromycin resistance of S. pyogenes. During 2001–
2003 there were no clindamycin or erythromycin resistant
strains, while during 2004–2005 there were isolated the resistant
strains we report.
Conclusions: The prevalence of macrolide resistance among S.
pyogenes is not uncommon (13, 72%). Efforts should focus on
development of guidelines, but also on appropriate use of
antibiotics. Penicillin G is still considered to be drug of choice for
S. pyogenes infections.
P800
Community-acquired methicillin-resistant
Staphylococcus aureus in Greek children
J. Dotis, M. Tsiakou, M. Tsivitanidou, D. Soﬁanou, E. Roilides
(Thessaloniki, GR)
Objectives: MRSA has been a major nosocomial pathogen
causing severe morbidity and mortality. More recently, serious
community-acquired MRSA (CA-MRSA) infections have been
reported worldwide. We aimed to deﬁne the frequency of
MRSA in paediatric patients of a tertiary care hospital and
estimate the proportions and drug susceptibilities of MRSA and
CA-MRSA in our region.
Methods: All cases of paediatric patients from whom Staphylo-
coccus aureus was isolated between Jan 2002 and Dec 2004 were
reviewed and compared with the results of a previous study (Jan
1999 to Dec 2001; ECCMID 2003, abstr 1256). CA-S. aureus and
CA-MRSA were deﬁned as isolates from cultures taken £ 2 days
after hospital admission from patients not hospitalized during
previous 3 months. Fisher’s exact test was used for the analysis.
Results: S. aureus was isolated from 168 children, and MRSA
from 28 (16.7%) as compared to 36.5% in previous study,
p < 0.001. The frequencies of MRSA and CA-MRSA are shown
in Table. Comparing the two periods, the peak frequency of
MRSA (42.9%) was in 2000, whilst the lowest frequency (16.9%)
in 2004, p = 0.003. The highest frequency of CA-MRSA (53.8%)
was in 2003, whilst the lowest (33.5%) in 1999, p=ns. From CA-
MRSA isolates, 89.3% were susceptible to clindamycin, 82.1% to
erythromycin, 100% to co-trimoxazole and 53.8% to tobramycin.
One CA-MRSA isolate was resistant to erythromycin and
susceptible to clindamycin. The children with MRSA were
ranged within 1 d to 17 yr. In general, MRSA tended to be
isolated from boys and infants younger than 45 d more
frequently than girls and older children, respectively.
Conclusion: (1) Approximately 80% of S. aureus isolated from
pediatric patients in our hospital are community-acquired, and
half MRSA’s isolated are CA-MRSA’s. (2) Compared to early
period, frequency of MRSA tends to decrease unlike CA-MRSA,
which tends to increase. (3) CA-MRSA isolates are susceptible to
alternative antibiotics. (4) Control of MRSA requires continuous
surveillance and appropriate use of antibiotics not only in the
hospital but also in the community.
P801
Seroprevalence of serogroup speciﬁc antibodies
against different serogroups of Neisseria
meningitidis (Serogroup A, C, W 135 and Y) in
healthy individuals in different age groups
I. Yildirim, R. Borrow, G. Lal, N. Andrews (Ankara, TR;
Manchester, London, UK)
Objective: Meningococcal disease is still a major global health
problem causing approximately 1.2 million cases per year and an
estimated 135,000 deaths. The predominant serogroups may be
different in each region and they can change by the time in the
same area. There is nomeningococcal vaccine introduced into the
routine schedule in Turkey yet. Since the distribution of sero-
groups is important to determine the antigens that will be
included in the vaccine,we aimed todetect the levels of serogroup
spesiﬁc antibodies from birth to the age after 60 in Turkey.
Materials and methods: From different regions representing
the West, East and the North side of the country, a total of 350
serum samples were included in the study. Fourteen different
age groups and 25 samples in age group were analysed.
Meningococcal serospesiﬁc IgG levels were identiﬁed by using
tetra-plex ELISA in Bioplex Array System, Bio-Rad.
Results: The pattern of the IgG levels against serogroup A, C,
W135 and Y from birth to the age after 60was dﬁfferent from each
other. Over all age groups, the geometricmean titer for serogroup
A was 3.21 lg/ml, serogroup C was 1.22 lg/ml, serogroup W
was 0.34 lg/ml, serogroup Ywas 0.55 lg/ml. In all serogroups a
decline in the IgG levels were detected between the age 6 and
12 months. For serogroup A and C, there was a inreasing trend
after the age of 10–14 years. A similar increase was seen in the
period of between the ages of 3 and 5 for serogroupW135 and Y.
Conclusions: To determine which serogroups are causing most
of the meningococcal infections is important because the disease
due to some serogroups can be prevented by active immuniza-
tion and there are different vaccines including different sero-
group antigens. In Turkish population, after the lost of maternal
antibodies between the age of 6 and 12 months, the level of
serogroup spesiﬁc IgG antibodies increases after 10–14 years
against serogroup A and C and during 3–5 years of age against
serogroup W135 and Y. This pattern of antibody distribution
suggests that serogroups A and C were the predominant
meningococci 0–14 years ago, however serogroups W135 and
Y are much more frequent in early childhood meningococcal
infectios currently. This data is parallel to the results of previous
and current surveillance studies and shows the importance of
age and time spesiﬁc seroprevelance investigations.
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Increasing nasopharyngeal carriage rate of
Neisseria meningitidis serogroup W135 in healthy
Turkish primary school students after 2000 Hajj
epidemic
I. Yildirim, S. Ercis, S. Uygun, G. Secmeer (Ankara, TR)
Objective: The usual source of meningococcal infections are the
asymptomatic human nasopharngeal carriers. Colonising and
infecting serogroups differ from country to country and this
information is important because the current and developing
vaccines are including only the predominant serotypes in that
area. Thus our study aimed to determine meningococcal
carriage rates among the primary school children and identify
the predominant serogroups.
Materials and methods: Throat swabs were cultured from
1500 healthy children randomly selected from primary schools
in Ankara, Turkey and recovered N. meningitidis were sero-
grouped by using conventional polymerase chian reaction
(PCR). Oligonucleotides in siaD gene (for serogroups B, C, Y
and W135) and in orf-2 gene (for serogroup A) were targeted
in PCR.
Results: Nasopharyngeal swabs were taken from 1500 pupils
attending to schools in the study and the children were aged 6–
14. The carriage rate of N. meningitidis rate in our region was
found to be 7.4% (111 of the 1500 samples). SerogroupW135 was
identiﬁed in 75 (67.5%), serogroup B in 12 (10.8%), serogroup Y
in 4 (3.68%) and serogroup C in 1 (0.9%) of the cultures.
Nineteen isolates of N. meningitidis could not be serotyped by
PCR.
Conclusion: Serogroup C is the most common N. meningitidis in
the developed countries and vaccination policies are being
tailored to prevent the infections caused mainly by this serotype.
Since asymptomatic carriers are presumably the major source of
pathogenic strains and one of the goals of the vaccination
against N. meningitidis is to prevent the carrier state the regional
rates of the N. meningitidis serogroups carried in the nasophar-
ynx is important to know for selecting the vaccine content.
Although the dominant meningococcal serogroups were sero-
group B and C in carriers and patients with invasive infections
up to the recent years, the rate of serogroup W135 infections are
increasing after the year of 2001. Our study showed that this
serogroup has been intensely colonized in healthy Turkish
children. The source of this colonization seems to be the pilgrims
in 2000 when international outbreak caused by a previously rare
serogroup W135, because approximately 150,000 Turkish pil-
grims travel annually to Saudi Arabia for Hajj. Although the
vaccine can not protect the persons from becoming asympto-
matic carriers, a vaccine including W135 meningococcal antigen
has to be used for the vaccination of children to prevent the
invasive disease.
P803
Evaluation of IgA secretory antibodies in
children with Helicobacter pylori infection
M.E. Cavazza, D. Ortiz, M.I. Urrestarazu, M. Correnti,
G. Daoud, N. Daoud, M. Perrone (Caracas, VE)
Helicobacter pylori is associated with peptic ulcer disease and
represents a risk factor in gastric cancer and maltoma. Secretory
IgA, is the predominant gastrointestinal mucosal antibody, with
an important effect against different antigens. The objective of
this study was to measure the salival speciﬁc secretory IgA anti-
H. pylori value in 30 children with chronic abdominal pain (13
female; 17 male, range 2–15 years old mean 7.3 b 3.8) and 30
children asymptomatic.
Patients and methods: Each child of the symptomatic group
underwent clinical evaluation, serum IgG anti- H. pylori
(Pyloriset-ORION), salival IgAs anti-H. pylori (ELISA, devel-
oped in our laboratory), gastric biopsy for histology, rapid urea
test.
Results: Chronic gastritis was found in 53% (30% positive H.
pylori, 23% negative H. pylori). Chronic active gastritis was
detected in 17%, all positive for H. pylori. A signiﬁcant tendency
to increase secretory IgA levels, related to the severity of the
histological gastric ﬁnding was observed (p = 0.0307); which
was signiﬁcantly higher in children with positive H. pylori and
chronic active gastritis than chronic gastritis (p = 0.0408). These
results probably reﬂect an important effect of the salival
secretory IgA antibody in the gastric immunity against H.
pylori infection associated with chronicity and activity of gastric
infection.
Acknowledgement: Grant: Fonacit 96001408.
P804
Resistance pattern of Staphylococcus aureus
clinical isolates from children
A. Kyratsa, E. Kontekaki, N. Charalambaki, A. Zambou,
E. Trikka-Graphakos (Athens, GR)
Staphylococcus aureus is one of the three most common causes of
nosocomial infections, while resistance to antimicrobials is
gradually rising.
Objectives: To determine antibiotic resistance of S. aureus
clinical isolates from children.
Methods: We studied retrospectively 124 strains of S. aureus
isolated during the last 5 years (2000–2004). Twenty-nine strains
were isolated from skin lesions, 25 wounds, 15 eye swabs, 14 ear
swabs, 13 nose swabs, 16 blood cultures, 7 umbilical swab and 5
urine specimens. Processing and follow-up was based on
conventional methods and identiﬁcation was performed by
Api-Staph (Biomerieux). Resistance of staphylococci was tested
by Kirby–Bauer method and MICs to 10 antibiotics were
determined by the agar dilution method, according to NCCLS
guidelines. Detection of inducible resistance to clindamycin was
tested with erythromycin-clindamycin ‘D-zone’ test. Moreover
resistance to methicillin was tested with the following methods:
(1) incorporation of oxacillin (6 mg/ml) in Muller–Hinton agar
enriched with 4% Nacl, (2) Etest method (AB Biodisk,Solna,Swe-
den), (3) estimation of zone diameter around cefoxitin disc (30ı`g)
and (4) agglutination with monoclonal antibody against PBP2a
protein (Biomerieux).
Results: Resistance of Staphylococcus aureus to methicillin
(MRSA) with all methods was 12.7%. Resistance rates to
antimicrobials was as follow: penicillin (87%), tetracycline
(24.4%), erythromycin (10.4%), clindamycin (5.8%), fucidic acid
(6.9%) and gentamycin (1.1%). Inducible resistance to clinda-
mycin was detected in 5.8%. The most common resistance
phenotype was oxacillin-tetracycline-fucidic acid. All specimens
were sensitive to rifampicin, chloramphenicol, glycopeptides,
streptogramines and oxazolidinones.
Conclusions: (1) Continuous increase of MRSA, necessitates the
use of a combination of laboratory methods for accurate
detection of methicillin resistance. (2) ‘D-zone’ test is a rapid
and reliable method for detection of inducible resistance to
clindamycin and can be used for discrimination of strains with
genetic potential to develop resistance during treatment.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P805
Incidence and antimicrobial resistance of
pathogens causing gastroenteritis in childhood
A. Kyratsa, E. Kontekaki, F. Ioannidou, Z. Kyriazi,
E. Trikka-Graphakos (Athens, GR)
Objectives: To evaluate the incidence and resistance pattern of
enteropathogenic bacteria and viruses in children.
Methods: A total of 6152 stool specimens were tested in our
laboratory during the years 1998–2005. All samples were gram
stained and plated in the appropriate common and selective
culture media. Detection of Rota and Adeno virus antigen was
performed with immunochromatography assay. Identiﬁcation
was performed with conventional methods and serological
typing with speciﬁc antisera in the National Reference Center.
Susceptibility to antibiotics was tested by Kirby–Bauer method
and MIC determination by the agar dilution method, according
to NCCLS guidelines.
Results: Bacterial gastroenteritis was detected in 18.4% of
specimens, viral in 14% and co-infection in 5.5%. The most
frequent isolate was Salmonella spp (54.2%) with S. enteritidis
being the commonest serotype (48.1%), followed by Campylo-
bacter jejuni (30.3%) with HS:2 as the predominant serotype.
Third most frequent pathogen was Shigella spp (6.8%) with
commonest serogroup Shigella ﬂexneri (80%) and predominant
serotype 2. Enteropathogenic Escherichia coli (EPEC) was detec-
ted in 5.2% of specimens, Yersinia enterocolitica in 1.4%, with
O:3 as the predominant serotype and Aeromonas hydrophila in
1.1%. Antigens of Rota and Adeno virus were detected in 11.5%
and 2.5% respectively. Resistance of Salmonella spp. to co-
trimoxazole was 5.4%, to ampicillin 32.2% and to nalidixic acid
33.5%. Resistance of S. ﬂexneri to ampicillin was 61.3% and co-
trimoxazole 27.2%, while both pathogens were sensitive to
ciproﬂoxacin. There was no resistance of Campylobacter spp. to
erythromycin.
Conclusions: 1. In order of frequency S. enteritidis, C. jejuni and
S. ﬂexneri were the predominant isolates, while Rota virus is
responsible for a high incidence of viral gastroenteritis. 2. High
incidence of resistance to ampicillin and co-trimoxazole and
susceptibility to ciproﬂoxacin was observed in Salmonella and
Shigella isolates. 3. Campylobacter gastroenteritis is usually self-
limited and erythromycin continues to be the drug of choice in
cases where treatment is necessary.
P806
Evaluation of bacterial microﬂora in the colon of
children with inﬂammatory bowel disease
T. Gosiewski, M. Strus, P. Heczko, K. Fyderek (Cracow, PL)
Objectives: Evaluation of bacterial microﬂora in the colon of
children with IBD and characterisation of quantitative and
qualitative changes of the G.I. tract ﬂora in children hospitalised
for the ﬁrst time because of UC (ulcerative colitis) or CD
(Crohn’s disease).
Methods: The study materials were faecal samples and intes-
tinal biopsies collected from 30 patients 1–18 years of age,
hospitalised for the ﬁrst time because of UC or CD in the Clinic
of Paediatrics, Gastroenterology and Nutrition in Cracow. The
control group consisted of children without signs of IBD in
colonoscopy. The stools were collected in three independent
fractions, at the time of preparing patients for colonoscopy:
Methods of qualitative and quantitative microbiological diag-
nostics: phenotyping methods FISH.
Results: In faecal samples of children with conﬁrmed IBD
versus control group there were no differences in global
populations of bacteria, only quantitative changes within spe-
ciﬁc bacterial genera, as follows: an increase in the population of
bacteria of Enterobacteriaceae and Streptococcus genera, conﬁrmed
both by culture and FISH; a decrease in the population of strictly
anaerobic bacteria, mainly of Biﬁdobacterium and Bacteroides
genera. Performing analogous examinations of intestinal tissue
biopsies, making use only of culture methods, the following
dependencies were observed: an increase in the total number of
bacteria in IBD patients; the remaining quantitative changes
within each of the bacterial genera showed the same tendency as
the results obtained from examinations of faecal samples. In case
of bacteria from Lactobacillus genus, a decrease of bacterial
population was noticed in children with IBD (using FISH in
faecal sample examinations and culture methods for tissue
biopsies).
Conclusions: A decrease in the population of anaerobic bacteria
(Biﬁdobacterium and Bacteroides) in IBD patients may be
caused by an inﬂammatory process which can generate reactive
oxygen species (ROS) toxic to anaerobic bacteria. Aerobic
bacteria (Enterobacteriaceae and Streptococcus) are insensitive to
oxygen and may grow in its presence; a decrease in the
population of Lactobacillus and Biﬁdobacterium in IBD patients
may be one of the reasons of exacerbation of inﬂammation
process.; FISH is more accurate than culture method because
hybridisation can detect all bacteria, even dead cells. It is the
reason why we observe signiﬁcantly higher results comparing
with culture method.
P807
Molecular epidemiology of Escherichia coli
diarrhoea in children in Tehran
S. Salmanzadeh-Ahrabi, E. Habibi, F. Jafari, M. Zali (Tehran, IR)
Objectives: Diarrhoeal diseases remain a major public health
problem in developing countries. Diarrhoeagenic Escherichia coli
strains include several emerging pathogens of worldwide public
health importance. This study investigated the role of four
categories of diarrhoeagenic E. coli in Tehranian children with
acute diarrhoea.
Methods: During a six-month period, stool specimens of
children under ﬁve years of age with diarrhoea (n = 200) and
matched controls without diarrhoea were studied for the
presence of enteroaggregative (EAEC), enteropathogenic
(EPEC), enterotoxigenic (ETEC) and shiga toxin-producing
(STEC) E. coli. PCR detection of six different genes of diarrhea-
genic E. coli in primary mixed culture of stool and subsequent
colony screening were used for identiﬁcation purpose. STEC
isolates were typed by O157 and H7 antisera.
Results: EAEC was the most prevalent category and was found
in 24% children with diarrhoea and 10% of control children
without diarrhoea (p < 0.0001). ETEC was isolated from 15.5%
of children with diarrhoea but was not isolated from control
children without diarrhoea (p < 0.0001). STEC was isolated from
15% children with diarrhoea and 2% of controls children
without diarrhoea (p < 0.0001). EPEC was found in 6% of
children with diarrhoea and 5% of control children without
diarrhoea showing no association with diarrhoea. Of 30 isolates
of STEC from children with diarrhoea, seven were O157:H7
while 23 were non-O157:H7.
Conclusion: We concluded that EAEC, ETEC and STEC were
signiﬁcant diarrhoeal pathogens in children with diarrhoea
while non-O157:H7 isolates of STEC were more prevalent than
O157:H7 isolates in diarrhoeal group.
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Antimicrobial susceptibility of urinary pathogens
in children from two tertiary care Greek hospitals
O. Vasilaki, P. Sikalidou, S. Karampa, A. Tzanakari,
S. Alexiou-Daniel, D. Soﬁanou (Thessaloniki, GR)
Objectives: Urinary tract infections (UTIs) are the second most
common infection after respiratory tract infections in children.
The purpose of this study was to determine the current
antimicrobial susceptibility patterns of pathogens causing UTIs
to pediatric patients from two different tertiary care Greek
hospitals.
Methods: Data were collected from patients admitted in the
paediatric units of the two hospitals during two-year period
(2003–2004). Identiﬁcation and susceptibility testing were per-
formed using the VITEK 2 automated system (bioMerieux,
France). Susceptibility data were interpreted using NCCLS
breakpoint criteria. Statistical analysis was performed using
the 1-way ANOVA (p < 0.01 and f > 0 was considered as
signiﬁcant).
Results: During the two-year period 665 isolates from urine
cultures in paediatric units of two hospitals were reviewed.
Escherichia coli (n = 436; 66%) was the predominant pathogen in
both hospitals, followed by Pseudomonas aeruginosa (n = 53; 8%)
and Proteus mirabilis (n = 51; 8%). According to ANOVA test
there was not statistical differences in the susceptibility rates
between the two hospitals. Susceptibility rates to commonly
used antimicrobial agents like ampicillin (AMP), amoxicillin/
clavulanate (AMC), cefotaxime (CTX), ceftazidime (CAZ), co-
trimoxazole (SXT), ciproﬂoxacin (CIP) for E. coli were 57%, 89%,
92%, 92%, 78%, 99% respectively. Among P. mirabilis isolates
80% were sensitive to AMC, 96% to CTX, 96% to CAZ, 71% to
SXT, 98% to CIP and 80% to AMP. P. aeruginosa were only
sensitive to ciproﬂoxacin 96%. Based on the resistance pheno-
type 8% of E. coli and 4% of P. mirabilis isolated from urine
cultures in paediatrics patients were resistant to broad- spec-
trum beta- lactam antibiotics.
Conclusions: E. coli remain the main causative agent of urinary
tract infections of paediatrics patients. The results reinforce the
need for continuous local surveillance to show the current
antimicrobial susceptibility data which can be used as aid to the
empirical treatment of UTIs in children.
P809
Urinary tract infection in neonates, a ﬁve-year
study (2000–2005)
Z. Mosayebi, A. Movahedian, R. Moniri (Kashan, IR)
Objectives: Urinary tract infection (UTI) is one of the serious
bacterial infections in the neonatal period. To determine the
epidemiology, aetiology, clinical pattern and antibiotic sensitiv-
ity in neonatal UTI a retrospective study was carried out during
a 5-year period.
Methods: The medical records of 38 neonates with proven UTI
(cultured by suprapubic aspiration) were investigated. Details of
gestational age, sex, clinical ﬁndings, blood culture, causative
organisms and antibiotic sensitivity were reviewed.
Results: During the study period (March 2000–2005), 3623
newborns were admitted in our neonatal unit, of which 38
had UTI which was conﬁrmed by suprapubic aspiration, giving
an incidence rate of 1.04% in general. UTI was more prevalent in
males than females (ratio 2.4:1). Of the affected newborns 82%
were term and 18% preterm.The most frequent symptoms were
jaundice (68.4%), lethargy (14%), fever (13%) and poor feeding
(5%). Eleven per cent (11%) had positive blood culture simul-
taneously.Escherichia coli (50%) and Klebsiella spp. (30%) were the
prominent pathogens isolated, both of them were highly
sensitive to amikacin and gentamicin respectively.
Conclusion: E. coli was the most common isolated microorgan-
ism. Jaundice may be the ﬁrst or the only sign of UTI in
newborns, therefore, obtaining urine culture in jaundiced
infants is reasonable.
P810
Longitudinal development of tobramycin
resistance in Pseudomonas aeruginosa isolates
from children with cystic ﬁbrosis and the effect
on clinical outcome
M.M. Doyle, P. McNally, G. Leen, J. Dier, P. Greally,
P.G. Murphy (Dublin, IE)
Objectives: To evaluate the longitudinal development of
Tobramycin resistance in Pseudomonas aeruginosa isolated from
sputum of children with cystic ﬁbrosis receiving inhaled
Tobramycin and to assess the clinical impact of the changes in
the Minimum inhibitory concentration (MIC).
Methods: Sputum was collected prospectively from all children
with a persistent growth of P. aeruginosa receiving Tobramycin
Inhaled Solution (TSI). Isolates were collected from Jan 2004 to
July 2005. All isolates resistant to Tobramycin (10 mcg/ml) by
disk diffusion were tested to evaluate the MIC. The following
data was recorded prior to and during treatment with inhaled
Tobramycin; anthropometric indices, antibiotic resistance of
P. aeruginosa strains, use of IV Tobramycin and forced expiratory
volume in one second (FEV1).
Results: Twenty-nine patients were treated with TSI during the
study period. In twenty-six patients, the P. aeruginosa developed
resistance to Tobramycin (10 mcg) as evaluated by disk diffu-
sion. In ten of the patients P. aeruginosa developed a Tobramycin
MIC of >1024 mcg/ml. After one year on TSI, this group
showed a greater fall in mean percent predicted FEV1 ((1.7% per
year v. +0.32% per year) and mean weight z scores ((0.36 SD
over 4 years v. (0.23 SD over 4 years) respectively when
compared to the group (19/29) whose Tobramycin MIC was
<1024 mcg/ml. This ﬁnding was independent of genotype,
pancreatic insufﬁciency or use of other medications. The
duration of treatment was similar in those with a MIC of
<1024 mcg/ml.
Conclusion: In patients with a MIC >1024 mcg/ml, there was a
tendency towards a more rapid fall off in both weight z scores
and FEV1. This is a consistent trend and demands further
scrutiny and a more detailed clonal analysis of the Pseudomonas
isolates.
P811
Predictors of mortality in children with
candidaemia
A.C. Pasqualotto, A.B. de Moraes, R.R. Zanini, L.C. Severo
(Manchester, UK; Porto Alegre, BR)
Objectives: Several studies have documented that survival
rates for children with candidaemia are signiﬁcantly better
than survival rates for adults, which has been linked to the
higher proportion of infections caused by Candida parapsilosis in
children. The aim of this study was to present, using multiva-
riate analysis, risk factors for death among paediatric patients
with candidaemia.
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Methods: This was a retrospective cohort study conducted in a
1200-bed Brazilian teaching hospital during 1995 and 2003.
Patients were considered paediatric if their age was £13 years-
old. Severity of candidaemia was determined by PRISM score
and shock requiring inotropic support. Patients who received
less than 72 h of antifungal therapy were considered to have
received no treatment. This criterion was also applied for
patients treated with low doses of antifungals (amphotericin B
desoxycholate: <0.6 mg/kg; ﬂuconazole: <6 mg/kg bds; and
liposomal amphotericin B: <3 mg/kg). Overall in-hospital
mortality was the main outcome studied.
Results: A total of 82 paediatric patients with candidaemia
were included in the study, including 19 neonates. Most of these
children were female (62.2%) and median age was 0.4 year-old.
Major underlying diseases were congenital malformations
(41.5%), haematological malignancies (11.0%), and solid
tumours (11.0%). Species other than C. albicans were the main
aetiology of candidaemia (79.3%), mainly C. parapsilosis (37.8%),
and Candida tropicalis (22.0%). Candida glabrata occurred in only
1.2%, and Candida krusei in 2.4%. Overall mortality was 40.2%.
Independent risk factors for death were failure to remove the
central venous catheter (p = 0.012), time from admission to
candidaemia > 45 days (p = 0.042), requirement of mechanical
ventilation (p = 0.011), and heart rate ‡ 175 bpm (p = 0.023). No
interaction was observed amongst the variables included in the
equation.
Conclusions: Our study highlights the importance of central
venous catheter removal in paediatric patients with candidae-
mia. Failure to do that was strongly associated with a poor
outcome, independently of severity of infection or receipt of
antifungal drugs.
P812
Bacterial isolates during bacteraemia in neonatal
units of a medical university hospital in Gdansk
B. Rybak, D. Piasecka-Pazik, A. Samet, M. Bronk, J. Szczapa
(Gdansk, PL)
Objectives: The aim of the study was to determine blood
cultures bacterial isolates from the Neonatal Units and their
susceptibility.
Methods: We analysed 758 blood cultures in 2003 and 2004.
Blood cultures from Neonatal Units patients were performed
using the BacT/Alert automated system (BioMerieux). Strains
were identiﬁed by classical method and VITEK GNI+ cards
(BioMerieux). Sensitivity was determined by the agar diffusion
method according to NCCLS guidelines.
Result: During this study 150 (20.2%) blood cultures were
positive, 605 (79.8%) were negative. A total of 151 bacterial
strains were isolated from blood cultures between 2003 and
2004. The coagulase negative and positive Staphylococci: Sta-
phylococcus epidermidis (43.7%) and Staphylococcus aureus (4.63%)
were the most common pathogen recovered from blood,
followed by members of Enterobacteriaceae (19.86%) including
Klebsiella spp. (7.28%), Escherichia coli (5.29%), Enetrobacter spp.
(5.29%). Three strains of Enterobacter aerogenes were ESBL
positive. We found 126 episodes of bacteremia and observed 8
episodes of polymicrobial bacteriemia and 1 persistent bacter-
aemia.
Conclusion: The coagulase-negative and positive Staphylococci
were most frequent casual agents of bacteraemia during study
period in neonatal units, however in most cases probably due to
contamination of the samples. Gram-negative bacteria especially
members of the Enterobacteriaceae are the second important
causes of bacteraemia in neonatal units. Great percentage of
Gram-positive cocci mentioned previously indicates the need of
investigation of blood collecting procedures.
P813
Incubation time for clinically signiﬁcant positive
neonatal blood cultures
H.L. Lim, A.J. Bint, A. Fenton, S.J. Moss (Newcastle-upon-Tyne,
UK)
Objectives: To determine the incubation time for clinically
signiﬁcant positive neonatal blood cultures.
Methods: Positive blood cultures from infants on the neonatal
intensive care unit (NICU) and post-natal wards of a teaching
hospital were prospectively and consecutively identiﬁed by a
clinical microbiologist. The blood cultures were processed on
the BacT/Alert 3D automated system (bioMe´rieux, USA). Data
was collected between April 2004 and October 2005. A neona-
tologist made an independent prospective assessment of the
clinical signiﬁcance of the same positive blood cultures.
Results: During the study period there were a total of 229
positive blood cultures. Prospective data on clinical signiﬁcance
was available on 179, from 111 infants. 106 of the infants were on
the NICU and ﬁve on the post-natal wards. Median gestational
age was 27 weeks (range 23–41 weeks) and median birth weight
was 950 g (range 385–3955 g). Median age at testing was 10 days
(range 0–101 days). Median number of positive blood cultures
was 1(range 1–7). All 38 microbiologically signiﬁcant positive
bacterial blood cultures (e.g. Group B Streptococcus and Entero-
bacteriaceae) and 8 blood cultures growing fungi were also
classiﬁed as clinically signiﬁcant. For the microbiologically
signiﬁcant bacterial isolates, 22(58%) were detected within the
ﬁrst 12 hours, 36(95%) by 24 hours and all by 36 hours. Bacteria
of uncertain microbiological signiﬁcance (e.g. coagulase negat-
ive Staphylococcus, Enterococcus species) were detected in 133
blood cultures, of which 87 were classiﬁed clinically signiﬁcant.
The incubation time for clinically signiﬁcant bacterial blood
cultures was longer than for solely microbiologically signiﬁcant
bacteria (Fig. 1): 26% being detected by 12 hours, 69% by
24 hours, 89% by 36 hours, 93% by 48 hours, 95% by 60 hours
and 100% by 96 hours.
Conclusions: This prospective study highlights the need to
consider a two tier approach with respect to the incubation time
for clinically signiﬁcant neonatal blood cultures; virulent bac-
teria are detected within 36 hours, whilst bacteria of uncertain
microbiological signiﬁcance can take longer to manifest. We
recommend antibiotic therapy can be stopped in clinically
asymptomatic infants with a negative blood culture at 36 hours
incubation time. However if there are clinical concerns of sepsis,
antibiotic therapy should be continued.
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P814
Predictive value of procalcitonin and serum
amyloid A protein levels in early detection of
pyelonephritis in childhood
M.P. Sourani, F. Haliotis, A. Kariyiannis, E. Hantzi,
L. Zachariadou, S. Avlonitis, I. Papassotiriou, K. Karavanaki
(Athens, GR)
Objectives: The detection of renal involvement during urinary
tract infection (UTI) is of great importance for the determination
of further investigation and monitoring. The objective of this
study was to determine the PCT and SAA values as markers of
renal involvement in UTI assessed by a [99Tcm]-dime-
rcaptosuccinic acid (DMSA) scintigraphy.
Methods: Sixty children aged 1 month to 10 years with or
without fever, who were admitted in a General Pediatric
Hospital with the suspicion of UTI were included in the
study. WBC count, CRP, ESR, PCT and SAA levels were
measured on admission. Renal involvement was assessed by
DMSA scintigraphy within 7 days after treatment initiation.
Results: When comparing the two groups: a. with or b. without
renal involvement, in the ﬁrst group signiﬁcantly increased
levels of PCT (4.38 vs 0.38 lg/L, p < 0.001) and increased levels
of SAA (483.7 vs 325.3 mg/L, p < 0.043) were found; moreover
in the ﬁrst group increased levels of ESR (78.5 vs 44.8 mm/h,
p = 0.012) and WBC (20.1 vs 15.6 · 103 lL, p = 0.043) were
found respectively. On the contrary CRP levels were not
different between two groups (87.7 vs 53.1 mg/L p = NS).
When analysing the groups according to the presence of fever,
in the febrile group the levels of PCT, SAA, CRP, ESR and
leukocyte counts were signiﬁcantly increased, in comparison to
the afebrile group respectively (PCT: 0.2 vs 2.17 lg/L, p < 0.001,
SAA: 90.3 vs 467.7 mg/L, p < 0.001, WBC: 10.7 vs 18.4 · 103 lL,
p < 0.001, ANC counts 5.7 vs 10.8 · 103 lL, p < 0.001, CRP: 8.5
vs 76.6 mg/L, p < 0.001, and ESR: 27.0 vs 66.8 mm/h,
p < 0.001). PCT was signiﬁcantly related to the severity of
renal lesions (as ranked by DMSA), while SAA and CRP were
not.
Conclusion: The serum PCT levels were found signiﬁcantly
increased in children with UTI when renal parenchymal
involvement was present. The SAA levels were signiﬁcantly
correlated with the severity of infection while they were not
related to the severity of renal lesions. Thus the PCT is a useful
marker for the prediction of the risk of severe renal lesions,
while the SAA is a marker of infection severity.
P815
Is there a place for moxiﬂoxacin in paediatric
practice? A report from a tertiary care paediatric
hospital
S. Jourdain, O. Stevart, P.R. Smeesters, P. Lepage, A. Vergison
(Brussels, BE)
Background: Moxiﬂoxacin (moxi) is recommended as a treat-
ment of hospitalised adults with community acquired pneu-
monia. Its pharmacokinetic allows an oral administration.
Unfortunately, there is no data concerning its paediatrics use.
Objective: To assess the indications, the tolerance and the
efﬁcacy of moxi use in hospitalised children. To evaluate the
costs saved by an earlier discharge.
Methods: All patients who had received moxi in a 170-bed
paediatric tertiary care hospital were retrospectively identiﬁed
by the pharmacy billing data. We reviewed the medical charts
and determined the number of outpatient days during which an
intravenous (iv) beta lactam therapy would have been required
and oral moxi was used. We calculated the cost of these days.
Results: Moxi was used in 23 children from March 2003 to
October 2005. The median age was 35 months (from 7 to 172).
No patient had received (iv) moxi. The indications were: earlier
discharge in 15/23 patients, venous access problems in 5/23,
therapeutic failure in 3/23. The main diagnosis was complicated
pneumonia associated with empyema (17/23), other diagnosis
were mastoiditis (3/23), ethmoiditis (1/23), abscess complica-
ting a knee arthritis (1/23) and a neck cellulites-adenitis (1/23).
The oral therapy was begun after a mean of 12.3 days (0 to 43) of
iv beta lactam therapy. The children received the following
regimens according to their weight: 1 · 100 mg/day (1/23),
2 · 100 mg/day (10/23), 2 · 150 mg/day (1/23), 2 · 200 mg/
day (9/23) and 1 · 400 mg/day (2/23). The oral moxi was given
during hospitalisation for 14/23 patients, whereas it was started
at discharge for the others. The children were discharged from
hospital after a mean of 15.5 days (7–43), which represents a
mean of 3731 euros saving per patient. The hospital stay in these
children was statically shorter than the stay with the standard
antibiotic regimen for these infections (21 days of iv beta
lactams); (t = (3.9, p = 0.001). All children had a routine
follow-up at 15 days and /or 1 month after discharge and no
adverse event was reported.
Conclusion: We report a series of 23 children successfully
treated with oral moxiﬂoxacine for severe infections. It was well
tolerated and it allowed a signiﬁcant shortening of the hospital
stay. This reduced the cost without compromising the efﬁcacy.
However, there is a need for pharmacokinetic and pharmaco-
dynamic studies in children as no appropriate dosage has been
determined.
P816
Leptin as an acute-phase reactant in urinary tract
infections in children
E. Demetriou, A. Margeli, F. Haliotis, M. Sourani,
L. Zachariadou, I. Papassotiriou, A. Konstantopoulos (Athens,
GR)
Objectives: It has been demonstrated in several experimental
animal models that leptin, an adipocyte-derived hormone/
cytokine that links nutritional status with neuroendocrine and
immune functions, is also an inﬂammatory mediator that might
act as an early acute-phase reactant in some conditions and not
in others.
Patients and methods: We studied the leptin response in 40
febrile children (1 month to 9 years of age) with conﬁrmed
bacterial urinary tract infection. Leptin levels were measured by
an enzymatically ampliﬁed ‘‘two-step’’ sandwich-type immu-
noassay (Diagnostic Systems Laboratories).
Results: Leptin levels were signiﬁcantly increased (mean value:
58.69 ± 5.05 pg/ml) in all 40 patients independently of their
BMI, at diagnosis of the infection and returned to normal levels
3 days after initiation of treatment (p < 0.001). We also noted
that in four of our subjects, leptin levels remained high or even
increased. In correlation with the rest of our laboratory data
(CRP, WBC and urine cultures) along with the clinical data
(fever, anorexia, general condition) these patients had not
responded to treatment and their infection was not considered
under control.
Conclusions: High leptin levels during inﬂammation are indic-
ative of normal expression of leptin genes and leptin receptor
and this suggests that leptin is also an ‘‘inﬂammatory marker’’
and might be an early indicator of the prognosis of the bacterial
infection. Similar results have been described in patients with
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sepsis, whereas the non-increase of leptin levels was associated
with increased mortality. The secretion of leptin in the ﬁrst
hours of inﬂammation in children is stimulated by the endo-
toxins of bacteria and can be induced by other inﬂammatory
mediators such as IL-1 and TNF-alpha, as it has been shown in
animal models. Leptin seems to play an important role being
part of the cytokine network and modulating the inﬂammatory-
immune response and the host defence mechanisms.
P817
Treatment of acute otitis media in primary
paediatric care and the risk factors for antibiotic
prescribing
K. Banasova, H. Hupkova, V. Foltan, J. Trupl (Bratislava, SK)
Backgrounds and objectives: Acute otitis media (AOM) is an
important problem mainly in children age. Objective of this
work was to analyse and validate antimicrobial treatment at
acute otitis media according guidelines. Also the using of
laboratory examinations and microbiology diagnostics to assess
aetiology of infection and consecutive antibiotic indication were
determined. To classify the factors which lead to antibiotic
prescription at AOM.
Methods: Multicentric prescription study at the acute respirat-
ory tract infections, four weeks in November 2003 in ﬁve Slovak
cities. The 66 paediatricians registered patient characteristics
(gender, age, weight), diagnosis, assumed aetiology, antibiotic
therapy, who prescribed it, risk factors of patients (allergy to
penicillin, dysimmunity, chronic respiratory tract disease, etc.)
into the protocols according same methodology. We evaluated
the using of auxiliary examination (laboratory, microbiology),
assumed aetiology and antibiotic prescription for a treatment an
acute otitis media. To predict the antibiotic prescription we use a
logistic regression (SAS).
Results: Out of 326 patient, to 173 (53.1%) antibiotic treatment
was indicated. The most frequent prescribing antibiotic were co-
aminopenicillins in 54 patients (31.2%; 95% conﬁdence interval
(24.3%; 38.1%)), second were penicillins in 37 cases (21.4%; 95%
CI (15.3%; 27.5%)), after that cephalosporins in 35 cases (20.2%;
95% CI 14.2%; 26.2%), aminopenicillins in 24 cases (13.9%, 95%
CI (8.7%, 19.0%)), macrolides in 18 cases (10.4%, 95% CI (5.9%;
15.0%)). In six out of ten patients with acute otitis media
antimicrobial therapy was according to the guidelines. To settle
aetiology of infection paediatricians used laboratory examina-
tion and microbiology diagnostics (42.3%; 20.6% respectively).
The most frequent risk factor was the attendance of collectively
institute (60.1%). The microbiology diagnostics contribute to
determine infection pathogen and to avoid antibiotic prescribing
(p = 0.01). Other statistically signiﬁcant factors which conduce
to antibiotic prescription were aetiology (p < 0.0001), city
(p < 0.0001), dysimmunity (p = 0.001) and attendance
(p = 0.005).
Conclusions: Main reason for antibiotic prescription at AOM is
according our results the aetiology which is assumed by GP, risk
factors of patient as attendance and dysimmunity and there is
also dependence on prescription habits within the city.
P818
The hygiene hypotheses revisited? Recurrent
childhood upper respiratory tract infections do
not reduce the risk of adult atopic disease
M.M. Rovers, W.A. Balemans, A.G. Schilder, E.A. Sanders,
G.A. Zielhuis, C.K. van der Ent (Utrecht, NL)
Background: The role of childhood upper respiratory tract
infections (URTI) in the development of atopic disease later in
life remains controversial.
Objective: To investigate the association between childhood
recurrent upper respiratory tract infections and both subjective
and objective measures of atopy and asthma in adulthood.
Methods: A birth cohort of 1055 members was followed
prospectively from ages 2 to 21 years. At ages 2–4 years detailed
information on upper respiratory tract infections was collected
3-monthly. At age 21 years a standardized questionnaire, lung
function, exhaled bronchial Nitric Oxide (FENO), total and
speciﬁc IgE were measured.
Results: Of the original cohort, 693 (66%) members completed
the questionnaire and 404 (60%) of them completed the objective
measures at 21 years. Children who experienced recurrent URTI
during childhood were not less likely to have asthma at age
21 years than children who did not experience recurrent URTI;
RR 1.45 (95% CI 0.95–2.21). Neither were recurrent URTI
associated with a decreased risk of allergic rhinitis (RR 0.99
(95% CI 0.79–1.25)), eczema (RR 1.19 (95% CI 0.81–1.75)), lung
function parameters, FENO, and IgE at the age of 21 years.
Conclusion: We could not conﬁrm the hygiene hypothesis, i.e.
recurrent URTI in childhood did not reduce the risk of atopic
disease in young adulthood.
Microbial bioﬁlms
P819
Genetic analysis of the bioﬁlm phenotype in
methicillin-resistant Staphylococcus aureus
E. O’Neill, H. Humphreys, J.P. O’Gara (Dublin, IE)
Objectives: Bioﬁlm development by meticillin resistant Staphy-
lococcus aureus (MRSA) represents an additional pathogenic
mechanism in its already impressive arsenal of virulence
determinants. Moreover the environmental regulation of bioﬁlm
formation may reﬂect an adaptive, pathogenic mechanism
employed by staphylococci to enhance colonisation under
appropriate clinical conditions. Enzymes encoded by the ica
operon synthesise an extracellular polysaccharide adhesin
implicated in bioﬁlm formation. However, preliminary research
in our laboratory (Fitzpatrick et al., 2005. J. Clin. Microbiol.
43:1973) revealed that glucose-induced bioﬁlm development in
MRSA isolates appears to be ica-independent. In this study we
investigated the contribution of ica and other bioﬁlm genes
associated with bioﬁlm development by clinical isolates of
MRSA.
Methods: Bacteriophage transduction with phage 80 was used
to generate ica operon deletion mutations in MRSA strains with
glucose-dependent bioﬁlm phenotypes. Deletion mutations
were also generated in other genes associated with bioﬁlm
development namely the staphylococcal accessory regulator
(sarA) and the accessory gene regulator (agr).
Results: Ica operon deletion mutations were created in three
clinical MRSA strains and the laboratory strain S. aureus
RN4220. ica operon deletion had no effect on the bioﬁlm
phenotype of the clinical MRSA strains but resulted in a bioﬁlm
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negative phenotype in S. aureus RN4220. Deletion of sarA in one
clinical MRSA isolate and in S. aureus RN4220 resulted in a
bioﬁlm negative phenotype. In contrast, deletion of the agr locus
did not affect the bioﬁlm phenotype in four clinical MRSA
strains tested or in S. aureus RN4220.
Conclusions: These ﬁndings support the existence of an ica-
independent bioﬁlm phenotype amongst clinical strains of
MRSA and further reveals that this MRSA bioﬁlm phenotype
is sarA-dependant and agr-independent. Further research is
ongoing to investigate the contribution of other genes implicated
in bioﬁlm formation in these important hospital pathogens.
P820
Combined exposure to sub-inhibitory levels of
vancomycin and therapeutic levels of aspirin
enhances bioﬁlm formation by Staphylococcus
epidermidis
M. Aljeldah, M. Upton (Manchester, UK)
Introduction: Staphylococcus epidermidis is increasingly recog-
nised as a cause of hospital acquired infection, especially
associated with implanted medical devices. The main virulence
factor in these infections is the ability to form bioﬁlms. Due in
part to this fact, but also to the high levels of methicillin
resistance in S. epidermidis, vancomycin is the drug of choice for
treating such infections. Patients receiving vancomycin treat-
ment of prophylaxis may have residual levels of vancomycin in
their blood. It has been shown previously that sub-minimum
inhibitory concentrations (MIC) of vancomycin may lead to
increased bioﬁlm formation. It has also been suggested that
acetylsalicylic acid (aspirin) can be combined with vancomycin
to inhibit bioﬁlm formation.
Methods: Eleven S. epidermidis isolates recovered from cases of
prosthetic joint infection were examined for bioﬁlm forming
properties in the presence of sub-MIC levels of vancomycin with
and without aspirin at a therapeutic level of 300 lg/ml.
Results: Vancomycin at sub-MIC levels signiﬁcantly enhanced
the density of bioﬁlms formed by some of the isolates tested.
When combined with aspirin, the ﬁndings were similar to those
obtained with vancomycin alone.
Conclusions: This study supports the previous suggestions that
sub-MIC levels of vancomycin may enhance S. epidermidis
bioﬁlm formation and highlight the importance of maintaining
vancomycin levels above the MIC at sites of medical device
implantation. In contrast to some previous reports, we suggest
that the use of aspirin at therapeutic levels is of little value in the
treatment of device related infection.
P821
Lactobacillus as a competitive bacteria in
Staphylococcus strains bioﬁlm formation
E. Walencka, B. Sadowska, M. Wieckowska-Szakiel,
W. Hryniewicz, B. Rozalska (Lodz, Warsaw, PL)
Objectives: The commensal microﬂora of the human body
plays a very important protective role, which is associated with
the colonisation of skin and mucous membranes, the production
of the bacteriocin-like inhibitory substances (BLIS) and fatty
acids or with the competition of the nutrients. One of the
‘‘barriers’’ against pathogens are the bacteria from Lactobacillus
genus. In our study we wanted to describe the activity of
Lactobacillus acidophilus against planktonic and sessile cultures of
Staphylococcus strains.
Methods: The inﬂuence of BLIS produced by ten Lactobacillus
acidophilus strains on the growth Staphylococcus aureus strains
(reference MSSA, clinical MRSA and clinical MRSA/hVISA) and
Staphylococcus epidermidis strains (MRSE) was determined by
two-layer plate assay and by dilution assay for bacterial culture
supernatants. The activity of BLIS against bacterial adherence
and bioﬁlm formation was estimated using spectrophotometric
assay (MTT). Colony forming units (CFU) method was used to
determine the coaggregation/interference of the bacteria form-
ing dual species bioﬁlms on the plastic carriers.
Results: The obtained results demonstrated variable anti-
staphylococcal activity among lactobacilli used in this study. It
was observed that the antagonism between selected L. acidophi-
lus strains and various staphylococcal strains does not only
inﬂuence the growth of planktonic staphylococci, but also their
adherence and bioﬁlm development. The displacement of S.
aureus and S. epidermidis from the surface by Lactobacillus in 50–
80% was observed. The BLIS and probably biosurfactant activity
of lactobacilli seems to play a very important role in these
interactions.
Conclusions: These observations encourage further studies of
bacterial interference which can be used for the prevention of
bioﬁlm formation. The ability of one strain to exclude others
from the same environment may be an alternative for unsuc-
cessful antibiotic therapy.
Acknowledgement: Supported by Grant No. 2 PO5A 149 29
from State Committee for Scientiﬁc Research.
P822
Dual species bioﬁlms: do staphylococci like other
bacteria?
E. Walencka, B. Sadowska, B. Rozalska (Lodz, PL)
Objectives: Different forms of the interdependencies between
microorganisms, like tolerance, interference commensalism or
synergism, develop during coexistence of bacteria in the same
ecological niche. They also play an important role when
multispecies bioﬁlm consisting of both physiologic or/and
pathogenic microﬂora is formed. The aim of the study was to
determine the interactions between staphylococci and other
bacteria and their inﬂuence on dual species bioﬁlm formation.
Methods: The interdependencies between Staphylococcus aureus
or Staphylococcus epidermidis clinical strains and selected refer-
ence or clinical strains of Pseudomonas aeruginosa, Proteus
mirabilis, Escherichia coli, Enterococcus faecalis were estimated in
different stages of dual species bioﬁlm formation. The inﬂuence
of bacteriocin-like inhibitory substances (BLIS) produced by
coaggregating strains on the growth of S. aureus A3 and S.
epidermidis A4c was determined by two-layer plate assay and by
dilution assay for bacterial supernatants. The activity of BLIS
against bacterial adherence and bioﬁlm formation was estimated
using spectrophotometric assay (MTT). The quantitative method
using the carriers of bioﬁlm was developed to determine the
composition of mixed bioﬁlms.
Results: All bacterial strains used for the study were capable of
the bioﬁlm formation with S. aureus and S. epidermidis, however
with different intensity. The antagonistic activity of BLIS on the
growth, adherence or/and bioﬁlm formation by S. aureus or S.
epidermidis was not always correlated with the blocking of
coadhesion. The biggest interference during staphylococcal
bioﬁlm formation was observed when E. coli and P. aeruginosa
strains were used as the second element of this structure.
Conclusions: Understanding of the mechanisms of bacterial
interference in mixed species bioﬁlms development and the
survival of different microbial species living at the close
proximity in the same matrix may help in the proceeding on
therapeutic strategies.
Acknowledgement: Supported by Grant No. 2 PO5A 149 29
from State Committee for Scientiﬁc Research.
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P823
Evaluation of the bioﬁlm-forming ability of
Staphylococcus aureus and Staphylococcus
epidermidis mastitis isolates
M. Oliveira, R. Bexiga, S.F. Nunes, L.M. Cavaco, F. Bernardo,
C.L. Vilela (Lisbon, PT; Glasgow, UK; Copenhagen, DK)
Objectives: Bioﬁlm-forming ability is increasingly being recog-
nized as an important virulence factor in staphylococci, facili-
tating their persistence in the host, evading its defences and
allowing bacterial survival at high antimicrobial concentrations.
Staphylococcus aureus remains the major pathogen related to
chronic mastitis, but in the last years Staphylococcus epidermidis
has emerged as an important mastitis agent. The present work
aimed at evaluating the bioﬁlm-forming ability of staphylococci
ﬁeld isolates from bovine subclinical mastitis.
Methods: In the present study bioﬁlm production by S. aureus
(n = 16) and S. epidermidis (n = 16) mastitis isolates, was eval-
uated in vitro by three distinct methods: phenotypic expression
of colony characteristics in congo red agar (CRA) (Freeman et
al., 1989), quantiﬁcation of bioﬁlm produced by optical density
measurement (Cucarella et al., 2002) and direct observation of
bioﬁlm occurrence in bacterial suspensions and in artiﬁcially
contaminated milk samples by ﬂuorescent in situ hybridization
(FISH). The FISH protocol included ﬁxation with paraformal-
dehyde, permeabilization of the bacterial membranes by lyso-
staphin and ethanol, hybridization with two 16S rRNA
oligonucleotide probes described by Kempf et al. (2000),
stringency washes and observation of the hybridized cells by
ﬂuorescence microscopy (Oliveira et al., 2005).
Results: According to the three methods, 37.5% of the S. aureus
isolates revealed the ability to produce bioﬁlm, being also
veriﬁed that 37.5% of the S. epidermidis isolates present this
virulence factor. The positive strains maintained the bioﬁlm-
producer ability in the artiﬁcially contaminated milk samples, as
observed by the FISH analysis.
Conclusion: Staphylococcus aureus are well established as clin-
ical and epidemiological pathogens, but our results show that
the potential pathogenic role of S. epidermidis as a major bovine
mastitis agent should not be neglected. Further studies are
required to elucidate the relevance of bioﬁlm formation upon
antibiotic susceptibility and increased antimicrobial resistance
due to horizontal gene transfer.
P824
Comparative activity of linezolid, quinupristin/
dalfopristin and vancomycin against bioﬁlm
produced by cystic ﬁbrosis isolates of
Staphylococcus aureus normal and small colony
variant phenotypes
P. Morelli, M. Mentasti, G. Manno (Genoa, IT)
Staphylococcus aureus (SA) is an important pathogen in cystic
ﬁbrosis (CF) patients (pts). Persistence of SA in CF has been
associated to the formation of bioﬁlm (BF) and the expression of
a subpopulation with small colony variant (SCV) phenotype.
Objectives: Determine ability and entity of BF formation of SA
and SASCV colonising CF pts attending the Genoa centre;
moreover the efﬁcacy of linezolid (L), quinupristin/dalfopristin
(QD) and vancomycin (V) to inhibit and disrupt BF produced by
both SA phenotypes was assessed.
Methods: Thirty-six SA (15 normal and 21 SCV phenotype)
recovered from 21 CF pts were identiﬁed by API ID 32 STAPH
(BioMerieux) and by nuc gene ampliﬁcation (BIBLIO), using SA
ATCC 29213 as quality control strain. Bioﬁlm quantitative assay,
antibiotic inhibition and disruption, were determined in micro-
titre plates (Christensen et al., 1985) by the spectrophotometrical
measure of 595 nm absorbance after crystal violet staining;
results were classiﬁed according to the categories described by
Stepanovic et al. (1999). For BF inhibition the following antibiotic
concentrations were used: L (0.25–0.50–1 mcg/ml), QD (0.125–
0.250–0.50 mcg/ml) and V (0.125–0.250–0.50 mcg/ml). For BF
disruption the following antibiotic concentrations were used: L
(2–4–8 mcg/ml), QD (4–8–16 mcg/ml) and V (4–8–16 mcg/ml).
Results: SA BF formation revealed 9/15 low and mid-low
(mean OD: 0.1552) 2/15 mid (mean OD: 0.2800), 4/15 mid-high
and high (mean OD: 0.9550) producers. SASCV BF formation
revealed 8/21 SASCV mid-low (mean OD: 0.1676), 7/21 mid
(mean OD: 0.2469) and 6/21 mid-high and high producers
(mean OD: 0.2932). Antibiotic activity on BF inhibition and
disruption is shown in Table 1.
Conclusions: In our study SASCV isolates showed higher BF
production compared to SA phenotypes. For BF inhibition, QD
and V showed a better activity on SA than on SASCV, while L
was more active on SASCV. For BF disruption all the three
antibiotics seemed more active on SASCV.
P825
Low prevalence of BAP gene (coding for bioﬁlm-
associated protein) in French isolates of
Staphylococcus aureus recovered from human and
animals species
E. Vautor, H. Carsenti-Dellamonica, R. Thiery (Sophia-Antipolis,
Nice, FR)
Objectives: Staphylococcus aureus is a common cause of mastitis
in dairy farm animals (cows, sheep and goats). The implication
of bioﬁlm in chronic infection in all species have triggered an
increasing interest in the characterization of genes involved in
bioﬁlm formation. Cucarella et al. (2001) identiﬁed a new gene
(6,831 nt) involved in bioﬁlm formation (bap coding for a
bioﬁlm-associated protein, Bap) in a small proportion of S.
aureus strains from mastitis in different species. The purpose of
this study was to investigate the presence of bap in various
isolates from human and animals species.
Methods: One hundred and ﬁfty S. aureus isolates, associated to
different pathologies, were recovered from various locations in
France and different species (cows, sheep, goats, pigs, rabbits,
poultry, horses and human). DNA extraction was performed
using an commercial kit according to the manufacturer’s
instruction with slight modiﬁcations. PCR were performed in
duplicate, using a primer pair (sasp-6m and sasp-7c) as
described by Cucarella et al. (2004) to detected the bap gene
and (coag2 and coag4) as described by Goh et al. (1992) to
control the negative results in the PCR.
Results: Although, the bap gene was detected in the bap
positive control strain (kindly provided by J.R. Penade´s, Spain),
all S. aureus tested so far, including bioﬁlm producing isolates
(data not shown), do not seem to carry the bap gene. The
presence of another gene (coa) was detected which indicated
that DNA degradation did not occur thus eliminating the risk of
false negative.
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Conclusion: The bap gene, also present in other pathogenic
Staphylococcus species, is not widely distributed in S. aureus
isolates. As shown by Tormo et al. (2005), it was found in a small
proportion among mastitis isolates of different species. This
gene is normally carried by SaPIbov2, a bovine S. aureus
pathogenicity island (Ubeda et al., 2003), and should be
associated with well-known genes [icaADBC operon (Cramton
et al., 1999), hla gene (Caiazza and O’Toole, 2003), rbf gene (Lim
et al., 2004)] to explain bioﬁlm production capacity. S. aureus is
fully capable of forming bioﬁlm in the absence of the bap gene.
P826
Contribution of bioﬁlm phenotype to the
pathogenesis of Staphylococcus epidermidis
neurosurgical device-related meningitis
N. Stevens, H. Humphreys, E. O’Neill, J.P. O’Gara, C. Greene,
T. Dillane, T. Sattar (Dublin, IE)
Objectives: The coagulase-negative staphylococci (CoNS), in
particular Staphylococcus epidermidis, have been identiﬁed as the
most common causative agents of neurosurgical device-related
meningitis. A common pathogenic feature amongst these bac-
teria is the ability to form bioﬁlm, and the intercellular adhesin
(ica) operon of S. epidermidis has an important function in
adherence and bioﬁlm development. The objective of this study
was to determine the role of icaADBC, which results in the
production of polysaccharide intercellular adhesin (PIA), in the
pathogenesis of neurosurgical device-related meningitis caused
by S. epidermidis isolates.
Methods: Eleven clinically signiﬁcant S. epidermidis isolates
were collected from neurosurgical patients with meningitis
and with an extra-ventricular drain in situ. The ability to form
bioﬁlm under laboratory conditions was determined using a
bioﬁlm assay. Each isolate was grown in brain heart infusion
broth (BHI) or BHI supplemented with 4% ethanol, 4% NaCl or
1% glucose. The PIA phenotype, as assessed by growth on congo
red agar (CRA), was determined for each isolate. PCR, using
primers speciﬁcally designed to amplify the entire ica operon,
and Southern blot analysis were used to determine the ica
genotype of each isolate. Reverse-transcription PCR (RT-PCR)
was used to determine icaR and icaA expression in the same
environmental conditions as above.
Results: PCR and Southern blot analysis conﬁrmed that 7 (64%)
of the isolates had an ica+ genotype. Under standard growth
conditions only one (9%) isolate had a strong bioﬁlm positive
phenotype, while bioﬁlm growth could be enhanced in a further
two (18%) isolates by the supplementation of the media with 4%
ethanol or 4% NaCl. RT-PCR analysis of icaA expression was
consistent with this. Interestingly, although ica transcription was
detected in the four remaining ica+ isolates, they were not
bioﬁlm-positive under any growth condition. There was also a
good correlation between the bioﬁlm phenotype and the PIA
phenotype, as determined by CRA colony morphology analysis.
Conclusion: This initial data suggests that icaA expression
alone is not sufﬁcient for bioﬁlm formation. Other genetic
factors, along with local conditions within the neurosurgical
device, may be important in this complex pathological process.
P827
Bioﬁlm formation of invasive GAS isolates
collected in immunocompromised and
immunocompetent patients
R.Gattringer, S. Reichmann,W.Graninger, E. Presterl (Vienna,AT)
Objective: The ability of Streptococcus pyogenes (GAS) to form
bioﬁlm-like bacterial communities during infection suggests that
the production of bioﬁlm may be important for pathogenesis of
invasive streptococcal infections. To examine a possible rela-
tionship between bioﬁlm-forming and underlying disease we
examined 35 isolates of GAS from blood cultures collected
between 1999 and 2005 (35 patients with soft tissue infections).
Methods: To test the ability of 35 blood stream isolates to form
bioﬁlms, the isolates were grown in microtitre plates in tryptone
soya broth for 24 or 48 hours. To examine the morphology of the
bioﬁlm formation the isolates were either examined unﬁxed or
ﬁxed with 2% glutaraldehyde using electron microscope scan-
ning (Philips XL30 ESEM). For quantiﬁcation they were ﬁxed
with 2% glutaraldehyde and dyed with 1% crystal violet to
measure the mean optical density (OD using a routine micro-
titre-plate-reader at 550 nm wavelength).
Results: Nineteen isolates (54.3%) were bioﬁlm forming and 16
(45.7%) of them showed no bioﬁlm. All isolates were sensitive to
penicillin, vancomycin and tigecyclin. Four isolates showed a
resistance to erythromycin and six isolates were resistant to
clindamycin. Twenty GAS were isolated from patients with no
immunosuppression and 15 GAS were found in blood cultures
from immunocompromised patients (six patients with HIV
infection; nine patients with long-term treatment with methot-
rexate or steroids). From the 20 isolates of immunocompetent
patients 11 (55%) isolates were bioﬁlm forming and 9 (45%)
isolates had no capabilities of bioﬁlm forming. Eleven GAS
isolates of 15 (73.4%) immunocompromised patients were
bioﬁlm forming and 4 (26.6%) strains showed no bioﬁlm. In
the six patients which were HIV positive the distribution
between bioﬁlm positive and negative were equal. Eight
(88.9%) isolates from patients receiving long-term methotrexate
or high-dose steroid treatment produced bioﬁlm.
Conclusion: These data suggest that bioﬁlm formation is not
pivotal for the pathogenesis of invasive GAS infection, however
hosts being immunocompromised because of long term met-
hotrexate or steroids treatment may be more susceptible to
invasive infection due to bioﬁlm forming GAS. Penicillin G is
still the therapy of choice. Resistance of clindamycin in 17.1%
warrants cautiousness towards the treatment with clindamycin.
P828
Bioﬁlm formation by E. faecalis in the microtitre-
plate assay does not correspond to bioﬁlm
formation on clinically relevant materials
A. Hallgren, G. Dunny (Linko¨ping, SE; Minneapolis, US)
Objective: To compare an often used screening method for
bioﬁlm formation, i.e., the microtitre-plate assay with 24-hour
bioﬁlm formation of E. faecalis on catheters and laboratory
dialysis membranes.
Methods: Four clinical E. faecalis isolates and a laboratory strain
(OG1RF) were used. The microtitre-plate assay was performed
as previously described with some modiﬁcations, using TSB
without glucose as growth medium and 0.1% saffranin or 0.5%
crystal violet as dyes. Each test was performed in quadruplicate
and performed at least twice on different days. For bioﬁlm
formation on clinically relevant materials, sterilely cut pieces of
lubricant coated latex urinary catheters, polyurethane central
venous catheters (CVCs) or cellulose membranes were placed in
5 mL of TSB without glucose, inocculated with 50 lL of an
overnight culture of respective isolate and incubated in 37 C for
24 h with gentle shaking. The pieces were washed three times
and subsequently sonicated and vortexed (10 s + 10 s) twice in
1 mL PBS. An aliquot of the bacterial suspension was then
serially diluted and plated for viable count. All tests were
performed in duplicate and performed at least twice on different
days.
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Results: With the microtitre-plate using crystal-violet two
isolates were considered non-bioﬁlm forming and three isolates
strong bioﬁlm forming, according to the criteria proposed by
Baldasarri et al. Using saffranin as stain gave similar results with
all the strong bioﬁlm forming isolates having comparable A490
values. However, on urinary catheters one strain (1128) formed
4–5 times more bioﬁlm (~107 cfu/cm2) than other isolates
(including OG1RF) with comparable values of absorbance in
the microtitre-plate assay. Similar results were seen when
cellulose membranes were used. The results the least divergent
from the microtitre-plate assay were when CVCs were used. The
two isolates considered non-bioﬁlm forming isolates, formed
less bioﬁlm than the others but still showed bioﬁlms with
~105 cfu/cm2 on catheters, CVCs and cellulose membranes.
Conclusion: Use of the microtitre-plate assay for screening
isolates for bioﬁlm formation might not give accurate informa-
tion concerning bioﬁlm formation on clinically relevant surfaces.
P829
Cell surface hydrophobicity, motility, and bioﬁlm
formation of Stenotrophomonas maltophilia
clinical isolates
G. Di Bonaventura, C. Picciani, A. Pompilio, R. Piccolomini
(Chieti, IT)
Introduction: Stenotrophomonas maltophilia is an opportunistic
pathogen colonizing patients in intensive care settings, especi-
ally those with underlying debilitating conditions such as
immunosuppression, malignancies, and implantation of foreign
devices. S. maltophilia has been reported to adhere to abiotic and
living surfaces and to organize itself in bioﬁlm on polystyrene
surfaces. The formation of bioﬁlms is a multistep process that
requires participation of structural appendages, such as ﬂagella
and type IV pili in P. aeruginosa. Further, the hydrophobicity of
bacterial surface is an important determinant in the adherence of
bacteria to both living and non-living surfaces, and it may
facilitate in vivo bacterial colonization of epithelial mucous
tissues and adherence to medical devices.
Objective: To investigate the relationship between motility, cell
surface hydrophobicity and bioﬁlm formation in S. maltophilia.
Methods: Forty S. maltophilia strains isolated from blood of
neutropenic patients were assayed for motility (swimming,
swarming, and twitching). Cell surface hydrophobicity was
assayed by microbial adherence to n-hexadecane test (MATH).
Strains were considered as hydrophilic when MATH < 20%.
Bioﬁlm formation on polystyrene microtitres was quantiﬁed by
absorbance (OD492) following staining by crystal violet dye
(CV). Pearson’s correlation index was calculated to determine
the relationship between CV, MATH, and motility. All tests
were performed in triplicate and repeated twice.
Results: Thirty-seven out of 40 (92.5%) strains were able to form
bioﬁlm (OD492 range: 0.119–0.345; mean OD492: 0.201). All
isolates showed swimming. On the contrary, swarming an
twitching were not visible in all samples. Eleven out of 40
(27.5%) strains resulted hydrophobic by MATH. Positive corre-
lation (r2 = 0.510; P < 0.05) was observed between CV and
MATH. Two strains with the biggest MATHs (50 and 47.5%,
respectively) were also the biggest bioﬁlm producers (0.345 and
0.323, respectively). There was no signiﬁcant correlation
between swimming and CV or MATH.
Conclusions: Our results suggested, for the ﬁrst time, that
hydrophobicity is a major determinant of bioﬁlm formation in S.
maltophilia. While the relative contributions of hydrophobicity to
the different steps of bioﬁlm formation in S. maltophilia are not
known, our results showed that hydrophobycity is not related to
the presence of ﬂagella.
P830
Molecular epidemiology and phenotypic
characteristics of chronic Pseudomonas
aeruginosa populations in cystic ﬁbrosis lungs
H.K. Johansen, L. Yang, A. Frost, L. Jelsbak, J. Haagensen,
N. Høiby, S. Molin (Copenhagen, Lyngby, DK)
Objectives: Chronic P. aeruginosa infections are associated with
poor prognosis for cystic ﬁbrosis (CF) patients. We have
investigated the geno- and phenotypes of isolates of P. aerugi-
nosa from seven chronically infected CF patients. From each
patient we have characterised clones isolated over periods of 1–
28 years.
Methods: In all cases the genotypes have been identiﬁed by the
use of a DNA dot-blot array. Using quantitative 16S rRNA in situ
hybridization (FISH) we have determined the apparent growth
rate distribution of P. aeruginosa in the CF lung.
Results: Our data show that most of the investigated patients
carry one or very few different strains, that some of these belong
to genotype clusters also found in other patients belonging to
the Danish CF Centre in Copenhagen whereas others have
unique clones. Clonal substitutions have taken place at some
point in time in most of the patients.In a search for general
phenotypic traits shared by most or all of the CF isolates of P.
aeruginosa we have focused on growth rates and related
phenotypes. All the isolates we have investigated so far display
slow growth in comparison with reference laboratory strains
and environmental isolates. In contrast, strains isolated from
newly infected CF children grow signiﬁcantly faster, suggesting
that there is a selection for slow growth in the CF lung.
Quantitative FISH data suggest that a large majority of the
bacterial cells in the CF lung grow with rates comparable to
those observed for the same cells growing in lab media. The
adaptation of P. aeruginosa in the CF lung is often associated
with bioﬁlm-like growth and over-production of alginate. From
direct in situ imaging of sputum samples we have identiﬁed
several modes of multi-cellular organisation. Some of these may
be comparable to bioﬁlm structures also found in vitro and
others, which share only little or no homology with the
commonly observed structures described for in vitro bioﬁlms.
Conclusions: Strain substitutions in chronically infected CF
patients take place frequently. Growth rates of CF isolates were
found to be low. Estimates of bacterial growth rates in the CF
lung show that the majority of the cells grow actively. Bacterial
aggregates were observed in the sputa from the majority of the
patients.
P831
Morphological changes induced by subinhibitory
concentrations of imipenem and piperacillin/
tazobactam on surface properties and adhesion
abilities of Pseudomonas aeruginosa
A.P. Fonseca, C.I. Extremina, A. Freitas da Fonseca, J.C. Sousa
(Porto, PT)
Objectives: Various antimicrobial agents are known to retain
some activity at subinhibitory concentrations (sub-MICs), caus-
ing bacteria to undergo ultrastructural changes. In general,
carbapenems such as imipenem (IMP), have a high afﬁnity for
penicillin binding proteins (PBP)-2, and cause the bacilli to form
round cells, whereas piperacillin/tazobactam (P/T), a b-lactam,
has a high selective afﬁnity for PBP-3, and induces the formation
of long ﬁlaments (1), which are associated to possible decrease
in protein adhesins. The aim of this study was to evaluate the
inﬂuence of the morphological changes induced by sub-MICs of
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IMP and P/T on surface properties and adhesion abilities of P.
aeruginosa strains.
Methods: In vitro antimicrobial activities were evaluated by
microdilution method (NCCLS) against three reference strains
(ATCC 27853, PAO1, AK1), three deﬁned PAO1 mutants with
deviating surface characteristics (MT1562, PT623, PAO1 algC)
and ﬁve P. aeruginosa clinical isolates. The strains were grown in
LB in the presence and absence of 0.5 times MIC of IMP or P/T.
The effects of different antibiotics on bacterial adhesion (1 h)
were studied using a modiﬁed microtitre-plate assay. The
changes on microbial adhesion to solvents (MATS) were
estimated by using a biphasic method, which calculates the
percentage of cells adhering to hexadecane (CSH) (apolar
solvent), chlorophorm (acidic solvent) and ethyl acetate (basic
solvent). The changes in cell morphology were assessed by light
microscopy, after a gram stain of all the strains.
Results: There were no differences between adhesion in strains
grown with IMP (round cells) or without in the majority of the
strains tested. A signiﬁcant decrease in adhesion and CSH was
found with P/T (ﬁlamentous cells) (1). In almost all the strains
there were no signiﬁcant differences between the presence and
absence of antibiotics in adhesion abilities to chloroform and to
ethyl acetate.
Conclusion: The formation of round cells is associated with no
modiﬁcation in adhesion and CSH comparing to a signiﬁcantly
decrease in the ﬁlamentous forms (1). In both morphologies
there was no modiﬁcation of the electron donor/basic and
electron acceptor/acidic characteristics of the bacterial strains
which allow them to maintain their bipolar character.(1) Fonseca
AP et al. Effect of subinhibitory concentration of piperacillin/
tazobactam on Pseudomonas aeruginosa. J Med Microbiol 2004;
53: 903–910.
P832
Inﬂuence of the salt concentration on bioﬁlm
formation by Salmonella spp.
I. Cirkovic, M. Svabic Vlahovic, N. Opavski, V. Mijac, S. Djukic,
S. Stepanovic, I. Cirkovic (Belgrade, CS)
Salmonella spp. are one of the most important foodborne
pathogens. More than 95% of cases of infections caused by
these bacteria are foodborne and these infections account for
about 30% of deaths resulting from foodborne illnesses. The
objective of the present study was to investigate the inﬂuence of
concentration of NaCl on bioﬁlm production by Salmonella spp.
The quantiﬁcation of bioﬁlm formation by 30 Salmonella spp.
strains was performed by the modiﬁed microtitre-plate test.
After overnight incubation in Trypcase-soy broth, supplemented
with 0.5%, 2.5%, 5%, 7.5% and 10% of NaCl, poured in 96-well
ﬂat-bottomed plastic microplates, bacterial bioﬁlms were ﬁxed
with methanol and stained with crystal violet. The bound dye
was released with 33% glacial acetic acid, and optical density
was measured at 570 nm by using an automated microtitre-plate
reader. Upon the optical densities of bacterial bioﬁlms, all
strains were classiﬁed into the following categories: no bioﬁlm
producers, weak, moderate or strong bioﬁlm producers. Differ-
ences in the quantity of produced bioﬁlm were examined by the
Friedman test, followed by the Wilcoxon signed ranks test. P
values of <0.05 were considered signiﬁcant. The number of
bioﬁlm producing strains was highest in broth with 0.5% of
NaCl (23, 76.7%), while 18 strains (60%) produced bioﬁlm in
broth supplemented with 2.5% NaCl and only one strain (3.3%)
in broths supplemented with 5%, 7.5% and 10% of NaCl. The
highest number of strains were moderate bioﬁlm producers
(30%) in broth with 0.5% of NaCl and weak bioﬁlm producers
(36.7%) in broth with 2.5% of NaCl. The quantities of bioﬁlm
produced by tested Salmonella spp. strains were signiﬁcantly
higher in medium supplemented with 0.5% and 2.5% of NaCl
than in medium with 5%, 7.5% or 10% of NaCl. The obtained
results showed that high salt concentration reduces the ability of
Salmonella spp. to produce bioﬁlm. The shown decrease capacity
for bioﬁlm production to increase salt concentration by Salmon-
ella spp. is also a result of possible interest in food industry.
P833
Effect of the acquisition of quinolone resistance
in bioﬁlm formation by Acinetobacter baumannii
clinical isolates
S. Marti, J. Sanchez-Cespedes, S. Soto, E. Oliveira, D. Bellido,
L. Actis, J. Vila (Barcelona, ES; Miami, US)
Objectives: The ability of Acinetobacter baumannii to form
bioﬁlm could, in part, explain the long survival of this
microorganism in hospitals. The objective of this work was to
analyse the potential relationship between the acquisition of
quinolone resistance and bioﬁlm production in A. baumannii.
Methods: Bioﬁlm formation was determined in 88 epidemio-
logically unrelated A. baumannii strains. Two quinolone-sus-
ceptible and bioﬁlm-producing A. baumannii strains (A15-43 and
77) were chosen to select for quinolone-resistant mutants with
clinaﬂoxacin and ciproﬂoxacin, respectively. Bioﬁlm: An over-
night culture was diluted 1:100 in LB broth and incubated
stagnant at 37 C for 24 and 48 h. The bioﬁlm was stained with
1% crystal violet and quantiﬁed at 570 nm after solubilization
with ethanol–acetone. Two-dimensional gel electrophoresis: cell
envelope proteins were puriﬁed and analysed by two-dimen-
sional gel electrophoresis, followed by protein identiﬁcation
using MALDI-TOF/TOF mass spectrometry.
Results: Thirty-eight percent of the strains were ciproﬂoxacin-
susceptible and bioﬁlm-positive while 20.5% of the strains were
ciproﬂoxacin-resistant and bioﬁlm-positive. The relationship
between bioﬁlm formation and ciproﬂoxacin susceptibility was
statistically signiﬁcant (p = 0.0014). The quinolone-resistant
mutants with a MIC for ciproﬂoxacin of 64 mg/L lost the ability
to form bioﬁlm. The comparative 2D gel electrophoresis
between the wild-type and mutant strains showed differences
in the expression of several proteins. One had a high homology
with CsuA/B, a protein involved in type 1 pili formation. This
protein appeared in the gel of the wild-type strains but it did not
appear in the gel of their quinolone-resistant mutants.
Conclusion: Quinolone-resistant A. baumannii strains are less
prone to produce bioﬁlm than their susceptible counterparts.
This association is linked to a decreased expression of type 1
ﬁmbrae, the ﬁrst step in bioﬁlm formation. Therefore, the results
obtained suggest that there is a relationship between bioﬁlm
formation and resistance to quinolones.
P834
Virulence factors of Proteus mirabilis involved in
encrustation of urinary catheters
A. Torzewska, S. Klinder, A. Czyrznikowska, A. Rozalski (Lodz,
PL)
Objectives: Catheter blockage by crystalline Proteus mirabilis
bioﬁlm is a major complication in long-term catheterized
patients. These bacteria adhere to catheter surface and form
bioﬁlm communities embedded in a polysaccharide matrix. The
bacterial urease generates ammonia from urea and elevates the
pH of the urine and bioﬁlm. Under this conditions calcium and
magnesium phosphates crystallize and became trapped in the
matrix. It blocks urinary catheter, causes obstruction of urine
ﬂow which can induce pyelonephritis, septicemia and urinary
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calculi. The aim of this study was to establish a role of P.
mirabilis major virulence factors in encrustation of catheter
surface.
Methods: P. mirabilis strains were recovered from Foley cath-
eters of long-term catheterized patients. The in vitro model was
used to analyse formation and crystallization of P. mirabilis
bioﬁlm. Catheter fragment was sonicated and the ﬂuid was
diluted and plated to establish the number of bacteria. Crystal-
lization was determined as the amount of calcium and magnes-
ium ions by atomic absorption spectroscopy. Activity of urease
was tested using method of Weatherburn. Colorimetric method
with Alcian Blue dye and enzyme-linked lectinsorbent assay
were used to study the ability of these bacteria to form
exopolysaccharides.
Results: It was found that all of tested P. mirabilis strains show
urease activity, form bioﬁlm and cause encrustation of catheter
surface. It has been shown some differences in intensity of
crystallization between the strains which may depend on
capacity to colonization of catheter surface and the presence of
bacterial polysaccharides. These strains produced polysaccha-
rides, but only three of them in signiﬁcant amount. P. mirabilis
strains producing polysaccharides had the strongest ability to
catheter encrustation, although urease activity of these strains
was low. It was also shown no correlation between adhesion
ability, urease activity of P. mirabilis and intensity of crystalliza-
tion.
Conclusion: Our observations suggest that in encrustation of
catheter by P. mirabilis macromolecules, e.g., polysaccharides on
bacterial surface may play an important role in enhancement of
crystallization initiated by urease activity.
P835
In vitro bioﬁlm formation by Candida spp. on the
surface of polyurethane and PVC catheters
D. Estivill, A´. Torres-Lana, A´. Arias, M.P. Are´valo (Manresa, La
Laguna, ES)
Objective: Catheterized patients have a signiﬁcantly increased
risk of infection. There are many associated risk factors such as
the frequency of lines changes, the duration of catheterization
and the type of catheter used. The aim of this work is to study
the bioﬁlm formation by different species of Candida on the
surface of two catheter materials such as polyurethane and
Polyvinyl chloride (PVC).
Material and methods: Seventy-two clinical isolates of Candida
and ﬁve from ATCC collection were used in this study (22 C.
albicans, 22 C. parapsilosis, 16 C. tropicalis and 17 C. glabrat). All
yeasts were grown in Sabouraud dextrose broth medium (SDB)
and incubated at 35 C in an orbital shaker at 60 rpm. Cells were
harvested after 18 h of incubation, washed twice with PBS pH
7.2 and cell suspensions were adjusted to an optical density of
1.0 at 540 nm. Catheters were cut into 1 cm segments and
sterilized with ethylene oxide. Standardized cell suspension
1 ml was applied to each segment and incubated for 90¢ at 35 C
for adhesion period. Segments were then incubated for up to
72 h at 35 C, in 1 ml of SDB with 500 mM galactose. After
bioﬁlm formation, catheter segments were removed and washed
with PBS to remove nonbioﬁlm cells. To determine the number
of viable cells attached, segments of catheter were washed,
placed in 2 ml of PBS and vortexed for 2 min. After dilution
with PBS, yeast suspensions were plated onto Sabouraud agar
plates, incubated at 35 C for 24 h.
Results: Results are expressed as logarithm of viable cells count
for ml (CFU/ml) for each species. For polyurethane the mean
CFU/ml for each specie (as expressed in log) were 12.329,
12.559, 12.760 and 11.768 for C. albicans, C. parapsilosis, C.
tropicalis and C. glabrata, respectively. For PVC the results were
12.969, 13.258. 12.626 and 12.516 for the same species. Evaluation
of two catheter materials with analysis of variance showed that
bioﬁlm formation by Candida species was slightly increased on
PVC, compared with polyurethane. The differences between
materials were signiﬁcatives (p < 0.05) for C. parapsilosis and C.
glabrata. Bioﬁlm formation by C. glabrata gave less bioﬁlm
growth than the other Candida species. C. parapsilosis showed the
greater bioﬁlm formation in PVC and C. tropicalis in polyureth-
ane. Scanning electron microscopy showed that after 72 h
Candida spp bioﬁlms consisted of a dense network of yeast,
pseudohyphae, and hyphae. Slime production was visible on the
surface of two materials.
P836
Bioﬁlm production in well characterised Candida
spp. isolated in Italy during the period 2002–2005
from paediatric and adult patients
A. Marchese, L. Gualco, R. Bandettini, C. Peri, L. Pescetto,
L. Ricagni, A. Cavallero, M.C. Ossi, E.A. Debbia, G.C. Schito
(Genoa, Milan, IT)
Objectives: To assess the rate of bioﬁlm production in a large
number of previously well characterised Candida spp. isolated
from clinical specimens in adult and paediatric patients. To
establish whether a correlation exists between bioﬁlm produc-
tion, resistance, site of infection and age of patients.
Methods: Five hundred and thirty-ﬁve Candida spp., including
418 C. albicans, 108 C. glabrata, 45 C. tropicalis, 43 C. parapsilosis
and 11 C. krusei, isolated from blood, urine, vaginal swabs and
respiratory samples have been studied. Two bioﬁlm producing
C. albicans, kindly provided by Jin et al. (2003), were used as
positive controls. Bioﬁlm production was quantiﬁed spectro-
photometrically.
Results: Production of bioﬁlm was more common among non-
albicans species (72.9%) than among C. albicans (46.4%)
(p < 0.001). In particular C. tropicalis and C. parapsilosis produced
more bioﬁlm than C. albicans and C. glabrata (p < 0.001). No
signiﬁcant differences in bioﬁlm production were observed
among C. albicans isolates from different specimens with the
exception of C. albicans strains from respiratory samples vs
urinary tract isolates or after grouping the strains according to
the patient’s age. Similar results were obtained for the other
species studied. C. tropicalis isolates resistant to one or more
antifungal drugs (ﬂuconazole, ketokonazole, ﬂucytosine and
amphotericinB) were found to be more frequently bioﬁlm
producers than susceptible strains (p < 0.001). This correlation
was not observed for the other species.
Conclusion: Bioﬁlm production was more related to the species
of Candida than to the site of infection. There were no important
differences in bioﬁlm production when grouping the strains
according to the patient’s age, site of infection and antifungal
susceptibility patterns, with the exception of antifungal resistant
C. tropicalis strains that produced bioﬁlm more frequently than
susceptible strains.
P837
Bioﬁlm communities on different construction
materials
A. Kimiran Erdem, E. Arslan, N. Dogruo¨z, Z. Zeybek, N. Sanli
Yu¨ru¨du¨, I. Tu¨retgen, A. Cotuk (Istanbul, TR)
Introduction: Bioﬁlm forms when bacteria adhere to surfaces in
aqueous environments and begin to excrete a slimy, glue-like
substance that can anchor them to surfaces. The formation and
presence of bioﬁlms in water systems have been reported
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frequently. The aim of this study is to determine the material
dependence of bioﬁlm and select the appropriate manufacturing
material for water systems.
Methods: The study was performed using polypropylene re-
circulating model system under constant hydraulic conditions,
which was fed up with tap water. Coupons of each material
were removed monthly from the system. Bioﬁlms on surfaces
were scraped by sterile swab and suspended in phosphate
buffer and vortexed for 60 s. Faecal and total coliforms (FC,TC),
aerobic mesophilic heterotrophic bacteria (AMHB) (22–37 C),
Pseudomonas, amoeba adhered to surface on different materials
[polyvinyl chloride (PVC), polyethylene (PE), polypropilene
(PP), galvanized steel (GSS), stainless steel (SS), copper (Cu),
glass (G), ceramic] in model system have been examined during
6 months period. On the other hand, the same microorganisms
have also been examined in the water at same model system.
Microorganism counts in the water were determined with
membrane ﬁltration method. Media used were m.FC-NKS for
FC, Endo-NKS for TC, R2A agar for AMHB, Cetrimide Agar for
Pseudomonas and NNA for amoeba. Cultures were incubated at
suitable temperatures and periods. After incubation, suspicious
bacterial colonies were counted by a Colony Counter, cultures of
amoeba were examined microscopically (10·).
Results: Neither FC nor Pseudomonas have determined on all
the material during 6 months periods. In this period, it has
determined that TC have increased gradually, have arrived at
maximum level at the fourth month, and have possessed on Cu
material at high level. It was found that AMHB counts have
reached maximum level at the second month, decreased later,
and have accumulated on GSS at high levels. Although amoeba
found on all materials during 4 months, they have not been
found on PVC, PP, PE at ﬁfth and sixth month. It has revealed
that GSS generally enhance to bioﬁlm formation signiﬁcantly.
On the other hand, plastic polymers, especially PVC were
supported the lowest bacterial numbers.
Conclusion: GSS surfaces support more microorganisms than
do other materials. We think that PVC can be used in the water
systems reliably because it supports less bioﬁlm.
P838
Bioﬁlm-positive microbes isolated from the
environment of life-boxes for allogenic
transplantations and from immunocompromised
patients
V. Hola, L. Horakova, F. Ruzicka, M. Votava, R. Tejkalova (Brno,
CZ)
The patient after an allogenic transplantation is immunosup-
pressed and whatever microbe which is normally considered as
non-pathogenic, can cause an infection. The life-boxes prevent
their contact with potential pathogens to avoid risk of infection.
We focused on the bioﬁlm-forming microbes in life-boxes for
allogenic transplantations, because the bioﬁlm formation is an
important factor of pathogenicity in all microorganisms. Bioﬁlm
protects bacteria against actions of antibiotics and disinfectants
and therefore bacteria can survive concentrations of antibiotics
and disinfectants even 1000· higher than planktonic forms of the
same bacteria. The aim of the study was to compare microbial
contamination of the environment of the life-boxes for allogenic
transplantations with standard hospital wards of the same
clinic. From October 2004 to January 2005 we collected 60
samples from standard hospital unit and from life-boxes for
allogenic transplantations of the Clinic of Internal Medi-
cine—Haematology and Oncology. After isolation of individual
strains, the microbes were determined and tested for the ability
to form bioﬁlm by the modiﬁed Christensen’s method. From 60
samples we isolated 116 different strains of microbes. In 49
(81.7%) samples bacteria were present, only 11 samples were
sterile (18.3%). The isolated strains were mostly Gram-negatives
(P. aeruginosa, S. maltophilia, K. pneumoniae, S. marcescens, E.
aerogenes, P. mirabilis, Acinetobacter sp.), of Gram-positive bac-
teria, S. epidermidis, M. luteus and Bacillus sp. were isolated. The
most frequently isolated species were P. aeruginosa and S.
maltophilia. The ability to form bioﬁlm was demonstrated in
71.2% of strains isolated from life-boxes and in 34.5% of strains
isolated from standard wards. The different number of isolated
strains on both departments may be caused by different
sanitation modes. The higher sanitation standards in life-boxes
might cause higher proportion of resistant bioﬁlm-positive
bacteria, although the absolute number of bacteria is lower in
comparison with standard hospital wards. Although all
microbes which we isolated from the hospital environment are
generally considered as low pathogenic or non-pathogenic, the
presence of virulence factors increases their clinical importance
and these strains represent risk of infections and colonization of
indwelling devices, particularly for immunocompromised
patients.
Acknowlegement: This work was supported by the Grant
Agency IGA MZ NR/7980-3.
P839
The effectiviness of impregnation of graft with
cefazolin in foreign body infection
D. Kilic, C. Agalar, E. Denkbas, F. Agalar, E. Ozturk,
M. Emirdogan, O. Deveci (Ankara, TR)
Objective: Foreign body infection (FBI) is a real problem in
clinical situations. In the present study, in vitro and in vivo
efﬁciacy of impraganation of mesh with cefazolin in prevention
of FBI.
Materials and methods: Strain: The microorganism was slime
positive, methicillin-resistant S. epidermidis (MRSE). Impregna-
tion: Cefazolin impregnated grafts were prepared by dipping
method. Naive meshes, in size of 5 · 10 mm were immersed
into the polylactic acid (PLA) solution in dichlorometahane
including cefazolin with different concentrations (i.e., 0.025, 0.05
and 0.3 g sefazolin/5 ml and 2% w/v of PLA solution).
Cefazolin impregnated and naive grafts with different concen-
tration (Group 1 = 0.025 g, Group 2 = 0.05 g, and Group
3 = 0.3 g) were incubated with 108 cfu/ml slime positive
MRSE. In vitro: After 24 and 48 hours of incubation, the
numbers of colonies were counted in an aliquot and adhered
to catheter. In vivo: Contaminated naı¨ve and cefazolin-impreg-
nated grafts (n = 10 in each groups) were implanted subcuta-
neously in the back of Swiss albino mouse. Grafts were
explanted at 7 days following implantation. Microbiologic
assessments and electron microscopic (JOEL JSM-5600 Japan)
evaluation of catheter segments were performed.
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Results: Impregnation of cefazolin decreased the numbers of
adherent bacteria to the grafts and the number of free bacteria
within the liquid medium signiﬁcantly in all groups. In all
comparisons; the decrease of bacterial counts were statistically
signiﬁcant, except the values at 48 hours of group 2 vs group 3.
Cfu counts in explanted grafts were signiﬁcantly less in
treatment than in control group and wound infection rates
also decreased, accordingly.
Conclusions: Impregnation of cefazolin to grafts by dipping
method may protect against FBI with MRSE during peri-
operative period.
P840
Bioﬁlm production by different strains of
Salmonella typhimurium: genetics, morphology
and role of surface and nutrient content of
medium
J.M. Romanova, N. Alekseeva, A.L. Andreev, T.A. Smirnova,
T.V. Stepanova, A.L. Gintsburg (Moscow, RU)
Objectives: To investigate the ability of bioﬁlm production by
14 different strains of Salmonella typhimurium in depending on
genotype and culture conditions in artiﬁcial systems: in 96-well
plastic microtitre plates, plastic and glass tubes, plastic Petri
dishes and on microscope glasses.
Methods: Quantitative bioﬁlm growth was monitored by using
an assay based on crystal violet staining, while planctonic
growth in the same cultures was monitored by absorbance in
iEMS Reader MF, and qualitative bioﬁlm growth—by digital
photo and visually. Morphology of the planktonic cells and cells
in the bioﬁlm was investigated by methods of transmission
microscopy of ultra-thin cessions.
Results and conclusions: Optimal rate between growth and
bioﬁlm indications for all strains was determined at initial cell
concentration 106-7 KOE/ml and T= 28 C culture incubation.
The nutrient content of the medium signiﬁcantly inﬂuenced the
quantity of produced bioﬁlm. The nutrient broth LB without
NACl was the most effective in promoting bioﬁlm formation,
than LB itself. The least quantity of bioﬁlm was formed in water.
The chemical content of plastic and glass also inﬂuenced bioﬁlm
formation. The ability to induce bioﬁlm on the walls of plastic
tubes is very suitable for visual screening of a number of strains.
We used this property for the testing of inﬂuence of some
proteins on the bioﬁlm production intensity. Plastic tubes were
treated before incubation by 1% BSA or milk proteins and
sterilized by ethanol. It seems to be, that protein pretreatment of
plastic surfaces increased adhesion and bioﬁlm production. It is
possible to conclude the more effective bioﬁlm production on
surfaces, contacting to blood proteins or food products. The
genotype of the strains also critically inﬂuenced the quantity of
produced bioﬁlm. Nonmotile mutants cells reduced ability to
form bioﬁlm. RpoS mutant cells produced signiﬁcantly less
bioﬁlm as compared with cells of isogenic parent strains. The
morphology of S. typhimurium grown as bioﬁlm or as planctonic
cells was also different.
P841
Bioﬁlm-associated anaerobic sulphate reducing
bacteria on galvanized steel surfaces
E. Ilhan-Sungur, I. Tu¨retgen, A. Cotuk (Istanbul, TR)
Objectives: Sulphate reducing bacteria (SRB) are found in
marine and freshwater sediments and even in human intestine.
Anaerobic SRB conduct dissimilatory sulphate reduction to
obtain energy, resulting in the release of a great quantity of
sulphide (H2S). H2S is toxic to human cells. While H2S causes
ulcerative colitis (UC) in human, SRB trigger liver abscess and
septicaemia. In addition to the effect of H2S, extracellular
polymeric substances produced by SRB may contain highly
immunogenic O-antigen. In addition to the effect of H2S,
extracellular polymeric substances produced by SRB may
contain highly immunogenic O-antigen. Such antigens may
cause an immune response in genetically predisposed individ-
uals and initiate to the inﬂammatory process characteristic of
UC. Also it has been reported that SRB cause corrosion of
various metals including carbon steels, stainless steels and
copper alloys. Galvanized steel (GS) is frequently used in the
construction of water containers and pipes, etc. owing to its
good resistance to corrosion and biofouling. In this study,
survival and enumeration of the SRB and heterotrophic bacteria
were investigated on GS coupons in bioﬁlm reactor during
180 days. Also total carbohydrate amount in bioﬁlm was
detected.
Methods: Bioﬁlms were allowed to develop for 180 days on
galvanized steel coupons within annular bioﬁlm reactor. For the
enumeration of heterotrophic bacterial counts, samples are
plated on R2A agar for 10 days at 27 C. Postgate medium B
was used for SRB cultures. Numbers of cultivable SRB were
determined by the most-probable-number technique. The
amount of carbohydrate on coupons was quantitated colorimet-
rically using the phenol-sulphuric acid method.
Results: There was a gradual increase in growth of SRB with
the time, similarly to heterotrophic bacteria. The cell concentra-
tions of SRB increased to a maximum of 140,000 SRB/cm2 after
180 days. The carbohydrate contents on coupons were correla-
ted with heterotrophic counts (R = 0.91, P < 0.05). After 90-day
period sessile heterotrophic counts and carbohydrate quantity
have reached to plateau stage.
Conclusion: GS is frequently used in construction of water
containers which provide ideal conditions for growing of
microorganisms especially SRB. Our ﬁndings suggest that SRB
cells attached and located in bioﬁlm on the GS surfaces even
though the toxic effect of zinc. This study points out that because
of SRB could be colonize on GS easily, they form a risk for
human health.
P842
Mechanism and effects of bioﬁlm formation on
fat-based materials
G. Cayli, I. Tu¨retgen (Istanbul, TR)
Objectives: Non-petroleum based polymers are attracting more
attention nowadays. For this group of polymers, especially fat
based polymers, ﬁnd a great application areas. After literature
search no related work was found about bioﬁlm formation on fat
based polymers. Therefore, the adhesion afﬁnities of different
candidate materials were tested regarding bacterial accumula-
tion using modiﬁed robbins device (MRD). Fat based polymers
that have different functional groups were compared against
changes on their surfaces by the aid of multiple internal
reﬂectance (MIR) spectroscopy before and after the experiments.
Methods: The bioﬁlm was established under standard hydrau-
lic conditions and tubular pipe ﬂow using a MRD. Discs of
different material are immobilized on MRD plugs and the
experimental setup was run 60-day period. The device is
connected to the distributed drinking water network. Twelve
different materials [acrylated-ESO (epoxidized soybean oil),
acrylated-ESO co-styrene, acrylated-ESO co-acrylic acid, ESO-
phtalic anhydrite, PEG-400 modiﬁed ESO co-styrene, ESO-
malonic acid, ESO-triethylenetetraamine, ESO-hekzamethylen-
ediamine, ESO-bis-phenol, polyvinylchloride, polyurethane,
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stainless steel] were tested in this study. The bacterial numbers
were determined by heterotrophic plate counting (HPC) after
30- and 60-day periods. Extracellular polymeric carbohydrates
on surfaces were analysed by phenol-sulphuric acid method.
The polymeric materials were analysed by MIR to determine
whether the chemical modiﬁcations were present or not on the
surfaces.
Results: We found the amount of bacterial accumulation on the
surfaces is largely depends on the functional groups at the
surfaces and some chemical modiﬁcations on the surfaces took
place. Signiﬁcantly high count of bacterial accumulation was
found on PEG 400 ESO after two periods. On ESO acrylic acid
and bis-phenol, signiﬁcant differences were observed between
30- and 60-day periods.
Conclusion: Bacterial accumulation was higher on the func-
tionalized surface than neutral surfaces. Amine functionalized
surfaces show the highest accumulation. The positive charge,
which causes from the ionization of amine groups, on the
surfaces would attract negatively charged bacteria. When
bacteria invade the surface they would use the fatty parts of
polymers as a nutrient.
P843
Impact of daptomycin compared to linezolid,
vancomycin, gentamicin, rifampin and
ceftriaxone on resolution of staphylococcal
adherence from surface of in vitro Silastic
Antibiotic Lock and Prosthetic Vascular Graft
biomedical devices
C. Edmiston, G. Seabrook, C. Johnson, B. Lewis, K. Brown,
J. Towne (Milwaukee, US)
Introduction: Infection of intravascular or implanted biomedi-
cal devices often involves bioﬁlm-forming staphylococci, recal-
citrant to antimicrobial therapy.
Objective: The present investigation compares the antimicro-
bial activity of Daptomycin to ﬁve selected anti-infectives in
resolving staphylococcal adherence from surface of biomedical
devices.
Methods: Five staphylococcal (four S. epidermidis and one S.
aureus) strains were selected for in-vitro adherence studies: (a)
ALM (silastic catheter) and (b) VGM (Dacron and polytetra-
ﬂuoroethylene). RP62A, M187sp11 and Sef141-98 are strongly
adherent strains, producing a copious bioﬁlm, while Sef141-98
and S. aureus ATCC 25923 are both negative for bioﬁlm
formation. Test strains were inoculated for 30 min (4.5 log10/
cfu) to ALM and VGM, rinsed 3·, incubated in TPN (Ca2+ = 3
mEq/L) solution (ALM) or phosphate-buffered saline (VGM)
with dextrose (0.75%) for 12 hours (35 C) to stabilize microbial
(bioﬁlm) adherence. Following stabilization, anti-infectives were
added at concentrations 20–40 · MIC. Antibiotic solutions were
replaced daily and antimicrobial impact on bacterial adherence
assessed at 0, 2, 4, 7 and 10 days postinoculation. Ten specimens
were evaluated at each time interval. Selected samples were
prepared for SEM.
Results: (a) ALM: Daptomycin = 100% reduction in bacterial
adherence by day-4; Vancomycin = 90% reduction by day-10;
Ceftriaxone = 85% reduction by day-10; Rifampin = 100%
reduction by day-4; Gentamicin = 100% reduction by day-7;
and Linezolid = 100% reduction by day-7. (b) VGM: Da-
cron—Daptomycin = 100% reduction in bacterial adherence by
day-4; Vancomycin = 90% reduction by day-10; Ceftriax-
one = 78% reduction by day-10; Rifampin = 100% reduction by
day-4; Gentamicin = 95% reduction by day-10; and Linezo-
lid = 100% reduction by day-7. PTFE—Daptomycin = 100%
reduction in bacterial adherence by day-2; Vancomycin = 100%
reduction by day-7; Ceftriaxone = 90% reduction by day-10,
Rifampin = 100% reduction by day-4, Gentamicin = 100%
reduction by day-7; and Linezolid = 100% reduction by day-2.
Conclusion: Daptomycin, rifampin and linezolid demonstrated
greater efﬁcacy in reducing microbial adherence of both bioﬁlm
negative and positive strains on surface of selected biomedical
substrates compared to vancomycin, gentamicin or ceftriaxone
(p < 0.01). Further studies are warranted, validating the clinical
efﬁcacy of Daptomycin in the treatment of biomedical device-
associated infections.
P844
The development of an Aspergillus fumigatus
bioﬁlm model to determine the effectiveness of
antifungal treatments in vivo
J. Butcher, G. Ramage, C. Williams (Glasgow, UK)
Objectives: To devise an in vitro bioﬁlm model of Aspergillus
fumigatus to allow the examination of the ability of antifungal
agents to inhibit/kill these bioﬁlms.
Methods: Polystyrene microtitre plates were selected to grow
bioﬁlms upon, based on previous studies for high throughput
analysis of bioﬁlms. Spores were collected from NCPF 7367 and
standardized at different densities in RPMI. Bioﬁlm growth
kinetics were then observed microscopically over 48 h (1, 2, 4, 6,
24 and 48 h) using a metabolic (XTT) and a biomass assay
(crystal violet). Standardized bioﬁlms formed from NCPF 7367
and several clinical isolates were then treated with antifungal
agents for 48 h and assayed for viability and biomass. We also
examined the effects of bioﬁlm development when antifungals
were added at 0, 1, 2 and 4 h postspore inoculation. Following
24 h incubation, the antifungal was removed and replaced with
fresh RPMI, and bioﬁlm development reassessed.
Results: Spore concentrations of 1 · 106/ml produced the
optimal conﬂuent bioﬁlm after 24 h. Bioﬁlm development,
assessed by both metabolism and biomass, indicated a slow
increase from 0 to 6 h, exponential growth to 24 h, followed by a
plateaus. Treatment of mature bioﬁlm structures with ampho-
tericinB, voriconazole and caspofungin was ineffective at clin-
ically achievable concentrations; even at high dosages both
metabolism and biomass only decreased minimally. When
voriconazole was added during the early stages of adhesion, a
dose-dependant effect was observed, and appeared effective at
therapeutic concentrations. Replenishment with fresh media
allowed bioﬁlm growth in at all concentrations.
Conclusions: We have developed a reproducible and robust
assay to analyse A. fumigatus bioﬁlms. The results suggest that
treatment of mature A. fumigatus bioﬁlms with antifungals is
futile. Nevertheless, voriconazole could be used as a prophy-
lactic. The use of this antifungal on early exposure to spores
prevented ﬁlamentation and subsequent bioﬁlm formation. The
continued use of voriconazole would be advocated, as removal
of the drug permits bioﬁlm regrowth. Overall, voriconazole
appears to offer excellent prophylactic properties against inva-
sive Aspergillosis.
P845
Inﬂuence of subinhibitory vancomycin
concentrations on bioﬁlm formation in coagulase
negative Staphylococci
A. Longauerova, D. Kotulova, L. Slobodnikova (Bratislava, SK)
Objectives: Detection of vancomycin MICs changes in coagu-
lase negative Staphylococci (CoNS) growing in bioﬁlm and in
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planktonic cultures. Inﬂuence of pretreatment with vancomycin
subinhibitory concentrations on bioﬁlm formation with respect
to use of vancomycin in prophylaxis.
Methods: Eighty-two CoNS strains isolated from joint pros-
theses infections of patients from ﬁrst orthopaedics clinic were
identiﬁed by standard microbiological methods. Antimicrobial
susceptibility was tested according to NCCLS. MICs to vanco-
mycin (VAN) were established by broth dilution according to
NCCLS, as well as by the E-test (AB Biodisk, Sweden). Bioﬁlm
production was detected by use of congo red agar plates,
Christensen method and microtitre plate bioﬁlm assay. Effect of
VAN on CoNS growing in bioﬁlm was detected by modiﬁed
microtitre plate bioﬁlm assay: bioﬁlm was formed in 96-well
microtitre plates, and than VAN was added in different
concentrations. Results were expressed as minimal bioﬁlm
inhibitory concentration (MBIC), and minimal bioﬁlm eradica-
tion concentration (MBEC). Inﬂuence of pretreatment with VAN
subinhibitory concentrations was detected in all strains: bioﬁlm
formation was detected by microtitre plate assay, which fol-
lowed after overnight cultivation of tested strains on solid
medium with VAN in subinhibitory concentrations.
Results: Bioﬁlm production was detected by three in vitro
methods. There were differences in amounts of produced bioﬁlm
when tested by different methods. The microtiter plate assay,
which detected bioﬁlm production in all of the tested strains,
seemed to be the most susceptible one. Detected MBICs were
higher than MICs in most of the strains. The greatest differences
were observed in strains with most extensive bioﬁlm production.
MBECs were 2–32 times higher than MBICs. In 50 (61%) strains,
pretreatment with VAN in subinhibitory concentrations consid-
erably decreased the amounts of produced bioﬁlm.
Conclusions: The most susceptible method for bioﬁlm detec-
tion was the microtiter plate assay. According to our results, for
therapy of endoplastitis caused by CoNS is not advisable to use
therapeutic guidelines based on MICs obtained in planktonic
cultures. Individual testing of MBEC should be necessary for
successful therapy of endoplastitis. Subinhibitory concentrations
of VAN decrease bioﬁlm production by CoNS; prophylaxis by
VAN during arthroplasty may have protective effect.
Brucella and Lyme borreliosis
P846
Brucellosis: retrospective evaluation of 133
hospitalized cases
Y.Z. Demiroglu, T. Turunc, H. Uncu, H. Arabaci, S. Colakoglu,
H. Arslan (Ankara, TR)
Objectives: In this study, we aimed to evaluate the clinical,
laboratory and treatment data of our cases with brucellosis and
to compare them with the data of other centres.
Methods: Medical records of 133 patients hospitalized between
January 2003 and May 2005 with the diagnosis of brucellosis
were reviewed. One of the two diagnostic criteria was required
along with the clinical ﬁndings; one being a SAT result of 1/160
or higher and the other is Brucella spp. isolation in automated
system blood culture bottles. Complete blood count, erythrocyte
sedimentation rate, CRP value, liver function test results on
admission for each patient were recorded. Cases presenting with
duration of symptoms less than 8 weeks were considered to be
acute, duration of 8 weeks to 1 year subacute and the duration
of more than 1 year was considered to be chronic.
Results: Eighty-one (61%) of the cases were female. Mean age
was 44.7 years. Eighty-four (63%) of the cases were diagnosed as
acute, 35 (26%) were subacute and 14 (11%) were chronic
brucellosis. History of fresh cheese or diary product consump-
tion was positive in 93 (69%) of the cases. Seventeen (13%) of the
patients were cattle-dealer and four of the patients had occupa-
tional risks (two veterinary surgeons and two laboratory
technicians). The most common symptom was fever (68%),
others were night sweats (64%), joint pain (52%), low back pain
(52%) and malaise (42%). The most common complications were
related to the haematopoietic system (38%). Anaemia was seen
in 41 cases, leukopenia in eight cases, and thrombocytopenia in
two cases. Elevation of erythrocyte sedimentation rate and CRP
were noticed in 61 (46%) and 46 (35%) of the cases, respectively.
Blood cultures grew Brucella spp. in 53 (40%) of the cases.
Second most commonly involved site was osteoarticular system
with 34 cases (26%). Nineteen cases had spondylodiskitis, seven
sacroileitis, three peripheric arthritis, four spondylodiskitis and
neurobrucellosis, one spondylodiscitis and sacroileitis. Eight
(6%) patients had neurological involvement and ﬁve (4%) had
genitourinary system involvement. The most commonly pre-
scribed regimen was doxycyclin plus rifampicin and strepto-
mycin was added in most of the complicated cases. Relaps was
seen in 14 (11%) of the cases. The most common side effect was
gastrointestinal intolerance.
Conclusion: Brucellosis can present with various clinical forms
in endemic areas and mimics several diseases.
P847
Brucellar epididymo-orchitis in South-eastern
Anatolia, Turkey
M.K. Celen, M.F. Geyik, C. Ayaz, S. Hosoglu, M. Ulug
(Diyarbakir, TR)
Objective: The different clinical and laboratory features and
response to treatment of patients with acute brucellar epidi-
dymo-orchitis reporting to a reference hospital in South-eastern
Anatolia of Turkey.
Patients and methods: In this study, 22 of 191 adult patients
with brucellosis, who presented with epididymitis or epidi-
dymo-orchitis at a university hospital in Diyarbakir from 1998 to
2004, were included. Positive blood culture or high agglutin-
ation titres of 1:160 and positive clinical manifestations of
brucellosis were the main criteria for diagnosing brucellosis.
Results: Epididymo-orchitis occurred in 22 patients (11.5%) of
191 with brucellosis. Most (68.2%) were 18–34 years old. All
patients complained of swollen painful testicles. Other present-
ing symptoms included undulant fever (90.9%), sweating
(63.6%) and arthralgia (13.6%). Sixteen patients gave a positive
history of ingestion of raw milk and milk products. Ten patients
had unilateral epididymo-orchitis; the remaining 12 had only
orchitis (bilateral in two, right in seven and left in three).
Leukocytosis was present in two patients; 18 had initial
agglutination titres of 1:160 and the remaining patient had a
positive blood culture. All patients received combined therapy
with streptomycin for the ﬁrst 21 days (or oral rifampicin for
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6–8 weeks) with doxycycline or tetracycline for 6–8 weeks. All
showed improvement, fever subsided in 2–4 days and the
scrotal enlargement and tenderness regressed. Only one patient
had a relapse within 1 year.
Conclusion: In brucellosis-endemic areas, clinicians encounter-
ing epididymo-orchitis should consider the likelihood of bru-
cellosis. Conclusively, brucellosis must be considered as a cause
of orchitis in especially endemic regions like Turkey. The
incidence of epididymo-orchitis was determined 11.5% in our
region. Most of the cases (90.9%) were unilateral. All patients
respond to medical management very well. Conservative man-
agement with combination antibiotic therapy is adequate for
managing brucellar epididymo-orchitis.
P848
Neurobrucellosis: experience with eight cases
C. Ayaz, M.K. Celen, M. Ulug, S. Hosoglu, M.F. Geyik
(Diyarbakir, TR)
Objectives: Brucellosis is a common infection in Turkey and a
serious medical problem. Neurobrucellosis is a rare manifesta-
tion of the diseases. The aim of this study is the presentation of
the cases with neurobrucellosis in our clinic.
Methods: Eight patients with neurobrucellosis, which were
followed during the period from 1998 to 2005 in our hospital,
were investigated retrospectively.
Results: Five of all patients were female and, three patients
were male. Mean age of patients was 34.7 ± 11.4 (range, 24–54)
years old. Touch on an animal was present all of patients and
eating of fresh cheese story was determined in six patients. All
of patients had complaints and clinical ﬁndings of brucella
infection. All of them applied to us with symptoms of
meningitis. In seven cases meningitis and one of them
meningoencephalitis, were determined. Cerebrospinal ﬂuid
(CSF) ﬁndings were abnormal in all of them. When the CSF
vas investigated 40–230 leucocyte/mm3 and erythrocyte 0–60/
mm3 in CSF, increasing of CSF glucose (range, 87–423 mg/dl),
decreasing of CSF/plasma glucose ratio (range, 15–38%), were
determined. While serum brucella antibody was positive in all
of them (standard agglutination ‡1/160), brucella antibody was
positive too in CSF at three patients (standard agglutination
‡1/40). Trio combinations of antibiotherapy (rifampicin, doxo-
cycline and cotrimoxazole/streptomycin/ceftriaxone) were
given for 3 or 6 months to all patients. Prednisolone 60 mg/
day was given to a patient which myelitis. The response of the
therapy was very well in all patients. The therapy was
completed and CSF ﬁndings were improved in all patients
except one. Motor dysfunction and losing of muscle force was
developed in lower army in this patient which was meningo-
encephalitis.
Conclusion: Neurobrucellosis is a rare but serious complication
of brucellosis and a diagnostic delay can enhance residual
disturbances.
P849
The effects of oxidative stress in patients with
infection of Brucella melitensis
M. Gul, E. Kurutas, P. Ciragil, M. Kilinc, M. Aral, O.F. Kokoglu
(Kahramanmaras, TR)
Objectives: In Turkey, brucellosis, mainly produced by Brucella
melitensis (B. melitensis), is one of the most important zoonoses
causing severe morbidity in humans. The infection in humans is
commonly acquired by drinking unpasteurized milk or eating
milk by-products derived from infected goats or cows. Oxida-
tive stress has been suggested to play a role in some physio-
logical conditions and infectious diseases. The present study
aimed to determine the effect of infections with B. melitensis on
antioxidant enzymes and malondialdehyde (MDA) in the serum
samples of patients.
Methods: The blood samples were inoculated at a volume of
10 ml into BACT/Alert Plus+Aerobic/F blood culture bottles.
When growth was detected, identiﬁcation of brucellae was
performed by H2S, urease production, and dye tests. Super-
oxide dismutase (SOD) activity was measured according to
the method described by Fridovich. Catalase (CAT) activities
were determined by measuring the decrease in hydrogen
peroxide concentration at 230 nm by the method of Beutler.
The protein concentration of the tissue was measured in
digital Spectronic-20 spectrophotometer by the method of
Lowry.
Results: Patient group consists of 14 (60.8%) male and 9
(39.1%) female, control group were consist of 11 (55.0%) male
and 9 (45.0%) female. There was no difference with respect to
age, sex, smoking status and body mass index among the
patients and healthy subjects. This parameters were taken out
of evaluation which can be thought to have effects on oxidative
stress. As shown in Table 1, the antioxidant enzyme activities
and MDA levels were higher in serum samples from patients
with B. melitensis compared to that from healthy subjects
(p < 0.05).
Conclusions: Cells and biological ﬂuids have an array of
protective antioxidant mechanisms such as glucose-6-phosphate
dehydrogenase, SOD, CAT and also reduced glutathione both
for preventing the production of free radicals and for repairing
oxidative damage.
P850
Doxycycline plus streptomycin versus
ciproﬂoxacin plus rifampicin in spinal brucellosis
E. Alp, R. Koc, A. Durak, O. Yildiz, B. Aygen, B. Sumerkan,
M. Doganay (Kayseri, TR)
Objectives: The optimal treatment regimen and duration of the
therapy is still controversial in spinal brucellosis. The aim of this
study is to compare the efﬁcacy, adverse drug reactions,
complications and cost of ciproﬂoxacin plus rifampicin versus
doxycycline plus streptomycin in the treatment of spinal
brucellosis.
Methods: The patients diagnosed as spinal brucellosis between
January 2002 and December 2004 were enrolled into the study.
Patients were enrolled into the two antimicrobial therapy
groups (doxycycline plus streptomycin vs. ciproﬂoxacin plus
rifampicin) consecutively. All the patients had at least 12 weeks
antibiotic therapy in the both group. The antibiotic therapy was
prolonged according to clinical improvement and the resolution
of magnetic resonance imaging ﬁndings. Furthermore, the
patients were followed up until 12 months after cessation of
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the therapy for the evaluation of sequelae and relapse. Only the
cost of antibiotic therapy was analysed for each patient.
Results: During the study period, 31 patients with spinal
brucellosis were enrolled into the two antimicrobial therapy
groups. Fifteen patients were included in doxycycline plus
streptomycin group and 16 patients were included in ciproﬂ-
oxacin plus rifampicin group. Forty-two levels of spinal column
were involved in 31 patients. The most common affected site
was lumbar vertebra (n = 32, 76%) and involvement level was
not different in two groups. The median duration of antibiotic
therapy was 12 weeks (range 12–24 weeks) in all patients. Eight
(25.8%) patients underwent surgical intervention. Despite the
disadvantages (older age, more prevalent operation and abscess
formation before the therapy) of the patients in the ciproﬂoxacin
plus rifampicin group, the duration of the therapy (median
12 weeks in both groups) and clinical response were not
different from the DS. The cost of ciproﬂoxacin plus rifampicin
therapy was 1.2 fold higher than the cost of doxycycline plus
streptomycin therapy.
Conclusion: Classical regimen (doxycycline plus streptomycin),
with the appropriate duration (at least 12 weeks), is still the ﬁrst
line antibiotics and alternative therapies should be considered
when adverse drug reactions were observed.
P851
Epidemiological features and clinical
manifestations of adult brucellosis in Turkey
M.A. Yetkin, C. Bulut, G.R. Yilmaz, F.S. Erdinc, S. Kinikli,
B. Oral, N. Tulek, A.P. Demiro¨z (Ankara, Samsun, TR)
Objectives: Brucellosis is one of the prevalent diseases in
Turkey. The object of this study is to determine the epidemi-
ological features and clinical manifestations of adult cases of
brucellosis admitted to our Department of Infectious Disease
and Clinical Microbiology.
Methods: A total of 324 patients diagnosed as brucellosis in our
clinic between 1999 and 2005 were reviewed. The diagnosis of
the cases was established by seropositivity and/or blood culture
positivity. Duration of symptoms, clinical symptoms and signs,
laboratory test results, clinical type of the illness (acute and
subacute/chronic) and coexistence of complications were recor-
ded. The chi-square, Fisher’s exact tests and Student’s t-test
were used for statistically analysis.
Results: The mean age of patients was 44.02, b 18.31 (range 15–
83 years). The male and female percentages were 56% and 44%,
respectively. Animal husbandry (59%), consumption of raw
milk and/or fresh cheese (25%), were the main risk factors for
brucellosis while there was no risk factors in remaining 16% of
patients. The percentage of patients who have/has brucellosis in
her/his family member or surrounding area was 36.7%. Fever,
sweating, fatigue and myalgia were the most frequent clinical
symptoms. Fever was the most frequent physical ﬁnding. The
percentages of acute, subacute and chronic cases were 61%, 24%
and 15%, respectively. High fever was detected more frequently
in the acute group of patients (p < 0.05). Complications were
detected in 163 of 324 (51.5%) cases. Osteoarticuler involvement
(25.2%), neurological involvement (6.2%), and genitourinary
involvement (6.2%) were the most common complications. In
9.5% of patients, elevated ALT levels due to brucellosis were
detected. Blood/bone marrow culture positivity rate was 45%
(123/273 patients). Culture positivity was 56% and 27% in acute
and subacute/chronic group of patients, respectively
(p < 0.0001). The complication rate was higher in acute cases
compared with subacute/chronic cases (p = 0.0.3). The male
patients had more complications (p < 0.01). Age was not found
as a risk factor for any complication (p > 0.05).
Conclusion: Most patients with brucellosis did have known
risk factors. The main risk factors were animal husbandry and/
or consumption of raw milk and/or fresh cheese. The compli-
cation rate is also quite high due to high prevelance of
brucellosis in our country. It is important to determine the
epidemiological features of the illness to control of the
infection.
P852
Analysis of the risk factors for brucellosis in an
endemic region
O. Ergonul, S. Deniz, N. Baykam, A. Celikbas, B. Dokuzoguz
(Ankara, TR)
Objectives: Early diagnosis and treatment of the acute brucel-
losis cases were targeted by screening the household members
of the index cases. It was also aimed to describe the causal
relations of acute brucellosis in an endemic region.
Methods: The study was performed in a brucellosis endemic
country. The household members of the index cases were
screened by agglutination test. The bacteria were isolated by
blood culture. After the household members were screened,
the risk factors for seropositive and index cases were studied
by multivariate analysis. Independent variables were gender,
consuming fresh cheese, blood groups, dealing with husban-
dry, contact with the placenta of the infected animals were
included to the model. Backward and forward selection were
performed.
Results: After admission of 30 index cases to the clinic, 112
household members of these cases were screened. Eighteen of
112 (16%) screened individuals had agglutination of >1/160.
The mean age was 31 (SD 19), and 52% of the subjects were
female. In multivariate analysis, consuming fresh cheese (OR:
3.2, CI: 1.01–10.4, p = 0.047), blood group A (OR: 2.4, CI: 1.06–
5.4, p = 0.035), dealing with husbandry, and contact with the
placenta of the infected animals (OR: 3.6, CI: 1.4–9.3, p = 0.009
were found to be associated with brucellosis. On the other
hand, in univariate analysis, the individuals with blood group
B were found to be protected from brucella infection
(p = 0.015).
Conclusion: (1) Screening of the people in brucellosis endemic
area should be considered, because of the opportunities for early
diagnosis and treatment. (2) The people in endemic areas should
be educated for not to eat fresh cheese and protect themselves
from the infected animals (3) To our knowledge, the different
blood groups were studied ﬁrstly by this study, and higher
prevalence of brucellosis among the individuals with blood
group A, and less prevalence among the individuals with blood
group B should be considered for further studies on pathogen-
esis mechanisms.
P853
Neurologic involvement among brucellosis cases
K. Ugurlu, O. Ergonul, S. Eren, A. Celikbas, N. Baykam,
B. Dokuzoguz (Ankara, TR)
Objectives: To determine the neurological involvement among
the brucellosis cases and describe the risk factors for the
development of neurobrucellosis.
Methods: In patient brucellosis cases were followed up pro-
spectively between 2002 and 2005 in an endemic region. The
patients with serum culture positivity or Standard tube agglu-
tination with Coombs (STA) >160 or fourfold increase of STA
were included to the study. Neurologic involvement was deﬁned
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as (i) isolation of Brucella spp. from CSF, or (ii) demonstration of
antibodies to Brucella >1/4 in the CSF and the presence of
lymphocytosis, increased protein and decreased glucose levels in
the CSF, or (iii) neurological ﬁndings not related to any other
neurological disease. Risk factors for neurological involvement
was analysed by logistic regression. Multivariate analysis was
performed to determine the predictors of neurobrucellosis. Age,
gender, numerous visits to physicians, brucellosis history,
duration of symptoms were included to the model.
Results: Two hundred brucellosis patients were included. The
mean age was 43, and 43% of the patients was female. The
number of neurobrucellosis cases was 68 (34%). Brucella spp.
was isolated in CSF of seven patients, STA in CSF was positive
among 62 cases, and abnormalities in CSF ﬁndings were
detected among 48 patients. In 12 cases, magnetic resonance
and/or computerized tomography revealed useful ﬁndings.
Headache was signiﬁcantly more common among neurobrucel-
losis cases (p = <0.001). The most common neurological ﬁndings
were meningeal irritation signs, unconsciousness, disorienta-
tion, confusion, paraparesia, incontinence, amenorrhea, diplo-
pia, dysarthria, papilledema, hipo-hyperreﬂexia, areﬂexia, loss
of hearing, cerebellar ataxia.The level of the aspartate amino-
transferase was higher among neurobrucellosis cases
(p = 0.014). Six patients with positive STA Coombs in CSF had
isolated serious headache as the neurologic symptom. Multiva-
riate analysis revealed that neurobrucellosis cases visited
numerous physicians (OR: 3, CI: 1.17–7.5, p = 0.021), partic-
ularly psychiatrists. One out of 68 neurobrucellosis cases was
died, three had neurological sequela.
Conclusions: (1) Magnetic resonance imaging and computer-
ized tomography support the diagnosis of neurobrucellosis. (2)
The patients with serious headache should be considered for
neurobrucellosis in endemic regions. (3) STA in CSF could be
positive without any neurologic signs in patients with systemic
brucellosis.
P854
Clinical manifestations of Lyme borreliosis in
Bulgaria and identiﬁcation of Borrelia species in
ticks
I. Christova, E. Tasseva, T. Gladnishka (Soﬁa, BG)
Objectives: Data on disease expression and epidemiological
characteristics of Lyme borreliosis in south-eastern Europe are
scarce.
Methods: To reveal features of Lyme borreliosis in Bulgaria,
clinical data and epidemiological characteristics of over 1200
patients were analysed. In addition, 300 Ixodes ricinus ticks
collected in two consecutive years by ﬂagging vegetation were
examined by polymerase chain reaction and reverse line blot
hybridization for the presence and identity of Borrelia burgdorferi
sensu lato species.
Results: Among patients, the most affected age group was 5–
9 years, followed by 45–49, 50–54, and 10–14 years. Lyme
borreliosis cases occurred throughout the year with two
peaks—one in June and second smaller one in September. The
most common clinical manifestation was erythema migrans
(EM), diagnosed in 69% of the patients. Multiple EM was
detected in 4.3% of the EM cases. Neuroborreliosis was the
second most common presentation of Lyme borreliosis, diag-
nosed in 19% of the patients. Lyme arthritis was found in only
8% of the patients. Heart and ocular manifestations were very
rare. Analysis of Borrelia prevalence revealed that ticks collected
from the same location and in the same month, but in two
consecutive years, had different prevalences of Borrelia infection.
B. afzelii was the predominant species, representing over 50% of
all Borrelia-positive adult ticks. The second most frequently
found species was B. burgdorferi sensu stricto. The prevalence of
B. garinii, B. valaisiana and B. lusitaniae was about 5%. Approxi-
mately 6% of the adult ticks carried more than one Borrelia
species simultaneously.
Conclusions: The high prevalence of B. afzelii is remarkable,
since neuroborreliosis, most frequently associated with B. garinii,
is the most common clinical manifestation of disseminated
Lyme borreliosis in Bulgaria. It could be speculated that, in
many cases, infections with B. afzelii are self-limiting, whereas B.
garinii has a greater capacity to survive in the host, leading to
progression of the disease.
P855
Seasonal patterns of the activity of host-seeking
Ixodes ricinus ticks in a tick-borne encephalitis
and Lyme borreliosis natural focus (Czech
Republic)
M. Daniel, K. Zitek, J. Valter, I. Kott, V. Danielova, J. Holubova,
B. Kriz (Prague, CZ)
Objectives: The aim of our research is focused on the short-
term risk assessment and prediction of day-to-day variations of
I. ricinus questing patterns informing about the actual changes in
the level of risk in tick-borne encephalitis and Lyme borreliosis
natural foci due to the daily weather conditions. Field studies
include also an examination of the closeness of relationship
between the so-called macro-scale weather as presented by
standard meteorological stations, and the authentic microcli-
mate of a typical forest ecosystem containing I. ricinus ticks and
tick-borne diseases pathogens.
Methods: Field observations were realized in the south-eastern
periphery of Prague where the experimental plots for tick
monitoring were established in relevant type of forest growth
(Querceto- carpinetum).The occurrence of tick-borne encephal-
itis virus in I. ricinus ticks and human infection of Lyme
borreliosis (caused by Borrelia afzelii) were reported from this
area. I. ricinus activity was investigated by ﬂagging method on
three plots (200 m2 each) in weekly intervals (March–Novem-
ber) during 2001–2005. The instruments for micrometeorological
observations were installed between the experimental plots.
Macrometeorological data were used from the nearby Czech
Hydrometeorological Institute observatory. Simple and multiple
linear regression and quadratic regression were used to test the
relation between the weather and I. ricinus activity.
Results: Eight models of the relationships were constructed and
tested, of which four were single-parametric and four were two-
parametric. Double quadratic regression provided far the best
results. The relationship between daily I. ricinus activity and
weather variation can be described using two- to three-param-
eter models. Three following models were found as the best: (a)
activity is quadratic function of temperature and soil moisture;
(b) activity is quadratic function of temperature and relative
humidity; and (c) activity is quadratic function of temperature
and precipitation.
Conclusion: The relationship between weather and tick beha-
viour is solid enough to be used for the prediction of tick host-
seeking activity and thus for the prediction of tick-borne
diseases infection risk using macrometeorological data as a
predictor.
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Diagnositic and laboratory methods in parasites and fungi
P856
Diagnosis of Giardia lamblia with microscopy,
striptest, ELISA and real-time PCR
M. Brinkman, D. Vastert, H. Wilke, B. Mulder (Enschede, NL)
Objectives: Giardia lamblia is the most frequently diagnosed
pathogenic intestinal parasite in the Netherlands. We compared
four different diagnostic methods for the detection of G. lamblia
in faeces in both acute and chronic diarrhoea.
Methods: Microscopic examination was carried out on stained
samples collected with triple faeces test (TFT). ELISA (Novitec
and Novatec Giardia lamblia ELISA), Giardia-strip (Coris
Bioconcept), and real time PCR for the detection of G. lamblia
were performed on corresponding fresh stool samples.
Results: Five hundred andﬁfteen faeceswere included. 154 fresh
watery specimens from acute diarrhoea were sent for bacterio-
logical examination and 361 TFT-samples, representing a more
chronic form of diarrhoea, were sent to the parasitology depart-
ment. Using real time PCR as the gold standard, the positive
predictive values of microscopy, ELISA and Giardia-strip were
100%, 99% and 50%, respectively. The sensitivity of microscopic
detection was 71% while that for Giardia-strip was only 5%.
Novitec ELISA was more sensitive (67%) than Novatec ELISA
(51%). Speciﬁcity of all methods was never lower than 97%.
Conclusion: Microscopy with triple faeces test is a very speciﬁc
method for the laboratory detection of G. lamblia in faeces with
good sensitivity. Both ELISA’s also have good sensitivity and
can be used as acceptable alternatives for microscopy. Giardia-
strip can not be used as an alternative, because of its very low
sensitivity. Real time PCR is a very sensitive and speciﬁc
method for the detection of G. lamblia.
P857
Diagnosis of Cryptosporidium parvum with
microscopy, striptest, ELISA and real-time PCR
D. Vastert, M. Brinkman, H. Wilke, B. Mulder (Enschede, NL)
Objectives: Cryptosporidium parvum remains largely under
diagnosed in current routine diagnostic procedures in micro-
biology laboratories. We compared four different diagnostic
methods for the detection of C. parvum in faeces in both acute
and chronic diarrhoea.
Methods: Microscopic examination (Auramin stain conﬁrmed
by Kinyoun stain), Crypto-strip (Coris Bioconcept), ELISA
(Novitec Cryptosporidium ELISA) and real time PCR for the
detection of C. parvum were compared.
Results: Five hundred and ﬁfteen faeces were included. One
hundred and ﬁfty-four watery specimens from acute diarrhoea
were sent for bacteriological examination and 361 triple faeces
test (TFT)-samples, representing a more chronic form of diar-
rhoea, were sent to the parasitology department. Using real time
PCR as the gold standard, the positive predictive values of
microscopy, Crypto-strip and ELISA were 100%, 85%and 99%,
respectively. The sensitivities of microscopic detection, Crypto-
strip and ELISA were 37%, 78% and 71%, respectively, while the
speciﬁcities of the three methods were never lower than 98%.
Remarkably, the majority of the positive Cryptosporidium sam-
ples were not found in watery stools, as described in all
textbooks, but rather in loose to mushy stools (57%). Further-
more, the majority of the positive watery samples were not sent
for parasitological examination but only for bacterial culture.
Conclusion: The widely used microscopy is a very speciﬁc but
less sensitive method for the laboratory detection of C. parvum in
faeces. Both ELISA and Crypto-strip have good sensitivity and
both positive and negative predictive values. Real time PCR is a
very sensitive and speciﬁc method for the detection of C. parvum.
The majority of positive Cryptosporidium samples were found in
mushy stools from children younger than 10 years old. Exam-
ination of watery stools sent only for bacteriological examination,
for the presence of C. parvum yields additional positive samples
which would otherwise not have been detected.
P858
New diagnostic method for pneumocystis using
ﬂow cytometry
C. Pina Vaz, S. Costa de Oliveira, G. Monteiro, T. Carvalho,
A. Rodrigues (Porto, PT)
Objective: Pneumocystis jiroveci is an opportunistic fungal
agent infecting immunocompromised hosts like AIDS and those
receiving immunotherapy. Diagnosis of pneumonia due to
Pneumocystis requires an accurate method. The laboratory
diagnosis is based upon the detection of the agent using
ﬂuorescent monoclonal antibodies on respiratory samples
using commercial kits. The organism does not grow in culture
and nucleic acid ampliﬁcation is still performed only in research
setting. Flow cytometry has been used as a valuable tool on
microbiology showing several advantages.
Materials and methods: Two hundred and twenty respiratory
samples (188 bronchial or bronchoalveolar samples and 32
traqueal aspirates secretions) were evaluated. The last were
treated with N-acetil-cysteine prior to analysis. The samples
were centrifuged and the sediment evaluated according two
methods. For ﬂuorescence microscopy the samples were
smeared on a slide and stained with 25 ll of the monoclonal
antibody of MeriﬂuorR- Pneumocystis. To optimize the staining
serial concentrations of the speciﬁc monoclonal (5, 10, 15, 20 and
25 ll), were used to stain positive samples. Thereafter, that all
the samples were stained with 5 ll, centrifuged (10 min at
3000 rpm) and resuspended on deionized water for ﬂow
cytometry analysis (FC). FC acquisition protocol was optimized
in order to deﬁne a scattergram and to determine the intensity of
green ﬂuorescence, FL1. A threshold of detection was evaluated
after diluting a positive sample and performing both analysis,
that is microscopy and FC analysis. Negative samples were
contaminated with 25 ll of suspensions (0.5 McFarland) of rods,
cocci and yeasts.
Results: All the positives samples by microscopy were positive
by ﬂow cytometry. FC detected eight positive samples that were
negative by microscopy. Such cases correspond to AIDS patients
with CD4 count below 200/mm3, presenting fever and respir-
atory infection; they were treated as positive and seven
improved. Samples contaminated with bacteria or fungi did
not show increased ﬂuorescence that is, no unspeciﬁc staining.
FC using a speciﬁc ﬂuorescent antibody, proved to be sensitive
and useful to detect Pneumocystis.
P859
Rapid identiﬁcation and separation of the yeast
according to their isoelectric point
F. Ruzicka, V. Hola, M. Horka, M. Votava (Brno, CZ)
Objectives: The yeasts of the Candida genus are considered as
important aetiological agents of nosocomial infections. The
frequent use of indwelling medical devices in the last decades
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is the cause of increasing incidence of non-albicans yeast
infections. The rapid detection and identiﬁcation of these
aetiological agents can help to choose appropriate therapy.
The yeasts as amphoteric particles are characterized by their
isoelectric points (pI). This value is determined by the balance
between the positive and negative surface charges, which are
determined by the surface composition of the bacterial cell.
Using one of the electromigration techniques, capillary isoelec-
tric focusing (CIEF), the bacteria are focused and separated
according to their pI. One of the advantages of this method is the
rapidity of the examination. Additionally, it enables to work
with small volumes of sample and to measure the results more
accurately.
Methods: The aim of the work was to evaluate the pI as a tool
for the detection, differentiation and identiﬁcation of clinically
important yeasts. The strains of Candida albicans, C. krusei, C.
parapsilosis, C. glabrata, C. kefyr, C. lusitaniae, Yarrowia lipolytica,
Saccharomyces cerevisiae, Trichosporon asahii and Geotrichum can-
didum were examined by means of the CIEF with on-column UV
detection. The isoelectric points of examined yeasts were
calculated via the comparison of the migration times of these
yeasts with the migration times of pI markers.
Results and conclusions: All examined yeast species were
focused according to their surface characteristics in distinct
zones. The independence of pI value on the reaction conditions
enables the standardization of the results. Assessment of the
isoelectric points of yeast strains isolated from serious infections
by means of CIEF represents the possible way for the detection
and identiﬁcation of these pathogens. This method is able to
reveal the simultaneous presence of different yeast species in the
sample. Moreover, the quantiﬁcation of bacteria is possible
according to the peak area in the electrophoreogram.
Acknowledgements: This work was supported by the Grant
Agency IGA MZ NR/7980-3 and by Grant Agency of the
Academy of Sciences of the Czech Republic IAA4031302.
P860
Evaluation of a rapid colorimetric test based on
trehalose use for identiﬁcation of Candida
glabrata
S. Kirdar, B. Gultekin, G. Evcil, A. Ozkutuk, G. Sener, N. Aydin
(Aydin, TR)
Objective: Non-Candida albicans Candida species have increas-
ingly become important cause of morbidity and mortality in
immunocompromised patients. Candida albicans remains the
most frequent cause of candidiasis, and Candida glabrata is the
second most frequent agent isolated from clinical infections. Due
to developing resistance to many azole antifungal agents,
including ﬂuconazole, the rapid identiﬁcation of C. glabrata is
essential for appropriate antifungal therapy. Many tests have
been developed for identiﬁcation of C. glabrata based on their
trehalose use, which is characteristic property of this species.
The aim of this study was to determine the ability of a rapid
trehalase test to identify C. glabrata isolates.
Methods: One hundred and ﬁfty-four isolates from several
clinical specimens were tested by a method developed by
Peltroche-Llacsahuanga et al. to evaluate its ability to discrim-
inate C. glabrata strains. Candida strains were identiﬁed by germ
tube test, their growth on corn meal Tween 80 agar, colonies
appeared on Mast ID-CHROMagar Candida medium (Mast
Diagnostics, Merseyside, UK), and if required by API 20C AUX
(bioMe´rieux, France) commercial kit. All isolates were taken
from Sabouraud dextrose agar containing 4% glucose incubated
at 37 C for 24 hours. The reference strains (C. glabrata standard
laboratory strain, C. albicans ATCC 90028, C. tropicalis ATCC 750,
C. krusei ATCC 6258) were used as control. One yeast colony
emulsiﬁed in 50 ll of citrate buffer (0.1 M, pH: 5.0) containing
4% (wt/vol) trehalose for 3 hours at 37 C. Presence of glucose
was detected by spotting 10 ll of this suspension onto a
dipstick. Glucose, generated by cleavage due to cell-bound
trehalase enzyme, was detected a commercial dipstick.
Results: Among 151 strains tested, 76 were C. glabrata, 47 were
C. albicans, 17 were C. krusei, ﬁve were C. parapsilosis, four were
C. tropicalis, three were C. keyfr, and one was C. utilis. Among 76
C. glabrata strains tested all were found positive by trehalase test.
Non-C. glabrata isolates were found negative by rapid trehalase
test. The trehalase tests allowed identiﬁcation of C. glabrata in
3 hours with 100% sensitivity and 100% speciﬁcity.
Conclusion: Our study showed that the trehalose assimilation
test is rapid, cost-effective, and simple to use. This test may be
helpful as a rapid identiﬁcation method of C. glabrata in routine
medical mycology laboratory.
P861
Immunodiagnosis of invasive candidiasis:
prospective serological evaluation of at-risk
patients in the French university hospital of
Grenoble
M. Franc¸ois, O. Faure, B. Lebeau, R. Grillot, H. Pelloux,
C. Pinel (Grenoble, FR)
The diagnosis of invasive candidiasis (IC) remains difﬁcult to
assess before positive blood cultures or positive biopsies. To
evaluate the interest of immunodiagnosis in hospitalized at risk
patients for the management of this fungal infection, we
evaluated the performance of serological methods routinely
used in the laboratory for Candida infections from January 2004 to
July 2005. Candida antibodies detection was performed by
indirect immunoﬂuorescence (IFI) and immuno electrophoresis
(IEP) on 1598 sera of 690 patients (mainly from haematology and
IUC: 54% and surgical patients: 30%). The latex agglutination test
Cand-tec (Ramco, USA) was used for antigen detection in 1450
sera of 495 patients. IFI slides have been prepared with a Candida
albicans strain (VW 32 Pasteur strain, Lille) and for IEP two
commercial somatic antigens of Candida albicans were used (Bio
Rad, USA and FSK2 from Microgen Bio products, USA). The
efﬁciency of the immunodiagnosis was evaluated in the group of
patients with proven IC according the criteria of OERTC. Among
the 39 patients with candidemia, antibody detection was per-
formed only on 17 patients and ﬁve of them showed high
antibodies level (sensitivity 30%). Fifteen other patients, mainly
from surgical departments, developed an invasive candidosis
(positive cultures from sterile ﬂuid, blood excluded, or positive
culture from organ biopsies). In these cases, the serological tests
were positive in sera of 12 patients (sensitivity 80%). The overall
sensitivity of the antibody detection was of 47%, the speciﬁcity,
the PPV and the NPV were respectively of 91%, 20% and 97%.
High antibody levels in patients without diagnosis of IC were
associated with abnormal Candida colonization. A particular arc
in IEP was more often present in sera of patients with deep
candidosis (PPV 38%). The sensitivity of the Cand-Tec was
disappointing; the sensitivity was of 5% in patients with
candidemia and only two patients with deep Candida infections
out of 15 showed positive results. The speciﬁcity, PVP and NPV
were, respectively, of 91%, 15%, and 93%. The antibody detection
in our survey showed higher performance than antigen detection
by the Cand-Tec method but the combination of both enhanced
the efﬁciency to diagnose IC. Despite the weak sensitivity,
especially in patients with haematological diseases, high anti-
body level and the presence of speciﬁc precipitin must lead to
highly suspect Candida dissemination.
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P862
Inﬂuence of culture medium on performance of a
yeast identiﬁcation system (MICRONAUT
Candida)
G. Haase, H. Schulze (Aachen, Bornheim, DE)
Objectives: Recently several novel antimycotic agents had been
introduced, e.g., caspofungin, voriconazole, and posaconazole.
Due to different susceptibility of yeast species recovered from
human specimens (e.g., low susceptibility of basidiomycetal
yeasts in the case of caspofungin) reliable species identiﬁcation
is of growing importance in order to select them for appropriate
resistance testing. The inﬂuence of the type of culture media
used for preparation of the inoculum for biochemical based
identiﬁcation kits had not been studied in depths. We have
tested the inﬂuence of three culture media on the performance of
a microtiter based identiﬁcation system (MICRONAUT Candida
[M-C], Merlin, Germany).
Methods: We tested 99 isolates compromising 21 different yeast
species. Isolates used were reference strains or had been
identiﬁed by sequence analysis (5¢ end 28S rDNA). Identiﬁcation
achieved by M-C was compared to the respective results of the
ID 32C [ID] identiﬁcation kit (bioMe´rieux, Nu¨rtingen, Ger-
many). Inoculum was prepared from three different commonly
used primary platting media (CHROMagarTM Candida, MAST,
Reinfeld, Germany, Sabouraud Dextrose Agar, Sabouraud Dex-
trose Agar [SD] with 0.5% chloramphenicol [SDC], BD, Heidel-
berg, Germany) in case of M-C. Microtitre plates were
photometrically evaluated after 24 h of incubation and identi-
ﬁcation was achieved by application of the respective software.
Inoculum for the ID was prepared from SDC and evaluated (24
and 48 h) by using the miniAPI reader.
Results: Overall false identiﬁcation was observed in case of C.
dubliniensis (M-C/ID; 1/2), C. guilliermondii (M-C/ID; 2/1), C.
lusitaniae (M-C/ID; 1/1), C. tropicalis (M-C/ID; 1/4), C. neofor-
mans (M-C/ID; 4/1), and S. cerevisiae (M-C/ID; 1/1). Failure of
identiﬁcation due to lack of the species in the respective data
base was observed in case of C. africana (M-C/ID; 4/4), and C.
viswanathii (M-C/ID; 1/1). Type of culture medium used had
only a minor inﬂuence on the identiﬁcation score. Singular or
dual misidentiﬁcation was observed in 4.4% of all M-C identi-
ﬁcation mostly seen when using SD (n = 7). Results of this study
are currently used for improvement of the M-C identiﬁcation
algorithm.
Conclusion: Type of culture media used for preparation of the
inoculum seems to have only a minor impact on the outcome of
biochemical tests. Veriﬁcation of performance of an identiﬁca-
tion system might only be necessary when changing the culture
media.
P863
Function of Candida albicans ALS5 and ALS7
genes on adhesion to FEP (polymer of
tetraﬂuoroethylene and hexaﬂoropropylene)
catheter and polyurethane catheter
P.L. Chan, R.W.F. Li, M.L. Chin, K.C. Chu, M. Hui, C.Y. Chan
(Sha Tin, Hong Kong, HK)
Objectives: To investigate the adherence of Candida albicans
ALS5 and ALS7 genes on FEP catheter and polyurethane
catheter.
Methods: ALS5 smaller allele and ALS7 from Candida albicans
strain SC5314 were cloned into pYES6CT plasmid and under a
GAL promoter control. Plasmids were transformed into Sac-
charomyces cerevisiae. The transformed S. cerevisiae was cultured
in SC selective mediumwith galactose for expression of Als5p or
Als7p. About 0.5 cm fragment of FEP catheter and polyurethane
catheter were incubated in 1 ml of the S. cerevisiae culture for
30 min. Catheters were washed and sonicated. One hundred
microlitre of the sonication ﬂuid was plated on sabouraud
dextrose agar and was incubated at 30 C for 2 days. Adherence
was expressed as a percentage of the number of colony forming
unit of the initial inoculum. The experiment on FEP catheter was
conducted in triplicate and the experiment on polyurethane
catheter was conducted in duplicate. Two independent experi-
ments were performed.
Results: The percentage of initial inoculum, representing the
adherence of the S. cerevisiae transformed with pYES6CT
(control), ALS5 smaller allele or ALS7 on both type of catheter
is low and nearly zero. There is no signiﬁcant difference in the
percentage of initial inoculum between the three groups for both
type of catheter (p = 0.058 for FEP; p = 0.104 for polyurethane).
The result is summarized in the ﬁgure followed.
Conclusion: Transformation of ALS5 smaller allele or ALS7 of
Candida albicans strain SC5314 into S. cerevisiae does not confer
adhesion properties on FEP catheter and polyurethane catheter.
P864
Comparative evaluation of Candida DNA,
mannan, anti-mannan antibodies and
(1-3)-b-D-glucan in the diagnosis of candidaemia
Z.U. Khan, F. Alam, A.S. Mustafa (Kuwait, KW)
Background and objective: A delayed diagnosis of candidae-
mia is associated with high mortality, and therefore, early
diagnosis and institution of appropriate therapy is essential to
improve prognosis. The aim of this study was to evaluate
sensitivity of four currently available assays, namely Platelia
Candida Ag for the detection of mannan, Platelia Candida Ab for
the detection of anti-mannan antibodies, snPCR for the detection
of DNA, and Fungitell for detection of (1–3)-b-D-glucan in the
diagnosis of candidaemia.
Methods: Thirty-two sera samples from 27 culture conﬁrmed
cases of candidaemia, 10 sera from Candida vaginitis patients,
and 30 sera from healthy controls were included in the study.
The ELISA-based tests were performed as per the instructions
provided by the manufacturers. The cut-off values for each test
were determined by determining mean + 3 standard deviation
of the control sera. DNA was extracted from the sera using
standard techniques and PCR was performed with generic as
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well as species-speciﬁc primers for C. albicans, C. parapsilosis, C.
glabrata, and C. tropicalis.
Results: In candidaemia patients, the sensitivity and negative
predictive value for the assys were as follows: Platelia mannan
84%, and 86%, anti-mannan antibody 56% and 68%, (1–3)-b-D-
glucan 75% and 67%, and Candida snPCR 88% and 88%,
respectively. When the tests were combined, the sensitivity for
mannan and anti-mannan improved to 94% and mannan and
(1–3)-b-D-glucan to 97%.
Conclusions: The results of the study suggest that the com-
bined detection of mannan and anti-mannan antibodies or
mannan and (1–3)-b-D-glucan may contribute to the early and
sensitive diagnosis of candidaemia or invasive candidiasis..
However, performance of snPCR offered an advantage over
mannan and glucan tests since it was species-speciﬁc and
detected 4 (12%) patients who were infected with more than one
species. This observation has therapeutic implications, since
Candida species have different anti-fungal susceptibility proﬁles.
Acknowledgement: Supported by College of Graduate Studies,
Kuwait University, Kuwait.
P865
Evaluation of tobacco agar for differentiation of
Cryptococcus neoformans
Z.U. Khan, R. Chandy (Kuwait, KW)
Background and objective: Cryptococcus neoformans is the etio-
logic agent of cryptococcosis, a systemic mycosis of humans and
animals with a world-wide distribution. The aim of the study
was to evaluate the efﬁcacy of tobacco agar as a differential
medium for C. neoformans and its serotypes.
Methods: One hundred and sixty-eight isolates of C. neoformans
originating from clinical specimens (n = 8), and environmental
sources (n = 160) were evaluated for their ability to produce
brown melanin-like pigment on tobacco agar. In addition,
reference strains or clinical isolates of C. neoformans (n = 10),
C. laurentii (n = 1), C humicola (n = 1), Candida albicans (n = 55),
C. parapsilosis (n = 9) , C. tropicalis (n = 8), C. krusei (n = 5) and C.
glabrata (n = 7) were also tested. Twenty-ﬁve gram of tobacco
obtained from commercially available cigarette brand (Marlb-
oro; tar 8 mg, nicotine 0.6 mg; Philip Morris Products SA,
Richmond, VA, USA) was mixed with 1 l of distilled water. The
mixture was boiled for 30 min and then ﬁltered through several
layers of gauze. To this ﬁltrate 20 g of agar was added and the
volume was made up to 1 l. The pH of the medium at this point
was 5.4. It was autoclaved at 121 C for 15 min. Twenty
millilitres medium was poured into each plate. The test cultures
were streaked on the medium and plates were incubated at
280 C and examined for development of brown-coloured
colonies up to 96 h.
Results: All the isolates of C. neoformans developed brown-
coloured colonies within 48 h. Induction of brown pigmentation
was discernible as early as12 h. Isolates belonging to serotypes B
(n = 62) and C (n = 1, reference strain) produced more intense
pigmentation (cherry brown) as compared to serotypes A
(n = 106) and D (n = 1, reference strain).
Conclusion: The results of the study suggest that tobacco agar
can be used as a differential medium for presumptive identi-
ﬁcation of C. neoformans from other Cryptococcus species and
Candida species. While isolates of serotype B produced more
intense brown pigmentation as compared to serotype A, this
phenomenon needs to be evaluated more extensively with
respect to serotypes C and D.
Acknowledgements: The authors are thankful to Prof. H. S.
Randhawa and Dr. Anuradha Chowdhary for providing envi-
ronmental isolates and some reference strains of C. neoformans.
P866
Comparison of Aspergillus fumigatus DNA and
galactomannan in serum and bronchoalveolar
lavage specimens of experimentally infected rats
S. Ahmad, Z.U. Khan, A. Theyyathel (Kuwait, KW)
Background and objective: Invasive aspergillosis is an import-
ant opportunistic mycosis associated with high mortality. Its
diagnosis is difﬁcult due to non-speciﬁc signs and symptoms
and low culture positivity. The aim of this study was to detect
Aspergillus fumigatus-speciﬁc DNA by recently developed nested
PCR (nPCR) in serum and bronchoalveolar lavage specimens of
experimentally infected rats and compare the results with
galactomannan detection.
Methods: Thirty Wistar rats, weighing between 150 and 170 g,
immunosuppressed with intraperitoneal injection of cyclo-
phosphamide were infected intravenously with 1 · 106 A.
fumigatus conidia. The rats were sacriﬁced on day 1, 3, 5, 7,
and 9 post-infection in groups of six each and their bronchoal-
veolar lavage (BAL), blood and lung tissues were cultured. The
serum and BAL specimens were collected for galactomannan
and nPCR tests. Sera and BAL specimens of six normal rats were
obtained to standardize base line values. The DNA from serum
and BAL specimens was extracted using standard procedure.
Galactomannan was detected by Platelia Aspergillus kit (Bio-
Rad, France) and A. fumigatus-speciﬁc DNA by nested PCR
using primers derived from the internally transcribed spacer
(ITS) regions 1 and 2.
Results: Sera and BAL specimens of six normal rats were
negative for galactomannan and A. fumigatus DNA. The per cent
of positive tests for galactomannan (cut-off value 0.5 ng/ml) and
nPCR in serum samples on day 1, 3, 5, 7, and 9 post-infection in
each group of animals was 83% and 50%, 100% and 66%, 66%
and 66%, 100% and 50% and 33% and 16%, respectively. The
overall positivity for galactomannan and nPCR was 76% and
50%, respectively. In BAL specimens, the per cent of positive
tests for galactomannan and nPCR in each group on day 1, 3, 5,
7, and 9 post-infection was 100% and 83%, 66% and 83%, 66%
and 66%, 100% and 66%, and 33% and 33%, respectively. The
overall percent positivity for galactomannan and nPCR was 73%
and 66%, respectively.
Conclusion: The results suggest that while the culture of the
lung tissues was positive for all the animals infected with A.
fumigatus, the overall positivity of galactomannan was slightly
higher than nPCR in both serum and BAL specimens in the
9 days post-infection follow-up.
Acknowledgements: Supported by Kuwait University
Research Admninistration Grant MI04/02.
P867
Candida spp. colonization and serum
anticandidal antibody levels in patients with
chronic urticaria
M.C. Ergon, T. Ilknur, M. Yucesoy, S. Ozkan (Izmir, TR)
Objectives: Bacterial and viral infections, parasites, fungi, food
and food additives are some of the aetiological factors hold
responsible for the pathogenesis of chronic idiopathic urticaria.
In this study, we aimed to investigate the triggering role of
Candida spp. colonization and infection in patients with chronic
idiopathic urticaria.
Methods: Thirty-eight patients with chronic idiopathic urticaria
who applied to Dermatology Clinic of Dokuz Eylul University,
Faculty of Medicine, and a control group consisted of 42 healthy
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individuals were included in the study. Stool and oral speci-
mens of two groups were cultured quantitatively on Sabouraud
dextrose agar (SDA) with chloramphenicol and gentamicin.
Yeast growth after 48 hours of incubation at 37 C on SDA was
evaluated as CFU/gram for stool specimens and CFU/ml for
oral specimens. C. albicans ELISA IgG/IgM/IgA test kits were
used for the detection of these antibodies against C. albicans in
sera of the patient and control group individuals.
Results: Yeasts were isolated from the stools of 60.5% of the
patient group and 50.0% of the control group and these rates
were 47.4% and 42.9% for oral specimens. When the results of
two groups were compared with t-test, no statistically signiﬁ-
cant discrepancies were detected between the groups for stool
(t = 0.28, p = 0.78) and oral (t = 0.19, p = 0.85) cultures. If the
colony counts of the cultures were compared with Mann–
Whitney U test, there were no signiﬁcant differences between
two groups for stool (z = 0, U = 241.5, p = 1) and oral (z = 0,
U = 162, p = 1) specimens. IgG, IgM and IgA antibodies were
positive in 36.8%, 23.8 and 5.3% of the patient group and in
42.9%, 19.1% and 4.8% of the control group. When the quantities
of IgG, IgM and IgA antibodies were compared by using paired
t-test, no statistical difference was detected between the two
groups (p = 0.93, 0.56 and 0.67, respectively). Chi-square test
was applied for the comparison of the qualitative values of IgG,
IgM and IgA antibodies of two groups and there was no
statistical difference between the groups (2 = 1.34, p = 0.26;
2 = 0.27, p = 0.88 and p = 0.70, respectively).
Conclusion: It is concluded that intestinal and oral colonization
of Candida spp. and previous Candida infection do not play
important triggering role in the aetiology of patients with
chronic idiopathic urticaria.
P868
Performance of three differential media for the
presumptive identiﬁcation of yeasts
M. Yucesoy, M.C. Ergon, S. Ozer (Izmir, TR)
Objectives: In order to facilitate yeast identiﬁcation process,
several chromogenic isolation media for species identiﬁcation of
clinical yeasts have been developed as rapid tests. This study
was performed to evaluate three chromogenic media, CHROM-
agar Candida (CAC) (CHROMagar, France), Albicans ID2 agar
(AID) (bioMe´rieux, France) Bromcresol Green Agar (BCG)
(Difco, France) for the presumptive identiﬁcation of yeasts.
Methods: A total number of 203 yeast strains including 128
Candida albicans, 21 C. tropicalis, 18 C. glabrata, 17 C. parapsilosis, 7
C. krusei, 6 Trichosporon spp., 4 C. kefyr, 1 C. guilliermondii, 1
Geotrichum candidum which were isolated from various clinical
specimens were included. The isolates were ﬁrst identiﬁed by
germ tube test, morphological characteristics on corn meal
Tween 80 agar and API 20 C AUX systems. The strains were
saved as stock cultures. Then they were inoculated into
Sabouraud dextrose agar and after purity check, they were
streaked onto CAC, AID and BCG plates. The results were read
by three different people and interpreted according to the
colour, texture of the colonies, colour of the plate and the
existence of halo around the colony after 24, 48 and 72 hours of
incubation at 37 C in the dark.
Results: All of the isolates grew well on the three media tested.
The sensitivity and speciﬁcity values for C. albicans were found
to be 100% and 100% for CAC; 97.7–100% and 94.7–97.3% for
AID; 93.0–99.2% and 24.0–68.0% for BCG at different incubation
periods, respectively. These values for C. tropicalis were 95.2–
100% and 100% for CAC; 14.3–95.2% and 9.3–23.1% for BCG at
various incubation periods, respectively. CAC was found to be
11.1–88.9% sensitive and 100.0% speciﬁc for C. glabrata; 100%
and 99.5% sensitive and speciﬁc for C. krusei.
Conclusion: CAC and AID can be recommended as reliable
methods for the presumptive identiﬁcation of C. albicans, C.
tropicalis, C. glabrata, C. krusei and C. albicans, respectively. The
sensitivity and speciﬁcity values obtained for the most isolated
Candida species for BCG are very low to be used for the
identiﬁcation process however; its usefulness as a differential
medium for primary isolation and detection of Candida species
from clinical specimens should be tested.
P869
Detection of Aspergillus galactomannan antigen
levels for antimicrobial agents by ELISA
M. Yucesoy, M.C. Ergon (Izmir, TR)
Objectives: False positive results in Aspergillus galactomannan
antigen detection by ELISA method from patients receiving
piperacillin-tazobactam have been reported. In this study, we
aimed to investigate A. galactomannan antigen levels for pipera-
cillin-tazobactam and other various antimicrobial agents that are
often used for the treatment of infections in immunocompro-
mised patients.
Methods: The level of galactomannan antigen was investigated
for piperacillin-tazobactam, ampicillin-sulbactam, ampicillin,
penicillin G, ceftriaxone, cefepime, imipenem, clarithromycin,
ciproﬂoxacin, vancomycin, gentamicin, trimethoprim-sulfa-
methoxazole, ornidazole, ﬂuconazole and amphotericin B. Anti-
gen levels were determined by using the Platelia Aspergillus
ELISA (Bio-Rad, France) according to the manufacturer’s
instructions. Samples were run in triplicate and the entire
experiment was repeated.
Results: Among the 15 antibiotics, ampicillin expressed highest
level of galactomannan with a galactomannan index (GI) of
0.540. Although this index value is not a positive result for the
presence of galactomannan according to the manufacturer’s
instructions, it can be accepted as positive according to the test
products with FDA approval. Piperacillin-tazobactam expressed
the second high level of galactomannan (GI = 0.235), however
this value is below the both cutoff limits. Galactomannan levels
for the other antibiotics ranged from 0.011 to 0.188.
Conclusion: It can be concluded that among the antibiotics that
was investigated in this study, ampicillin might cause a false
positive result in galactomannan antigen test by ELISA because
it showed signiﬁcant level of galactomannan antigen and
piperacillin-tazobactam can also cause cross reactivity in the
sera of patients due to its relatively high galactomannan level in
the test.
P870
Mycological evaluation and suitability for
detecting dermatophytes on sabouraud-
gentamicin-chloramphenicol-2-agar
M. Mempel (Munich, DE)
Sabouraud-Gentamicin-Chloramphenicol-2-agar (SGC2; 43651-
bioMe´rieux) is designated for the isolation of yeasts and moulds
from clinical specimens. Under the ‘‘Limitations’’ section in the
package insert, the description of the culture medium states:
‘‘This medium is not recommended for the detection of
dermatophytes’’.
Objectives: The purpose of this study was to evaluate the
suitability of SGC2 for the detection of dermatophytes in clinical
specimens and with clinical isolates. Performance of SGC2 was
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compared in terms of growth rate, colony morphology, pig-
mentation and formation of conidia with the following media:
Sabouraud dextrose agars from Merck and from Oxoid and
dermatophyte selective media (Selektiv-Agar fu¨r Pathogene
Pilze from Merck, Dermasel agar from Oxoid).
Methods: One hundred clinical specimens (nail cuttings, skin
scrapings and hair stubs) were inoculated on SGC2 and
incubated at 25 C up to 21 days. The presence of a positive
dermatophyte culture had already been conﬁrmed via prior
culturing all materials on dermatophyte-selective media. More-
over, four hundred clinical isolates including 312 strains of
Trichophyton spp., 76 strains of Microsporum spp. and 12 strains
of Epidermophyton spp. were examined on SGC 2, in comparison
to the media speciﬁed above. Growth rate, morphology and
pigmentation of the colonies and the microscopic structures
were studied simultaneously for all media after incubation at 5,
7, 10,14 and 21 days.
Results: Ninety-nine of one hundred clinical specimens were
detected positive for dermatophytes on SGC2. All dermato-
phytes exhibited good growth on SGC2 and growth rates typical
for the particular species, as well as typical colony morphology,
pigment formation and microscopic characteristics. Performance
was comparable to that observed for prepared agar plates from
other manufacturers and occasionally somewhat better.
Conclusion: Due to these results, SGC2 medium permits the
isolation of dermatophytes in spite of the current restrictive
wording in the limitation section of the package insert. Thus, the
SGC2 medium is an universal mycological medium that enables
detection of dermatophytes in addition to yeasts and moulds.
Toxoplasmosis
P871
Pregnant women and toxoplasmosis
I. Machado, I. Sousa, H. Angelo (Porto, Lisbon, PT)
Objectives: Evaluation of the knowledge of women on toxo-
plasmosis in Portugal.
Methods: A survey on the self-perceptive knowledge was
carried out, in parturient women of Portugal. Results were
obtained from 48 out of 50 hospitals, in total 7362 valid surveys.
Results: 77.3% of the women had already heard about toxo-
plasmosis; among these 85.7% had declared to know what this
infection is. Age was a very important factor to knowledge, as
about 50% of women <20 years had never heard of toxoplas-
mosis before. Compared to women with 30–39 years, the
adjusted odds ratio (OR) for women <20 years was 3.6 (95%
CI: 2.72, 4.77). Education is the main factor that inﬂuences the
knowledge of parturient women on toxoplasmosis, being deeply
related to the profession. Compared to graduate women, the OR
for women with only the primary school was 43.6 (95% CI: 22.58,
84.08). The knowledge of this infection also varies with the place
of information, but mostly with the region of the country. It is in
the North of the country that the knowledge is worse—OR 2.4
(95% CI: 1.94, 2.85), compared to Lisbon and Tejo Valley.
Women’s most common source of information is the doctor
(77%). The information places are mainly ‘‘other places/private
consultation’’ (38.5%) and the ‘‘local healthcare center’’ (35.8%),
even though the percentages vary depending on the district
surveyed.
Conclusions: As health professionals do not always transmit
their patients the information in a way that allows its exact
perception, education inﬂuences the most the knowledge par-
turient women have on toxoplasmosis. It is essential that health
professionals adapt the way they communicate with the women
they assist.
P872
Congenital toxoplasmosis prevention in Portugal
I. Machado, I. Sousa, H. Angelo (Porto, Lisbon, PT)
Objectives: To evaluate the prevention done in Portugal on
congenital toxoplasmosis, concerning primary and secondary
prevention.
Methods: A survey on the self-perceptive knowledge was
carried out, in parturient women of Portugal. Results were
obtained from 48 out of 50 hospitals, in total 7362 valid surveys.
Results: Primary prevention precautions that are most com-
monly known among parturient women are ‘‘eating well-
cooked meat’’, ‘‘avoiding contact with cats’’ and ‘‘eating well-
washed salads’’. It was detected some confusion related to the
choice of certain correct and incorrect primary prevention steps,
such as between ‘‘avoiding contact with cats’’ and ‘‘avoiding
contact with dogs’’ or between ‘‘eating well-cooked meat’’ and
‘‘eating well-cooked ﬁsh’’. 67.1% of the women had declared to
have done prevention during the pregnancy to be protected
from toxoplasmosis, even though the prevention was not always
the most correct. Thus, 62.1% of the pregnant women with
positive serology for Toxoplasma gondii had taken unnecessary
precautions, but 18% of the pregnant women with negative
serology did not take the necessary precautions. It was also
veriﬁed that, due to incorrect procedures in secondary preven-
tion, there are useless expenses: between women with positive
serology for T. gondii, 98.8% of primiparous women repeated
useless analysis for toxoplasmosis, as well as 57.9% of the
multiparous women. Still in the group of women with positive
serology to T. gondii, 10.7% had done monthly analysis during
the pregnancy, and 49.5% had done quarterly analysis.
Conclusions: Gestations are frequently badly planned, leading
to an incorrect implementation of the prevention. The prevention
for congenital toxoplasmosis in Portugal is frequently being
incorrectly made, not only as far as the primary prevention is
concerned, but also regarding the secondary one. In this area
specialized training shouldbe carriedout for healthprofessionals.
P873
Screening for Toxoplasma gondii, Rubella virus
and cytomegalovirus in pregnant women
S. Baka, E. Makrakis, D. Hassiakos, I. Logginidis, S. Meretaki,
E. Kouskouni (Athens, GR)
Objectives: Toxoplasma gondii, rubella virus and cytomegalovi-
rus (CMV) are responsible for some of the most common
infections associated with congenital anomalies. These infections
also cause mild maternal morbidity. Nevertheless, recognition of
maternal disease is very important for the clinician. In order to
determine the immune status of the organism against those
microorganisms, seroprevalence of IgM and IgG antibodies
proved to be very helpful tests. Ideally, these tests should be
performed before the pregnancy is diagnosed, but usually, they
are requested in the ﬁrst trimester of pregnancy. We conducted
this study in order to detect the seroprevalence of IgM and IgG
antibodies to Toxoplasma gondii, rubella virus and CMV.
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Methods: We analysed antibodies against T. gondii, rubella
virus and CMV, performed as a routine check in the ﬁrst
trimester of pregnancy in women attending our hospital. IgM
and IgG were determined using enzyme immunoassays, EIA
WELL, Toxoplasma IgM and IgG, Rubella IgM and IgG, and
Citomegalovirus IgM and IgG (RADIM, Italy), respectively.
Results: A total of 1466 patients were tested for the presence of
antibodies. In agreement to our ﬁndings, we divided our study
population as having: acute infection (when only IgM were
positive), recent infection (both IgM and IgG positive) or past
infection (only IgG positive). Out of the 1466 pregnant women
we determined one acute Toxoplasma infection, whereas recent
infection in 1.2% and past infection in 20.1%. For rubella and
CMV acute infection was detected in 0.2% and 0.3%, recent
infection in 1.0% and 1.8%, while past infection in 81.2% and
69.2%, respectively.
Conclusion: Our data demonstrate that even a low prevalence
of primary infections during pregnancy or a high prevalence of
seronegative women supports the idea that routine prenatal
screening is justiﬁed. Clinicians must appropriately advise
women on preventive measures to avoid these infections
during their pregnancy.
P874
Screening for acute toxoplasma infection during
pregnancy: compliance to the French programme
of 41,086 pregnancies in the Rhoˆne-Alpes region
C. Cornu, A. Bissery, R. Ecochard, F. Gueyfﬁer, F. Peyron,
M. Wallon (Bron, Lyon, FR)
A national programme aimed at preventing congenital toxo-
plasmosis has been set up in France which is legally mandatory
and requires a serology during the ﬁrst three months of
pregnancy for women for whom there is no certitude about a
previous immunity against toxoplasmosis, and for all women
identiﬁed as seronegative, a monthly serology throughout their
pregnancy including a ﬁnal serology at delivery. However,
neither the compliance with the program nor its efﬁcacy have
been evaluated.
Objectives: To evaluate the compliance with the mandatory
French prenatal screening program for toxoplasmosis in preg-
nant women.
Methods: Descriptive, transversal study, using the data bases of
the Rhone-Alpes public health insurance system. Compliance
with the recommended screening schedule of 37,353 pregnant
women who delivered between July 1st, 2002 and June 30th,
2003 and had at least one serology for toxoplasmosis was
analysed. Our criteria for satisfying compliance were: (1) ﬁrst
test before 13 weeks after conception, (2) no between-test
interval greater than 35 days, (3) last test within 28 days of
delivery, and (4) a global assessment based on the combination
of the three individual criteria. Patients characteristics associ-
ated with a poor compliance were studied for each criteria.
Results: Mean age of pregnant women was 29 years (SD 5) and
mean gestation duration was 263 days (SD 13), 37.6 weeks. The
ﬁrst diagnostic test was done before 13 weeks of gestation in
73% of women and after the 14th week in 9.53%; 20% of women
had all subsequent tests done within 35-day intervals; 60% had
their last test done within 28 days of delivery and 7% only met
all three criteria. Multivariate analysis identiﬁed factors (age,
social and employment status of women, proﬁle of physicians
who prescribed the tests, delivery in a public or private hospital)
which were associated with satisfying compliance with one or
more criteria. Their exact impact will be discussed in an attempt
to assess the responsibility attributable to women, physicians,
biologists for this poor application of legal recommendations.
Conclusion: Identiﬁcation of likely explanations for the non
respect of the French legal recommendations regarding preven-
tion of congenital toxoplasmosis will be followed by speciﬁc
measures which effectiveness in the long term will have to be
assessed.
P875
High prevalence of IgM antibodies against
Toxoplasma gondii in Mexican pregnant women
R. Figueroa, D. Correa, M. Vela, A. Fernandez, I. Can˜edo,
M. Perez, H. Luna, C. Gonzalez, E. Calderon, H. Gonzalez,
J. Ortiz, J.L. Hernandez, V. Ortega (Mexico City, MX)
Objective: To know the prevalence of anti-Toxoplasma gondii
IgM antibodies in pregnant women that are attended at a Third
level Hospital of Perinatal Medicine in Me´xico.
Methods: At the National Institute of Perinatology (INPer)
(Me´xico, City), a Third level Hospital of Perinatal Medicine,
where high risk pregnancies are attended, a screening study of
anti-Toxoplasma IgM antibodies was performed, using blood
spots and serum samples taken from pregnant women. The
study period was from February 25th to July 7th, 2005. The
patients were captured at the prenatal control consult, and
signed a consent to be included in the study; afterwards 6–10
blood drops that were spotted onto standard ﬁlter papers
normally used for screening purposes. The screening serologic
test was a speciﬁc IgM-capture ELISA. From positive patients,
we obtained a second venous blood sample that was used for
conﬁrmatory IgM-western blot and IgG-ELISA.
Results: Screening was performed on 437 pregnant women
within a gestation period between 14 and 28 weeks. The mean
age of the patients was 26.3 + 6.5 years. There were 38 patients
positive to IgM anti-Toxoplasma antibodies, giving a prevalence
of 8.7 per 100 pregnant women screened. Nine positive patients
were younger than 20 years (23.7%), 16 (42.1%) were between 20
and 30 years and 13 (34.2%) were older that 30 years. The
prevalence of speciﬁc IgM according the age group was: 13 per
100 in pregnant women below 20 years of age, 9 per 100 in those
pregnant women between 20 and 30 years and 6 per 100 in the
group older than 30 years.
Conclusion: At the INPer the prevalence of Toxoplasma infec-
tion is high. The youngest pregnant women presented a higher
incidence. The high incidence was expected because of the type
of patients attended, many of them with history miscarriages.
Toxoplasma infection screening during pregnancy is the principal
action to prevent foetal infection and development of the
congenital toxoplasmosis syndrome, our data support the
speciﬁc screening of this infection in the high risk pregnancy
group.
P876
Impact of health education for the primary
prevention of Toxoplasma infection in pregnancy:
lessons from the ERIS study
M. Wallon, D.T. Nguyen Hoang Hanh, F. Peyron, G. Cheˆne
(Lyon, Bordeaux, FR)
Objectives: Our study was designed to assess the ability of
health education to improve knowledge and preventive beha-
viour of susceptible pregnant women regarding toxoplasmosis.
Methods: An intervention trial was initiated in the French
Rhone Alpes region in 1993. Pregnant women seronegative for
Toxoplasma gondii were enrolled in the ﬁrst trimester of gestation
by physicians randomly allocated to two groups according to
their city of practice. Physicians in the intervention cities (group
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A) were asked to give their patients a booklet and an audiotape
including advices on how to avoid toxoplasmosis mixed with
global information regarding pregnancy while physicians in the
control cities (group B) were not instructed to change anything
from their usual practice. Physicians and participants were
blinded to the study question. Knowledge and risk behaviour
for toxoplasmosis and other topics related to pregnancy were
measured through two questionnaires completed at inclusion
and at delivery. Analysis was limited to 2790 women (56%) for
whom both questionnaires were available.
Results: No difference was found between arms regarding
socio-demographic indices. At baseline no signiﬁcant difference
was found between group A and B regarding (a) knowledge or
(b) behaviour: (a) 64% and 66% respectively knew all answers
regarding consumption of raw meat or unwashed salad as risk
factors; 44% and 46%, respectively, correctly answered all
questions on the preventive effect of hand washing before
eating or after handling raw meat (b) 88% and 89%, respectively,
reported washing vegetables eaten raw; 26% and 27% reported
always washing hands before eating or after handling potential
sources of contamination; among the 97% who ate meat in the
60 days preceding inclusion, 44–45% did not eat undercooked
meat. Comparison between delivery and baseline showed a
moderate gain in knowledge that was signiﬁcantly associated
with assignment to group A. Better habits regarding meat
consumption and hand washing were also reported at delivery,
signiﬁcantly associated with good baseline knowledge and
behaviour but not with assignment to group A.
Conclusion: Education can improve knowledge of risk factors
for Toxoplasma infection but no evidence was found regarding
changes in behaviour. Additional anthropological studies are
needed to identify effective ways to reduce risk behaviours in an
attempt to prevent acute maternal infections in pregnancy and
consequently congenital toxoplasmosis.
P877
Multicentre proﬁciency testing programme for
molecular detection of Toxoplasma gondii in
amniotic ﬂuid
K. Kaiser, A. Van Loon, H. Pelloux, J. Ferrandiz, S. Picot,
P. Wallace, F. Peyron (Lyon, FR; Utrecht, NL; Grenoble, FR;
Glasgow, UK)
Diagnosis of Toxoplasmosis during pregnancy is hampered by the
lack of reliable method and by lab to lab discrepancies. PCR is
widely used with various predictive values. In order to assess
the performance of nucleic acid ampliﬁcation technologies
(NATs) for the detection of Toxoplasma gondii, a pilot proﬁciency
panel was designed. The proﬁciency panel consisted of ﬁve
lyophilised coded samples with various concentrations of
parasites diluted in amniotic ﬂuid and a negative control. The
positive samples included T. gondii in a range of concentration
between 5 and 1000 parasites per ml. Five reference laboratories
evaluated the production process. The performance was ana-
lysed in combination with a questionnaire on the applied
methods. Thirty-three laboratories in 17 countries participated
with a total of 38 data sets. An extensive heterogeneity in the pre
analytic and analytic procedures was observed. The percentage
of data sets achieving correct results on all panel samples was
42.1%, two or more incorrect or equivocal results were reported
in 14 (36.8%) data sets. The lowest concentration corresponding
to ﬁve parasites per ml was not identiﬁed correctly in 15 (39.5%)
data sets. False-positive was reported by two laboratories witch
were not checking for contamination. In 32 (84.2%) data sets an
‘‘in-house’’ methods was used, and in 16 (15.8%) sets a
commercial assay was tested. Overall, the results of this study
demonstrated the need for improvement in the molecular
detection of T. gondii and for procedure standardization in the
diagnosis by nucleic acid ampliﬁcation.
P878
Using the new IMMULITE 2000 toxoplasmosis
IgM (l-capture) kit for the diagnosis of human
toxoplasmosis
E. Woitrin, I. Jost, R. Fassotte (Dudelange, LU)
Objectives: In many countries, the prevention of congenital
toxoplasmosis calls for regular serological monitoring of
nonimmunized pregnant women throughout pregnancy. Diag-
nosing toxoplasmosis is difﬁcult because of the lack of speciﬁc
clinical signs. Diagnosis therefore relies heavily on the
serological detection of IgM and IgG antibodies directed
against Toxoplasma gondii. Identiﬁcation and quantiﬁcation of
IgG antibodies rarely poses any difﬁculties as most standard
tests have a high level of sensitivity and speciﬁcity. However,
detecting IgM antibodies is often more problematic given the
poorer speciﬁcity of the available methods. In contrast with
methods using an indirect sandwich format, it has been
demonstrated that a l-capture methodology can be more
speciﬁc and sensitive. This is the context in which we
assessed the new IMMULITE 2000 Toxoplasma IgM test
(l-capture) from Diagnostic Products Corporation (Los Ange-
les, USA).
Methods: In May and June 2005, we tested 151 samples, 23 of
which were frozen, using four different systems for the
detection of IgM antibodies against T. gondii: the DPC IMMU-
LITE 2000 l-capture, bioMerieux VIDAS, Abbott AxSYM and
DiaSorin LIAISON assay. VIDAS Toxo IgG Avidity was also
used to measured the avidity of anti-Toxoplasma IgG in samples
established as either discordant or positive by the four inves-
tigated diagnostic methods.
Results: Of the 151 samples tested, 13 were positive and 120
proved to be negative according to all four methods, while 18
showed discordance by at least one of the techniques used.
Seven samples showed discrepant values on the LIAISON
platform as compared to the other three systems, ﬁve on the
AxSYM, two on the VIDAS and on the IMMULITE 2000 only
one. With the IgG Avidity method we were able to determine for
each method the relevance of the IgM antibodies compared to
the stage of infection.
Conclusion: The result of our work should be taken into
account when interpreting a positive result using one of the four
methods examined. The VIDAS and AxSYM methods have been
available for some time and have been discussed in numerous
publications. Moreover, it has been demonstrated that VIDAS
offers better speciﬁcity than AxSYM. We can state that the
IMMULITE Toxoplasma IgM (l-capture) assay have shown very
good sensitivity and speciﬁcity as well as excellent discrimin-
ation between serum samples obtained in the early and late
stages of Toxoplasma infection.
P879
Development of novel cytomegalovirus and
toxoplasma IgG avidity assays using an antigen
competitive format ‘‘AVIcomp’’ on the Abbott
ARCHITECT Instrument
G.T. Maine, S. Hsu, D. Smith, I. Curdt, J. Herzogenrath (Abbott
Park, US; Wiesbaden, DE)
Objectives: Development of novel Cytomegalovirus (CMV)
and Toxoplasma (Toxo) IgG avidity assays using an antigen
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competitive ‘‘AVIcomp’’ format on the automated ARCHITECT
instrument.
Methods: Conventional IgG avidity assays for a variety of
infectious diseases employ chaotropic reagents, for example,
urea or diethylamine, to distinguish between antibodies of low
and high avidity. The AVIcomp competitive assay format does
not use chaotropic reagents but relies on mass action using
aqueous antigen to discriminate between low and high avidity
antibodies. Two IgG assays were performed in the AVIcomp
format to determine the Avidity Index (AI) on the ARCHITECT
instrument as follows. In Assay No. 1, the patient sample was
pretreated with buffer and in Assay No. 2 the patient sample
was pretreated with aqueous CMV (viral lysate) or Toxo
(puriﬁed MBP-P30 (SAG1)) antigen. Pretreatment of the patient
sample with aqueous antigen blocks binding of high avidity IgG
antibodies to the solid phase in the subsequent assay step.
Microparticles coated with CMV or Toxo antigens were then
added to each assay, washed, and anti-human IgG conjugate
was then added and signal generated. The ratio of the signal in
Assay No. 2 over the signal in assay No. 1 was proportional to
the amount of low avidity anti-CMV or anti-Toxo IgG present in
the patient sample. Since the Avidity Index for an avidity assay
is deﬁned as the proportion of high avidity antibodies present in
the patient sample, the results of the AVIcomp assay were
transformed mathematically as follows: AI(%) = [1-(Signal
Assay No. 2/Signal Assay No. 1)] · 100.
Results: The preliminary results of the ARCHITECT CMV IgG
avidity assay and the ARCHITECT Toxo IgG avidity assay were
compared to the Radim CMV IgG and Vidas Toxo IgG avidity
assays, respectively, by testing seroconversion panels, pregnant
women and random blood donor patient populations. The
relative agreement between the ARCHITECT and Radim CMV
IgG assays was 98.7% with a correlation coefﬁcient r = 0.88. The
relative agreement between the ARCHITECT and Vidas Toxo
IgG assays was 100% with a correlation coefﬁcient r = 0.97.
Conclusion: These preliminary results suggest that the per-
formance of the novel CMV and Toxo IgG avidity assays
employing AVIcomp technology was equivalent to conventional
avidity assays using chaotropic reagents.
P880
Preliminary evaluation of the Abbott
ARCHITECT anti-toxoplasma IgG, IgM and IgG
avidity assays
G.T. Maine, S. Hsu, C. Patel, D. Smith, J. Munoz, M. Gardiner,
M. Palafox, E. Frias, L. Gu, M. Wilson, R. Holzman, Rn. Stricker,
Rt. Stricker (Abbott Park, US; Geneva, CH)
Objectives: Preliminary evaluation of a panel of human anti-
Toxoplasma (Toxo) immunoassays on the automated ARCHI-
TECT instrument.
Methods: The three Toxo assays for the ARCHITECT instru-
ment are two-step immunoassays utilizing recombinant antigen
coated paramagnetic microparticles for the capture of human
anti-Toxo antibodies and an acridinium-labeled anti-human IgG
or IgM monoclonal antibody for human anti-Toxo antibody
detection. Recombinant MBP-P30 (SAG1) coated microparticles
were used in the ARCHITECT Toxo IgM and IgG avidity assays
whereas MBP-P30 (SAG1) and CKS-P35 (GRA8) coated micro-
particles were used in the ARCHITECT Toxo IgG assay.
Samples from pregnant women, blood donors, hospital patients,
selected RF and characterized Toxo IgM positive samples, and
seroconversion panels were tested on the new ARCHITECT
Toxo IgG, IgM, IgG avidity assays in comparison to the Abbott
AxSYM Toxo IgG, IgM, or Vidas Toxo IgG avidity assays. The
performance of the ARCHITECT Toxo IgG avidity assay was
also evaluated by comparison to clinical information.
Results: The ARCHITECT Toxo IgG assay has a relative
sensitivity of 99.4% and a relative speciﬁcity of 99.4% when
compared to AxSYM Toxo IgG assay. The ARCHITECT Toxo
IgM assay has a relative sensitivity of 98.7% and a relative
speciﬁcity of 94.6% when compared to AxSYM Toxo IgM assay.
The seroconversion sensitivity of the ARCHITECT Toxo IgG and
IgM assays was comparable to the AxSYM assays. The ARCHI-
TECT Toxo IgG avidity assay using ‘‘AVIcomp’’ technology has
a clinical sensitivity and speciﬁcity of 100% and 99.3%, respect-
ively. The relative agreement between the ARCHITECT and
Vidas Toxo IgG avidity assays was 100%.
Conclusion: The performance of the three new ARCHITECT
Toxo immunoassays was comparable to the reference assays.
P881
Performance evaluation of the VIDIA
toxoplasmosis IGG and IGM assays
P. Thulliez, C. Leprince, M. Marcoux, J. Piche (Paris, Marcy
l’Etoile, FR)
Objective: Compare the clinical performance of the new VIDIA
Toxoplasmosis IgG and IgM assays (bioMe´rieux, France) with
in-house serologic tests using clinical specimens.
Material: A total of 1148 frozen and fresh serum samples from
pregnant women, male patients, infants and immuno-compro-
mised patients was used for testing. Sensitivity and speciﬁcity of
the VIDIA TOXO IgG were determined on all sera in compar-
ison with the Dye test. Sensitivity and speciﬁcity of the VIDIA
TOXO IgM were determined on 628 sera in comparison with the
in-house IgM-ISAGA and patient clinical data. A correlation
study was performed by testing 110 sera for IgG and 115 for IgM
in comparison with the VIDAS Toxo IgG II and VIDAS Toxo
IgM (bioMe´rieux, France) respectively. Seroconversion panels
(n = 10) were tested on both VIDIA and VIDAS systems. In case
of discrepancies, complementary testing was performed with
the in-house high-sensitivity (HS) agglutination test for IgG.
Results: For clinical samples, sensitivity was found 99.7% for
the VIDIA Toxo IgG and 100% for the VIDIA Toxo IgM. The
speciﬁcity was 99.5% for the VIDIA Toxo IgG when compared to
the Dye test and the speciﬁcity of the VIDIA Toxo IgM was
98.9% when compared to the ISAGA assay. The correlation
coefﬁcient of IgG titers was 0.91. IgM detection agreement was
found 100% between VIDIA and VIDAS. The same number of
seroconversion panels (n = 10) was detected with the VIDIA
and VIDAS systems.
Conclusion: The VIDIA Toxo IgG and VIDA Toxo IgM assays
show an excellent sensitivity and speciﬁcity. Early seroconver-
sion samples show the same delayed detection of IgG with the
VIDIA as the VIDAS when compared with the Dye and HS tests.
P882
Toxoplasma gondii antibodies in 72 patients who
attended emergency wards in three hospitals in
Stockholm due to infective cat bites
K. Westling, C. Jorup-Ro¨nstro¨m, B. Evenga˚rd (Stockholm, SE)
Objectives: Toxoplasma gondii causes severe infections in im-
munocompromised patients and may also infect the foetus of
the pregnant women. The seroprevalence of toxoplasmosis in
fertile women in Stockholm has in previous studies been
reported to be 14%.
Methods: Patients who attended Emergency Wards in three
hospitals in Stockholm due to infected cat bites were investi-
gated by antibodies to Toxoplasma gondii, IgM and IgG (ELISA,
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commercial methods). The patients were offered a follow-up at
the Outpatients. Department and an additional sample of
antibodies was performed.
Results: In 72 patients (51 women and 21 men, median age 53
years) antibodies to T. gondii were analysed in samples from the
ﬁrst visit at hospital, IgG antibodies were found in 20 patients
(15 women and 5 men), in addition both IgM and IgG antibodies
were found in one (female) patient. At follow-up at the
Outpatients Department Toxoplasma gondii antibodies from 34
patients were analysed, no case of seroconversion was found
between the visits.
Conclusion: Seropositivity to T. gondii was found in 28% of the
patients with infected cat bites that is higher than previous
studies from fertile women, however in this study the median
age was higher.
Staphylococci and surgical infections
P883
Survey of the epidemiology of
methicillin-resistant Staphylococcus aureus
infections in Greece
V. Chini, A. Foka, O. Koureli, A. Athanassiadou,
G. Dimitracopoulos, I. Spiliopoulou (Patras, GR)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA)
is one of the most frequent causes of community- and hospital-
acquired infections (CA-MRSA, HA-MRSA). The aim of the
present study was to characterize the MRSA clones in relation to
clinical specimens and to investigate their spread in the hospital
environment and the community during a four-year period.
Methods: We collected the MRSA from clinical specimens of
different patients admitted at the University Hospital of Patras
during 2001–2004. The MIC of oxacillin was determined by the
agar dilution method in Mueller-Hinton supplemented with 2%
NaCl, according to the guidelines of NCCLS. PBP2a production
was investigated by a Latex agglutination test (bioMerieux) in
all S. aureus. PCR ampliﬁcation with speciﬁc primers was
applied for the detection of mecA gene and 338 MRSA were
identiﬁed. Clonal types were determined by PFGE of chromo-
somal DNA SmaI digests.
Results: An increase of MRSA infections was observed: 23% in
2001, 28% in 2002, 28% in 2003 and 44% in 2004. The majority of
MRSA were isolated from the Department of Surgery (DS)
(range 34–46%); while in 2004 there was a signiﬁcant increase in
the Intensive Care Unit (ICU) (17%) and the community (40%).
PFGE classiﬁed the 338 isolates into six clonal types with distinct
resistant phenotypes. Type A included 28 strains (8%) resistant
only to b-lactams. Type B 70 (21%) and type E 21 (6%) strains
exhibiting a multiresistant phenotype were isolated mainly from
abscesses and pulmonary tract, respectively. Two hundred and
twelve strains (63%) classiﬁed to type C were resistant to
b-lactams and fusidic acid, associated with wounds and soft
tissue infections. Three (0.8%) strains were characterized as type
F resistant to erythromycin, while the newly described type G
included 4 strains (1.2%) resistant to gentamicin, tobramycin
and kanamycin. Among the CA-MRSA predominated PFGE
type C, while in the ICU were spread strains of type E.
Conclusions: An increase of infections caused by MRSA was
observed during the study period due to the spread of clone C in
the community and the hospital environment.
P884
Nasal carriage rates of Staphylococcus aureus
which are resistant and sensitive to oxacillin in
hospital staff and hospitalised patients
H. Irmak, S. Cesur, F. Yildiz, C. Bulut, S. Kinikli, A.P. Demiro¨z,
Z. Aygu¨n (Ankara, TR)
Aim: The aim of this study is to determine the carriage rate
of methicillin resistant and sensitive Staphylococcus aureus
(S. aureus) in hospital staff (physician, nurse and auxiliary
personnel) of the Ankara Training and Education Hospital) and
patients hospitalized in intensive care unit, and surgery and
internal medicine wards and risk factors related to carrier status.
Material and method: Overall 1000 people (500 hospital staff
and 500 hospitalized patients) were included in the study.
Samples of nasal swab were inoculated into mannitol-salt agar,
oxacillin resistance screening agar base (ORSAB) and chromo-
genic MRSA agar media, respectively. Coagulase positive
colonies that yielded yellow colour in mannitol-salt agar were
considered as S. aureus. Colonies that yielded blue colour in
ORSAB medium and/or those that yielded pink or lilac colour
in chromogenic MRSA agar medium were considered as
methicillin resistant S. aureus (MRSA). Coagulase positive
colonies that were grown only in mannitol-salt agar were
accepted as methicilline sensitive S. aureus (MSSA). The conﬁr-
mation of methicillin resistance in S. aureus strains were made in
accordance with CLSI criteria using oxacillin, methicillin and
cefoxitin discs in Mueller-Hinton agar medium.
Results: Nasal carriage rates were found to be 2% (10/500) for
MRSA and 9.2% (46/500) for MSSA in hospital staff. In
hospitalized patients, MRSA carriage rate was 6.4% (32/500)
and MSSA carriage rate 14.4% (72/500). The majority of the staff
who were nasal carriers were auxiliary health personnel
(attendant, cleaning personnel) and most of them worked in
intensive care units and surgical clinics.
Conclusion: The training of auxiliary health personnel on
hospital infections, routes of transmission and preventive
measures, screening of health staff working in clinics where
hospital infections and colonization are prevalent and the
patients hospitalized in these clinics for colonization at period-
ical intervals and treatment of colonization if necessary are
important for the prevention of MRSA infections. This project
was supported by Scientiﬁc and Technical Research Council of
the Turkish Republic (TUBITAK) with project number of SBAG-
AYD 493.
P885
Nasal carriage of Staphylococcus aureus among
patients and personnel of a haemodialysis unit
A. Sergounioti, F. Sergouniotis, A. Basdeki, P. Sergouniotis,
E. Papoulia, E. Petinaki (Amﬁssa, Larissa, GR)
Nasal carriage of Staphylococcus aureus portends an increased
risk of peritonitis and other serious infections for haemodialysis
patients, thus increasing morbidity and mortality.
Objectives: The aim of our study was to determine the
incidence of S. aureus nasal carriage among patients and
personnel of the Haemodialysis Unit of a Secondary General
Hospital (120 beds) and to investigate the study of the
genotypical and phenotypical characters of the strains yielded.
Methods: A total of 35 individuals were examined during
autumn 2005. Samples taken from the anterior snares of the
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twenty-ﬁve haemodialysed patients and the ten personnel of the
Haemodialysis Unit of our Hospital were cultured. The strains’
identiﬁcation was performed by catalase production, 24-hour
coagulase test, and the API Staph system (Biomerieux, Marcy L’
toile, France). All the strains were tested for the production of
PBP2a (Slidex MRSA, Biomerieux, Marcy L’ toile, France). Their
susceptibility to antibiotics was performed by the disk diffusion
technique and the results were interpreted according to the
criteria of the N.C.C.L.S. Moreover, molecular analysis for the
mecA gene and the Panton-Valentine leucocidin (PVL)-encoding
genes, lukF and lukS, was performed by PCR.
Results: The prevalence of S. aureus nasal carriage among
patients was 48% (12 out of 25) and 20% among personnel (2 out
of 10). The strains isolated from the patients were all MSSA and
did not carry the PVL-encoding genes. All the MSSA strains
were susceptible to glycopeptides, linezolid, quinopristin/dal-
fopristin, cotrimoxazole, quinolones, rifampicin, amikacin, gen-
tamicin, and netilmicin, whereas their susceptibility to fucidic
acid, erythromycin and clindamycin was 92%, to tetracycline
85% and to penicillin 23% respectively. Only one strain carrying
the mecA gene was recovered. This MRSA strain was isolated
from a nurse and proved to be multisusceptible.
Conclusions: The haemodialysis unit of our hospital was found
to have higher incidence of S. aureus nasal carriage among
patients and personnel compared to other larger haemodialysis
units of tertiary hospitals in Greece. However, MRSA carriage
was rare and the most of the S. aureus strains isolated were
multisusceptible.
P886
MRSA carriage in children undergoing cardiac
surgery in Georgia
A. Nanuashvili, N. Jashiashvili (Tbilisi, GE)
Objectives: Staphylococcus aureus has been and continues to be a
signiﬁcant human pathogen. Although asymptomatic coloniza-
tion with S. aureus is common, it appears to be an important
factor in the development of most infections due to this
organism. In the past two decades, methicillin-resistant S.
aureus (MRSA) has increased in incidence in many parts of the
world as agent of nosocomial infection. The spread of MRSA has
become an alarming problem throughout the world. We studied
the problems of the carriage of S. aureus in children, prevalence
of MRSA, the correlation of the staphylococci carriage with the
cardiac surgery intervention in the past.
Methods: At the Tbilisi Children’s Cardiac Surgery Hospital it
has been studied 294 patients, who underwent cardiac surgery
from January 2003 to December 2004. The age of patients varied
from 1 day to 18 years. From 294 operations 246 were primary
ones, and 48 cases were reoperations. The average time period
between the primary and reoperations was about 1.5 years.
Prior every operation the smears from the throats of the patients
were investigated.
Results: From 294 patients, prior the operation Staphylococci
carriage was discovered in 121 cases (41.2%). Prior 171 primary
operations – in 72 cases (41,9%), and prior 48 reoperations – in 18
cases (37.5%). 121 isolated strains of S. aureus the Oxacillin
resistance was registered in 17 ones. Thus, 5.8% of 294 patients
examined were the MRSA carriers. Prior the primary operation
10 patients (4.1%) were MRSA carriers, and in the case of
reoperations 7 patients (14.6%) were MRSA carriers.
Conclusion: Prior the primary and reoperations a signiﬁcant
difference between the numbers of S. aureus carriage was not
discovered. A substantial difference in the numbers of MRSA
carriage was discovered prior primary (4.1%) and reoperations
(14.6%). Thus, according to the studied cases, the operation did
not affect the percentage of the S. aureus carriage, but increases
the number of the carriage of the MRSA strains.
P887
Coagulase-negative staphylococci in a surgical
hospital
A. Zilevica, R. Treimane, R. Paberza, T. Tracevska (Riga, LV)
Objectives: The growing interest in coagulase-negative Staphy-
lococci (CoNS), particularly, S. epidermidis and S. haemolyticus, as
the etiological factors of nosocomial infections, is connected with
the increasing number of implanted medical device or catheter
related infections and bacteraemia. The aim of this study was to
detect the prevalence of CoNS infections in a surgical hospital,
and to characterize the species spectrum and methicillin
resistance (MR).
Methods: The study was conducted during 2003–2004 at the
Hospital of Traumatology and Orthopaedics, Riga, Latvia. CoNS
isolated from clinical specimens were identiﬁed up to a species
level. The antimicrobial susceptibility to a panel of antimicro-
bials was tested by the standard agar disk diffusion test (BBL)
according to NCCLS standards and the E-test. Methicillin
resistance was conﬁrmed by genotypic proﬁles, deﬁned by
hybridization with the mecA gene in PCR and the latex
agglutination test with a Slidex MRSA detection kit.
Results: The incidence rate of the isolated MR CoNS was
signiﬁcantly increased from 1.15% in 1998 to 18.5% in 2003 and
33.3% in 2004. During 2003, 143 CoNS cultures were isolated
and identiﬁed. 89 of them were S. epidermidis, 16 – S. haemolyt-
icus. A few cultures of S. hominis, S. capitis, S. warneri, S.
saprophyticus, S. simulanswere documented. During 2004, 54 and
11 cultures of S. epidermidis and S. haemolyticus were isolated.
Methicillin resistance among S. epidermidis was 17.3% in 2003,
and 37.2% in 2004. In S. haemolyticus, it was high – 52.9% and
100%. 17 cultures of S. haemolyticus were analysed for the
presence of the mecA gene. According to the PCR results, all
showed the presence of the 310-bp fragment of the mecA gene.
The Slidex MRSA test was shown as very accurate for detection
of the methicillin-resistant S. haemolyticus – the latex agglutin-
ation was clearly observed in all 17 cultures. 11 cultures were
tested for MIC. According to the E-test results, only 2 cultures
exhibited 8 mg/ml. In others, MIC was 256 mg/ml. For antibi-
ogram typing, 46 cultures of MR S. haemolyticus were used. At
least ﬁve different proﬁles were observed.
Conclusion: The results suggest that the methicillin resistance
among CoNS has markedly increased in our hospital within
recent years. The mecA gene detection and Slidex MRSA latex
agglutination tests provide a reliable identiﬁcation of MR
S. haemolyticus.
P888
Prevalence of methicillin-resistant
Staphylococcus aureus infection among inpatients
colonised with MRSA
A. McVeigh, S.F. FitzGerald, L.E. Fenelon (Dublin, IE)
St Vincent’s University Hospital is a 492-bed tertiary referral
teaching hospital. Like many Irish hospitals, methicillin-resist-
ant Staphylococcus aureus (MRSA) is endemic. While information
on both numbers of patients colonized with MRSA and rates of
MRSA bloodstream infections is routinely collected, data on the
proportion of MRSA-colonized patients who had infection
attributable to MRSA was not available. We carried out a
point prevalence study on a single day, which included all in-
patients colonized with MRSA to determine the rate of MRSA
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infection in our hospital. All patients known to be colonized
with MRSA were assessed to determine whether or not they
were infected with MRSA on the day of study. Routine
demographic data was collected along with information relating
to duration of MRSA colonization, source of acquisition, length
of stay, risk factors for MRSA infection, antimicrobial treatment
and site of infection. Patients were divided into 2 groups: those
who were colonized only and those who were being treated for
MRSA infection. The patients in the second group were further
subdivided according to whether or not they had infection
according to CDC criteria. Forty-one inpatients were colonized
with MRSA (9% of all inpatients) on the day of study – 22 (54%)
were male, 19 (46%) female and the average age was 68.4 years.
Thirteen patients (32%) were being treated for MRSA infection –
of which seven (17% of MRSA-colonized inpatients and 1.5% of
all inpatients) had deﬁnite infection according to CDC criteria.
Of those, ﬁve infections were acquired in our hospital and two
were healthcare-associated. One patient had probable infection;
another was receiving appropriate empirical antimicrobial
therapy. The remaining four were being treated inappropriately.
We now have an indication of the rate of deﬁnite MRSA
infection and the number of cases treated as MRSA infections in
our institution. Although an incidence study would be ideal,
there are simply not the resources to put this in place at present.
We plan to repeat the point prevalence study monthly to allow
us to monitor rates of MRSA infection and identify risk factors
for infection.
P889
The role of screening and antibiotic prophylaxis
in the prevention of percutaneous gastrostomy
site infection caused by methicillin-resistant
Staphylococcus aureus
S. Thomas, S. Cantrill, D.J. Waghorn, A. McIntyre (High
Wycombe, UK)
Introduction: Peristomal wound infection is a common com-
plication of percutaneous endoscopic gastrostomy (PEG) espe-
cially in hospitals where methicillin-resistant Staphylococcus
aureus (MRSA) is endemic. Recent evidence suggests antibiotic
prophylaxis at the time of the PEG insertion may reduce post-
procedure infections. We have examined rates of PEG associated
MRSA infection before and after the introduction of an MRSA
screening, decontamination and antibiotic prophylaxis protocol.
Patients and methods: Retrospective case detection ascertained
new MRSA associated PEG site infection (isolated 1 month post
procedure), over a 33-month period (January 2002 to September
2004). Prospectively from October 2004, patients requiring PEG
insertion and found to be MRSA positive underwent nose
(Mupirocin ointment, tds) and skin (Aquasept shampoo 2%
triclosan) decontamination for 5 days prior to PEG insertion and
received prophylactic teicoplanin 400 mg IV 30 minutes before
the procedure. MRSA negative patients were given co-amoxiclav
1.2–1.8 gm IV. Peristomal wound sites were monitored by
hospital infection control nurses for 1 month post PEG insertion
for inﬂammation and purulent discharge and infected looking
wound sites were swabbed. Rates of peristomal MRSA infection
in patients pre- and post-screening/prophylaxis were compared.
Results: Peristomal MRSA infection was identiﬁed in 5 of 41
(12%) PEG insertions in 2002, 7 of 35 (20%) in 2003 and 7 in 24
(29%) in 9 months of 2004: Overall infection rate of 19%. Of 25
patients undergoing new PEG insertions from Oct 2004 (4
known and 5 identiﬁed by the screening as MRSA positive) only
1 (not previously MRSA positive) developed MRSA PEG site
infection, but only 14 days post procedure (4%) (2 p < 0.05 for
2004 comparison, p > 0.05 for 2002, 2003 and pooled).
Conclusions: Screening for MRSA before a PEG procedure,
followed by treatment of positive patients and appropriate
antibiotic prophylaxis, can reduce PEG associated MRSA wound
infections. Topical nasal mupirocin, combined with an anti-
staphylococcal skin agent and followed by intravenous teicopl-
anin prophylaxis at the time of the procedure appears to be an
effective regimen. The protocol and treatment used here was
well tolerated by all patients and was easy to administer for
nursing/medical staff. In MRSA endemic clinical areas, the risk
of developing wound site infection may remain for some time
post procedure unless high standard wound care is maintained.
P890
Surgical site infection and delayed sternal closure
after open-heart surgery
A. Arnaiz, J.P. Horcajada, J.M. Bernal, J.D. Garcı´a-Palomo,
A. Sarralde, M.C. Farin˜as (Santander, ES)
Introduction: Delayed sternal closure is a surgical technique
aimed to avoid cardiac compression in some open heart surgery
patients. Little is not known about the risk of surgical site
infection related to this procedure.
Methods: Retrospective study of sternotomies left open after
cardiac surgery and delayed sternal closure between 1994 and
2000. Characteristics of patients and surgery, as well as postop-
erative complications were recorded.
Results: 51 patients were included. Thirty (58.8%) were men
and 21 (41.2%) women. Mean age was 68.7 (9.7) years. 30 (59%)
patients had a comorbidity Charlson index > 2. Nine (17.6%)
patients were diabetic. Indications for cardiac surgery were:
valve replacement 18 (35.3%), myocardial revascularization 14
(27.5%), both procedures 11 (21.6%) and other 8 (15.6%). Mean
(SD) surgery duration was 302 (135) minutes. Fifty (98%)
patients received antibiotic prophylaxis, 17 (34%) of them
during more than 1 day. Indications for DSC were: incontrol-
lable haemorrhage 25 (49%), cardiac compression 23 (45%) and
arrhythmia 3 (6%). Sternotomy remained opened for 1.8
(1.2) days. Among patients with delayed sternal closure (51),
there were 0 deep surgical site infection (mediastinitis) and 2
(5.7%) superﬁcial surgical site infection due to Citrobacter
freundii, Corynebacterium striatum, and Staphylococcus epidermidis.
Other infections recorded were: 20 (39.2%) respiratory tract
infections, 4 (7.8%) catheter-related bacteremia, 2 (3.9%) urinary
tract infections, and 1 (1.9%) other. Mean days of hospitalization
was 36.5 (39) days. Global in-hospital mortality was 22 (43.1%).
Death occurred in a mean (SD) time of 20 (36) days. 8 (36%)
patients died during the period with sternotomy opened.
Causes of death were: cardiogenic shock 15 (68%), septic
shock 4 (18%), hypovolemic shock 1 (4.5%) and anoxic
encephalopathy 2 (3.9%).
Conclusions: In patients with delayed sternal closure the risk of
surgical site infection is low. However, mortality is very high,
mainly due to non-infectious complications.
P891
The importance of risk indexes for stratifying
surgical site infection rates
S. Cairns, R. Hill, J. Reilly (Glasgow, UK)
Objectives: To determine compliance in completion of the three
ﬁelds required to determine the NNIS risk index score and to
identify categories of surgery that are not stratiﬁed well by the
NNIS risk index.
Methods: From 1st January 2004 to 31st December 2004, data on
14660 surgical procedures were collected as part of the manda-
tory surgical site infection (SSI) surveillance programme in
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Scotland. The percentage of not recorded values for the three
ﬁelds required to calculate the NNIS risk index score; ASA
score, wound class and operation duration were calculated for
each category of surgery. The percentage of records where the
NNIS risk index score was unable to be determined due to not
recorded data was calculated for each category of surgery. The
Scottish surgical category speciﬁc infection rates were stratiﬁed
by NNIS risk index and plotted in a graph alongside the
corresponding NNIS category speciﬁc infection rates.
Results: Completion of the ﬁelds used to calculate the NNIS
risk index varied depending on the risk factor and surgical
procedure category. The percentage of records where the NNIS
risk index could not be determined due to missing risk factor
data ranged from 12.8% for operations for fractured neck of
femur to 42.3% for caesarean section surgery. The infection rates
for all surgical procedures were not stratiﬁed well by the NNIS
risk index. Additionally, the procedure speciﬁc infection rates
did not follow the expected pattern when stratiﬁed by the NNIS
risk index score.
Conclusion: Compliance in completion of ﬁelds used for risk
stratiﬁcation should be improved to allow adjustment for risk
factors. In addition, the currently used NNIS risk index does not
adequately stratify the Scottish SSI infection rates and further
modelling work on risk factors is required to develop procedure
category speciﬁc risk indexes for use in the Scottish setting.
P892
MRSA hand colonisation among health care
workers
Z. Kocak Tufan, H. Irmak, S. Cesur, C. Bulut, S. Kinikli,
A.P. Demiroz (Ankara, TR)
Objectives: In this study, it is intended to ﬁnd out the
colonisation of methicillin-resistant Staphylococcus aureus
(MRSA) on hands of doctors and other health care workers
(nurses, attendants, etc) during their daily work. The study was
held in Ministry of Heath Ankara Research & Training Hospital.
Methods: Totally 100 persons including doctors, nurses and
other health care workers who work in intensive care units,
general medicine and surgery departments and have direct
contact with patients’ open wounds were included to this study.
Screening was performed during routine daily work regardless
of hand washing. Samples were inoculated directly as smears
from both hands to Baird Parker agar (RTA laboratories,
Kocaeli, Turkey). After 48 hours of incubation, black colour
forming colonies which grow 103 cfu or more were accepted for
evaluation of Staphylococcus aureus (S. aureus). The colonies
which are Gram positive, catalase positive, coagulase positive
and shows yellow pigmentation in mannitol agar were identi-
ﬁed as S. aureus. The isolated strains were inoculated to
‘‘oxacillin resistance screening agar ’’ and chromogenic MRSA
agar medias to investigate metisillin resistance. Then the
methicillin resistances of the colonies which grow in these
medias were conﬁrmed with disc diffusion method using
oxacillin disc in Mueller Hinton agar.
Results: There were 103 or above S. aureus growth in 68% of
hands of medical staff while remaining 32% show no growth or
less than 103 so not included to study. MRSA hand colonisation
was found in 12 staff of 68 (17.6%).
Conclusion: The high rate of MRSA hand colonisation shows
that the medical staff do not obey the hand washing rules during
their daily work. But it is not possible to determine if this
colonisation is persistent or temporary because the study was
held regardless of hand-washing. Because of that our study
which we will also compare the colonisation rates before and
after handwashing is continuing.
P893
Susceptibility of MRSA to octenidine
dihydrochloride
Z. Al-Doori, D. Morrison, P. Goroncy-Bermes, G.F.S. Edwards,
C.G. Gemmell (Glasgow, UK; Norderstedt, DE)
Methicillin-resistant S. aureus (MRSA) strains are a major cause
of sepsis in hospitals and they can lead to skin infections,
septicaemia and death. Antiseptics, such as octenidine dihydro-
chloride, are used for the treatment of MRSA infected patients.
The ability of bacteria and especially MRSA to develop resist-
ance to antimicrobials, especially antibiotics is well documented
and resistance to biocides has also been reported. It is important
that products should be tested for any resistance arising from
repeated and continued exposure. 76 MRSA (including several
clonal variants of the two dominant UK MRSA: EMRSA-15 and
EMRSA-16) and 24 MSSA from Scottish hospitals were tested for
MIC to octenidine dihydrochloride (OCT) according to NCCLS
methodology. Adaptation/Tolerance studies were performed on
representatives of the ﬁve major international MRSA clones
(CC5, CC8, CC22, CC30 and CC45). Isolates were grown in BHI
broth in the presence of increasing concentrations of OCT for a
period of up to 3 months. Octenidine dihydrochloride MIC of
the parent and adapted isolates were determined. The MIC50 for
the 76 MRSA and 24 MSSA was 4 lg/ml and 2 lg/ml,
respectively and MIC90 for both was 4 lg/ml (range 24 lg/
ml). The parent isolates of all ﬁve clones tested in the adaptation
studies had an MIC of 4 lg/ml to OCT. Following continuous
exposure to increasing concentrations of OCT over a three
months period some differences were observed between clones
in their ability to grow at increasing concentrations. The highest
OCT concentrations allowing growth in broth were as follows:
CC5 (8 lg/ml), CC8 (4 lg/ml), CC22 (6 lg/ml), CC30 (7 lg/
ml), and CC45 (8 lg/ml). Although growth occurred at concen-
trations higher than the MIC of the ‘‘parent’’ strain the MIC of
the adapted isolates was identical to that of the parent (4 lg/
ml). In conclusion, the data indicates that, under these experi-
mental conditions, the ﬁve epidemic MRSA clones tested failed
to acquire resistance/reduced susceptibility following continu-
ous exposure to increasing concentrations of octenidine dihy-
drochloride.
P894
Study on bacterial contamination of surgical
rooms and delivery centres of Hamadan hospitals
and health care centres
R. Youseﬁ mashouf, S. Sahamas Vala (Hamadan, IR)
Objectives: In order to identify bacterial agents that causing
nosocomial infection, a cross-sectional study was carried out in
24 health care centres and hospitals in Hamedan, western Iran.
Materials and methods: In this study 554 samples were
collected from different parts of surgical rooms and delivery
centres from 24 health care centres, during 1 year. The samples
were collected from ﬂoor, air, suction device, cuters, tables,
surgical beds, walls, electric shock devices, sialectic light, eye
microscope manometer, incubator, infant scales. The samples
were culture on Blood agar and EMB agar by sterile cotton
swabs. A smear was also prepared for Gram staining. The
species were then identiﬁed by serotyping and biochemical
tests.
Results: The mean frequency of contamination was 66.9% in
surgical rooms (66.5%) and delivery centres (69.3%), the distri-
bution of Gram-positive bacteria was 52.8% and Gram-negative
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bacteria was also 47.2%. The most important Gram-positive
bacteria were: Staphylococcus aureus, Streptococcus pyogenes,
Staphylococcus epidermidis and Bacillus subtilis. The most import-
ant Gram-negative bacteria were: Klebsiella pneumoniae, Enterob-
acter spp., E. coli, Pseudomonas aeroginosa and Acinetobacter
baumanii.
Conclusion: Our results showed that Gram-positive bacteria
were most common bacterial agents that isolated from surgical
rooms and delivery centres in Hamedan, western Iran. Our
results also indicated that contamination was relatively high in
studied places. It is suggested that operative rooms and delivery
centres should be controlled regularly by health authorities.
P895
Reduction in the incidence of staphylococcal
infections in hospital environment after the
starting of the guideline of perioperative
antibiotic prophylaxis
G. Gattuso, D. Tomasoni, L. Palvarini, D. Berra, C. Chiarelli,
R. Stradoni, A. Scalzini (Mantua, IT)
Nosocomial infections caused by MRSA are increasing; more-
over only few studies concerning the trend of MRSA after the
application of perioperative antibiotic prophylaxis (PAP) guide-
line have been conducted.
Objectives: Comparing the general incidence of staphylococcal
and MRSA infections in the Hospital of Mantua versus the
incidence of staphylococcal and MRSA in the surgical wards
after the introduction of PAP’s guideline.
Methods: The hospital is a 530-bed tertiary care teaching
hospital in Mantua with 30,000 patients admission per year.
Two periods have been compared: 2nd Six Months (S) of 2002-
1st S of 2003 (period A) and 2nd S of 2003-1st S of 2004 (period
B), respectively before and after the introduction of the guideline
of PAP. Statistical analysis has been performed using Mercurio
(DIANOEMA) software; the rates of incidence of Staphylococcal
and MRSA infections has been compared using the Fisher test.
Results: In the period A 10407 microbiological examinations
have been executed; 637/10407 cases (6.1%) were positive for S.
aureus and 119/637 (18.6%) were MRSA. In the period B 8421
microbiological exams have been performed: 315/8421 (3.7%) S.
aureus and 81/315 (25.7%) MRSA. In the period A a signiﬁcant
increase of MRSA was found in the surgical wards comparing to
the other wards: 58.6% vs 22.9% (p = 0.001), whereas in the
period B was checked a relevant decrease of MRSA in the
surgical wards compared to the general data (25.0% vs 25.7%)
(p = ns). In the second period the data of MRSA in the surgical
wards were found signiﬁcantly reduced (58.6% vs 25.0%)
(p = 0.001). Moreover in the period B the global antibiotic
consumption was reduced with an increment of the cephalo-
sporins of 1st generation (+11.5% of cephazolin) used correctly
in surgical prophylaxis, while a remarkable decrease of con-
sumption of cephalosporin of 3rd and 4th generation (respect-
ively: )59% and )12.7%).
Conclusions: 12 months after the introduction of PAP a signi-
ﬁcant reduction of incidence of MRSA infections was found in
the surgical wards; moreover such result can be ascribed to a
greater adhesion to norms of ‘‘good clinical practice’’.
Streptococci - skin and soft tissue infections
P896
Characterisation of a clone of methicillin-
resistant Staphylococcus aureus responsible for
community-acquired staphylococcal toxic shock
syndromes
P.-Y. Donnio, C. Michelet, C. Collet, N. Lafforgue, O. Petsaris,
P. Tattevin, M. Cormier (Rennes, FR)
Objectives: To characterize Staphylococcus aureus isolates pro-
ducing TSST-1 resistant to methicillin and fusidic acid but
susceptible to ciproﬂoxacin, recovered from community-
acquired as well as hospital-acquired infections.
Background: Staphylococcus aureus can produce many virulence
factors and some of them, like the Panton-Valentine leucocidin
(PVL) or the toxic shock syndrome toxin (TSST-1), are coded by
accessory genes which have been acquired by some strains.
Until recently, community-acquired staphylococcal infections
were caused by methicillin-susceptible strains, but since a few
years, epidemic infections due to methicillin-resistant S. aureus
(MRSA) have been reported worldwide. Many community-
acquired MRSA from European countries produce PVL, but to
our knowledge only few strains have been described to produce
TSST-1. We report here two cases of staphylococcal toxic shock
syndrome (TSS) due to methicillin-resistant S. aureus (MRSA). If
one of them was clearly community-acquired, acquisition of the
other one was perhaps related to childbirth at hospital maternity
although the onset occurred at home with colonization of all
members of family.
Methods: MRSA responsible for TSS have been characterized
by MLST, SCCmec typing, spa typing and PFGE. Furthermore
we have looked for TSST-1 production by isolates with the same
antibiotic resistance pattern (susceptible to ciproﬂoxacin and
resistant to oxacillin, tobramycin and fusidic acid) isolated
between May 2004 and August 2005. Consequently nine addi-
tional isolates have been characterized by PFGE, SCCmec
typing, and spa typing.
Results: MRSA strains producing TSST-1 have been recovered
from 11 infections or colonization but TSS have been diagnosed
for only 2 patients. Isolates from TSS cases were identiﬁed as
MRSA ST5-IV. By PFGE, among the nine additional strains
seven were found closely related to each other and to the
previous one. All these 9 isolates have a SCCmec type IV and a
t002 or t002-related spa type.
Conclusion: Although some isolates have been recovered from
hospitalized patients our ﬁndings suggest that strains belonging
to the clone ST5-IV TSST-1+ were community-acquired. Among
9 patients infected or colonized, only 2 have developed a TSS.
P897
Antibiotic resistance of Gram-positive bacteria
that cause severe skin and soft tissue infections in
a Turkish university hospital
S. Gu¨ndes, F. O¨zkan, S. Akhan (Kocaeli, TR)
Background: Since assessing the extend and severity of skin
and soft tissue infections is difﬁcult, therapy is often started
before deﬁnitive microbiological and diagnostic data are avail-
able. The majority of SSTIs are caused by Staphylococcus aureus
and B-hemolytic Streptococci. B-lactam/B-lactamase inhibitor
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therapy have been using in empirical therapy for SSTIs in our
hospital. The purpose of this study is to determine the research-
based evidence and to re-evaluate our antibiotic regime used.
Methods: Eligible patients were hospitalized adults, between
June–November 2005, with a diagnosis of a SSTIs, proven to be
caused by a Staphylococcus or Streptococcus strain. The presence
of at least 2 of the following characteristics was required: local
heat; purulent drainage from a wound; erythema; body tem-
perature 37.8  C; stage 1, 2, 3 ulcer severity on Wagner scale;
and WBC count 10,000/mm3.Cases of osteomyelitis, decubitis
ulcers and burns were excluded. Resistance against nine-teen
known or novel antibiotic were investigated with VITEC 2
system.
Results: Ninety-six gram-positive bacteria were isolated from
73 patients. Of these bacteria, 60.2% were S. aureus (60.9% were
methicillin resistant), 16.1% S. epidermidis, 5.8% S. haemolyticus,
5.8% Streptococcus viridans, 4.4% S. pyogenes, 4.4% S. agalactia,
and 2.9% were S. hominis. The highest resistance ratios were
belong to ampicillin (85.2%), tetracycline (44.8%), and erythro-
mycin (33.8%) groups. Second or 3rd generation cephalosporin
resistance (cefaclor 30.8%-cefotaxim 32.3%) was not different
statistically from amoxicillin/CA 29.4%,ampicillin/SB 32.3% or
imipenem 30.8%. Gentamycin resistance was 19.1%, rifampin
resistance was 17.6%, clindamycin resistance was 10.2%.
Ciproﬂoxacin resistance was higher (17.6%) than levoﬂoxacin
(10.2%). No resistance found against glycopeptides (vancomy-
cin, teicoplanin), Zyvoxid, quinupristin-dalfopristin and moxiﬂ-
oxacin.
Conclusion: Our recent surveillence datas support that 8090%
of these pathogens remain susceptible to clindamycin, rifampin,
and quinolones. But, we have an increasing resistance against
cephalosporin, antistaphylococcal penicillin, or other b-lactam
group antibiotics. These drugs with newer quinolones, and
zyvoxid may be an effective choice both in outpatient clinics and
in hospitalized patients.
P898
Contrasting features of Group A streptococci
from asymptomatic carriage and diverse infection
sites
D. Rolo, R. Pires, L. Sobreira, A. Morais, L. Lito, M.J. Salgado,
R.M. Barros, I. Peres, G. Trigueiro, C. Cardoso, J.G. Marques,
I. Santos-Sanches (Caparica, Oeiras, Lisbon, Miraﬂores, PT)
Objectives: To determine whether particular clones of Group A
streptococci (GAS) were related to a particular tissue site of
isolation or disease and the role of carriers as reservoirs of
virulent and macrolide-resistant clones.
Methods: 854 GAS collected during 19992003, in Lisbon area,
from four origins: asymptomatic oropharyngeal carriage (CA,
n = 592), tonsillitis/pharyngitis (TS, n = 180), skin and soft-
tissue infection (SI, n = 47) and invasive sites (IV, n = 35), were
tested for macrolide resistance frequency and phenotypes (M or
MLSB) by disk diffusion. All drug-resistant isolates (n = 224)
and a fraction of the drug-susceptible isolates from all origins
(n = 133) were characterized by T-typing and pulsed-ﬁeld gel
electrophoresis (PFGE), which was used to estimate a clonality
index (no. of PFGE patterns/ no. of isolates per origin) and
select major clones for sequencing (emm typing and MLST).
Macrolide resistance genes - mef(A), erm(B), erm(A), and
virulence genes - speA, speC, ssa, prtF1, were detected by PCR.
Results: Macrolide resistance was much higher in TS (30%), SI
(25.5%) and CA (17.4%) than in IV (5.7%) isolates. Among the
macrolide-resistant isolates, the M phenotype (mefA+) was
predominant in CA (75%) and TS (60%) while the MLSB
phenotype (ermB+/ermA-) was found in 50% of the SI isolates.
The most common T-types in relation to clinical origin were:
T12/T3.13.B3264/T4/T1 (62.5%) in CA, T8.25.Imp19/ T12/T3
(47.6%) in TS, T28/T12 (36.4%) in SI and T1/T3.13.B3264 (28.6%)
in IV. The most predominant virulence gene in each origin was:
speC in SI (57.1%), speA in CA (34.1%), ssa and prtF1 in TS
(35.4% and 51%, respectively). In IV isolates, speC and prtF1
were more frequent (49% and 43%, respectively) than speA
(26%) and ssa (3%). Clonality was higher in CA isolates (0.1)
than among infection GAS populations (0.6). Clonality of M
phenotype isolates was high in CA (0.1) and TS (0.2) and three
major M phenotype clones comprised the majority of the throat
isolates (CA and TS). One of these clones (T1; emm1;MLST-
ST28) also included GAS from SI and IV infections.
Conclusion: The abundance of speA and speC exotoxins in
asymptomatic pharyngeal GAS was impressive stressing the
role of carriers as reservoirs of highly virulent strains, which
seem to be associated mainly with throat infections rather than
with skin or severe invasive infections. Carriers may also be the
reservoirs of macrolide resistant M phenotype GAS strains with
no apparent tissue site preference.
P899
Description of the epidemiology of multiple
clusters of Streptococcus pyogenes infection in a
rehabilitation hospital
J. Dave, J. Bell, C. Fraser, H. Venkatesh, E. Olson, M. Emery,
A. Efstratiou (Edinburgh, London, UK)
Objective: Description of the epidemiology and management of
multiple clusters of Streptococcus pyogenes in a rehabilitation
hospital
Method: Multiple clusters of infected and colonised patients
with Streptococcus pyogenes including one staff were identiﬁed on
two wards over six months. In February a cluster of ﬁve patients
and a member of staff were identiﬁed with Streptococcus pyogenes
isolated from hand lesion, ear and eye swabs and wounds. The
ward was closed, deep cleaned, appropriate antibiotic treatment
administered and symptomatic staff were screened. Subse-
quently two further patients with the organism were identiﬁed
on the same ward despite implementing an education pro-
gramme and reinforcing standard infection control measures. A
further cluster of three patients was identiﬁed on another ward
in May. One of these patients continued to be positive for the
organism when a third cluster of ﬁve patients was identiﬁed two
months later.
Results: The wards were closed, patients isolated or cohorted,
screening throat and skin lesion swabs were obtained from staff
and patients, environmental cleaning implemented and stand-
ard infection control precautions and education was reinforced.
The strains were typed and the three major types detected were
emm1, emm87 and emm28. These also reﬂected the major types
found in the local community. The strains isolated from patients
differed from the staff member. All strains from one ward had
the emm28 type whilst the other ward had emm87 type,
suggesting spread within the same ward but not between the
two wards. In two patients, the organism was isolated despite at
least 48 hours of previous penicillin treatment.
Conclusion: Control of the incident required communication
of all stakeholders including infection control, public health,
ward staff and managers. Characterisation of the strains
conﬁrmed the epidemiology of these infections. Azithromycin
was successful in eradicating Streptococcus pyogenes especially
in the patients with persistent infection despite penicillin
therapy.
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P900
The EPISA study: a recent epidemiological study
in outpatients with skin and soft tissue infection
in France
V. Jarlier, P. Bernard, P. Menday, A. Santerre Henriksen (Paris,
Reims, FR; Ballerup, DK)
The EPISA study was instigated to monitor the susceptibility of
Staphylococcus aureus causing primary or secondary skin and soft
tissue infections in the community in various regions of France.
General Practitioners in 60 centres, located in 7 different
geographic areas (Reims, Evreux, Cholet, Niort, Toulouse,
Montpellier and Marseille) participated in the study. Between
December 2003 and August 2004, 480 patients were included of
whom 477 provided laboratory data and from whom 205 S.
aureus isolates were grown from skin or soft tissue swabs (197
patients, 8 with 2 distinct strains). Of the 197 patients with S.
aureus, 104 (53%) had a primary and 93 (47%) had a secondary
skin and soft tissue infection. Swabs from patients were
analysed by a central laboratory (GR Micro, London) and
susceptibility to penicillin, oxacillin, erythromycin, clindamycin,
tetracycline, gentamicin, fusidic acid, rifampicin, ciproﬂoxacin,
vancomycin and mupirocin was tested by microbroth dilution.
All but fourteen of the 205 S. aureus isolates were resistant to
penicillin (86%) and 12 (5.8%) were resistant to oxacillin. Rates
of resistance to other antibiotics were as follows: erythromycin
32%, clindamycin 3.4%, tetracycline 5.8%, gentamicin 0.5%,
ciproﬂoxacin 9.3%, fusidic acid 4.4%, rifampicin 0%, vancomy-
cin 0% and mupirocin 1%. Fourteen (6.8%) isolates were
susceptible to all of the 11 tested antibiotics, 112 (54.7%) were
resistant to one antibiotic, 58 (28.3%) to two antibiotics, 12 (5.9%)
to three antibiotics, 4 (2.0%) to four antibiotics and 5 (2.5%) to
ﬁve antibiotics. Results from the French EPISA study indicate
that multiple drug resistance is nowadays common among S.
aureus isolates from skin and soft tissue infection in the
community in France, since 10.4% of the isolates were resistant
to at least three antibiotics. Whether those multiple resistant
strains spread from the hospitals or are related to clones
prevalent in community remains to be investigated.
P901
Serotypes and antimicrobial susceptibilities of
pneumococci isolated from children with acute
otitis media during 2003–2004
Paraskakis, H. Kirikou, A. Makri, M. Papadatou,
E. Bozavoutoglou, E. Petridou, A. Charisiadou, A. Chrissaki,
A. Vogiatzi, N.J. Legakis, D.A. Kafetzis (Athens, GR)
Objectives: To determine the serotypes and antibiotic resist-
ance of pneumococci isolated from children of our geographical
area suffering from acute otitis media (AOM) during a two year
period (20032004).
Methods: A prospective study was conducted in three major
Paediatric Hospitals of major area of Athens to study pneumo-
coccal AOM in children up to 14 years, from January 2003 to
December 2004. In children with clinical evidence of AOM,
middle ear ﬂuid was taken by tympanocentesis or in those
presenting with otorrhea sample was taken by calginate swabs.
The serotyping was carried out by the Quellung reaction. The
antimicrobial testing was performed by the disc diffusion
method according to the current NCCLS guidelines. The MICs
of penicillin, amoxicillin and cefotaxime in non-susceptible to
penicillin strains (PNSP) were determined by the Etest method.
The erythromycin resistant determinants were characterized by
the double-disc induction test.
Results: Overall, 215 of Streptococcus pneumoniae isolates were
obtained from children with AOM. The major serotypes iden-
tiﬁed including 19F (53.0%), 14 (9.8%), 9V (7.9%), 6B (7.0%), 3
(6.5%), and 23F (4.6%), all together comprising 88.8% of isolates.
The potential coverage rates by the 7-valent conjugate vaccine
formulation was 84.6%. The resistance rates of the isolates were
as follows: penicillin; P (62.3%; intermediately susceptible 42.3%
and resistant 20.0%) cefotaxime (1.9%; intermediately suscept-
ible 1.4% and resistant 0.5%), amoxicillin (2.3%), erythromycin;
E (60.0%), clindamycin (18.6%), cotrimoxazole; Co (54.9%),
tetracycline; T (48.4%), chloramphenicol (4.2%). All pneumo-
cocci were susceptible to rifampin and vancomycin. The
majority of the erythromycin-resistant pneumococci exhibited
the M-phenotype (65.1%), followed by the constitutive (31.0%)
and inducible (3.9%) MLSB phenotype. Multi-drug resistant
isolates (resistant to three or more classes of antimicrobials)
were detected in 54.4% of the middle ear sample with the multi-
drug resistant pattern PECoT more frequently isolated (53.8%).
Conclusions: Our data indicate that: a) The 7-valent conjugate
pneumococcal vaccine could reduce morbidity in children. b)
Despite the high rates of resistance to multiple antimicrobials, a
spectrum of other antibiotics, including amoxicillin, remains
highly active against the penicillin non-susceptible pneumococci.
P902
Serotype distribution and antimicrobial resistance
of Streptococcus pneumoniae causing invasive
disease in childhood (2001–2004); microbiological
observations from Central Greece prior to the
systemic pneumococcal vaccination era
Paraskakis, A. Charisiadou, H. Kirikou, A. Makri,
M. Papadatou, E. Bozavoutoglou, A. Chrissaki,
H. Papavasileiou, D.A. Kafetzis, N.J. Legakis,
A. Pangalis (Athens, GR)
Objectives: To determine the serotypes and antibiotic resist-
ance of pneumococci isolated from children with invasive
disease during 20012004, just before the systematic application
of the 7-alent conjugate vaccine in Greece.
Methods: Concecutive pneumococcal isolates from children
with suspected bacteremia/sepsis seen at three major Paediatric
Hospitals of Athens from January 2001 to December 2004, were
included in the study. The antimicrobial testing was performed
by the disc diffusion method. The MICs of penicillin, amoxicil-
lin, cefotaxime and oﬂoxacin in non-susceptible to penicillin
strains (PNSP) were determined by the Etest method. The
erythromycin resistant determinants were characterized by the
double-disc induction test. The serotyping was carried out by
the Quellung reaction.
Results: A total of 186 invasive Streptococcus pneumoniae isolates
(IPD) were obtained from children with bacteremia/sepsis. Of
these, 161 were recovered only from blood, and 25 from an
additional source; 20 from CSF, and 5 from other material (joint
ﬂuid, ascitic ﬂuid, and bone aspirations). The age of bacteremic
patients ranged from 22 days to 14 years. Most of pneumococci
(55.4%) were from children aged <2 years. The IPD isolates were
distributed into 19 serotypes of which serotype 14 was prevalent
(44.6%), followed by 6B (11.3%), 9V (7.5%), and 19F (6.5%). The
potential coverage rates by the 7-valent conjugate vaccine
formulation was 75.3%, and encountered more often among
isolates derived from children <2 years of age than older ones
(87.4% coverage vs. 60.2%). Among the IPD isolates 17.2% were
PNSP and 1.2% intermediately susceptible to cefotaxime. Only a
small number of PNSP (0.5%) exhibited MICs of penicillin
>1 mg/l. High rates of resistance were observed to erythromy-
cin and cotrimoxazole (30.1% and 23.7%, respectively). All
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pneumococci were susceptible to amoxicillin, oﬂoxacin, and
vancomycin. The majority of the erythromycin-resistant pneu-
mococci (85.7%) exhibited the M-phenotype. Multi-resistant
isolates accounted for 11.3% of the IPD sample and were more
often isolated from younger (<2 years) than older children (71.4
vs. 28.6%).
Conclusions: These data indicate that: a) The 7-valent conjugate
pneumococcal vaccine could potentially prevent a substantial
proportion of episodes of bacteremic disease in Greek paediatric
population. b) The b-lactams remain suitable antimicrobials for
empiric therapy of invasive disease in this setting.
P903
Clinical characteristics and outcome of 22 patients
with invasive infection due to vancomycin-
resistant E. faecium
C. Theilacker, H. Bertz, M. Bussmann, J. Huebner, W.V. Kern for
the VRE Task Force
Objective: Until recently, vancomycin-resistent Enterococci
(VRE) have not been a major clinical problem in many European
countries, including Germany. Here we report the clinical and
microbiologic features of a cohort of patients with invasive VRE
infections in a German tertiary care hospital.
Methods: During a prolonged outbreak that started in 2004, a
total number of 167 adult patients were identiﬁed to be
colonized and/or infected by VRE of whom 22 (13%) developed
invasive infection [20 bloodstream infection (BSI), 2 peritonitis].
Clinical characteristics and outcomes of these patients were
assessed after structured retrospective chart review.
Results: All VRE were identiﬁed as E. faecium, and all infections
were hospital-acquired. The mean age was 53 years. 20 (91%)
patients with invasive VRE infection had cancer (16 haemato-
logic malignancies, 4 solid tumours), and two patients had liver
cirrhosis. Of the cancer patients, 17 (85%) were not in remission.
Nine had recently undergone allogeneic haematopoietic stem
cell transplantation. 12 (60%) had neutropenia at the time of the
BSI. A signiﬁcant co-pathogen was found in 10 (45%) of patients.
36% of patients had received vancomycin, 23% metronidazol
and 45% a 2./3. generation cephalosporin within 7 days prior to
VRE bacteraemia. The 4-week crude mortality rate in our cohort
was 59%. The mean duration of bacteraemia was 2, 7 days. In
patients dying with VRE bacteraemia the duration of bacterae-
mia was signiﬁcantly longer than in those surviving (4, 3 vs. 1,
1 days, p = 0.04). 4 deaths (33%) were thought to be attributable
to VRE bacteraemia by clinical judgement. 81% of patients
received an antimicrobial agent effective against VRE (15
linezolid, 1 quinupristin/dalfopristin, 2 a combination of both).
Conclusion: In our study population, VRE bacteraemia was
largely conﬁned to high-risk patients and especially those with
uncontrolled haematologic malignancy. In a signiﬁcant number
of patients, additional signiﬁcant co-pathogens were found. The
overall and attributable mortality of VRE bacteraemia in this
cohort was high, despite utilisation of antimicrobials active
against VRE.
P904
Molecular characterisation of group B
Streptococcus serotype III subtypes 1–4 in Hong
Kong
M. Ip, E. Cheuk, M. Tsui, F. Kong, D.T.N. Leung, G.L. Gilbert
(Hong Kong, HK; Westmead - Sydney, AU)
Objectives: To characterize Group B Streptococcus (GBS) Sero-
type III Subtypes I–IV by PFGE, surface protein genes, mobile
genetic elements and multi-locus sequence typing.
Methods: 136 non-duplicate GBS serotype III isolates from
patients admitted to Prince of Wales Hospital, Hong Kong,
during 1993–2003, were examined. These included 73 isolates
from bacteraemia and meningitis cases, 15 from wound/pus
and 48 from swabs of newborns or from genital tracts of
pregnant mothers. The isolates were differentiated into four
subtypes, III-1, III-2, III-3, and III-4, by sequencing of the
capsular polysaccharide genes, cpsE to cpsG and the isolates
were typed by PFGE, gene speciﬁc PCRs on surface proteins
(Rib or C alpha and beta, Alp2 and Alp3 protein genes) and
mobile genetic elements including IS1548, IS861, IS1381, ISSa4
and GBSil. Multi-locus sequence types of the representative
strains for each subtype were also identiﬁed by PCR and
sequencing.
Results: 52.2% (71) of isolates belonged to subtype III-1, 25.0%
(34) were subtype III-2, 5.1% (7) were III-3 and 17.7% (24) were
III-4. Subtype III-1 was characterized by possessing the IS1548
and Rib protein gene, representatives belong to ST19 by MLST.
Subtype III-2 also possessed the Rib protein gene, and GBSil,
and belong to ST17. Subtype III-3 are heterogenous on PFGE,
possessed Alp2 protein gene, and representatives belonged to
ST23. Subtype III-4 constituted mainly invasive isolates from
non-pregnant adults, and these strains have indistinguishable
PFGE pattern, possessed C alpha protein and IS1381, and have
unique ST by MLST (allelic proﬁle 9-5-7-1-3-3-2) The distribution
of strains from invasive disease versus colonizing strains for
each subtype was calculated by Chi-squared test. Isolates of
subtype III-4 predominantly were invasive strains (p £ 0.01)
whilst non-invasive strains were signiﬁcantly distributed in
subtype III-1 (p £ 0.05) and no statistical signiﬁcance for subtype
III-2 or 3. Subtype III-4 constituted invasive isolates from non-
pregnant adults, and was not isolated in neonates or genital tract
of pregnant mothers.
Conclusion: GBS Serotype III subtypes-1 and -2 are known to
cause invasive neonatal disease. An increase in invasive disease
in healthy non-pregnant adults recently in Hong Kong may be
due to the presence of subtype III-4 which was not seen in
neonates.
P905
Role of isolation of Corynebacterium spp.
organisms in different clinical settings, including
intensive care
R. Manfredi, A. Nanetti, S. Morelli, R. Valentini, L. Calza,
F. Chiodo (Bologna, IT)
Background: Corynebacterium spp organisms are commonly
isolated, by their pathogenic role is still poorly known.
Methods: A bacteriological-clinical survey was conducted on
all inpatients of our teaching Hospital, in order to identify all
Corynebacterium isolates, and to assess them according to
involved species, clinical materials, and hospital setting, with
special attention on intensive care units (ICU).
Results: Of 161 Corynebacterium isolates of year 2004, 17 C.
glucuronolyticum strains came from semen assessed during
FIVET screening procedures, and were not further evaluated.
Corynebacterium spp represented the most frequent isolate (78
episodes, with 4-11 repeated isolation in 2 patients), followed by
C. striatum (33 strains), C. jeikeium (15), C. urealyticum (6), C.
propinquum (5), C. afermentans (3), C. macgihley and Corynebacte-
rium group G-1 (2 cases each). The most frequent clinical
specimens were blood cultures (41), blood/CVC (14), bronchial
aspirates/BAL (25), ascites/pleural effusion (14), surgical
wound/ulcers (13), urine (12), and drainages (11). Interestingly,
while all C. jeikeium and C. propinquum isolates came from blood
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
and catheters, Corynebacterium spp prevailed (>80%) in blood
and lower respiratory tract cultures, C. striatum predominated
in wound infections, ulcers, and drainages (>60%). When
making a four-year survey of Corynebacterium strains isolated
from all ICU since year 2001, 24 disease episodes were
conﬁrmed in 21 patients (15 males and 6 females, aged 32–
90 years). Corynebacterium spp accounted of 11 isolates, followed
by C. striatum (6), C. jeikeium (4), C. group G-1 (2), and C.
macginley (1), while among clinical specimens bronchial aspir-
ate/BAL prevailed (11 cases), over blood (6), peritoneal ﬂuid/
abdominal drainage (5), and surgical wounds (2).
Conclusion: Corynebacterium spp. are assessed with increasing
interest, but their clinical role remains unclear. Based on their
unpredictable sensitivity proﬁle, further epidemiologicao`, clin-
ical, and therapeutic studies are strongly needed.
P906
Skin colonisation of Corynebacterium jeikeium
M. Demirbilek, F. Can, A. Kundakci, A. Guven, E. Sirma, P. Cay,
H. Arslan (Ankara, TR)
Objective: Corynebacterium jeikeium is an opportunistic patho-
gen particularly in immunosuppressed and neutropenic
patients. The multiresistance of C. jeikeium clinical isolates is a
common feature and often responsible for failure of antibiotic
therapy. The aim of this study was to evaluate occurrence of
these microorganisms in skin ﬂora of different patient popula-
tions and to demonstrate antibiotic resistance proﬁles.
Methods: Fifty hospitalized patients from intensive care unit, 50
patients with different dermatological disorders from policlinic
and 20 volunteers as the control group were included to the
study. Skin smears were taken from axillar region of patients.
Specimens were cultivated in blood agar + tween 80 medium for
48 hours – 7 days, at 37C. Identiﬁcations were based on
conventional methods and Api Coryne test. Antibiotic sensitiv-
ity tests were performed by disc diffusion and agar dilution
methods according to NCCLS standards.
Results: C. jeikeium were isolated from 38% of hospitalized
patients, 6% of patients with dermatological problems and 2% of
control group. Multidrug resistance was established from 77% of
isolates.
Conclusion: This study showed us the colonization rates of C.
jeikeium were higher in hospitalized patients and dermatological
disorders did not affect these rates. Opportunistic infections are
usually caused by endogenic ﬂora so the high colonization rate
may be a problem for hospital acquired infections with these
multidrug resistant organisms.
P907
Serotype distribution of Streptococcus
pneumoniae-resistant strains isolated in Western
Pomeranian Region of Poland in 2001-2003
M. Nowosiad, S. Giedrys-Kalemba (Szczecin, PL)
Objectives: S. pneumoniae is a main causative agent of upper
respiratory tract infections and severe systemic diseases. In face
of abrupt antimicrobial resistance increase and clonal spread of
multiresistant strains, vaccine prophylaxis seems to be an
important way of antipneumococcal defence. The aim of this
study was to analyse serotype distribution of S. pneumoniae
resistant strains isolated in our region during three years (2001–
2003) and determination of pneumococcal vaccines effective-
ness.
Methods: Using E-test method and the NCCLS criteria for
benzylpenicillin, erythromycin, clindamycin, tetracycline, co-
trimoxazole, ceftriaxone, chloramphenicol, vancomycin, imipe-
nem, 80 resistant strains were obtained. Serotyping was
performed using reference method of capsular swelling with
pneumococcal diagnostic antisera kit of Statens Serum Insitut
(Copenhagen).
Results: Resistance to 8 out of 9 determined antibiotics (except
vancomycin) was described, with 63% of MDR strains. Serotype
was determined for 73 strains, 2 were described as non-vaccine
related, 5 were untypeable. We observed 9 different serotypes in
following percentages: 6B—27.5%, 19F—21.3%, 23F—12.5%,
9V—12.5%, 14—8.8%, 18C–2.5%, 11A—1.3%, 33F—1.3%,
6A—3.8%. Eight of them can be found in 23-valent vaccines
(except 6A type, which shows cross immunogenicity in serogrup
6), including 93.3% (and with 6A—97.3%) of serotyped resistant
strains. In case of 7-, 9-, 11-valent vaccines this percentage is
similar and concern 90.7% strains (with 6A – 94.7%). Serotype
23F was the most penicillin nonsusceptible with 80% of such
strains and 4 of all 5 high penicillin resistant strains observed in
the study. The highest number of MDR strains (41%) belonged
to serotype 6B and all strains of this serotype were MDR. Other
serotypes consisted of following percentages of MDR strains:
23F-80%, 14-71%, 19F-58.8%, 9V-40%, 18C, 11A, 33F-0%.
Conclusions: The majority of strains in the study are of
serotypes present in pneumococcal vaccines. New generation
7-, 9-, 11-valent conjugated vaccines despite smaller serotypes
spectrum, cover not much lower percentage of strains observed
in our region, and because of their immunogenicity in children
under two year of live, can be more effective in antipneumo-
coccal defence. Such a low amount of non vaccine related
resistant strains in study could be a result of low antipneumo-
coccal vaccination in Poland. The higest multiresistance degree
show serotype 6B, and serotype 23F is the most nonsusceptible.
ESBL and carbapemenase producing Gram-negative organisms
P908
First report of a metallo beta-lactamase produced
by a Klebsiella pneumoniae clinical isolate in the
United Kingdom
F. M’Zali, T.A. Collyns, M. Taylor, M. Elliot, H. Inns, S. Picton,
N. Young (Leeds, UK)
Background: Class B carbapenem-hydrolysing beta-lactamases
are metallo-beta-lactamases. Such enzymes are of great clinical
signiﬁcance as they degrade virtually all beta-lactams; so there
may be very few therapeutic options remaining. They have been
reported worldwide almost exclusively in Pseudomonas aerugi-
nosa and other non fermenting Gram-negative bacilli.
Methods: The K. pneumoniae isolate was recovered from the
urine of a 4-year old febrile neutropenic child who had received
previous beta-lactam agents including meropenem. The isolate
had reduced susceptibility to meropenem (MER) and imipenem
(IMP) by disk diffusion testing and was only susceptible to
ciproﬂoxacin.
Results: The isolate was identiﬁed using API 20E (Biomerieux,
France). The Minimum Inhibitory Concentration (MIC) of IMP
and MER as measured by E-test (AB Biodisk, Sweden) were
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16 mg/l and 8 mg/l respectively. PCR ampliﬁcation using
speciﬁc primers for bla IMP and bla VIM was performed and
an 830 bp product was ampliﬁed when using primers speciﬁc
for bla IMP. Nucelotide sequence analysis of the PCR product
identiﬁed the gene as bla IMP-9. Further molecular screening
showed the bla IMP-9 to be located on a 200 kb plasmid and
associated with a Class 1 integron.
Conclusions: Metallo-beta-lactamases producing P. aeruginosa
have been increasingly reported from different parts of the
world including from the UK. This important class of enzymes
is also emerging in Enterobacteriaceae. This is the ﬁrst report of an
isolate of the Enterobacteriaceae family expressing a metallo-
carbapenemase from the UK. The spread of new resistance
determinants among nosocomial pathogens is of concern. This
report highlights the continuing global emergence of these
resistance determinants.
P909
Pandrug-resistant Providencia rettgeri producing
PER-1 extended-spectrum beta-lactamase and
VIM-2 metallo-beta-lactamase
K.S. Shin, B.R. Son, J. Kim (Cheongju, Daegu, KR)
Objectives: The PER-1 enzyme, an Ambler class-A extended-
spectrum beta-lactamase (ESBL), can hydrolyse most exten-
ded-spectrum beta-lactams except carbapenems and the VIM-2
type metallo-beta-lactamase (MBL) can hydrolyze all beta-
lactams except monobactams. These bla genes are identiﬁed
mostly in Pseudomonas spp. and Acinetobacter spp. During May
to July, 2004, three strains of Providencia rettgeri with pandrug-
resistance were isolated from urinary specimen of three
patients hospitalized with a same hospital room and they
were examined for the phenotypic and genotypic character-
istics.
Methods: The minimal inhibitory concentration [MIC] was
determined by broth microdilution method. The double disk
synergy test and EDTA-disk synergy test were carried out for
the screening of ESBL and MBL production, respectively. The
PCR and sequencing analysis were performed for blaPER-1,
blaIMP-1, blaVIM-1, blaVIM-2, and class I integron. The DNA
ﬁngerprinting of genomic DNAs was performed by a random
ampliﬁed polymorphic DNA [RAPD] analysis.
Results: In vitro antimicrobial susceptibility test, these strains
were resistant to all tested antibiotics, including ampicillin,
piperacillin, cefazolin, cefotaxime, ceftazidime, cefepime, aztre-
onam (MICs, >256 lg/mL), cefoxitin (MIC, 128 lg/mL), imipe-
nem (MIC, 16 lg/mL), meropenem (MIC, 8 lg/mL), amikacin
(MIC, 128 or >128 lg/mL), tobramycin (MIC, 128 or >128 lg/
mL), gentamicin (MIC, 64, 128 or >128 lg/mL), and ciproﬂoxa-
cin (MIC, >64 lg/mL). All three strains were positive for the
double disk synergy test and EDTA-disk synergy test indicating
co-production of ESBL and MBL both and blaPER-1 and
blaVIM-2 were detected in all three strains by a subsequent
PCR analysis. PCR ampliﬁcation for class 1 integron yielded a
ca. 3,700 bp fragment, which was subsequently sequenced,
revealing that the detected blaVIM-2 gene was part of a class 1
integron. RAPD analysis showed the same pattern of three
strains indicating a single clonal origin.
Conclusions: Pandrug-resistant Providencia rettgeri strains were
isolated from urinary specimen and they carried blaPER-1 and
blaVIM-2 both in a single strain. The emergence of the strains
which co-produce ESBL and MBL both in a single strain deserve
great attention due to the limitation of antibiotics for the
treatment of infection caused by these bacteria.
P910
An outbreak of VIM-4 producing
multidrug-resistant Pseudomonas aeruginosa
isolates from three different towns in Hungary
B. Libisch, M. Muzslay, M. Knausz, M. Gacs, L. Ro´kusz,
J. Mina´rovits, I. Kustos, M. Fu¨zi (Budapest, Gyo˜r, Pe´cs, HU)
Objectives: We have recently started monitoring metallo-beta-
lactamase (MBL) producing clinical isolates at the National
Center for Epidemiology, Hungary. In 2005 a cluster of MBL
producing P. aeruginosa infections were observed in North-West
Hungary. Our aim was to characterise these isolates by molecu-
lar and phenotypic tools and to establish their epidemiological
relationship.
Methods: Antibiotic resistance was determined according to the
CLSI recommendations. The MBL Etest and IPM-EDTA disk test
were used for screening multidrug-resistant P. aeruginosa iso-
lates. PFGE was carried out using the SpeI enzyme and analysed
by computational methods. Integrons and blaVIM genes were
ampliﬁed by PCR and sequenced with an ABI Prism 3700
Sequencer. Serotyping was carried out by monovalent O11 and
O12 antisera.
Results: To date we have characterised 31 VIM-positive P.
aeruginosa isolates from three intensive care units in three
different towns in North-West Hungary. The isolates were
cultured from clinical samples of thirteen patients, from the
hospital environment and from faecal samples. Among the
clinical samples trachea and drain samples were most prevalent.
One patient with no previous related clinical history was
identiﬁed as a carrier on admission, suggesting the presence of
VIM-positive strains in the community. We have also identiﬁed
carrier patients who were transferred between the concerned
hospitals thus providing an epidemiological link between them.
Several isolates were only sensitive to polymyxin. Macrorestric-
tion proﬁling revealed that the strains selected for PFGE analysis
from three different towns were clonally related and were also
of serotype O11. One of these isolates was analysed for integron
content and structure. These studies revealed the presence of
three different integrons within this strain, with the largest one
of more than 3 kb. This class 1 integron was sequenced and
carried a blaVIM-4 gene cassette in its ﬁrst position.
Conclusions: This is the ﬁrst reported outbreak of MBL pro-
ducing clinical pathogens from Hungary. Our observations
together with several other VIM-producing isolates from differ-
ent regions of the country suggests that MBL producing P.
aeruginosa should be regarded as an important emerging
multidrug-resistant pathogen in Hungary.
P911
Molecular epidemiology of VIM-producing
P. aeruginosa isolated in four European countries
C. Giske, B. Libisch, C. Colinon, E. Scoulica, M. Fu¨zi,
G. Kronvall, G.M. Rossolini (Stockholm, SE; Budapest, HU; Siena,
IT; Heraklion, GR)
Objectives: P. aeruginosa producing VIM-type metallo-b-lacta-
mases have originally been detected in Mediterranean countries
and, more recently, also in Poland, Sweden and Hungary. In the
last two cases strain import from Greece was suggested. Our
study was designed to explore relatedness between P. aeruginosa
isolates producing enzymes of the VIM-1 lineage from Medi-
terranean countries and those emerging in Northern and Eastern
Europe.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Methods: Twelve clinical isolates of P. aeruginosa producing
VIM-1-like enzymes from Italy (n = 7), Hungary (n = 2),
Sweden (n = 2) and Greece (n = 1) were studied. The genetic
typing methods MLST, PFGE, RAPD and ﬂiC sequence analysis
were applied, as well as comparison of integron structure and
serotype.
Results: Based on the results of the typing methods isolates
were classiﬁed into four major groups. Group 1 was formed by 6
serotype O11 isolates from Italy with similar PFGE proﬁle,
identical MLST proﬁle and ﬂiC type a. Five different integron
structures were observed in this group, all of them with the
blaVIM-1 cassette in the ﬁrst position. Group 2 contained a single
non-serotypable Italian isolate with clearly distinct MLST and
PFGE patterns. Three serotype O12 isolates constituted Group 3:
two from Hungary [PA396, PA555] and one from Sweden
[AK5493]. These three strains clustered together by RAPD, had
an identical ST, and harboured ﬂiC type b. The two Hungarian
isolates were potentially related by PFGE, while the Swedish
isolate was not. Both PA396 and AK5493 were isolated from
Greek national patients. The Hungarian isolates had similar
integron structures, featuring blaVIM-4 in the last position,
while the Swedish isolate had a different structure. The fourth
group comprised two serotype O11 isolates, one from another
Greek patient in Sweden, and the other [Ps100] from Heraklion,
Greece. The two strains had identical STs and ﬂiC type a, but
different PFGE patterns. In both isolates blaVIM-4 was found in
the ﬁrst position of the integron, but the other cassettes differed.
Interestingly, Ps100 was found to be closely related to group 1
isolates by RAPD, although their MLST proﬁles were different.
Conclusions: Our results indicate a clonal diversity of VIM-1-
like-positive P. aeruginosa spreading in Europe, but also under-
score the role of human carriage in the international spread of
MBL producing P. aeruginosa. MLST can be useful to establish
epidemiological relationships between isolates that are discrim-
inated by PFGE.
P912
Metallo-beta-lactamase-producing Pseudomonas
spp. and Acinetobacter spp. in Korean hospitals:
emergence of SIM-1-producing Acinetobacter
baumannii
K. Lee, M-N. Kim, T.Y. Choi, K.S. Hong, S. Lee, D.H. Whang,
D. Yong, Y. Chong (Seoul, KR)
Objectives: Acquired metallo-beta-lactamases [MBLs] have
been increasingly reported in clinical isolates of gram-negative
bacilli worldwide. The 5th MBL type, blaSIM-1 was ﬁrst detected
in A. baumannii clinical isolates at a Korean tertiary care hospital.
The aim of this study was to determine any change of the types
of MBL and prevalence of MBL-producing isolates among
Pseudomonas spp. and Acinetobacter spp. collected from Korean
Nationwide Surveillance of Antimicrobial Resistance
(KONSAR) program-participating hospitals in 2005.
Methods: Non-duplicate, imipenem-resistant isolates of Pseu-
domonas spp. and Acinetobacter spp. were collected in 2005 from
23 KONSAR hospitals. MBL production was screened by the
imipenem disk Hodge test and imipenem-EDTA + SMA double
disk synergy test. blaIMP-1, blaVIM-2 and blaSIM-1 alleles were
detected by PCR using heat-extracted DNA template.
Results: Among the imipenem-resistant isolates tested, 42 of
397 (10.6%) P. aeruginosa, 8 of 12 (66.7%) Pseudomonas spp. and
27 of 177 [15.3%] Acinetobacter spp. were MBL producers.
Among the MBL producers, 37 and 13 isolates of Pseudomonas
spp. had blaVIM-2 and blaIMP-1 alleles, respectively, and 10, 9
and 8 isolates of Acinetobacter spp. had blaIMP-1, blaSIM-1
and blaVIM-2 alleles, respectively. MBL-producing isolates of
Pseudomonas spp. and Acinetobacter spp. were detected in 15 of
23 (65%) and 9 of 23 (39%) hospitals, respectively. MBL-
producing isolates existed in 9 of 10 cities/provinces in Korea.
Conclusion: VIM-2 type MBL continued to be dominant type in
Pseudomonas spp., but in Acinetobacter spp., SIM-1-producing
isolates emerged and prevalence of IMP-1-, SIM-1- and VIM-2-
producing isolates were similar. It is a concern that Acinetobacter
isolates producing the new MBL, SIM-1, are detected in two
hospitals.
P913
Outbreak of multidrug-resistant Acinetobacter
baumannii producing the carbapenem
hydrolysing beta-lactamase OXA-58 in a general
intensive care unit in Southern Italy
L. Pagani, R. Migliavacca, E. Nucleo, M.M. D’Andrea, M. Spalla,
C. Terulla, E. Aquilini, M. Labonia, M. Li Bergoli,
G.M. Rossolini (Pavia, Siena, San Giovanni Rotondo, IT)
Objectives: The oxacillin-hydrolyzing beta-lactamases belong-
ing to Ambler class D are emerging resistance determinants in
Gram-negative nosocomial pathogens. Since the ﬁrst description
of a carbapenem-hydrolyzing oxacillinase in 1993, several
oxacillinases with a carbapenem-hydrolysing activity have
been reported in MDR isolates of A. baumannii, but their
epidemiology remains largely unknown. In this work we
describe an outbreak due to A. baumannii producing the OXA-
58 class D. carbapenemase in a general Intensive Care Unit of an
Italian Hospital.
Methods: Sixteen nonreplicate carbapenem-resistant isolates of
A. baumannii were collected from 16 inpatients at the Intensive
Care Unit of the S. Giovanni Rotondo Hospital (Southern Italy)
during the period November 2003 February 2004. Most isolates
(14/16) were from the lower respiratory tract. MIC of imipenem
(IPM) was determined by a microdilution test as recommended
by CLSI. Double-disk test in MH agar plus cloxacillin (250 mg/
L), was used for phenotypic detection of oxacillinases produc-
ers. IEF coupled with a bioassay, PCR ampliﬁcation with
primers speciﬁc for blaOXA-23, blaOXA-40 and blaOXA-58
were carried out to identify the OXA-type determinants. The
clonal relationships between the isolates were evaluated by
PFGE and Rep-PCR.
Results: All carbapenem-resistant A. baumannii isolates (MICs
range 16–64 mg/L) were shown to produce a beta-lactamase (pI
7.2) active on oxacillin and IPM by the bioassay. In all cases the
oxacillin hydrolysing beta-lactamase was identiﬁed as OXA-58
by molecular methods. The OXA-58 producers were also
resistant to all beta-lactams, all aminoglycosides but amikacin
and to ﬂuoroquinolones. Genotyping showed that all the OXA-
58 producers were clonally related suggesting a clonal spread
within the ward.
Conclusion: This is the ﬁrst report of a nosocomial outbreak
caused by A. baumannii producing OXA-58 in Italy. The
spreading of carbapenem-hydrolysing oxacillinases is of con-
siderable concern for antimicrobial chemotherapy.
P914
Carbapenem-hydrolysing oxacillinase OXA-40 in
an Acinetobacter haemolyticus clinical isolate
S. Quinteira, L. Peixe (Porto, PT)
Objectives: A. carbapenem-resistant A. haemolyticus strain was
isolated, in 2002, from an university hospital where an endemic
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multi-drug resistant (MDR) A. baumannii is currently been
observed. The aim of this study was to determine the molecular
basis of carbapenem resistance in this isolate.
Methods: A. carbapenem-resistant A. haemolyticus strain was
isolated from a urine sample of a medicine ward attending
patient in a Porto university hospital. Identiﬁcation was per-
formed using the API32GN system and by sequencing the 16S
rRNA genes. MICs of beta-lactams and colistin were determined
by Etest and agar dilution method, respectively. Susceptibility to
non-beta-lactam antibiotics was performed by the disk diffusion
method. Genes were sought by PCR with blaIMP, blaVIM
and blaOXA-24-like speciﬁc primers. Obtained products were
sequenced.
Results: The isolate was identiﬁed as A. haemolyticus, based on
the results of 16S rRNA genes sequencing. It presented resist-
ance to imipenem, meropenem (MIC of ‡ 32 mg/L), to amox-
icillin and its association with clavulanic acid, ureidopenicillins
and their associations (MIC of ‡ 256 mg/L), and was susceptible
to cefepime and cefpirome (MIC of 8 mg/L), ceftazidime and
aztreonam (MIC of 4 mg/L). It showed resistance also to colistin
(MIC of 4 mg/L), to ciproﬂoxacin and variable behaviour to
aminoglycosides. No PCR evidence suggested the presence of
blaIMP or blaVIM type genes but a PCR product with blaOXA-
24-like speciﬁc primers was obtained. Sequencing showed the
presence of a OXA-40 enzyme.
Conclusion: In this study we describe, for the ﬁrst time, the
presence of OXA-40 enzyme in a A. haemolyticus clinical isolate.
Although the spreading of OXA-40, both in the Iberian Penin-
sula and France, has been correlated with the progressive
dissemination of a single A. baumannii clone, the observation of
this enzyme in a different, previously unreported, genomic
species, A. haemolyticus, poses new questions on OXA-40
dissemination.
P915
Inﬂuence of carbapemen resistance on outcome in
Acinetobacter baumannii bacteraemia in an
intensive care unit
R. Zaragoza, J.J. Camarena, A. Artero, S. Sancho, R. Gonzalez,
J.C. Navarro, J. Nogueira (Valencia, ES)
Objectives: The aims of this study were to determine the
prevalence and clinical features of A. baumannii bacteremia
(ABB) in an Intensive Care Unit, to identify the clinical
differences between Carbapenem resistant and carbapenem-
susceptible episodes, to know their prognosis, and ﬁnally to
deﬁne if carpapenem resistance is a factor independently
associated to hospitality and related mortality in ICU patients
with ABB.
Methods: From 1996 to 2005, 322 patients with a clinically
signiﬁcant bacteremia were prospectively evaluated in ICU of a
teaching hospital. Carbapenem resistant A. baumannii (CR) was
deﬁned as the laboratory documentation of strains of Acinetob-
acter which were not susceptible to Imipemen and Meropenem.
Clinical and microbiological variables were studied. A multiva-
riate analysis was performed to determine the factors inde-
pendently associated to hospitality and related to bacteremia
mortality in ICU patients with ABB.
Results: Seventy-nine (29%) of 322 ICU bacteremias were due to
ABB. A sixty- eight percent of them were CR episodes. The
mean age of patients with ABB was 60.6 years (SD 13.3) and the
relation between men/women was 3.1. APACHE II score was
19.3 (SD 7.8). The incidence of inadequate empirical antibiotic
treatment was 51.8% in ABB patients. The principal origins of
ABB were: respiratory (49.3%), unknown (20.2%) and catheter
(15.1%). Severe sepsis or septic shock was present in 56.9%. The
global and related mortality rate for ABB was 56.9% and 25.3
There were no differences in APACHE II or SOFA score,
presence of septic shock, foci of infection between CR and
susceptible episodes. Only the incidence of inadequate empirical
antimicrobial treatment was statistically higher in CR group
(59.2% vs 25%; p = 0.009). No differences were also found in
Global (62.9% vs 55%) and related mortality (27.7 vs 15%) rates
between two groups. In a multivariate analysis CR was not
independently associated with global or related mortality in
ABB patients. Only the presence of severe sepsis or septic shock
(OR 6.3; 95% CI 2.1-18.9; p = 0.001) was an independent
predictor of hospitality mortality in critically ill patients with
ABB.
Conclusions: The prevalence of ABB is very high among
critically ill patients, and majority of them are CR. Although
CR implies a higher rate of inappropriate empirical antimicro-
bial treatment, CR is nor associated with an increased global or
related mortality in critically ill patients with ABB.
P916
Risk factors for nosocomial imipenem-resistant
Acinetobacter baumannii infections
G. Baran, A. Erbay, H. Bodur, P. Onguru, E. Akinci, N. Balaban,
M.A. Cevik (Ankara, TR)
Objectives: To identify the risk factors for nosocomial imipe-
nem-resistant A. baumannii (IRAB) infections.
Methods: The study was conducted prospectively between
January to December 2004 at a tertiary care hospital in
Ankara. The patients who had nosocomial A. baumannii infec-
tions were enrolled to the study. The characteristics of the
patients who had IRAB infections and imipenem-sensitive A.
baumannii (ISAB) infections were compared. Only the ﬁrst
isolation of A. baumannii was considered. Nosocomial infections
were deﬁned according to CDC criteria.
Results: IRAB was isolated from 66 (53.6%) patients, and ISAB
was isolated from 57 (46.3%) patients during the study period.
IRAB were most frequently isolated from tracheal aspirate
(28.7%) and blood (21.2%) cultures whereas, ISAB were most
frequently isolated from wound (33.3%) and blood (31.5%)
cultures. Mean duration of hospital stay until A. baumannii
isolation was 20.8 ± 13.6 days in IRAB infections whereas
15.4 ± 9.4 days in ISAB infections. 65.1% of the patients with
IRAB infection and 40.3% of patients with ISAB infection were
followed at intensive care unit (ICU). Previous carbapenem use
was present in 43.9% of the patients with IRAB and 12.2% of the
patients with ISAB infection. According to the univariate
analysis female sex, ICU stay, emergent surgical operation,
total parenteral nutrition, having central venous catheter,
endotracheal tube, urinary catheter, previous antibiotic use
and previous administration of carbapenems were signiﬁcant
risk factors for IRAB infections (p < 0.05). In multivariate
analysis, longer duration of hospital stay until A. baumannii
isolation [odds ratio (OR), 1.043; 95% conﬁdence interval (CI),
1.003 -1.084, p = 0.032], previous antibiotic use (OR, 5.051; 95%
CI, 1.004-25.396, p = 0.049) and ICU stay (OR, 3.1; 95% CI, 1.398-
6.873, p = 0.005) were independently associated with imipenem
resistance.
Conclusions: Our results suggest that the nosocomial occur-
rence of IRAB is strongly related to an ICU stay, duration of
hospital stay and IRAB occurrence may be favoured by the
selection pressure of previously used antibiotics.
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P917
Dissemination of extended-spectrum beta-
lactamase producers in natural environments in
Northern Portugal
J. Rocha, H. Neto Ferreira (Porto, PT)
Objectives: The aim of this study was to detect ESBL produc-
ers, in natural water streams reaching the sea and compare with
those isolated from sea water samples. Our previous work,
showed contamination of marine coastal water with antimicro-
bial resistant bacteria, namely ESBL (extended-spectrum
b-lactamases) producers. This question alerted us to the origin
of this contamination. In that way, it was our purpose to look for
possible contamination sources, in water streams reaching the
beach.
Methods: Natural water streams (probably including raining
water streams) reaching the sea, were collected in July 2004 and
2005 (beach season, in Portugal), from 3 beaches of the Porto
area. Isolates were selected by membrane ﬁltration technique
and the ﬁlters were placed on Mac Conkey agar and Mac
Conkey agar with ceftazidime (2mg/l) or cefotaxime (2mg/l).
Colonies of lactose fermenters were randomly selected and
screened for ESBL production by the double disc synergy test.
Identiﬁcation of the selected strains was achieved by classic
biochemical tools and ID 32 GN. Susceptibility to antimicrobial
agents was determined according to the CLSI guidelines.
b-lactamases were characterized by isoelectric focusing.
Results: The natural water streams accessed, in this work, seem
to be impacted by faecal contamination of unknown origin, with
antimicrobial resistant strains, namely ESBL producers. At least
4 water streams isolates, were able to transfer the ESBL gene, by
conjugation.
Conclusion: Our tries to understand coastal sea water contam-
ination with ESBL producers, showed that natural water streams
reaching the seashore, are, in at least some part, responsible for
seawater contamination with ESBL producers. Future work
intends to ﬁnd the origin of contamination of these natural
environments. This situation seems relevant in terms of public
health and environmental protection, once these are some of the
beaches used by the Porto population. The incoming of ESBL
producers to natural environments and the transferability of the
ESBL genes by conjugation, might provide a track for environ-
mental dissemination of resistant bacteria and genes, that may
create a source of transferable traits for environmental bacteria,
inﬂuencing natural reservoirs of resistance.
P918
The presence of extended-spectrum b-lactamase-
producing Escherichia coli is a prognostic factor
for patients with E. coli bacteraemia
G. Peralta, J. Pelayo, E. Lopez, L. Garcia-Maurin˜o, M.P. Roiz,
I. De Benito, J.C. Garrido, S. Sanchez-Ortiz, P. Fombellida,
M.J. Rodriguez-Lera, L. Ansorena (Torrelavega, ES)
Objectives: Escherichia coli is one of the ﬁrst causal agents of
bacteraemia. However the published information about their
prognostic factors is scarce, and not recent, so we decided to
analyse this aspect in our patients with Escherichia coli bacter-
aemia.
Methods: Cases of Escherichia coli bacteraemia were identiﬁed
by using the microbiology laboratory database. The charts of all
patients with Escherichia coli bacteraemia attended at our
hospital between January 2001 and December 2004 were
reviewed with a questionnaire. Blood cultures had been incu-
bated in the BacT/ALERT system (BioMerieux). In statistical
analyses, Student‘s t-test was used for the comparison of mean
values and chi square test and Fisher‘s exact test for the
comparison of categorical data (two tailed). A stepwise logistic
regression was performed for multivariate analysis.
Results: During the period of the study blood cultures were
performed in 10132 patients, 372 of them (3.7%) with Escherichia
coli isolation. The origin of the bacteraemia was a urinary
infection in 219 (80.5%), unknown in 61 (16.4%), biliar in 57
(15.3%) and other origins in 35 (9.4%). Twenty three patients
(6.2%) died during the admission. Patients who died were older
(76.8±10.5 years vs 70.4±16.1 years), had a higher Charlson
index (2.1±2 vs 1.1±1.6), more frequently had an antecedent
of dementia (17.4% vs 3.6%), a non-urinary origin of the
bacteraemia (59.6% vs 37.6%), a severe sepsis or shock (56.5%
vs 8.3%), had a lower albumin plasmatic concentration
(2.2±0.6mg/dL vs 2.7±0.5mg/dL) and more frequently
had a bacteraemia cause by Extended-Spectrum b-Lactamase
producing Escherichia coli (21.7% vs 2.7%). In the multivariate
analysis only a non urinary origin of the bacteremia (OR: 3.36;
95% CI, 1.2–9.38), the presence of severe sepsis or shock (OR:
9.14; 95% CI, 3.47–24.07) and the presence of extended-spectrum
b-lactamase producing Escherichia coli in the blood cultures (OR:
5.78; 95% CI, 1.38–24.47) were associated with the prognosis.
Conclusions: Escherichia coli bacteraemia, had a relatively low
mortality among our patients. The existence of severe sepsis or
shock, a non-urinary origin of the bacteraemia, and the presence
of extended-spectrum b-lactamase producing Escherichia coli in
the blood cultures were prognostic factors.
P919
Extended-spectrum b-lactamase producing
Enterobacteriaceae in Lebanese ICU patients:
epidemiology and patterns of resistance
Z. Daoud, N. Hanna, R. Hajj, C. Moubareck,
F. Doucet-Populaire, N. Hakime´ (Beirut, LB; Paris, FR)
Introduction: The objective of this study is to assess the faecal
carriage of ESBL producing bacteria in patients and health
workers of intensive care unit of ﬁve Lebanese hospitals over a
three-month period.
Methods: Faecal samples were collected in a period of 4 months
from 378 patients that were admitted to the ICU in addition to 58
health workers of the same units. ESBL production was detected
by double disk synergy as described by Jarlier et al. Then
antibiotic susceptibility of ESBL-producing strains was deter-
mined by disk diffusion method and an enhancement of the
zone of inhibition zone around ceftazidime, cefepime, aztreo-
nam, and cefotaxime towards the clavunate-containing disk
indicated the presence of ESBL’s. Antibiotic susceptibility and
MIC were determined by E-test.
Results: In total, 1442 faecal samples were collected during the
whole study period from 278 ICU patients of the participating
5 hospitals. 118 strains isolated from 72 subjects were identiﬁed
as ESBL-PS including 95 (80.5%) E. coli, 16 (13.6%) Klebsiella
pneumoniae and 7 (5.6%) Enterobacter cloacae. The general
characteristics of patients are represented in the table 1.
Fourty one new patients, for whom a conversion from negative
carriage at ICU admission to positive carriage after admission
was noted, in addition to 18 patients who were previously
colonized (at admission) then recolonized after at least
48 hours of ESBL producing strain eradication, were consid-
ered as acquisition cases (59 patients and 86 isolates). A higher
rate of multiple carriages was detected among these acquisition
cases (21double carriages and 3 triple carriages of ESBL-PS).
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The ﬁgure shows the distribution of carriage of ESBL-PS over
the different phases of ICU stay. The best susceptibility of
ESBL-PS was associated to amikacin with values raging
between 71.4%–92%. Ciproﬂoxacin followed by Trimetho-
prim-sulfamethoxazole seem to be associated with the lowest
susceptibility (0–10% for ciproﬂoxacin and 9.5%–50% for TMX)
excluding NN hospital in both cases.
Conclusion: Our results highlighted the increasing occurrence
of ESBL-PS in the ICU environment of Lebanese hospitals
suggesting the serious endemicity of this issue. On the other
hand, it shows clearly that limited therapeutical alternatives are
available for the treatment of infections produced by ESBL-PS.
This is alarming for Infection Control and in the Lebanese
hospitals and medical centres.
P920
Susceptibility pattern and prevalence trend over
four years of extended-spectrum b-lactamase
producing Klebsiella spp. from intensive care
units: MYSTIC Program Brazil
C. Kiffer, S. Andrade, P.J. Turner, C. Mendes (Sao Paulo, BR;
Cheshire, UK)
Objective: To evaluate the susceptibility pattern and prevalence
trend over four years of ESBL-producing Klebsiella spp respon-
sible for nosocomial infections in intensive care units (ICUs)
participating in 2001, 2002, 2003, and 2004 editions of the
MYSTIC Program in Brazil.
Methods: Two hundred and ﬁfteen Klebsiella spp clinical
isolates were collected by the ﬁve ICUs participating in each
of the four yearly editions of the MYSTIC Program in Brazil, as
follows: n = 50 (2001), n = 43 (2002), n = 66 (2003), and n = 56
(2004). Minimal inhibitory concentrations (MICs) were deter-
mined by E-test methodology to cefotaxime (CTX), ceftazidime
(CAZ), cefepime, piperacillin/tazobactam, imipenem, merope-
nem, tobramycin, gentamicin, and ciproﬂoxacin. Isolates of
Klebsiella spp with increased MICs (‡1.5 mcg/ml) for CAZ and/
or CTX were considered as possible ESBL-producing pheno-
types according to NCCLS criteria. Interpretations followed the
respective year NCCLS documents. A chi-square for trend test
(Altman, 1999) was applied to identify ordered differences in the
ESBL rates along the four years studied. A chi-square test was
also applied to compare the aggregated ESBL production rates
of 2001–2002 and 2003–2004. P values below 0.05 were consid-
ered signiﬁcant.
Results: The table presents susceptibility and ESBL producing
rates of all Klebsiella spp isolates collected from the ICUs
according to the year of isolation. Both carbapenems presented
virtually full and stable susceptibility rates at all years. How-
ever, the remaining drugs showed decreasing susceptibility
rates from 2001–2004, except for 2002. The chi-square for trend
test yielded a p value of 0.02 for the ESBL rate among all four
years. The aggregated 2001–2002 ESBL production rate was
53.7% (n = 50/93) and the 2003–2004 was 69.6% (n = 85/122).
The chi-square test to compare the aggregated ESBL production
rates among 2001–2002 and 2003–2004 yielded a p value of 0.01.
Conclusions: The prevalence of isolation of ESBL-producing
Klebsiella spp has increased signiﬁcantly over four years in the
units evaluated. Thus, decreasing susceptibility rates were
observed among all antimicrobials evaluated in each year
against these pathogens, with only the carbapenems presenting
virtually full and stable activity. However, a biased sample
cannot be ruled out, due to either possible clonal spread or
overvalued resistant clinical isolates.
P921
Nosocomial outbreak due to an extended-
spectrum betalactamase producer Enterobacter
cloacae
A. Manzur, A. Soriano, L. Calatayud, F. Tubau, M. Saballs,
M. Pujol, F. Gudiol, J. Ariza (Hospitalet Llobregat, ES)
Enterobacter spp. have been associated with nosocomial out-
breaks, generally involving strains that overproduce their
chromosomal b-lactamase. However the presence of extended-
spectrum b-lactamases (ESBL) have been rarely reported in
these strains. Only sporadic cases of ESBL-E. cloacae (ESBL-EC)
have been recognised in our hospital for the last years (5
unrelated cases in 2004).
Objective: To describe the clinical and molecular epidemiology
of an outbreak caused by an ESBL-EC strain, in a Cardio-
Thoracic Intensive Care Unit (CT-ICU).
Methods: Prospective surveillance of patients with infection/
colonisation caused by ESBL-EC and weekly screening for faecal
carriage among all patients admitted to the CT-ICU during the
outbreak period (Jul–Sep 05). Production of ESBL was suspected
by decreased susceptibility to expanded-spectrum cephalospo-
rins and conﬁrmed by a positive sinergy test with clavulanic
acid. Clonal relatedness was determined by pulsed-ﬁeld gel
electrophoresis (PFGE).
Results: From July to August 2005, 7 patients were identiﬁed in
the CT-ICU as having ESBL-EC, 4 males, mean age
67 + 10 years. Six patients had clinical isolates and 1 was
identiﬁed by screening samples. Prior ICUs stay was
13.9 + 5.8 days and 6 patients had cardiac surgery. All were
exposed to central venous and urinary catheters and mechanical
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ventilation. Four patients developed infection: 3 pt. primary
bacteraemia, 1 pt. Ventilator-associated pneumonia. Three
patients were treated with carbapenems and 1 pt. with catheter
withdrawal. The observation of resistance to expanded-spec-
trum penicillins and cephalosporins including cefepime, along
with quinolones, gentamycin and tobramycin, allowed us to
suspect the presence of an ESBL in these strains. PFGE revealed
a clonal spread. The review of antibiotic consumption showed a
huge increase of cefepime use during June and July 05. The
outbreak was stopped with implementation of barrier measures
and cephalosporins restriction.
Conclusion: The accurate microbiological surveillance identi-
ﬁed an outbreak of ESBL-EC in an CT-ICU, related to cefepime
consumption. The ESBL production could be an increasing
problem in common nosocomial pathogens other than E. coli or
K. pneumoniae.
P922
Clinical and epidemiologic features of extended-
spectrum b-lactamases strains for a two-year
period in a third level hospital
M.V. Garcı´a, R. Rodriguez, M.M. Gallardo, F. Ropero,
E. Granados, A. Hernandez, A. Pinedo (Ma´laga, ES)
Objectives: For the last years we are being witness of an
increase of ESBLs productive strain isolations, making more
difﬁcult managing carrier patients. Our aim is to get to know the
clinical and epidemiologic features of the ESBLs productive
strains in the population attending our hospital.
Methods: A retrospective study was carried out from January
2003 to December 2004, where a total number of 6795 strains
were isolated out of which 5847 were E. coli and 948 were K.
pneumoniae. Antimicrobial suceptibilities were carried out by the
MicroScan Walkaway automized system and by disk difussion
test and E-test. Double-disk synergy test and E-test were used
for screening ESBLs. The results interpretation were according
NCCLS guidelines.
Results: Out of the total number of isolations obtained, the
percentage of ESBLs strains was 3.3% (224) of which 87 (38.8%)
were isolated during the year 2003 and 137 (61.1%) during 2004.
Most of the strains were E. coli isolations 212 (94.6%) and only 12
(5.3%) of K. pneumoniae. In 59.37% of the cases the origin was
extrahospitalarian being E. coli the species isolated more fre-
quently, while in the intrahospitalarian 58.3%were K. pneumonia.
Urine was the sample where it was isolated more frequently. The
224 ESBL strains belonged to 150 patients 92 (61.3%) women and
58 (38.6%) men with an average age of 60 years old (range: 1–98).
Hospitalized cases were 37.33% (56) and most of them in the
internal medicine department (30.3%), followed by the Intensive
Care Units. Progress of the hospitalized patients went to
resolution in 71.4% of the cases being exitus in 28.5% of them.
In reference to sensitivity, co-resistance was detected with
quinolones, fosfomycin, trimethoprim-sulfamethoxazole (TSX)
and aminoglycosides, observing that the co-resistance more
frequently found was with quinolones 68.1% followed by TSX
9.2%, aminoglycosides 28.3% and fosfomycin 4.4%. Only 37
(18.4%) did not show co-resistance with other groups of antibi-
otics. The co-resistance combination more frequently found was
ESBLsmore resistant to quinolones and TSX in 30.3% of the cases.
Conclusions: An important increase of ESBLs isolations have
been proven from the year 2003 to the year 2004. Most of the
strains were E. coli and of extrahospitalarian origin, being K.
pneumoniamore frequently isolated at intrahospitalarian level. A
high level of co-resistance has been detected among ESBLs
strains, where quinolones are the antibiotic family mostly
affected.
P923
Risk factors for cephalosporin-resistant (ESBL
and AMPc producing) Gram-negative enteric
bacilli infection in renal and kidney-pancreas
transplant patients
L. Linares, C. Cervera, F. Marco, J.A. Martinez, R. Perello,
F. Cofa´n, M.J. Ricart, N. Esforzado, F. Oppenheimer, A. Moreno
(Barcelona, ES)
Objectives: In our setting, cephalosporin-resistant gram-neg-
ative infections in renal and kidney-pancreas (RRPT) patients
have been increasing over time. For this reason, we decided to
investigate the risk factors for infection with cephalosporin
resistant gram-negative bacilli (CRGN) in this group of
patients.
Methods: From January to July 2005 all patients undergoing
RRPT were prospectly evaluated. Pre-transplant detection of
ESBL-producing gram-negative bacilli colonization was per-
formed by culture of a rectal swab in MacConkey agar
supplemented with cefpodoxime. The variables evaluated
were: gender, age, underlying diseases (mellitus diabetes,
chronic liver and heart diseases), immunosuppression, acute
rejection episodes, surgical reinterventions, need for nephros-
tomy, use of antibiotics and post-transplant infections.
Results: We included 58 patients, 37 of whom were men (64%),
with a mean age of 46 years (SD: 14 years). Forty-eight patients
underwent kidney and 10 kidney-pancreas transplantation. The
incidence of pre-transplant ESBL-producing gram-negative
bacilli bowel colonization was 14% (in all cases Escherichia
coli). The incidence of CRGN infection was 15.5% (9 patients), of
which 6 were urinary tract infections (3 ESBL E. coli, 2 AMPc C.
freundii and 1 ESBL Klebsiella spp) and 3 surgical wound
infections (1 ESBL E. coli, 1 AMPc C. freundii and 1 ESBL
Klebsiella spp). Three cases developed bacteremia (3 cases E. coli).
Underlying diseases, immunosuppressive therapy, prior bacter-
ial infection, use of antibiotics and prior acute rejection were not
associated with increased risk of CRGN infection. Previous use
of carbapenems did not prevent CRGN infection (p = 1.0). A
trend towards the association of ESBL-producing E. coli colon-
ization with ESBL-producing E. coli infection was observed (25
vs 4%;OR 8.0; 95% CI 0.95–67.7; p = 0.09). The need for
nephrostomy (OR 11.25; 95% CI 1.6–81.6; p = 0.025) and surgical
reintervention (OR 5.6; 95% CI 1.2–24.9; p = 0.03) were associ-
ated with higher risk of CRGN infection.
Conclusion: In our setting, the incidence of infection with
CRGN and the prevalence of stool colonization with ESBL-
producing gram-negative bacilli in RRPT patients was high.
Patients requiring major surgical reintervention or those who
need nephrostomy are at higher risk of developing CRGN
infections. Patients with rectal carriage of ESBL-producing
gram-negative bacilli may be at risk for ESBL infections, but a
larger study is needed to conﬁrm this results.
P924
Distribution of class 1 and class 2 integron types
among ESBL-producing Enterobacteriaceae
recovered from Portuguese hospitals
E. Machado, R. Canto´n, F. Baquero, J. Sousa, T. Coque, L. Peixe
(Porto, PT; Madrid, ES)
Objectives: To analyse the overall prevalence and distribution
of class 1 and class 2 integron types among ESBL-producing
Enterobacteriaceae from different Portuguese nosocomial envi-
ronments.
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Methods: We studied 105 ESBL-producing Enterobacteriaceae
recovered from patients attending at Portuguese hospitals (Oct
2002–May 2004): 41 Klebsiella pneumoniae (KP), 6 Klebsiella
oxytoca, 37 Escherichia coli (EC), 10 Enterobacter aerogenes (EA), 3
Enterobacter cloacae, and 8 Proteus mirabilis (PM). Bacterial
identiﬁcation was performed by the Vitek System. Antibiotic
susceptibility was performed by the standard disk diffusion
method. ESBL expression was searched by the double disk
synergy test. Characterization of ESBL was performed by IEF,
PCR for blaTEM, blaSHV, blaCTX-M, and sequencing. Class 1
and 2 integrons were searched by PCR, typed by RFLP using
AluI and TaqI as restriction enzymes, respectively, and identiﬁed
by sequencing (one per RFLP type).
Results: ESBL among the isolates studied were identiﬁed as 53
TEM, 28 SHV, and 25 CTX-M. Class 1 integrons were more
prevalent than class 2 integrons (70% vs 5%). Presence of class 1
integrons was higher among TEM (46/53, 87%) than among the
other ESBL—types-producing isolates (19/28, 68% for SHV; 7/
25, 28% for CTX-M), and among KP, EA, and PM isolates (85%,
100%, and 100%, respectively). Class 2 was only detected among
TEM-producing EC and PM (5/53, 10%). Eight different class 1
integrons were found, each containing different gene arrange-
ments: A) aacA4, B) aadA1, C) aadA2, D) dfrA10-aadA1, E)
dfrA17-aadA5, F) drfA12-orfF-aadA2, G) aac3Ia’’-orfX- -aadA1,
and H) aac6’Iic-orf. Type A was the most frequently found and
observed in all TEM-24 producing isolates. Type B was associ-
ated to isolates producing SHV-55. For CTX-M-producing
isolates we only detected the presence of Type E (3 CTX-M-
14), and F (1 CTX-M-15). Types C, D, G, and H were only
detected in isolates harbouring SHV-2, TEM-52, TEM-110 and
SHV-12, respectively. Only one class 2 integron type was found
(dfrA1-sat1-aadA1). Ten isolates harboured two class 1 integ-
rons of different size and in four strains was observed simul-
taneous presence of class 1 and 2 integrons.
Conclusion: Class 1 integrons are widely distributed among
ESBL-producing Enterobacteriaceae from Portuguese hospitals. A
low diversity of integron types was observed, some of them
being detected only in strains producing a speciﬁc ESBL which
suggests their co-transference in mobile elements.
Metallo b-lactamases and integrons
P925
Interactions of ceftobiprole with serine
carbapenemases
A.M. Queenan, W. Shang, K. Bush (Raritan, US)
Objectives: Ceftobiprole is a cephalosporin with broad-spec-
trum antimicrobial activity against methicillin-resistant staphy-
lococci, penicillin-resistant streptococci, and most gram-negative
pathogens. Ceftobiprole is very stable to hydrolysis by the
staphylococcal b-lactamase PC1 and the AmpC b-lactamases from
gram-negative bacteria, with hydrolysis rates of less than 1%
those for cephaloridine. The class A carbapenemases that are
occurring more frequently among the Enterobacteriaceae have not
been studied with ceftobiprole. Therefore, the stability of
ceftobiprole and the comparator cephalosporins, ceftazidime
and cefepime, was determined in the presence of the Class A
serine carbapenemases found in K. pneumoniae (KPC-2) and S.
marcescens (SME-3).
Methods: b-lactamases were partially puriﬁed by gel ﬁltration
and ion exchange chromatography. Initial hydrolysis rates were
determined spectrophotometrically in 50 mM phosphate buffer
pH 7.0. KM and Vmax were determined using the Hanes plot.
Hydrolysis rates were expressed relative to hydrolysis of
cephaloridine. Imipenem was used as a positive control for
hydrolysis.
Results: The SME-3 carbapenemase hydrolyzed ceftazidime, ce-
fepime and ceftobiprole at less than 1% the rate for cephalor-
idine (0.01, 0.17 and 0.49%, respectively). The KM for
ceftazidime was 170 mM, and ceftobiprole and cefepime had
similar KM values of 270 and 280 mM. The KPC-2 carbapenemase
hydrolyzed ceftazidime, cefepime and ceftobiprole at £11% the
rate for cephaloridine (0.06, 2.4 and 10.6%, respectively). The
KM values for these three cephalosporins were similar, at 231,
306 and 213 mM, respectively. The rates of hydrolysis for the
cephalosporins were generally less than for imipenem.
Conclusion: Ceftazidime, cefepime and ceftobiprole were only
slowly hydrolysed by both carbapenemases tested, and had
sufﬁciently high KM values such that the enzymes would not
be saturated under physiological conditions and Vmax would
never be attained. The KPC-2 b-lactamase displayed higher
relative hydrolysis rates for the cephalosporins than the SME-3 b-
lactamase. Ceftobiprole stability was more similar to cefepime
than to ceftazidime.
P926
Post-genomic detection of CAR-1, a new subclass
B3 metallo-beta-lactamase from the important
plant pathogen Erwinia carotovora
M. Stoczko, J.M. Fre`re, G.M. Rossolini, J.D. Docquier (Siena, IT;
Lie`ge, BE)
Objectives: Metallo-beta-lactamases (MBLs) are zinc-depend-
ent enzymes which commonly hydrolyse most beta-lactams.
Apart from the clinically important enzymes (IMP, VIM, SPM,
GIM and SIM), most MBLs are resident enzymes found in
bacterial species of minor clinical interest (e.g. Flavobacteria,
Caulobacter crescentus). The recent progress of genome sequen-
cing revealed a wide distribution of genes encoding MBL-like
proteins in both prokaryotes and eukaryotes. Although the
presence of genes encoding functional MBL in these organisms
and their relationship with acquired enzymes remain unclear,
such enzymes represent interesting models for structure –
function relationship studies. Here, we report the functional
properties of CAR-1, a new MBL from Erwinia carotovora.
Methods: The blaCAR-1 ORF was detected by screening the
available genome databases for the protein sequences sharing
high sequence identity with known MBLs and conserved zinc-
binding motifs. The ECA2849 (blaCAR-1) ORF from E. carotovora
subsp. atroseptica SCRI1043 was cloned in vector pBC-SK to
obtain recombinant plasmid pBC-CAR where the beta-lactamase
gene was expressed under the Plac promoter in Escherichia coli
DH5alpha. The in vitro antimicrobial susceptibility proﬁle was
determined using the microdilution method as recommended
by the CLSI and a inoculum of 105 CFU/well. Beta-lactamase
activity was measured spectrophotometrically with different
beta-lactam compounds.
Results: In the genome of E. carotovora, an important plant
pathogen, an ORF was detected (ECA2849) that encodes a 342-aa
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protein exhibiting 23% and 27% sequence identity with CAU-1
and JAP-1 MBLs, respectively, and a notably longer N-terminal
domain (41 additional residues in comparison with L1).
blaCAR-1 was expressed in E. coli, and beta-lactamase activity
was detected (Sp. act., 3600 nmol/minÆmg protein using cefu-
roxime as substrate), that was inhibited >95% after addition of
5 mM EDTA. In kinetic assays, the enzyme exhibited a strong
preference for cephalothin (KF), cefuroxime (CXM) and cefo-
taxime (CTX). These data were in agreement with the suscep-
tibility proﬁle observed in E. coli, which showed resistance to
KF, CXM and CTX (MICs: 64, 256 and >16 mg/l, respectively)
but only decreased susceptibility to other agents, except cefep-
ime and aztreonam.
Conclusion: A new functional subclass B3 MBL was identiﬁed
in the genome of the important plant pathogen E. carotovora.
Acknowledgement: Supported by EU grant no. HPRN-CT-02-
00264.
P927
Co-existence of VIM-type metallo-beta-lactamase
and PER-1 type extended-spectrum
beta-lactamase in clinical isolates of
Pseudomonas aeruginosa
G. Metan, N. Gurkan Aydin, P. Zarakolu (Kayseri, Ankara, TR)
Objective: Beta-lactamases are one of the major resistance
determinants described for Pseudomonas aeruginosa strains. The
PER-1 type extended-spectrum beta-lactamase (ESBL) has been
ﬁrst reported in some P. aeruginosa isolates in Turkey and
widespread across the country. The VIM-type metallo-beta-
lactamase (MBL) is another enzyme acting as carbapenamases
and 11 variants have been identiﬁed. VIM-5 has recently been
reported in a P. aeruginosa isolate in Turkey. We have conducted
a study aimed to determine the probability of co-existence of
those different types of beta-lactamases in the clinical isolates of
multi-drug resistant P. aeruginosa in Hacettepe University Adult
Hospital.
Method: Sixty-seven clinical isolates of P. aeruginosa recovered
from patients with nosocomial infections between January 2002
and December 2004 are included in the study. The isolates are
identiﬁed by Sceptor (Beckton–Dickinson, USA) and stored at -
80C until study time. PCR is performed for detection of blaVIM
and blaPER-1 genes.
Results: According to the results of PCR experiments, 15
isolates are positive for PER-1 and 4 isolates are VIM positive.
Interestingly, 3 of the PER-1 positive isolates are also positive for
VIM enzyme. Two of the VIM and PER-1 positive isolates are
recovered in 2002 and the other in 2004 from different units of
the hospital.
Conclusion: Carbapenems are the ﬁrst drugs of choice for the
treatment of infections due to ESBL producing Gram negative
bacilli. With the exception of aztreonam, VIM type MBLs
hydrolyze all beta-lactamases, including carbapenems. The co-
existence of MBLs and ESBLs in the same strain complicates the
situation, resulting in a multidrug resistant strain of P. aerugi-
nosa. This situation has been rarely reported as case reports in
the English literature and to the best of our knowledge, this
limited study is the ﬁrst epidemiological analysis to identify a
clinical isolate of P. aeruginosa producing both PER-1 type ESBL
and VIM type MBL. These ﬁndings highlight the need for
further systematic surveillance to allow for early recognition of
threatening combinations of resistance determinants among
nosocomial pathogens.
P928
VIM-2 metallo-beta-lactamase in Pseudomonas
aeruginosa strains from Zagreb, Croatia
B. Bedenic, A. Mazzariol, N. Jarza-Davila, V. Plecko,
G. Cornaglia, R. Fontana (Zagreb, HR; Verona, IT)
Objectives: The worldwide spread of acquired metallo-beta-
lacctamases (MBLs) in gram-negative bacilli has become a great
concern. MBLs possess a broad hydrolysis proﬁle that includes
carbapenems and almost all extended-spectrum beta-lactams.
The aim of this investigation was to characterize metallo-beta-
lactamases (MBLs) in P. aeruginosa isolates from Zagreb, Croatia.
Materials and methods: Hundred P. aeruginosa isolates with
reduced susceptibility to either imipenem or meropenem were
tested for the production of MBLs by E test MBL. The strains
were isolated during 2002 to 2005 at the Clinical Hospital Center
Zagreb and University Hospital Merkur in Zagreb. The suscep-
tibility to a wide range of antibiotics was determined by broth
microdilution method. The strains which gave a positive results
in the E test were chosen for the further investigation. The
presence of blaVIM and blaIMP genes was tested by PCR. The
amplicons were sequenced from both sides. Hydrolysis of
0.1 mM imipenem by crude enzyme preparations of beta-
lactamases was monitored by UV spectrophotometer at
298 nm. Inhibition of enzyme activity was determined by
measuring the residual carbapenemase activity after incubation
of the crude extracts with 2 mM EDTA. Outer membrane
proteins were prepared and analysed by SDS-PAGE. Pulsed
ﬁeld gel-electrophoresis (PFGE) was performed to determine if
the strains were clonally related.
Results: Eight out of 100 isolates were positive for MBLs by E
test. Six strains were resistant to imipenem and meropenem.
Resistance to ciproﬂoxacin was detected in 4 and to aztreonam
in 3 of these strains. Six strains were identiﬁed as VIM MBLs
producers by PCR. Sequencing of blaVIM genes revealed the
production of VIM-2 beta-lactamase in all six strains. No IMP
MBLs producers were detected by PCR. All VIM beta-lactamase
producing isolates hydrolyzed imipenem. The enzyme activity
ranged from 1.2 to 42 nmol/imipenem/min/mg of protein.
Carbapenemase activity was almost completely inhibited by
2 mM EDTA. Loss of OprD2 protein was found in 4 strains. The
strains were not clonally related by PFGE.
Conclusions: This investigation proved the occurrence of VIM-
2 beta-lactamase among P. aeruginosa strains from Zagreb,
Croatia. The strains harbouring VIM-2 beta-lactamase were
resistant to all beta-lactam antibiotics, aminoglycosides and
ﬂuoroquinolones and pose a serious therapeutic problem in our
hospitals.
P929
First detection of blaVIM-2 and blaVIM-4
metallo-beta-lactamase genes in Pseudomonas
putida isolates in Belgium
P. Bogaerts, H. Rodriguez, C. Bauraing, A. Deplano,
Y. Glupczynski, M.J. Struelens (Yvoir, Brussels, BE)
Objectives: Multi-drug resistant Pseudomonas aeruginosa (Pa)
are emerging nosocomial pathogens. Metallo-beta-lactamase
(MBL)-producing Pa resistant to carbapenems have escalated
worldwide since 2000, limiting therapeutic options and causing
major concern. MBL have also been reported occasionally in
non-aeruginosa Pseudomonas (P. putida, P. ﬂuorescens). We des-
cribe the ﬁrst identiﬁcation of VIM-2 and VIM-4 producing
Pseudomonas putida in Belgium.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Methods: During systematic screening of multi-drug resistant
Pseudomonas species isolates in two Belgian university hospitals,
we collected two clinical isolates of Pseudomonas putida with
MBL-producing compatible susceptibility proﬁle. The two
strains were further analysed for determining resistance mech-
anism and were characterised using PCR, sequencing of the
integron and PFGE genotyping.
Results: Two clinical isolates of Pseudomonas putida (Pp) origin-
ating from two different Belgian hospitals located in Brussels
were highly resistant to meropenem and imipenem
(CMI > 32 mg/L). Synergy imipenem/EDTA was observed by
two different double disk tests (diam. imipenem/EDTA vs
diam. imipenem >6) and by the E-test MBL strip (ratio MIC
imipenem/MIC imipenem-EDTA ‡8). Speciﬁc PCR targeting
blaIMP gene was negative but PCR targeting blaVIM and
integrase 1 genes were positive for both strains. Sequencing the
integron between 5’-conserved sequence and 3’-conserved
sequence revealed two different gene organisations inside the
class 1 integron. One strain revealed blaVIM-2 gene next to an
unidentiﬁed ORF. The other strain contains a blaVIM-4 gene
next to an aacA4 gene that share common structural features
with class 1 integron previously reported in Poland Pseudomonas
aeruginosa isolates [JAC (2004) 53, 451–456]. PFGE genotyping
conﬁrms that the two Belgian isolates were sporadic.
Conclusion: To our knowledge, this is the ﬁrst report of a VIM-
2/VIM-4 MBL-producing Pseudomonas putida strains identiﬁed
in Belgium in a clinical setting. The different and original
structure of their integrons and distinct genomic backgrounds
revealed that these strains were not epidemic and were
unrelated to each other. These ﬁndings illustrate the horizontal
spread of MBL genes among species of pseudomonads other
than P. aeruginosa.
P930
Genetic structure of a VIM-2-encoding integron
from a Pseudomonas aeruginosa clinical isolate
from Belgium
J.D. Docquier, M.M. D’Andrea, G. Christiaens, R. Boreux,
T. Giani, J.M. Fre`re, P. De Mol, G.M. Rossolini (Siena, IT; Lie`ge,
BE)
Objectives: Acquired metallo-beta-lactamases (MBLs), due to
their extremely broad substrate proﬁle and their potential for
diffusion via horizontal transfer of mobile genetic elements,
represent a worrisome evolution in the antimicrobial resistance
landscape. VIM-type MBLs, ﬁrst detected in Italy, are now
widespread in Europe, Asia and the Americas, and have been
detected in clinical isolates of Pseudomonas spp., Acinetobacter
spp., Enterobacteriaceae and other nonfastidious gram-negative
nonfermenters.
Methods: Bacterial identiﬁcation and susceptibility proﬁles
were determined using an automated Vitek II platform. Carb-
apenem-resistant clinical isolates obtained in the period Oct–Dec
2003 from different wards of the University Teaching Hospital
in Lie`ge (Belgium) were assayed for imipenem-hydrolysing
activity using a spectrophotometric test and were screened for
the presence of IMP- or VIM-type MBLs by RFLP–PCR. The
structure of the MBL-containing class 1 integron was deter-
mined by PCR mapping and direct DNA sequencing of
ampliﬁcation products.
Results: Among 10 carbapenem-resistant P. aeruginosa isolates,
only one produced an EDTA-inhibited imipenem-hydrolysing
activity. A PCR analysis revealed the presence of a blaVIM gene.
This isolate (3163608), isolated from a decubitus ulcer of a
73-year-old male inpatient, was resistant to most beta-lactam
antibiotics (including carbapenems, expanded-spectrum
cephalosporins and beta-lactam/beta-lactamase inactivator
combinations), aminoglycosides and ﬂuoroquinolones while it
was intermediate to aztreonam (MIC, 16 mg/l), gentamicin
(8 mg/l) and susceptible to colistin (2 mg/l). DNA sequencing
revealed an original integron structure containing two gene
cassettes encoding a VIM-2 MBL and an AADA5 aminoglyco-
side adenylyltransferase, respectively.
Conclusion: Although carbapenem-resistant Pseudomonas aeru-
ginosa isolates are relatively unfrequent at our institution, one
VIM-2-producing isolate was identiﬁed. The original structure
of the VIM-2-encoding class 1 integron found in this isolate
underlines the important potential of diffusion of such genes in
different genetic contexts.
Acknowledgement: Supported by EU-HP grant nos. HPRN-
CT-2002-00264 and LSHM-CT-2003-503335.
P931
Spread of In58 containing blaVIM-2 among
Pseudomonas aeruginosa
A. Brizio, A. Silva, E. Canas, T. Ferreira, L. Lito, J. Melo Cristino,
M.J. Salgado, A. Duarte (Lisbon, PT)
In recent years, a large proportion of resistance to carbapenems
in Pseudomonas aeruginosa can be attributed to metallo-beta-
lactamases (MBL) genes presented in class 1 integrons. Six
imipenem resistant P. aeruginosa were isolated in 2004 (2
isolates) at Santa Maria Hospital (HSM) and in 2005 (four
isolates) at Santo Anto´nio Capuchos Hospital (HC), located in
Lisboa. The clinical isolates were screened for MBL production
by EDTA disk synergy test. PCR experiments with speciﬁc
primers were used to detect MBL genes (blaIMP and blaVIM) as
well as to characterise the integrons containing these genes. The
blaVIM-2 gene was found in all isolates and was located in
integron containing more three gene cassettes: aacA7, aacC1 and
aacA4. This integron was identical to the integron In58 previ-
ously found in P. aeruginosa identiﬁed in 1998 in Paris. In
Portugal the blaVIM-2 gene cassette has already been identiﬁed
in a different class 1 integron from Klebsiella pneumoniae clinical
isolate. To assess the clonal relatedness between the isolates,
molecular characterisation was performed using M13 ﬁnger-
printing. The two isolates from HSM had the same M13 pattern
as two others isolates recovered from HC, suggesting a clonal
spread between the two hospitals. The remaining isolates from
HC were epidemiological unrelated. Our ﬁnding contributes to
the observation that blaVIM-2 genes are disseminated in
Portugal and underline the need for intensiﬁed epidemiological
surveillance.
P932
Metallo-beta-lactamase gene blaSPM-1:
evaluation of its vicinities in unrelated
Pseudomonas aeruginosa strains isolated from
distinct Brazilian hospitals
M. Castanheira, M.A. Toleman, T.R. Walsh, H.S. Sader,
A.C.C. Pignatari, A.C. Gales (Sao Paulo, BR; Bristol, UK; North
Liberty, US)
Objective: To reveal the genetic environment around blaSPM-1
in unrelated Pseudomonas aeruginosa (PSA) strains and the
possible role of the common region 4 (CR4) in the blaSPM-1
mobilization. Although common regions (CR) have been located
near resistance genes, the role and function of these genetic
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elements has not been well established. A new allele of CR
element, CR4, was recently described upstream of blaSPM-1.
CR4 was located downstream of groEL, a chaperonin encoding
gene.
Methods: 25 clonally unrelated PSA strains (distinct ribotype
and PFGE patterns) harbouring blaSPM-1 isolated from 7
Brazilian cities were evaluated. Primers designed for detection
of blaSPM-1 were used with primers targeting the CR and groEL
to determine the presence of these elements in the vicinity of
blaSPM-1. In addition, degenerated primers were designed
against CR elements and used to amplify target strains. The
amplicons had been sequenced in both strands and the DNA
sequencing results analysed.
Results: Amplicons of expected size (800 pb) with CR primers
were detected in all 25 isolates. PCR performed anchoring CR
primers to blaSPM-1 produced amplicons of 1.5 kb. Sequencing
showed that CR4 was located straight upstream of blaSPM-1 in
all evaluated isolates. The presence of groEL was also detected
in the 25 isolates. DNA sequencing results demonstrated the
same features in all 2 kb amplicons obtained by PCR using
groEL primers.
Conclusion: groEL followed by CR4 were found upstream of
blaSPM-1 in all unrelated PSA isolated from distinct Brazilian
geographic regions. The same arrangement of these genes,
without any insertions or deletions, was recovered from all 25
PSA isolates, showing a very conserved structure. These
ﬁndings indicate that CR4 and groEL have been mobilized
along with blaSPM-1 and that CR4 may not be responsible for
blaSPM-1 dissemination among SPM-producing PSA isolated in
Brazil. Although the mobilization of the plasmid carrying
blaSPM-1 is difﬁcult due to its size (around 100 kb), based on
our results, it seems more likely that this element may be
responsible for the mobilization of blaSPM-1.
P933
Discrepancy in the metallo-beta-lactamase
phenotypic tests results associated with diversity
in the promoter region of class 1 integrons
M. Castanheira, R.C. Picao, R.E. Mendes, A.C.C. Pignatari,
H.S. Sader, A.C. Gales (Sao Paulo, BR; North Liberty, US)
Objective: The expression of metallo-beta-lactamase (MBL)
genes was studied in MBL-producing Enterobacter cloacae and
Klebsiella pneumoniae isolates due to discordant phenotypic test
results for detection of MBL production.
Methods: Four E. cloacae and two K. pneumoniae isolates that
possess blaVIM and blaIMP (see table below) isolated between
2001 and 2005 were evaluated. All isolates were submitted to
MBL phenotypic detection: disk approximation method with a
beta-lactam substrate (ceftazidime or imipenem) associated with
a MBL inhibitor (EDTA and mercaptopropionic acid) and
hydrolysis assay against imipenem. Search for the MBL genes
was carried out by PCR followed by DNA sequencing. Class 1
integron promoter regions were also sequenced.
Results: The results are summarized in the table shown below.
The disk approximation test detected all isolates as MBL
producers. In contrast, only 3 of 6 isolates demonstrated positive
hydrolysis results against imipenem. The isolates showing
imipenem hydrolysis also had a signiﬁcant inhibition of imipe-
nem activity when previously treated with 25 mM EDTA. All
MBL genes were located in the ﬁrst position of class 1 integrons
and just one promoter, Pant, was present in the MBL carrying
integrons. However, the DNA sequence of the promoter region
was different among the MBL carrying integrons.
Conclusions: Hydrolysis assays against imipenem and me-
ropenem have been considered an important tool for MBL
detection; however, in the current study the disk approxima-
tion method demonstrated better performance than the imi-
penem hydrolysis assay for detection of MBL production. Our
ﬁndings suggest that differences in the promoter DNA
sequence directly inﬂuenced the expression of MBL genes,
and consequently the proper phenotypic method to detect
them. This is the ﬁrst report to correlate the diversity of the
promoter strength with MBL expression in Enterobacteriaceae
isolates.
P934
Biochemical characterisation of IND-NF16
metallo-beta-lactamase
M. Perilli, B. Segatore, B. Caporale, C. Pellegrini, G. Celenza,
F. De Santis, M. Fiore, C. Luzi, J.D. Docquier, G.M. Rossolini,
G. Amicosante (L’Aquila, Siena, IT)
Objectives: Metallo-b-lactamases (MBLs) constitute an heterog-
enous family of enzymes that are most prevalent in nonfer-
menting Gram-negative bacteria and more recently in
Enterobacteriaceae. The spreading of new metallo-b-lactamases
resistance determinants among nosocomial pathogens could
represents a world wide problem. Actually several type of MBLs
were characterized: VIM-, IMP-, GOB-, SPM-, IND-types
belonging to three subclasses.
Methods: The nature of gene was determined by PCR and
direct sequencing. Sequence was determined on two independ-
ent ampliﬁcation products for each isolate. The amplicons
corresponding to blaIND-NF16 was cloned in pET-9a vector
and transformation of recombinants plasmids was performed
using Escherichia coli BL21(DE3) competent cells. IND-NF16
metallo-b-lactamase was puriﬁed from E. coli BL21(DE3) (pET-
9a-INDNF16), by two chromatographic steps using Mono Q and
Mono P chromatographic column. Steady-state kinetic param-
eters (Km and kcat) were determined by measuring substrate
hydrolysis under initial rate conditions and by using Hanes
linearization of the Michaelis–Menten equation. Inhibition by
chelating agents was studied in 30 mM sodium cacodilate buffer
pH 6.5 at 30 C, using 100 lM nitroceﬁn as the reporter
substrate, in the presence of different concentration of EDTA,
1,10-o-phenantroline, and pyridine-2,6-dicarboxylic (dipicolinic)
acid.
Results: Compared to IND-1, the IND-NF16 enzyme showed
17 amino acid residues mutated. The IND-NF16 metallo-b-
lactamase was puriﬁed by two chromatographic steps which
yielded the enzyme as more than 95% pure. Under our
experimental conditions, IND-NF-16 metallo-b-lactamase was
able to hydrolyze several b-lactams except ceftazidime,
cefepime, aztreonam and moxalactam. Concerning the inter-
actions with chelating agents, such as EDTA, dipicolinic acid
and 1,10-o-phenantroline, IND-NF16 showed a Ki value of
815 lM, 3.0 lM, 7.3 lM, respectively. The enzyme was shown
to have t/2 of stability of 90’ (40C), 25’ (45C) and <1 min
(55C).
Conclusions: A new IND MBL variant was identiﬁed in a CDC
group II B clinical isolate. The present report points to the
presence of MBL genes in clinical isolates of this group of
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bacteria. MBL production can be an efﬁcient mechanism of
carbapenem resistance in these isolates.
P935
Phenotypic detection of metallo-beta-lactamases
in Acinetobacter baumannii strains intermediately
resistant to imipenem and susceptible to
meropenem
A. Koutsoukou, A. Stylianakis, S. Tsiplakou, M. Tachtatzis,
E. Tsakona, I. Feskou, A. Sideri (Athens, GR)
Objective: The purpose of our study was to determinate the
proportion of metallo-beta-lactamases producing Acinetobacter
baumanii strains that were multidrug resistant and showed
intermediate resistance to imipenem and susceptibility to
meropenem.
Methods: We studied 57 non-repetitive Acinetobacter baumanii
strains collected from hospital infection samples over a 3-year
period (from 2003 to 2005). Identiﬁcation and susceptibility
testing were performed using the Vitek 2 Automated System
(Biomerieux). The examined strains were intermediately resist-
ant to imipenem and susceptible to meropenem. MIC values of
imipenem and meropenem were determined by the Vitek 2
system and conﬁrmed by E-test (AB Biodisk, Solna, Sweden),
according to NCCLS guidelines. These strains were also tested
by E-test MBL [Imipenem (IP)/Imipenem plus EDTA (IPI)] for a
possible metallo-beta-lactamases production.
Results: The imipenem MIC values of the examined strains
were greater or equal to 6 mg/L and less than 16 mg/L. The
meropenem MIC values were lower than 4 mg/L. We found 14
(24.5%) positive results, that showed a reduction in the imipe-
nem in the presence of EDTA (IPI) of greater or equal to 8-fold
(IP/IPI > 8) and they were interpreted as probably metalo-beta-
lactamases producers, 9 (15.8%) were negative and 34 (59.7%)
undetermined results. 29 out of 34 strains with undetermined
results had imipenem-MIC value of 6 mg/L.
Conclusions: The phenotypic detection of metallo-beta-lacta-
mases was easy to perform but the interpretation of the results
was rather complicated. Nevertheless, the laboratory detection
of these enzymes is important because our results showed a
notably high proportion of metallo-beta-lactamases producing
intermediately resistant to imipenem and susceptible to me-
ropenem Acinetobacter baumanii strains. These strains should not
be underestimated since they are isolated mainly from samples
of ICU patients, are multidrug resistant and can cause thera-
peutic failure.
P936
Metallo-beta-lactamase production in
Gram-negative bacteria detected by double disk
synergy and combined disk tests in Turkey
I. Yildirim, D. Gur, S. Uygun, G. Secmeer (Ankara, TR)
Objective: Anti-bacterial resistance due to metallo -lactamases
(MBL) has been reported in Gram negative bacilli such as
Pseudomonas aeruginosa, Klebsiella pneumonia, Klebsiella oxytoca,
Acinetobacter baumanii and Stenotrophomonas maltophilia which
are among the most common bacterial agents in nasocomial and
neutropenic infections. This class of enzymes hydrolyse carb-
apenems as well as broad spectrum cephalosporins such as
ceftazidime. Although antibacterial resistance rates are quite
high against both of these drugs, it is not known how much of
this resistance is related to MBLs in this area, we aimed to
investigate the rate of MBLs positivity in Gram negative isolates
resistant to carbapenems, ceftazidime or both.
Materials and methods: During the period from May 2004 to
July 2005, a total of 92 isolates found to be resistant to
carbapenems, ceftazdime or both were included in the study.
To determine the MBL activity, double-disk synergy test using a
ceftazidime disk and 2-mercaptopropionic acid (2MPA) disk
and IMP-EDTA disk diffusion method were used.
Results: Out of 92 isolates, 34 (36.9%) were carbapenem
resistant, 81 (88.0%) were ceftazidime resistant and 21 (22.8%)
were resistant to both antibiotics. The rate of MBL positivity
was 11 in 26 (42.3%) P. aeruginosa, 2 in 46 (4.3%) K. pneumonia,
7 in 8 (87.5%)S. maltophilia, 3 in 5 (60.0%) A. baumanii. None of
the K. oxytoca was MBL positive. Eight of 24 MBL-positive
isolates were resistant to one of the study drugs (3 to
ceftazidime and 5 to carbapenems) and remaining 16 isolates
were resistant to both antibiotics. This means that the rate of
the MBL causing resistance to both carbapenem and ceftaz-
idime is 66.6% in MBL positive isolates and 17.4% (16/92) in
carbapenem and/or ceftazidime resistant Gram negative
bacilli.
Conclusions: The present study has shown that MBLs are
among the most important reasons for the antimicrobial resist-
ance to carbapenems and ceftazidime in Gram negative bacilli in
our region and most of them cause resistance to both carbap-
enems and ceftazidime. Since these enzymes are transferable,
infection control and antibiotic control measures are important
to prevent the spread of MBLs.
P937
Real-time PCR detection of free circular
intermediates of gene cassettes inserted in
resistance integrons
S. Pollini, E. Del Tordello, M.R. Oggioni, G.M. Rossolini (Siena,
IT)
Objectives: Integrons provide a major contribution to the
spread of antimicrobial resistance, by promoting the dissemin-
ation and expression of functional genetic units, the gene
cassettes, in bacterial genomes. The aim of this study was to
set up a real-time PCR assay to investigate the mobilisation of
resistance determinants carried by gene cassettes via circular
intermediates.
Methods: Real-time PCR experiments were performed on DNA
samples obtained from a Pseudomonas aeruginosa clinical isolate
harbouring a chromosomal resistance integron (RI) that carries
clinically-relevant resistance gene cassettes (blaVIM-1, aacA4,
aphA15) and from laboratory strains of P. aeruginosa and
Escherichia coli carrying the same RI on a non-conjugative
plasmid. Circular intermediates of gene cassettes were detected
by real-time PCR using primers designed in divergent orienta-
tion on the resistance genes. An E. coli strain carrying the RI and
over-expressing the intI1 integrase gene, known to enhance the
frequency of cassettes excision and representing a widely used
model, was used as control.
Results: Real-time PCR protocols were established to detect and
quantitate circular intermediates of blaVIM-1, aacA4 and
aphA15 gene cassettes. The size and nucleotide sequence of
the obtained amplicons were consistent with the expected
excision product. Contribution of duplicated gene cassettes in
the detection of circular intermediates was also investigated.
Notable diversity of generation of circular intermediates of the
various gene cassettes was observed, depending on the nature of
the cassette and its position inside the cassette array, and on the
bacterial host.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Conclusions: A real-time PCR assay was set up to detect and
quantitate circular intermediates of RI gene cassettes, that could
be useful to investigate the mobilization rate of resistance
determinants in clinical isolates and to compare their relative
rates, under different growth conditions and in different
bacterial hosts.
P938
ISAba1 transposition induced by ciproﬂoxacin
produces hyperexpression of the AmpC
cephalosporinase of Acinetobacter baumannii
M. Ruiz, S. Martı´, F. Ferna´ndez Cuenca, A´. Pascual, J. Vila
(Barcelona, Seville, ES)
Objective: The purpose of this study was to analyse the
prevalence of ISAba1 (IS) in 76 epidemiologically-unrelated A.
baumannii clinical isolates and to investigate the induction of
ISAba1 transposition by ciproﬂoxacin (CI).
Materials and Methods: 221 A. baumannii strains were isolated
from 28 different hospitals in Spain in a multicentre study. MICs
of ceftazidime (TZ) and CI were determined by a microdilution
system and the E-test. Genotyping was performed using PFGE
and REP-PCR. The ampC gene, the IS element and the location
of IS upstream from the ampC gene were detected by PCR. Two
strains were chosen to analyse the induction of IS transposition
by CI since both were susceptible to CI (MIC of 0.5 lg/ml) and
TZ (MIC of 4 lg/ml), had the IS element located outside the
promoter region of the ampC gene. These strains were also
incubated overnight with LB broth containing 0.25 lg/ml with
and without CI. The next day they were spread onto Mueller-
Hinton plates containing 32 lg/ml of TZ. Analysis of the mRNA
of these strains was performed by RT-PCR.
Results: In 74 (97.3%) out of the 76 strains analysed, the ampC
gene was detected and 51 (69%) strains were positive for the IS
element. Among the A. baumannii strains containing the IS
element in 40 (78.4%) this element was located in the promoter
of the ampC gene. All strains with the IS element located in the
promoter region of the ampC gene were resistant to TZ, whereas
only 27.3% of the A. baumannii strains without it were resistant
to this antibiotic. All the strains carrying this construct were
resistant to CI. The average ratio of IS transposition induced by
CI was ~2.5 · 10)4.
Conclusion: Quinolones can induce the transposition of the IS
element to the promoter region of the ampC gene generating
overexpression of ampC and transforming the susceptible strain
into one that is resistant to TZ.
P939
Prevalence of class 1 integrons and MIC values in
indigenous and pathogenic E. coli strains in
different age groups
K. Truusalu, E. Sepp, J. Shchepetova, K. Loivuke, P. Naaber,
K. Stroo, K. Sepp, M. Mikelsaar (Tartu, EE)
E. coli belongs to indigenous intestinal microﬂora yet causing
several intestinal and extraintestinal infections. The antibacterial
treatment can facilitate the transmission of resistance gene
cassettes, e.g. integrons between indigenous and infectious
strains. However, there are few data on the prevalence of
Class I integron and antibiotic resistance pattern of E. coli from
different origin.
Objective: We aimed to compare the occurrence of Int1 gene
and its associations with MIC values in indigenous, uropatho-
genic and sepsis-causing strains of E. coli in children and in
adults.
Methods: A total of 30 indigenous E. coli strains were isolated
from stool of 10 antibiotic naı¨ve children (age <1 year, born in
1998) and another 30 strains from stool of 9 people aged
>65 years. The pathogenic E. coli strains were recovered from
urine (n = 32) of 13 children (aged 2 mo–8 years, born in 1997–
98) with recurrent urinary tract infection and from blood of 27
septic patients (age 45–84 years). The MIC values to ampicillin,
cefuroxime, cefotaxime, meropenem, gentamicin, ciproﬂoxacin
and sulfamethoxazole were measured by E-test. Microbial DNA
was extracted using QIAamp DNA Mini Kit. Int1 was detected
by PCR with primers IntI-F and IntI-R.
Results: The prevalence of IntI gene in indigenous and patho-
genic E. coli strains was 28% and 29%, respectively. The
prevalence of the gene was higher in children than in adults
(28 vs 6; p < 0.001) but it did not depend on the origin of the
strain nor on the underlying illness or previous antibacterial
treatment. The presence of IntI gene was positively correlated
with MIC values to ampicillin (r = 0.246; p = 0.009), cefuroxime
(r = 0.29; p = 0.002), cefotaxime (r = 0.206; p = 0.03), sulfa-
methoxazole (r = 0.280; p = 0.003) and negatively to gentamicin
(r = -0.323; p < 0.001).
Conclusions: The presence of IntI gene in E. coli is associated
with higher MIC values to beta-lactam antibiotics and sulfa-
methoxazole but not to gentamicin. The prevalence of IntI gene
does not depend on the origin of the strain (indigenous or
pathogenic) but is associated with the age: the presence of IntI
genes in E. coli was higher in children.
P940
New integron-independent trimethoprim
resistance gene dfr24, detected in urinary isolate
of Escherichia coli
M. Grape, L. Sundstro¨m, G. Kronvall (Stockholm, Uppsala, SE)
Objectives: In a material of 69 trimethoprim resistant Gram-
negative urinary isolates, as many as 11 resulted negative with
PCR for all known classes of integrons and four of the ﬁve
known dfr-genes not carried by integrons. The mechanisms for
trimethoprim resistance in these 11 isolates are the subject for
further investigations. Here we report the ﬁnding of a previ-
ously unknown trimethoprim resistance gene in one of the 11
selected isolates.
Methods: A shotgun cloning approach has been used to
identify DNA fragments containing the trimethoprim resistance
mechanism. The entire DNA from the isolate was digested with
four restriction endonucleases separately and randomly ligated
into pUC18 vectors. The ligation reactions were transformed
into TOP10 E. coli recipient cells without any further puriﬁca-
tion. The transformed E. coli were grown on antibiotic plates
containing trimethoprim and ampicillin to select for vectors
with inserted fragments containing the desired resistance
mechanism. The fragments were subjected to sequence analysis
from primers directed to the ﬂanking regions of the polylinker in
the vector.
Results: So far, one isolate not yet characterized with respect to
molecular cause of trimethoprim resistance was showed to carry
a previously unknown dfr-gene. This gene, which has been
named dfr24, is in contrast to most known dfr-genes not carried
as a gene cassette in an integron. The gene product, the
dihydrofolate reductase DHFR24, is only 38% identical to
DHFR8 and 32% identical to DHFR9 which are also encoded
by genes not inserted as gene cassettes in integrons. The protein
seems however somewhat more related to housekeeping
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dihydrofolate reductase genes of various organisms. The
sequence of the new dfr24 gene has been published at EMBL
with accession number AJ972619.
Conclusions: The total number of trimethoprim resistance dfr-
genes is probably far from known yet. Of the 25 dfr-genes
known at present, 12 were published the last 5 years and the
majority of them were identiﬁed in sequence analysis of
integrons. The new gene detected in this study, dfr24, is only
distantly related to integron-borne dfr-gene cassettes, and with
this approach of shotgun cloning probably more integron-
independent dfr-genes can be identiﬁed. Furthermore, the sub-
selection of integron-negative trimethoprim-resistant isolates
this new gene origins from has a potential for more such
discoveries.
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